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1.3: Summary 
 
 The atypical Ser/Thr kinase target of rapamycin (TOR) is a central 
controller of cell growth and proliferation. TOR forms two distinct multiprotein 
complexes, TORC1 and TORC2, which are structurally and functionally 
conserved from yeast to humans. Four major inputs control mammalian TOR 
(mTOR): growth factors, such as insulin; cellular energy levels, such as the 
AMP:ATP ratio; stress, such as hypoxia; and nutrients, such as amino acids. 
mTOR controls cell growth by the positive and negative regulation of several 
anabolic and catabolic processes, respectively, that collectively regulate cell 
size and proliferation. These cellular processes include autophagy, 
cytoskeleton rearrangement, glycolysis, lipogenesis, nutrient transport, 
ribosome biogenesis, and translation. Dysregulation of the mTOR signaling 
network has been associated with aging, and a multitude of diseases 
including cancer, cardiovascular disease, diabetes, inflammation, immune 
dysfunctions, and neurodegeneration. However, relatively few direct 
substrates of either one of the two mTOR complexes, mTORC1 and 
mTORC2, are known.  
 To determine downstream effectors of mammalian TOR (mTOR), we 
applied a functional, quantitative phosphoproteomics workflow to identify 
novel mTORC1 or mTORC2 regulated phosphorylations. Raptor and Rictor 
are essential components of mTORC1 and mTORC2, respectively. To 
distinguish phosphorylations regulated by mTORC1 or mTORC2, we 
specifically deleted Raptor or Rictor using an inducible gene knockout system 
in mouse embryonic fiberblasts (MEFs). We detected 4584 phosphorylation 
sites on 1398 proteins, and identified 335 novel mTOR effectors. Many of the 
novel effectors are implicated in cancer and metabolic diseases, but have no 
known links to mTOR. To distinguish direct mTOR substrates from indirect 
effectors, we combined peptide array in vitro kinase assays with 
phosphorylation motif analysis. This revealed that mTORC1 phosphorylates 
CAD in vivo and in vitro. CAD (carbamoyl-phosphate synthetase 2, 
aspartate transcarbamylase, and dihydroorotase) is the initial and rate 
limiting enzyme in de novo pyrimidine synthesis. The macrolide rapamycin, 
which forms a complex with FKBP12, binds and acutely inhibits mTORC1 but 
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not mTORC2. Rapamycin treatment inhibited growth factor stimulated CAD 
phosphorylation and oligomerization, decreased de novo pyrimidine 
synthesis, and delayed progression of S-phase where CAD activity is 
essential. Thus mTORC1 phosphorylates CAD and thereby stimulates de 
novo pyrimidine synthesis to promote cell proliferation. 
 Separately, we characterize the autophosphorylation of mTOR 
on Ser2481. Insulin stimulates the phosphorylation of mTOR at Ser2481 
specifically in mTORC2. Knockout of Rictor, but not Raptor, abolished mTOR 
autophosphorylation at Ser2481. Prolonged treatment with rapamycin, which 
indirectly inhibits mTORC2 complex formation, inhibited Ser2481 
phosphorylation. Surprisingly, mTORC2 autophosphorylation at Ser2481 
temporally occurs after the insulin-induced phosphorylation of Akt/PKB and 
the SGK1 substrate NDGR1. Mutation of Ser2481 to aspartic acid rendered 
mTOR unable to phosphorylate Akt/PKB in vitro. However the function of 
mTOR-Ser2481 phosphorylation in vivo remains elusive, as mutation of 
mTOR-Ser2481 did not alter Akt/PKB phosphorylation in vivo.  
 In summary, mTORC1 and mTORC2 regulate the phosphorylation of a 
functionally diverse set of substrates to control several anabolic and catabolic 
processes that determine cell size and proliferation. As a central controller of 
cell growth and proliferation, mTOR plays a key role in regulating 
development, whereas dysregulation of mTOR signaling has been linked to 
aging and diseases such as cancer and metabolic disorders. 
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1.4: Abbreviations 
  
4E-BP1: eukaryotic translation initiation factor 4E binding protein 1 
AGC:   cAMP-dependent protein kinase [PKA]/protein kinase G  
  [PKG]/protein kinase C [PKC] 
Akt/PKB: rac protein kinase alpha/ protein kinase B 
CAD:   carbamoyl-phosphate synthetase 2, aspartate  
  transcarbamylase, and dihydroorotase 
DEPTOR:  DEP-domain-containing mTOR-interacting protein 
DNA-PK: DNA-dependent protein kinase  
IMAC:  immobilized metal affinity chromatography 
LC-MS/MS:  liquid chromatography coupled to mass spectrometry 
mLST8: mammalian lethal with SEC13 protein 8 
MS:   mass spectrometry 
mTOR:  mammalian [or mechanistic] target of rapamycin 
mTORC1:  mTOR complex 1 
mTORC2:  mTOR complex 2 
NDGR1: N-myc downstream regulated 
PI3K:   phosphoinositide 3-kinase 
PIKK:   phosphatidylinositol 3-kinase-related kinases 
PRAS40:  proline-rich Akt/protein kinase B [PKB] substrate 40 kDa 
PRR5: proline-rich protein 5 [also called Protor] 
PKC:  protein kinase C 
Raptor: regulatory associated protein of mTOR complex 1 
Rictor:  rapamycin insensitive companion of mTOR 
S6K:  ribosomal protein S6 kinase 
SGK:  serum/glucocorticoid regulated kinase 1 
SILAC: stable isotope labeling with amino acids in cell culture 
Sin1:  SAPK [stress-activated protein kinase]-interacting protein 1 
SREBP-1: sterol regulatory element binding protein-1 
TSC:  tuberous sclerosis complex 
ULK1:  unc-51-like kinase 1 
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2.0: Introduction 
 
To appropriately control cell growth and proliferation, cells respond to a 
variety of environmental cues to regulate the synthesis of essential building 
blocks such as proteins, lipids, sugars, nucleotides and other metabolites. The 
mammalian target of rapamycin (mTOR) is an atypical Ser/Thr kinase 
structurally and functionally conserved from yeast to human that positively 
regulates cell growth, proliferation, and survival, while inhibition of mTOR 
signaling extends lifespan (reviewed in (Laplante and Sabatini, 2009b; 
Wullschleger et al., 2006)). mTOR forms two multiprotein complexes, mTOR 
complex 1 (mTORC1) and mTOR complex 2 (mTORC2).  
 Nutrients and growth factors activate mTORC1, whereas low cellular 
energy levels or hypoxic stress inhibit mTORC1. Upon activation, mTORC1 
positively regulates protein translation, ribosome biogenesis, lipogenesis, and 
inhibits autophagy. mTORC2 is activated by growth factors via PI3K 
(phosphoinositide 3-kinase) dependent ribosome association (Zinzalla et al., 
2011). Upon activation, mTORC2 regulates the phosphorylation of several 
AGC kinases including Akt/PKB, SGK, and canonical PKCs to control cell 
survival and cytoskeleton rearrangement (reviewed in (Jacinto and Lorberg, 
2008)). Thus mTORC1 and mTORC2 link external growth signals to the 
internal growth capacity of the cell.  
 As central controllers of cell growth and proliferation, the mTORC1 and 
mTORC2 signaling networks are key regulatory nodes whose functions 
regulate development and aging, while dysregulation of mTOR signaling has 
been linked to cancer and metabolic disorders (reviewed in (Zoncu et al., 
2010)). mTORC1 and mTORC2 signal via distinct substrates to collectively 
control spatial and temporal cell growth, which ultimately determines cell size 
and regulates proliferation (reviewed in (Robitaille and Hall, 2008; Yang and 
Guan, 2007)). However, relatively few direct substrates of either one of the 
two mTOR complexes are known.  
 
Regulation and function of mTOR phosphorylation 
 mTOR is the founding member of the phosphatidylinositol 3-kinase-
related kinases (PIKK) family (Manning et al., 2002), which includes Ataxia 
telangiectasia mutated (ATM); ATM and Rad3 related (ATR); DNA-dependent 
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protein kinase (DNA-PK); suppressor with morphological effect on genitalia 1 
(SMG1); and transformation/transcription domain-associated protein 
(TRRAP). Despite the homology to lipid kinases, mTOR has not been 
demonstrated to have lipid kinase activity, and the significance of mTOR 
homology to lipid kinases remains unknown. 
 mTOR has a predicted molecular weight of 280 kDa, and an apparent 
molecular weight of 220 kDa. The amino (N) terminus of mTOR contains 20 
tandem HEAT (Huntingtin, Elongation factor 3, PR65/A subunit of protein 
phosphatase 2A, TOR) repeats (Diagram 1). This region is followed by a FAT 
(FRAP (FKBP12-rapamycin-associated protein)/TOR, ATM, TRRAP) domain, 
an FK506-binding protein 12 (FKBP12)-rapamycin binding (FRB) domain, the 
kinase domain, and a carboxy (C)-terminal FATC domain. The HEAT repeats 
mediate protein-protein interactions (Perry and Kleckner, 2003), while the FAT 
and FATC domains that flank the catalytic site modulate mTOR activity via an 
unknown mechanism. The FAT and FATC domains are found as a pair in all 
PIKK family members.  
The c-terminal region of mTOR situated between the catalytic domain 
and the FATC contains a repressor domain (RD) (Scott et al., 1998; Sekulic et 
al., 2000). Addition of an antibody (mTAB1) that recognizes the repressor 
domain (Brunn et al., 1997), or partial deletion of the repressor domain (amino 
acids 2430-2450) increases mTOR in vitro kinase activity (Edinger and 
Thompson, 2004). mTOR is phosphorylated at three sites within the repressor 
domain: Thr2446, Ser2448, and Ser2481. AMPK phosphorylates Thr-2446 
(Cheng et al., 2004) whereas S6K phosphorylates Ser2448 (Chiang and 
Abraham, 2005; Holz and Blenis, 2005) and mTOR autophosphorylates 
Ser2481 (Peterson et al., 2000). However, mutation of Thr2446 or Ser2448 
has no effect on mTOR kinase activity (Cheng et al., 2004; Chiang and 
Abraham, 2005; Holz and Blenis, 2005). Thus an unidentified residue within 
the repressor domain may play an important regulatory role. 
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Diagram 1: mTOR. A schematic of mTOR domain organization and 
phosphorylation sites are shown. Repressor domain (RD). Images were 
generated with Prosite’s MyDomains Image Creator.  
 
 
mTORC1 and mTORC2 are distinct complexes 
 mTOR forms two distinct multiprotein complexes, mTORC1 and 
mTORC2, which are structurally and functionally conserved from yeast to 
human (Diagram 2). 
mTORC1 is composed of mTOR, Raptor, and mLST8 (also called 
GβL). Whole-body knockout of mTOR is embryonic lethal in mice. 
Homozygous mTOR-/- mice die at embryonic (E) day E5.5 to E6 (Gangloff et 
al., 2004; Murakami et al., 2004). Similar to mTOR, Raptor-/- mice die at day 
E5.5 to E6.5, suggesting that both mTORC1 components are required for 
progressing past the same stage of embryonic development (Guertin et al., 
2006). Additionally, mTORC1 associates with PRAS40 and DEPTOR, 
proteins that negatively regulate mTORC1 activity (Peterson et al., 2009; 
Thedieck et al., 2007; Vander Haar et al., 2007; Wang et al., 2007).  
mTORC2 is composed of mTOR, Rictor, Sin1, mLST8, and 
PRR5/PRR5L (also called Protor 1/Protor 2) (reviewed in (Cybulski and Hall, 
2009)). PRR5 is not required for the interaction between mTOR, Rictor, Sin1, 
and mLST8. Deletion of Rictor or Sin1 is embryonic lethal, as mice die after 
day E10-E10.5 (Guertin et al., 2006; Jacinto et al., 2006). Additionally, loss of 
Sin1 disrupts Rictor association with mTORC2. Surprisingly, although mLST8 
is a component of both mTORC1 and mTORC2, mLST8 knockout mice die at 
day E10.5, phenotypically resembling Rictor-/- mice (Guertin et al., 2006). 
Furthermore, mLST8 is required for Akt/PKB hydrophobic motif (HM) 
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phosphorylation, but not S6K signaling. These data suggest that mLST8 has 
an essential role only in mTORC2.  
 Studies in yeast, flies and mammalian cells have shown that mTOR is 
found in oligomeric supercomplexes, that are likely to be mTORC1-mTORC1 
and mTORC2-mTORC2 homodimers (Wang et al., 2006; Wullschleger et al., 
2005; Zhang et al., 2006). Multimeric mTOR may have higher kinase activity 
than monomeric mTOR. It remains to be determined how oligomerization is 
regulated and how it may lead to increased kinase activity. 
 
Diagram 2: mTORC1 and mTORC2 are conserved regulators of cell 
growth and proliferation. mTOR forms two distinct, multiprotein complexes, 
mTORC1 and mTORC2, which are structurally and functionally conserved 
from yeast to human. 
 
 
Pharmacological inhibition of mTORC1 and mTORC2  
The macrolide rapamycin, which forms a complex with FKBP12, binds 
and allosterically inhibits mTORC1 but not mTORC2. In some cells, prolonged 
treatment with rapamycin (>24 hours) can inhibit mTORC2 complex assembly 
(Sarbassov et al., 2006). Recently, several groups have independently 
developed ATP-competitive inhibitors of mTOR, which include PP242, Torin1, 
and Ku-0063794 (reviewed in (Sparks and Guertin, 2010)). Pharmacological 
inhibition of mTOR signaling with ATP-competitive inhibitors lead to the 
discovery that mTORC1 has rapamycin-resistant functions. In mammals, 
rapamycin treatment incompletely mimics Raptor deletion (Feldman et al., 
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2009; Thoreen et al., 2009). mTOR ATP-competitive inhibitors target both 
mTORC1 and mTORC2, thus limiting the usefulness of these compounds as 
research tools. However, ATP-competitive inhibitors of mTOR may prove 
useful as future cancer therapeutics. PP242 was shown to inhibit the 
proliferation of cancer cells to a greater extent than rapamycin (Janes et al., 
2010). 
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2.1: Upstream regulation of mTORC1  
 Four major inputs control mTORC1: growth factors, such as insulin; 
cellular energy levels, such as the AMP:ATP ratio; stress, such as hypoxia; 
and nutrients, such as amino acids (Diagram 3) (reviewed in (Robitaille and 
Hall, 2008)). mTORC1 integrates signaling from growth factors, cellular 
energy levels, and hypoxia through an upstream negative regulator called the 
tuberous sclerosis complex (TSC1-TSC2), a heterodimeric GTPase-activating 
protein (reviewed in (Huang and Manning, 2008)). 
  
Growth factors activate mTORC1 by inhibiting TSC1-TSC2  
 Growth factors, such as insulin, inhibit TSC1-TSC2 through receptor 
tyrosine kinase (RTK) mediated activation of the phosphoinositide 3-kinase 
(PI3K) pathway. Insulin binds and activates the insulin receptor (IR), a 
receptor tyrosine kinase (RTK). The insulin receptor substrate (IRS), and 
subsequently active PI3K, are then recruited to the insulin receptor (reviewed 
in (Taniguchi et al., 2006)). The cellular level of phosphatidylinositol-3,4,5-
trisphosphate (PI(3,4,5)P3) are maintained by the antagonistic actions of the 
lipid kinase PI3K and the lipid phosphatase PTEN. Activation of PI3K 
promotes Akt/PKB and PDK1 recruited to the plasma membrane (reviewed in 
(Fayard et al., 2010)). At the plasma membrane, Akt/PKB and PDK1 bind 
directly to PI(3,4,5)P3, where PDK1 phosphorylates and activates Akt/PKB 
(Alessi et al., 1997). Activated Akt/PKB then phosphorylates and functionally 
inactivates TSC2 (Gao et al., 2002; Inoki et al., 2002; Tee et al., 2003). The 
TSC1-TSC2 complex can also be inhibited by canonical MAPK signaling. 
Similar to Akt/PKB, active ERK or RSK can phosphorylate and inhibit TSC2 
GAP activity (Ma et al., 2005). Inactivation of TSC1-TSC2 allows GTP-bound 
Rheb to activate mTORC1 (Garami et al., 2003; Inoki et al., 2003). In addition 
to inhibiting TSC1-TSC2, Akt/PKB phosphorylates PRAS40 at Ser247 and 
inactivates it, which leads to mTORC1 activation (Sancak et al., 2007; Vander 
Haar et al., 2007). mTORC1 can further phosphorylate PRAS40 at Ser183 
and Ser221 (Fonseca et al., 2007; Oshiro et al., 2007). Growth factor 
activation of mTORC1 leads to the phosphorylation and subsequent 
degradation of DEPTOR, a negative regulate of mTORC1 activity (Peterson et 
al., 2009). 
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Low cellular energy and hypoxic stress inhibit mTORC1 via TSC1-TSC2 
 In contrast to growth factors that inhibit TSC1-TSC2, low cellular 
energy and stress activate TSC2 GAP activity. Low energy (high AMP:ATP 
ratio) activates AMP-activated protein kinase (AMPK) to phosphorylate TSC2 
(Inoki et al., 2003). AMPK phosphorylation of TSC2 inhibits mTORC1 by 
increasing TSC2 GAP activity toward Rheb, a Ras-like GTPase. In addition to 
phosphorylating TSC2, AMPK also inhibits mTORC1 by directly 
phosphorylating Raptor (Gwinn et al., 2008). Mutations of the AMPK upstream 
activating kinase, LKB1, results in hyperactive mTORC1 signaling, thereby 
linking LKB1 to the TSC1-TSC2 mTORC1 pathway (Corradetti et al., 2004). 
Hypoxia inhibits mTORC1 signaling through the HIF1-mediated up regulation 
of two homologous proteins REDD1 and REDD2 (Regulated in Development 
and DNA damage response genes 1 and 2 ). REDD acts to activate TSC1-
TSC2, independently of LKB1-AMPK, in order to inhibit mTORC1 (Brugarolas 
et al., 2004; Sofer et al., 2005). The stress and energy signaling pathways are 
likely to be further associated, as prolonged hypoxia leads to ATP depletion 
and activation of AMPK.  
 
Amino acids activate mTORC1 downstream of TSC1-TSC2 
In contrast to growth factor stimulation, amino acid activation of 
mTORC1 occurs independently of TSC1-TSC2 (Smith et al., 2005). Activation 
of mTORC1 by amino acids requires the Ras-like GTPases Rheb and Rag, 
both of which bind directly to mTORC1 (reviewed in (Duran and Hall, 2012)). 
Amino acids stimulate mTORC1 localization to a late endosomal/lysosomal 
compartment containing active Rheb. mTORC1 is recruited to the lysosomal 
compartment by the actions of lysosome associated protein complexes 
including Rag heterodimers, Ragulator, and vacuolar-ATPase (v-ATPase). 
Rag heterodimers (RagA or RagB binding to RagC or RagD) promote the 
translocation of mTORC1 to the lysosomal compartment (Sancak et al., 
2008). Furthermore, Rag heterodimers are recruited to the lysosomal 
compartment via Ragulator, a scaffolding protein complex that is composed of 
MP1, p14, and p18 (Sancak et al., 2010). Additionally, v-ATPase, which 
interacts with Ragulator, is required for amino acid activation of mTORC1 
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(Zoncu et al., 2011). Thus amino acid stimulated v-ATPase-to-Ragulator-to-
Rag-to-mTORC1 binding facilitates the activation of mTORC1 by lysosome 
associated, active Rheb. hVps34 has also been implicated in the amino acid 
activation of mTORC1 (Gulati et al., 2008; Nobukuni et al., 2005). However, in 
flies Vps34 functions downstream of TOR (Juhasz et al., 2008). How amino 
acids GTP-load, and thereby activate, the Rag GTPases to ultimately activate 
mTORC1 remains to be determined. Intriguingly, MAP4K3 acts upstream of 
Rag-mediated mTORC1 activation (Yan et al., 2010). Amino acids stimulate 
MAP4K3 activity to phosphorylate an unknown substrate upstream of the 
Rag/Ragulator complex. Where as under amino acid starved conditions, 
PP2A T61 epsilon inhibits MAP4K3 and thus subsequent mTORC1 activation. 
Upon activation, mTORC1 promotes protein translation, ribosome biogenesis, 
lipogenesis, and inhibits autophagy.  
 
Diagram 3: mTORC1 signaling network. Amino acid and growth factor 
activation of mTORC1 promotes cell growth and proliferation. 
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2.2: Upstream regulation of mTORC2 
 In contrast to the detailed understanding of mTORC1 activation, the 
upstream regulators of mTORC2 have only recently been described (Diagram 
4). Further work is necessary to refine how growth factor signaling activates 
mTORC2. 
 
Growth factors activate mTORC2 via PI3K signaling 
 Growth factors signal to mTORC2 via receptor tyrosine kinase (RTK) 
activation of PI3K. Similar to the activation of mTORC1, upon insulin stimuli, 
the insulin receptor substrate (IRS) and subsequently active PI3K are 
recruited to the insulin receptor. The cellular level of phosphatidylinositol-
3,4,5-trisphosphate (PI(3,4,5)P3) are maintained by the antagonistic actions 
of the lipid kinase PI3K and the lipid phosphatase PTEN. Activation of PI3K 
promotes the association of mTORC2 with intact 80S ribosomes. The 
interaction between mTORC2 and the ribosome is required for mTORC2 
activation, independent of protein translation (Zinzalla et al., 2011) . How 
(PI(3,4,5)P3) promotes mTORC2 association with the ribosome and 
subsequent activation remains a mystery, but PI(3,4,5)P3-containing 
liposomes do not stimulate mTORC2 in vitro kinase activity (Frias et al., 
2006). Growth factor activation of mTORC2 leads to the phosphorylation and 
subsequent degradation of DEPTOR, a negative regulate of mTORC2 activity 
(Peterson et al., 2009).  
 
A mTORC1 mediated negative feedback loop inhibits mTORC2 
 The TSC1-TSC2 complex may function upstream of mTORC2, but this 
activity is independent of TSC2 GAP activity (Huang et al., 2008). Loss of 
TSC1-TSC2 inhibits the phosphorylation of mTORC2 substrates, while 
simultaneously hyper-activating mTORC1. Hyper-active mTORC1 inhibits 
mTORC2 signaling through multiple mechanisms involving S6K and Grb10. 
Active S6K directly phosphorylates Rictor and IRS, which is part of a negative 
feedback loop that attenuates insulin signaling (Dibble et al., 2009; Harrington 
et al., 2004; Shah et al., 2004; Treins et al., 2009). mTORC1 phosphorylates 
and stabilizes Grb10, which also attenuates PI3K signaling to mTORC2 (Hsu 
et al., 2011; Yu et al., 2011). Additionally, loss of TSC1-TSC2 increases ER 
  17 
stress, which then inhibits mTORC2 via GSK3β mediated phosphorylation of 
Rictor (Chen et al., 2011). It is unclear to what degree S6K-mediated Rictor 
phosphorylation, IRS inhibition, and increased ER stress individually 
contribute to mTORC2 inactivation. 
 
Alternative mechanisms of mTORC2 activation 
 In dictyostelium, RasC is an upstream regulator of TORC2, 
independent of PI3K and canonical MAPK signaling. RasC physically binds to 
TORC2 and activates it through an unknown mechanism (Cai et al., 2010; 
Charest et al., 2010). Mammalian Ras can also bind to Sin1 in vitro, but the 
physiological significance of this interaction has not been demonstrated 
(Schroder et al., 2007). Additionally, mTORC2 and mTORC1 bind to 
phosphatidic acid (PA), suggesting that PA could facilitate membrane 
localization of mTOR (Fang et al., 2001). Taken together, this data suggests 
that growth factors activate mTORC2 though multiple mechanisms. 
Alternatively, mTORC2 may form distinct sub-complexes that differentially 
respond to upstream signaling from RTK or G-protein coupled receptor 
(GPCR) inputs. In support of the second hypothesis, mTOR and Rictor 
associate with different Sin1 isoforms (Sin1.1, Sin1.2, or Sin1.5) to form three 
distinct mTORC2 complexes. Interestingly, the in vitro kinase activity of 
mTORC2 containing the Sin1.5 isoform is insensitive to insulin stimulation 
(Frias et al., 2006). Upon growth factor activation, mTORC2 promotes cell 
survival and cytoskeleton rearrangement.




Diagram 4: mTORC2 signaling network. Growth factor activation of 
mTORC2 promotes cell survival and cytoskeleton rearrangement.
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2.3: Downstream effectors of mTORC1 
 
mTORC1 positively regulates protein translation 
 mTORC1 activates cap-dependent translation initiation and elongation 
by phosphorylating the eukaryotic initiation factor 4E (eIF4E)-binding protein 1 
(4E-BP1) and the p70 ribosomal S6 kinase (S6K) (Beretta et al., 1996; 
Gingras et al., 2001; Hara et al., 1997; Pearson et al., 1995). The 
phosphorylation of 4E-BP1 prevents its binding to eIF4E, enabling eIF4E to 
then associate with eIF4G to stimulate translation initiation (Holz and Blenis, 
2005). mTORC1 and phosphoinositide-dependent kinase 1 (PDK1) 
phosphorylate and activate S6K. Activated S6K then promotes translation 
initiation by phosphorylating eIF4B, programmed cell death protein 4 (PDCD4) 
and eEF2 kinase (eEF2K) (Dorrello et al., 2006; Wang et al., 2001). 
Phosphorylation of eIF4B and PDCD4 activates translation initiation, whereas 
phosphorylation of eEF2K up regulates translation elongation. S6K also 
promotes the translation efficiency of spliced mRNAs via S6K-Aly/REF-like 
substrate (SKAR) (Ma et al., 2008). SKAR associates with mRNAs in a 
splicing-dependent manner, where it then recruits activated S6K and thereby 
preferentially enhances translation of spliced mRNAs. Additionally, S6K 
phosphorylates 40S ribosomal protein S6, but the significance of this 
phosphorylation is unknown. mTORC1 associates with its substrates 4E-BP1 
and S6K through Raptor and a TOR signaling (TOS) motif in 4E-BP1 and S6K 
(Nojima et al., 2003; Schalm and Blenis, 2002). The TOS motif is a conserved 
five-amino-acid sequence that is necessary for the in vivo phosphorylation of 
these proteins by mTORC1. A similar substrate recognition motif has not been 
identified for mTORC2.  
 
mTORC1 promotes ribosome biogenesis 
 mTORC1 promotes the synthesis of ribosomes and transfer RNAs 
(tRNAs). Rapamycin blocks the biosynthesis of ribosomes by inhibiting 
transcription of RNA polymerase I (Pol I)-dependent rRNA genes, Pol II-
dependent ribosomal protein genes (RP genes), and Pol III-dependent tRNA 
genes (reviewed in (Martin and Hall, 2005)). mTOR controls Pol I via the 
essential transcription initiation factor TIF-1A (Transcriptional Intermediary 
Factor 1A). Rapamycin treatment leads to TIF-1A inactivation, and thus 
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impairs formation of the transcription initiation complex. Furthermore, TIF1A 
translocates from the nucleus to the cytoplasm upon rapamycin-mediated 
mTORC1 inactivation (Mayer et al., 2004). In yeast, the forkhead-like 
transcription factor FHL1 functions as a TOR-dependent regulator of Pol II-
dependent RP gene expression (Martin et al., 2004). mTORC1 regulates of 
Pol III-mediated gene expression by directly phosphorylated and inhibiting 
MAF1, a Pol III transcriptional repressor (Michels et al., 2010). mTORC1 
associates with TFIIIC, is recruited to Pol III-transcribed genes, and relieves 
MAF1 mediated repression, thus allowing Pol III transcription to occur 
(Kantidakis et al., 2010). mTOR also controls ribosome biogenesis by 
promoting translation of 5' oligopyrimidine (TOP) mRNAs (Schwab et al., 
1999). 5' TOP mRNAs, defined by a 5' oligopyrimidine tract, encode 
components of the translation apparatus, including ribosomal proteins and 
elongation factors. 
 
mTORC1 positively regulates lipogenesis 
 mTORC1 positively regulates de novo lipogenesis by activating sterol 
regulatory element binding protein-1 (SREBP-1) (reviewed in (Laplante and 
Sabatini, 2009a)). SREBP-1 is an basic helix loop helix transcription factor 
that regulate lipogenesis by controlling the expression of genes required for 
cholesterol, fatty acid, and triglycerides synthesis. mTORC1 positively 
regulates the activity of SREBP-1 by phosphorylating and inhibiting Lipin1 
(Peterson et al., 2011). Lipin1 is phosphatidic acid phosphatase that 
negatively regulates SREBP-1 activity. Growth factor stimulated, mTORC1 
mediated phosphorylation of Lipin1 inhibits Lipin1 nuclear localization. Lipin1 
that has been phosphorylated by mTORC1 cannot enter the nucleus and 
inhibit the transcriptional activity of SREBP-1. It remains to be determined 
how the phosphatidic acid phosphatase activity of Lipin1 inhibits SREBP-1. 
 
mTORC1 inhibits autophagy 
mTORC1 negatively regulates macroautophagy, a starvation-induced 
catabolic process where bulk cytoplasm is enclosed in a double membrane 
structure and delivered to the vacuole for degradation. Rapamycin induces 
autophagy in yeast and human tissue culture, demonstrating the conserved 
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role of mTORC1 as an inhibitor of autophagy (Kamada et al., 2000; Paglin et 
al., 2005). mTORC1 directly inhibits autophagy by phosphorylating and 
repressing unc-51-like kinase 1 (ULK1), component of a conserved protein 
complex composed of ULK1, autophagy-related gene 13 (ATG13) and focal 
adhesion kinase family-interacting protein of 200 kDa (FIP200) (Ganley et al., 
2009; Hosokawa et al., 2009; Jung et al., 2009). mTORC1 also directly 
phosphorylates and represses DAP1 (Koren et al., 2010). Unlike the 
ULK1/ATG13/FIP200 complex, DAP1 is a negative regulator of autophagy.  
Thus via positive and negative regulation, mTORC1 activity tightly controls the 
absolute level of cellular autophagy. Additionally, dysregulation of mTORC1 
may contribute to cancer cell survival, as tumor cells may temporarily activate 
autophagy to overcome nutrient deprivation under poor growth conditions.  
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2.4: Downstream functions of mTORC2  
 Unlike mTORC1, which can be specifically inhibited by rapamycin, 
mTORC2 is insensitive to acute rapamycin treatment. Thus, many of the 
downstream effectors and physiological functions of mTORC2 remain 
unknown.  
 
mTORC2 controls AGC kinase activation and protein stability  
 mTORC1 and mTORC2 phosphorylate and thereby activate several 
members of the AGC kinase family (reviewed in (Jacinto and Lorberg, 2008)). 
The AGC kinase activated by mTORC1 includes S6K, while mTORC2 
regulates Akt/PKB, SGK, and PKCα (Chung et al., 1992; Facchinetti et al., 
2008; Garcia-Martinez and Alessi, 2008; Sarbassov et al., 2005). mTOR 
phosphorylates the hydrophobic motif (HM) in the AGC kinases to stimulate 
kinase activity. In S6K and SGK, phosphorylation of the HM creates a docking 
site for PDK1 and subsequent phosphorylation of the AGC kinase activation 
loop (reviewed in (Pearce et al., 2009)).  
 In response to growth factors, mTORC2 phosphorylates Akt/PKB at the 
hydrophobic motif (Akt/PKB-Ser473) (Sarbassov et al., 2005). Where as, in 
response to DNA damage, DNA-PK regulates Akt/PKB HM phosphorylation 
(Bozulic et al., 2008). PDK1 phosphorylates Akt/PKB at the activation loop 
(Akt/PKB-Thr308) (Alessi et al., 1997). Phosphorylation of both the activation 
loop and hydrophobic motif is required for the full activation of Akt/PKB. 
Ablation of Sin1 or Rictor results in loss of Akt/PKB HM phosphorylation, yet 
the phosphorylation of several Akt/PKB targets is unaffected (Guertin et al., 
2006; Jacinto et al., 2006). This suggests that either the phosphorylation of 
Akt/PKB-Ser473 alters substrate specificity, or that in the absence of active 
Akt/PKB, other AGC kinases such as SGK, S6K or RSK can phosphorylate a 
subset of Akt/PKB substrates. Notably, mTORC2 is required for Akt/PKB 
mediated phosphorylation of Foxo1/3a.  
 Additionally, mTORC2 regulates phosphorylation of the turn motif (TM) 
in Akt/PKB and canonical PKCs to promote AGC kinase protein stability 
(Facchinetti et al., 2008; Ikenoue et al., 2008). In yeast, TOR phosphorylates 
and activates the AGC kinases Gad8, Ypk2, and Sch9 (Kamada et al., 2005; 
Matsuo et al., 2003; Urban et al., 2007). Future studies may reveal additional 
AGC kinases that are regulated by mTOR. 
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mTORC2 promotes cell survival 
mTORC2 deficient cells are sensitive to stress induced apoptosis 
(Jacinto et al., 2006). mTORC2 promotes cell survival through the activation 
of Akt/PKB and serum and glucocorticoid-inducible kinase (SGK), two AGC 
kinases that have both distinct and overlapping substrates.  Akt/PKB 
negatively regulates the pro-apoptotic protein BAD, while SGK regulates the 
phosphorylation of NDRG1, and both kinases negatively regulate FOXO 
(Brunet et al., 1999; Datta et al., 1997; Murray et al., 2004). Interestingly, 
mTORC2 activity is required for prostrate tumorigenesis in PTEN null tumors, 
and not for normal prostate function (Guertin et al., 2009). This suggests that 
inhibiting mTORC2-mediated cell survival would be attractive cancer 
therapeutic target with few side affects to healthy tissue.  
 
mTORC2 regulates cytoskeleton remodeling  
 mTORC2 regulates actin cytoskeleton remodeling in yeast, and is 
important for chemotaxis and cell migration in dictyostelium and mammals 
respectively (Charest et al., 2010; Jacinto et al., 2004; Kamada et al., 2005). 
Furthermore, loss of mTORC2 perturbs cell morphology and inhibits dendritic 
tiling (Koike-Kumagai et al., 2009). mTORC2 dependent cytoskeleton 
remodeling is likely mediated by the mTORC2 effectors PKCα, Paxillin, and 
Rac1 (reviewed in (Cybulski and Hall, 2009)). The molecular mechanism by 
which mTORC2 regulates these effectors to control cytoskeleton remodeling 
has not been well characterized. 
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Identification of novel mTORC1 and mTORC2 substrates 
The mTORC1 and mTORC2 signaling networks have emerged as 
central controllers of cell growth that are important for development, aging, 
and diseases such as cancer and diabetes. In mice, tissue specific knockouts 
of mTOR or mTORC1/mTORC2 components have demonstrated that mTOR 
plays a key role in regulating muscle atrophy, glucose metabolism, and lipid 
metabolism (reviewed in (Polak and Hall, 2009)). To better understand how 
cell growth and proliferation is regulated, we sought to determine which novel 
substrates mTORC1 and mTORC2 phosphorylate. Relatively few direct 
substrates of either mTORC1 or mTORC2 are known. Identifying novel mTOR 
substrates may reveal new therapeutic options to target mTOR dysregulation 
in cancer and metabolic disorders. 
 Here we developed a functional proteomics workflow to quantitatively 
identify novel mTORC1 or mTORC2 regulated phosphorylations, and 
distinguish between direct mTOR substrates and indirect effectors. In total, we 
identified 335 novel mTORC1 or mTORC2 substrates or indirect effectors. We 
identified CAD as a potential mTORC1 substrate. CAD, (carbamoyl-
phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase), 
is the initial and rate limiting enzyme of the de novo pyrimidine synthesis 
pathway, a conserved and essential metabolic pathway important for cell 
growth and proliferation (Tatibana and Shigesada, 1972). CAD activity is 
essential in highly proliferating cells, particularly in S-phase. (Karle and Cysyk, 
1984; Swyryd et al., 1974). We validated that CAD is a direct substrate of 
mTORC1, and determined that mTORC1 positively regulates growth factor 
stimulated de novo pyrimidine synthesis to promote S-phase progression. 
Thus our quantitative phosphoproteomic workflow revealed a novel mTORC1 
substrate that positively regulates cell proliferation. Our research provides 
new insights into how signaling networks regulate the synthesis of essential 
metabolic building blocks such as proteins, lipids, and nucleotides. 
 
mTOR autophosphorylation is specific to mTORC2 
Separately, we set out to investigate the functional consequence of 
mTOR-Ser2481 phosphorylation, which occurs within a repressor domain. We 
show that mTOR autophosphorylation at Ser2481 is specific to mTORC2, 
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requires an intact mTORC2 complex, and is stimulated by growth factors. 
Unexpectedly, mTORC2 autophosphorylation at Ser2481 temporally occurred 
after the phosphorylation of mTORC2 substrates. Furthermore, mTOR 
autophosphorylation at Ser2481 negatively regulated mTORC2 in vitro activity 
towards Akt/PKB. However the function of mTOR-Ser2481 phosphorylation in 
vivo remains elusive, as mutation of mTOR-Ser2481 did not alter Akt/PKB 
phosphorylation in vivo.  
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3.0: Results 
  
3.1: Quantitative phosphoproteomics reveal that mTORC1 
phosphorylates CAD and positively regulates de novo pyrimidine 
synthesis 
 
Quantitative phosphoproteomics reveals 335 novel mTORC1 and 
mTORC2 effectors 
 Relatively few direct substrates of either mTORC1 or mTORC2 are 
known. Here we developed a functional proteomics workflow to quantitatively 
identify novel mTORC1 or mTORC2 regulated phosphorylations, and 
distinguish between direct mTOR substrates and indirect effectors. We 
integrated stable isotope labeling by amino acids in cell culture (SILAC) (Ong 
et al., 2002), preparative SDS-PAGE fractionation (Li et al., 2007), 
phosphopeptide enrichment (Bodenmiller et al., 2007), high accuracy mass 
spectrometry (Olsen et al., 2005), and bioinformatic programs (Cox and 
Mann, 2008) to quantify and identify mTORC1 or mTORC2 regulated 
phosphorylation changes in vivo. Mass spectrometry (MS) has been used 
successfully to analyze the global, in vivo phosphorylation targets of kinases 
and phosphatases (Bodenmiller et al., 2010; Pan et al., 2009). To identify the 
specific mTORC1 and mTORC2 regulated phosphoproteomes, we deleted 
Raptor or Rictor using an inducible gene knockout system in mouse 
embryonic fibroblasts (MEFs) (Cybulski et al., 2012; Patursky-Polischuk et al., 
2009). Raptor and Rictor are essential components of mTORC1 and 
mTORC2, respectively (Figure 1A).  
 We then performed a series of quantitative phosphoproteomic 
experiments to identify novel proteins whose phosphorylation changed in an 
mTORC1 or mTORC2 dependent manner (Figure 1B). Using a SILAC triple 
label strategy, we analyzed four biological replicate experiments, rotating 
each SILAC label per biological replicate. Each biological replicate was 
measured as two technical replicates yielding a total of 220 nano-LC-MS/MS 
runs. Phosphopeptide quantification was reproducible across technical and 
biological replicates, with a R2 value of 0.9884 and 0.6131 respectively 
(Figure 1C and Figure 1D). Using a 1% false discovery rate (FDR), we 
detected 4584 unique phosphorylation sites on 1398 proteins. 
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 For a phosphorylation to be identified as being regulated by mTORC1 
or mTORC2, we chose a stringent cut-off of >1.5 standard deviations (SD) 
from the log2 transformed mean ratio (iRapKO/Control, iRicKO/Control, or 
iRicKO/iRapKO) (Figure 1E). Furthermore the phosphorylation must have 
been detected in 2 out of 4 biological replicates in the Raptor knockout or 
Rictor knockout experiments. In total, the phosphorylations of 335 proteins 
were significantly changed, identifying these as mTOR substrates or indirect 
effectors (Table 1). We detected and correctly identified 18 previously 
validated mTORC1 or mTORC2 regulated phosphorylations on 9 mTOR 
effectors including Raptor, Rictor, GSK3β, NDRG1, PRAS40, and S6. We 
confirmed by western blot that the in vivo phosphorylation of GSK3β-pS9, 
NDRG1-pT330, and S6-pS235/236 match our observed SILAC ratios, further 
validating our phosphoproteomic analysis (Figure 2B).  
To identify a direct substrate of mTOR, we then focused on the 
phosphorylations that were down regulated by mTORC1 or mTORC2 
inhibition, respectively. Many of the novel effectors are implicated in cancer 
and metabolic diseases, but have no known links to mTOR (Figure 1F). Thus 
mTORC1 and mTORC2 control cell growth and proliferation by regulating a 
diverse set of direct substrates and indirect effectors. Additionally, we 
compared our mTOR regulated phosphoproteome to previously published 
studies (Hsu et al., 2011; Yu et al., 2011). These studies and our own 
incompletely identified the known mTOR effectors, suggesting additional 
novel mTORC1 or mTORC2 substrates remain to be revealed (Figure 1G). 
Thus all three datasets are likely sampling different parts of the global mTOR 
regulated phosphoproteome.
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Figure 1: Functional phosphoproteomics reveals 335 novel mTORC1 or 
mTORC2 regulated phosphoproteins. A. Knockout of Raptor or Rictor 
inhibits mTORC1 or mTORC2 signaling, respectively. We generated floxed 
Raptor or Rictor mouse embryonic fibroblasts with an intergraded 4-OHT 
inducible Cre. Three days after 4-OHT treatment, Raptor or Rictor protein 
levels are decreased by 90%. This decrease corresponds to a decrease in 
mTORC1 or mTORC2 signaling. * denotes non-specific band. 
B. Quantitative phosphoproteomic workflow used to identify mTORC1 or 
mTORC2 regulated phosphorylations. We detected 4584 phosphorylation 
sites on 1398 proteins and identified 335 novel mTOR effectors. C. 
Phosphopeptide quantification is robust across technical replicates, 
R2=0.9884. D. Phosphopeptide quantification is reproducible between 
biological replicates, R2=0.6131. E. Global distribute of all 4584 
phosphopeptides. Regulated phosphorylations are +/- >1.5 SD of the log2 
transformed ratio mean. F. KEGG pathways that are statistically enriched in 
the mTOR regulated phosphoproteins. G. Comparison of mTOR regulated 
phosphoproteins identified in three different phosphoproteomic studies. 
 
 
Identification of mTOR consensus motif 
To determine if mTOR controls the phosphorylation of specific motifs in 
vivo, we analyzed the primary amino acid sequence surrounding the down 
regulated phosphorylations with Motif-X (Schwartz and Gygi, 2005). 
Phosphorylation motif analysis revealed that mTORC1 and mTORC2 
regulates the phosphorylation of pS-P and pT-P sites (potential direct mTOR 
phosphorylation sites) and R-x-x-pS sites (consensus site for AGC kinases, 
including mTOR effectors proteins S6K, SGK, Akt/PKB, and canonical PKCs) 
(Figure 2A). We confirmed the in silico results by examining the 
phosphorylation of R-x-x-pS/T sites known to be regulated by AGC kinases 
Akt/PKB, SGK, and S6K (Figure 2B). These results suggest that mTOR 
regulates the novel effectors directly or via AGC kinase activation.  
To distinguish between direct mTOR substrates and indirect effectors, 
we performed a peptide array mTOR in vitro kinase assay. mTOR robustly 
phosphorylated peptides corresponding to validated mTOR substrates 
Akt/PKB and 4E-BP1 (Figure 2C). In total 33% of peptides identified in the 
mTORC1 and mTORC2 regulated phosphoproteomes were directly 
phosphorylated by mTOR in vitro (Figure 2D and Table 1). Thus the proteins 
these phosphorylation sites correspond to are identified as potential direct 
mTOR substrates.  
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Phosphorylation motif analysis of the peptides which mTOR can 
phosphorylate in vitro revealed that mTOR phosphorylated two distinct types 
of phosphorylation motifs: pS/T-P sites and hydrophobic motif (HM) F-x-x-F-
pS-Y sites (Figure 2E). We confirmed that mTORC1 and mTORC2 regulate 
HM phosphorylations in vivo using phospho-specific motif antibodies against 
bulky hydrophobic (Φ) sites (Figure 2F). Many of the putative 
phosphorylations detected by the motif antibodies were similar, and therefore 
mTOR independent. However, we detected thirteen phosphorylations that 
were regulated by mTORC1 or mTORC2. 
The remaining sites that mTOR phosphorylated in vitro did not contain 
a well defined amino acid motif. In vivo and in vitro, mTORC1 can also 
phosphorylate serine followed by glutamine residues (pSer-Gln) such as 
those in MAF1 (Michels et al., 2010). This is consistent with our data that 
mTOR directly phosphorylated a wide range of motifs. Thus mTOR is a 
promiscuous kinase, having a preference rather than an absolute requirement 
for serine or threonine followed by a proline (Ser/Thr-Pro), and serine or 
threonine flanked by bulky hydrophobic residues (Φ-Ser/Thr-Φ). 
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Figure 2: 33% of the phosphopeptides identified by mass spectrometry 
can be directly phosphorylated by mTOR. A. Analysis of the amino acid 
sequence surrounding phosphorylations down regulated by deletion of Raptor 
or Rictor. Motif-x was used to determine phosphorylation motifs that were 
significantly enriched above the mouse proteome. B. Phosphorylation at 
Akt/PKB, SGK, or S6K regulated R-x-x-S/T sites are decreased by Raptor or 
Rictor knockout. Four days after 4-OHT treatment, cells were harvested and 
mTOR signaling pathway was analyzed by western blot. Protein lysates are 
the same as those in Figure 3F, and Supplemental Figure 7. C. Peptide array 
mTOR in vitro kinase positive controls are shown in insert. D. In vitro 
phosphorylation of novel mTOR regulated peptides by recombinant mTOR. 
Peptides identified in the mTORC1 and mTORC2 regulated 
phosphoproteomes were synthesized on cellulose membranes using a 
MultiPep robotic spotter. Membranes were then subjected to an in vitro kinase 
assay using gamma-32P ATP and recombinant mTOR. Each peptide was 
synthesized in duplicate with a matching peptide where Ala was substituted 
for Ser/Thr. Image was false colored for visual clarity E. mTOR primarily 
phosphorylates pS/T-P sites (37.5%) and F-x-x-F-pS-Y sites (25.0%). In vitro 
kinase motif analysis was performed with WebLogo. F. mTORC1 and 
mTORC2 regulate at least 13 distinct hydrophobic (Φ) site phosphorylations 
in vivo. iRapKO and iRicKO MEFs were treated as in Figure 2B. Protein 
lysates are the same as those in Figure 2B, and Figure 3F. 
 
 
Identification of CAD as a novel mTORC1 substrate 
 To identify a direct substrate of mTORC1 or mTORC2, we focused 
further on the novel effectors whose peptide could be phosphorylated by 
mTOR in vitro. One putative substrate of particular interest to us was CAD 
(carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and 
dihydroorotase). CAD is the initial and rate limiting enzyme of the de novo 
pyrimidine synthesis pathway, a conserved and essential metabolic pathway 
important for cell growth and proliferation (Tatibana and Shigesada, 1972). In 
our phosphoproteome data, CAD-Ser1859 phosphorylation was specifically 
down regulated by Raptor knockout (Table 1), and mTOR robustly 
phosphorylated the same peptide in vitro (Figure 3A). Additionally, we 
identified that CAD contains a putative TOS motif of FELVI (aa 1389 – 1393) 
(Figure 3B and 3C). CAD enzymatic activities and protein are conserved from 
worms to human, while in yeast CAD function is conserved by the action of 
two genes, URA2/URA4. In mammals, similar to the activation of mTORC1, 
de novo pyrimidine synthesis is positively regulated by growth factors (Graves 
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et al., 2000; Smith and Buchanan, 1979). Thus CAD was an ideal candidate 
to be an mTORC1 substrate. 
To validate that mTORC1 regulation of CAD phosphorylation was not 
specific to MEFs, we examined if rapamycin could inhibit CAD 
phosphorylation in HeLa cells. Growth factors robustly stimulated the 
phosphorylation of CAD-pS1859 in a rapamycin sensitive manner (Figure 3D), 
without altering CAD expression (Figure 3E). Therefore we generated a 
phospho-specific antibody against CAD-Ser1859. We validated that the 
antibody specially recognized CAD-Ser1859 phosphorylation (Figure 3F). In 
agreement with our mass spectrometry results, western blot experiments 
confirmed that CAD-Ser1859 phosphorylation was stimulated by growth 
factors in a rapamycin sensitive manner (Figure 3E). Similarly, CAD-Ser1859 
phosphorylation was specifically inhibited upon Raptor, but not Rictor, 
knockout (Figure 3G). We then confirmed that mTOR could phosphorylate 
CAD in vitro (Figure 3H). In agreement with our results in vivo, mass 
spectrometry identified that mTOR phosphorylated CAD in vitro at Ser1859 
(data not shown). Thus CAD is a novel mTORC1 substrate. Finally, to 
determine if mTORC1 mediated phosphorylation of CAD was physiologically 
relevant, we examined the phosphorylation of CAD in liver specific TSC1 
knockout mice (L-TSC1 KO). Deletion of tuberous sclerosis protein 1 (TSC1) 
leads to hyper activation of mTORC1 (Shah et al., 2004). In the liver, CAD-
Ser1859 phosphorylation was increased in TSC1 knockout mice. 
Furthermore, the increase in CAD Ser1859 phosphorylation was specifically 
inhibited by rapamycin treatment (Figure 3I). Thus mTORC1 directly regulates 
the rapamycin sensitive phosphorylation of CAD in vivo and in vitro. 
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Figure 3: CAD is a novel mTORC1 substrate A. Peptide array mTOR in 
vitro kinase spots for CAD-Ser1859. B. CAD contains a putative TOS motif of 
FELVI (aa 1389 – 1393). TOS motif conservation in human mTORC1 
substrates. C. Diagram of CAD protein, mTORC1 regulated phosphorylation 
site, and TOS motif. The first three metabolites of the de novo pyrimidine 
synthesis pathway are synthesized by the CPS (carbamoyl-phosphate 
synthetase), ATC (aspartate transcarbamylase) and DHO (dihydroorotase) 
domains of CAD, respectively. D. Rapamycin inhibits growth factor stimulated 
phosphorylation of CAD-pS1859. Values are expressed as mean +/- SD. ** 
indicates a statistical difference of **p<0.01. n=3. HeLa cells were grown in 
SILAC media for 7 days and then treated with rapamycin for 1h. CAD was 
immunoprecipitated, trypsinized, and analyzed by nano-LC-MS/MS. E. 1 hour 
rapamycin treatment in HeLa cells does not alter CAD expression, while CAD-
Ser1859 phosphorylation is inhibited. HeLa cells were serum starved for 
starved 16 hours, prior to restimulation with 10% dialyzed serum +/- 100nM 
rapamycin. F. G9c cells, which lack endogenous CAD, were transfected with 
either wild type or mutant CAD in the presence of growth factors. The 
mTORC1 dependent phosphorylation of CAD is only detected in wild type 
CAD. G. Deletion of Raptor inhibits CAD-Ser1859 phosphorylation. iRapKO 
and iRicKO MEFs were treated as in Figure 2B. Protein lysates are the same 
as those in Figure 2B, and Supplemental Figure 7. H. mTOR phosphorylates 
CAD in vitro in a PP242 sensitive manner. CAD was immunoprecipitated and 
incubated with mTOR for 30min at 37C. S6K is an mTORC1 in vitro kinase 
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assay positive control. I. CAD-Ser1859 phosphorylation is regulated by 
mTORC1 in the mouse liver. Ctrl: TSC1-fl/fl mice, KO: TSC1-fl/fl; Albumin-Cre 
mice. 12 week old littermates were starved overnight and treated with 
rapamycin or sham (0.9% NaCl) for six hours prior to sacrifice.  
 
 
mTORC1 positively regulates de novo pyrimidine synthesis 
 We then determined what biological relevance mTORC1 mediated 
phosphorylation of CAD had on de novo pyrimidine synthesis. In de novo 
pyrimidine synthesis, CAD synthesizes the pyrimidine ring from glutamine, 
bicarbonate, and aspartic acid. The pyrimidine ring is then attached to ribose 
to form a pyrimidine nucleotide. To measure the rate of de novo pyrimidine 
synthesis, we metabolically labeled newly synthesized pyrimidines with N15-
amide labeled glutamine (Figure 4A). We then performed a quantitative 
metabolic flux analysis using targeted uHPLC-MS/MS to measure the rate of 
N15 incorporation into UDP and UTP, thus allowing us to determine the 
relative rate of de novo pyrimidine synthesis. N15-amide labeled glutamine 
was taken up by the cells independent of growth factors or rapamycin 
treatment (Figure 4B). N15 incorporation was not detected in an intermediate 
of the pentose phosphate pathway (6-phospho-gluconate (6-PG)) 
demonstrating the specificity of the N15 labeling to newly synthesized 
pyrimidines (Figure 4B).  
Under starved conditions, we observed a low level of de novo 
pyrimidine synthesis, whereas growth factors stimulated an increased in the 
synthesis of UDP and UTP. Furthermore, rapamycin treatment completely 
inhibited the growth factor stimulated de novo pyrimidine synthesis, thereby 
decreasing the absolute de novo synthesis of UDP and UTP by 62.4% and 
57.8%, respectively (Figure 4B). The observed low to high metabolic flux 
through de novo pyrimidine synthesis is consistent with a CAD enzymatic 
transition from a low activity to a high activity conformation (Cohen et al., 
1985). 
Additionally, rapamycin inhibited the growth factor stimulated increase 
in DHOA, the final CAD synthesized metabolite, as well as OA and UTP 
intercellular concentrations (Figure 4C). Conversely, rapamycin did not inhibit 
the growth factor stimulated increase in purine synthesis, as measured by 
GDP and GTP concentrations (Figure 4D). Thus, mTORC1 positively 
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regulates CAD activity to control growth factor stimulated de novo pyrimidine 
synthesis.  
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Figure 4: mTORC1 positively regulates growth factor stimulated de novo 
pyrimidine synthesis. A. Diagram depicting de novo pyrimidine synthesis 
pathway. B. Rapamycin treatment inhibits growth factor stimulated de novo 
pyrimidine synthesis of UDP and UTP. HeLa cells were serum starved for 
starved 16 hours, prior to restimulation with 10% dialyzed serum +/- 100nM 
rapamycin. At time point 0, pyrimidines were metabolically labeled by feeding 
HeLa cells 4mM N15-amide labeled glutamine. Metabolites were then 
measured using a targeted approach with uHPLC-MS/MS. C. Rapamycin 
inhibited the growth factor stimulated increase in DHOA, OA, and UTP cellular 
concentrations. D. Rapamycin does not inhibit the growth factor stimulated 
increase in GDP or GTP levels. Total cellular concentrations of metabolites 
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were calculated by comparing the amount of metabolites in the cells to a N15 
labeled internal standard and exogenous metabolite standard curves. Values 
are expressed as mean +/- SD. * indicates a statistical difference of *p<0.05, 
**p<0.01, ***p<0.001. n=3-6. 
 
mTORC1 regulates CAD oligomerization 
To identify a potential mechanism of how mTORC1 regulates CAD 
activity, we examined the cellular distribution of endogenous CAD. Growth 
factors stimulated the formation of punctate structures containing CAD. 
Whereas rapamycin treatment inhibited the formation of CAD punctate 
structures, closely resembling serum starvation (Figure 5A and 5B). Punctate 
structures were only observed in the presence of antibody specific to CAD 
(data not shown). 
In vitro CAD can oligomerize into a hexamer (Lee et al., 1985). 
Furthermore, CAD orthologs assemble into large oligomers (Zhang et al., 
2009). Thus the CAD punctate structures may be CAD oligomers. Using 
immunoelectron microscopy, we observed that growth factors stimulated the 
formation of CAD punctate structures in the cytoplasm (Figure 5C). In 
agreement with the immunofluorescence results, punctate structures were 
only observed in the presence of antibody specific to CAD (Figure 5C). 
Additionally, we tested whether CAD could colocalize with proteins that 
form punctate structures in immunofluorescence microscopy. CAD did not 
colocalize with EEA1 (early endosomes), LAMP-2 (lysosomes), Catalase 
(peroxisomes), and Complex IV subunit I (mitochondria) supporting our 
hypothesis that the CAD punctate structures are CAD oligomers (Figure 5D).  
We then enriched for CAD oligomers using glycerol gradients (Figure 
5E and 5F). Growth factors stimulated the formation of CAD oligomers in a 
rapamycin sensitive manner (Figure 5E and Figure 5G). Furthermore, 
mutation of CAD-Ser1859 to Ala inhibited the growth factor stimulated 
formation of CAD oligomers (Figure 5F and Figure 5H). Thus mTORC1-
mediated phosphorylation of CAD-Ser1859 promotes growth factor dependent 
CAD oligomerization.  
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Figure 5: Rapamycin regulates CAD oligomerization. A. Rapamycin 
inhibits the growth factor stimulated translocation of CAD to punctate 
structures. HeLa cells were synchronized in early s-phase using a double 
thymidine block. Following synchronization, cell were serum starved for 16h 
hours in D-MEM containing with 0.1% D-FCS + 2.5mM thymidine, followed by 
30min AA starvation in 1xPBS. Cells were then released in DMEM (starved) 
or DMEM + 10% D-FCS +2xAA (stimulated) or DMEM + 10% D-FCS + 2xAA 
+ 100nM rapamycin (rapamycin). Endogenous CAD was then visualized by 
immunocytochemsitry after 1h rapamycin treatment. B. Quantification of 
Figure 5A. Black bars represent the mean. *** indicates a statistical difference 
of p<0.001. n=116 cell counted per condition C. CAD forms oligomeric 
structures. HeLa cells were serum starved for starved 16 hours, prior to 
restimulation with 10% dialyzed serum for 1hour. Endogenous CAD was then 
visualized by immunoelectron microscopy. Three representative aggregate 
structures are shown. Punctate structures were only observed in the presence 
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of antibody specific to CAD. D. CAD punctate structures did not colocalize 
with EEA1 (early endosomes), LAMP-2 (lysosomes), Catalase (peroxisomes), 
and Complex IV subunit I (mitochondria). HeLa cells were serum starved for 
starved 16 hours, prior to restimulation with 10% dialyzed serum. Endogenous 
CAD and the corresponding membrane marker were then visualized by 
immunocytochemsitry after 1h restimulation. E. HeLa cells were serum 
starved for 16h hours in D-MEM containing with 0.1% D-FCS, followed by 
30min AA starvation in 1xPBS. Cells were restimulated with DMEM (starved) 
or DMEM + 10% D-FCS + 2x AA (stimulated) or DMEM + 10% D-FCS + 2x 
AA + 100nM rapamycin (rapamycin) for 1 hour. CAD oligomers were then 
isolated on 10-35% sucrose gradients. F. Mutation of CAD-Ser1859 to Ala 
inhibited the growth factor stimulated formation of CAD oligomers. G9c cells 
were transfected with either wild type or mutant CAD. CAD oligomers were 
isolated on 10-35% sucrose gradients. Gradient fractions are run across 
multiple SDS-PAGE gels. G. The peak fractions from CAD oligomers isolated 
in Figure 5E are shown. H. The peak fractions from CAD oligomers isolated in 
Figure 5F are shown. 
 
 
mTORC1 regulates cell cycle progression 
In the absence of exogenous pyrimidines, CAD activity is essential for 
cell proliferation (Patterson and Carnright, 1977), and particularly important for 
proper S-phase progression (Mitchell and Hoogenraad, 1975). Therefore, we 
examined if the decrease in de novo pyrimidine synthesis induced by 
rapamycin treatment had a physiological effect on cell cycle progression. 
Cells were synchronized in early S-phase using a double thymidine block to 
circumvent the G1/S arrest that prolonged rapamycin treatment induces 
(Heitman et al., 1991; Terada et al., 1993). Similar to serum starvation, 
rapamycin treatment delayed S-phase progression by 32% (Figure 6A). As 
the cells entered G2/M, the delay in cell cycle progression increased to 52%, 
consistent with an additional requirement for mTORC1 in G2/M (Ramirez-
Valle et al., 2010). Furthermore, the rapamycin-induced delay in cell cycle 
progression was rescued by the addition of exogenous pyrimidines (Figure 
6A).  
In cells lacking endogenous CAD activity, cell proliferation is dependent 
on the supply of exogenous pyrimidines (Figure 6B). In the absence of 
exogenous pyrimidines, expression of wild type CAD rescued the cell 
proliferation defect, while expression of mutant CAD (Ser1859Ala) that cannot 
be phosphorylated by mTORC1 only partially restored cell proliferation (Figure 
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6B). This data supports our model where mTORC1 phosphorylation of CAD 
promotes cell proliferation by regulating CAD oligermization, and thus a CAD 
enzymatic transition from a low activity state to a high activity oligomerized 
conformation. Thus mTORC1 controls cell proliferation in part by positively 
regulating de novo pyrimidine synthesis.  
To examine the potential clinical relevance of our results, we further 
tested the ability of rapamycin to inhibit cell proliferation. Everolimus, a 
synthetic rapamycin derivative, is used currently as a cancer therapeutic 
(Motzer et al., 2008). However, rapamycin does not strongly inhibit 
proliferation in all cell types (Figure 6C), (Neshat et al., 2001). Therefore we 
reasoned that inhibition of mTORC1 combined with a chemotherapeutic 
nucleoside (6-azauridine) would synergistically deplete pyrimidine pools, and 
thus be a potent inhibitor of proliferation in cell types that are resistant to 
rapamycin treatment. In HeLa cells, we observed that the addition of 
rapamycin and 6-azauridine inhibited cell proliferation to a greater extent 
than rapamycin or 6-azauridine alone (Figure 6D). Proliferation was 
inhibited by 42.8% at low nanomolar concentrations of each drug (10nM 
rapamycin + 64nM 6-azauridine). Thus the combination of rapamycin and 6-
azauridine together may increase the therapeutic window for cancer therapy, 
particularly in tumors that do not respond to rapamycin treatment.  
In summary (Figure 6E), we have shown that mTORC1 regulates cell 
proliferation, in part, by regulating CAD phosphorylation and oligermization to 
promote de novo pyrimidine synthesis. 
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Figure 6: Rapamycin inhibits s-phase progression. A. Exogenous 
pyrimidines rescue the rapamycin-induced delay in cell cycle progression. 
HeLa cells were synchronized in early S-phase using a double thymidine 
block. Cells were then released in DMEM (starved) or DMEM + 10% D-FCS + 
2x AA (stimulated) or DMEM + 10% D-FCS + 2x AA + 100nM rapamycin 
(rapamycin), +/- 30µM uridine. DNA content was analyzed by flow cytometry. 
B. Expression of wild type CAD, but not mutant CAD, restored normal cell 
proliferation. G9c cells, which lack endogenous CAD activity, were transfected 
with either wild type or mutant CAD. Cells were visualized with crystal violet 
five days after transfection. C. Rapamycin strongly inhibits proliferation in 
MEFs, but not HeLa cells. MEFs or HeLa cells were grown for three days in 
DMEM + 0.1% D-FCS (starved), DMEM + 10% D-FCS (stimulated), or DMEM 
+ 10% D-FCS + 100nM rapamycin (rapamycin). Cells were then visualized 
with crystal violet. D. Rapamycin and 6-azauridine inhibited cell proliferation 
to a greater extent than rapamycin or 6-azauridine alone. HeLa cells were 
grown for 42 hours +/- rapamycin and 6-azauridine. Cell proliferation was 
then measured with an AlamarBlue assay. The black bar represents cell 
proliferation in the presence of 10nM rapamycin. Values are expressed as 
mean +/- SD. * indicates a statistical difference between (rapamycin + 6-
azauridine) vs (rapamycin) or (6-azauridine) alone. *p<0.05, **p<0.01. n=3 E. 
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mTORC1 promotes cell proliferation by regulating CAD phosphorylation, 
oligermization, and activity to positively regulate de novo pyrimidine synthesis. 
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3.2: mTOR autophosphorylation at Ser2481 regulates  
mTORC2 in vitro kinase activity 
 
Growth factors stimulate mTOR autophosphorylation at Ser2481 
specifically in mTORC2 
To investigate the functional consequence of mTOR phosphorylation, 
we examined how growth factors affect mTOR-Ser2481 phosphorylation. 
mTOR phosphorylation at Ser2481 is stimulated by insulin or serum, and 
inhibited by wortmannin (Figure 7A). Thus mTOR phosphorylation at Ser2481 
is growth factor responsive. This data is inconclusive to determine if 
Phosphoinositide 3-kinase (PI3K) is upstream of mTORC2 as wortmannin can 
directly inhibit mTOR. Acute (1 hour) rapamycin treatment inhibits mTORC1 
but not mTORC2. As mTOR-Ser2481 phosphorylation is not sensitive to 
acute rapamycin treatment (Figure 7A) (Peterson et al., 2000), we 
hypothesized that this phosphorylation site might be specific to mTORC2. To 
test this, we isolated mTORC1 or mTORC2 complexes by immuoprecipitating 
Raptor or Rictor, which are specific components of mTORC1 and mTORC2, 
respectively. We observed that mTOR phosphorylated at Ser2481 was found 
specifically in mTORC2, whereas mTOR phosphorylated at Ser2448 was 
observed in mTORC1 and mTORC2 (Figure 7B). We then confirmed that 
mTOR phosphorylation at Ser2481 requires mTOR kinase activity in vivo 
(Figure 7C) and in vitro (data not shown). Thus mTOR autophosphorylation at 
Ser2481 is observed specifically within mTORC2. Additionally, we observed 
that mTOR phosphorylated multiple interacting partners, including Raptor, 
Rictor, and Sin1, in vitro (Figure 7D). 
Next we examined if mTOR autophosphorylation at Ser2481 required 
specific components of mTORC1 (Raptor) or mTORC2 (Rictor and Sin1). 
Using inducible Rictor or Raptor knockouts MEFS (Cybulski et al., 2012; 
Patursky-Polischuk et al., 2009), we observed that knockout of Rictor blocked 
mTOR autophosphorylation of Ser2481, where Ser2481 phosphorylation was 
unaffected by Raptor knockout (Figure 7E). Phosphorylation of Ser2481 was 
also blocked in constitutive Sin1 -/- mouse embryonic fiberblasts (MEFs) 
(Figure 7F).  Finally, prolonged rapamycin treatment (24 hours), which 
indirectly inhibits mTORC2 complex formation (Sarbassov et al., 2006), 
inhibited mTOR-Ser2481 phosphorylation (Figure 7G). Thus growth factors 
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stimulate mTORC2 autophosphorylation at Ser2481, and mTOR-Ser2481 
autophosphorylation is dependent on mTORC2 complex integrity. 
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Figure 7: Growth factors stimulate mTOR autophosphorylation at 
Ser2481 specifically in mTORC2. A. HEK293 cells were serum starved 
overnight in 0.1% FBS, then restimulated with 100nM insulin or 10% FBS for 
15min. Cells were pretreated with 100nM rapamycin for 1h or 100nM 
wortmannin for 30 min as indicated. B. HEK293 cells were stimulated with 
100nM insulin for 15min prior to lysis. mTORC1 or mTORC2 
immunocomplexes were purified via Raptor or Rictor antibodies. Equal 
amounts of mTOR were loaded. C. HA-mTOR or HA-mTOR kinase dead (KD) 
were expressed in HEK293 cells. 48 hours post-transfection, cells were 
stimulated with 100nM insulin for 15min. HA-mTOR and HA-mTOR KD were 
then immunoprecipitated with HA antibodies coupled to protein-A sepharose. 
D. HEK293 or HeLa cells were serum starved overnight in 0.1% FBS, then 
restimulated with 100nM insulin. Endogenous mTORC1 or mTORC2 was 
immunoprecipitated with Raptor or Rictor specific antibodies treated as 
described for the in vitro kinase assay. 32P-ATP-labeled bands were excised 
and digested by trypsin, and the corresponding proteins identified by mass 
spectrometry. E. Knockout of Rictor or Raptor was induced with 1µM 4-OHT 
72 hours prior to cell lysis. Cells were then serum starved overnight in 0.1% 
FBS, and stimulated with 100nM for 15min. F. Cell extracts from either 
constitutive Sin1 -/- MEFs or control MEFs. G. iRicKO MEFs were treated with 
100nM rapamycin for the indicated time. 
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 mTORC2 autophosphorylation at Ser2481 temporally occurs after the 
insulin-induced phosphorylation of Akt/PKB 
 Next we investigated the temporal regulation of the mTOR signaling 
network. Surprisingly, mTORC2 autophosphorylation at Ser2481 temporally 
occurred after the insulin-induced Akt/PKB and NDRG1 phosphorylation 
(Figure 8A). Maximal phosphorylation of Akt/PKB and NDGR1 occurred 
between 2min - 5min after insulin stimulation, whereas maximal mTORC2 
autophosphorylation at Ser2481 occurred 15min – 30min after insulin 
stimulation. In contrast to the phosphorylation of mTOR-Ser2481, maximum 
mTOR phosphorylation at Ser2448 occurred between 30min - 45min and 
corresponded temporally to the maximum phosphorylation of S6K-Thr389. 
Thus maximum phosphorylation of mTOR-Ser2481 occurs after the 
phosphorylation of mTORC2 substrates in vivo. This data suggests mTOR-
Ser2481 phosphorylation may inhibit mTORC2 activity. 
To examine the functional role of mTORC2 autophosphorylation at 
Ser2481, we mutated mTOR Ser2481 to either alanine (Ala) or aspartic acid 
(Asp). Mutation of Ser2481 to either alanine or aspartic acid did not disrupt 
mTORC1 or mTORC2 complex stability (Figure 8B). Thus mTOR-Ser2481 is 
not required for mTORC1 or mTORC2 complex integrity. To determine if 
mTOR-Ser2481 regulates mTOR kinase activity, we then preformed in vitro 
kinase assays using Akt/PKB as a substrate. Wild type mTOR and mTOR-
Ser2481Ala phosphorylated Akt/PKB-Ser473, while kinase dead mTOR and 
mTOR-Ser2481Asp could not phosphorylate Akt/PKB in vitro (Figure 8C). As 
mTOR-Ser2481Asp was unable to phosphorylate Akt/PKB in vitro, we 
hypothesized that mutation of mTOR-Ser2481 to alanine may render mTOR 
constitutively active. However, mTOR-Ser2481Ala immunoprecipitated from 
insulin stimulated cells phosphorylated Akt/PKB in vitro to a greater extent 
than in serum-starved conditions (Figure 8D). Thus mutation of Ser2481 to 
alanine is not sufficient to render mTOR constitutively active. This data is in 
agreement with recent findings that growth factor stimulated mTORC2 
activation requires a direct interaction with intact ribosomes (Zinzalla et al., 
2011).  
We then investigated the in vivo function of mTOR-Ser2481 
phosphorylation. Expression of kinase dead (KD) mTOR, mTOR-Ser2481Ala, 
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or mTOR-Ser2481Asp did not significantly affect the in vivo phosphorylation 
of Akt/PKB Ser473 (data not shown). As no dominate negative affect was 
observed with kinase dead mTOR, we concluded the levels of endogenous 
mTOR were sufficient to regulate Akt/PKB phosphorylation. Thus the 
functional role of mTORC2-Ser2481 autophosphorylation in vivo remains 
elusive.  
We then further characterized the regulation of mTOR phosphorylation 
at Ser2448. We observed that mTOR-Ser2448 was phosphorylated in 
mTORC1 and mTORC2 (Figure 7B), and that mTOR-Ser2448 
phosphorylation was reduced by Raptor, but not Rictor, knockout (Figure 7E). 
In agreement with our results, mTOR-Ser2448 phosphorylation was 
previously shown to be mediated by S6K1 (Chiang and Abraham, 2005; Holz 
and Blenis, 2005). Therefore, we investigated if there was possible crosstalk 
between mTORC1 and mTORC2 via S6K1 phosphorylation of Ser2448 in 
mTORC2. HEK293 cells were treated with rapamycin for 1 hour before 
specifically immuoprecipitating mTORC1 or mTORC2. We observed that 
acute rapamycin treatment did not block Ser2448 phosphorylation in 
mTORC2, whereas mTOR disassociated from Raptor upon rapamycin 
treatment (Figure 8E). In agreement with these observations, rapamycin 
treatment partially decreased mTOR-Ser2448 phosphorylation in vivo when 
S6K1 phosphorylation was completely inhibited (Figure 8E). Thus mTORC2 
phosphorylation at Ser2448 is Rictor-independent and rapamycin insensitive. 
The functional of mTOR-Ser2448 phosphorylation in both mTORC1 and 
mTORC2 is unknown. 
In summary (Figure 8F), we observed that growth factor stimulated 
mTOR autophosphorylation at Ser2481 was specific to mTORC2, occurred 
after the phosphorylation of mTORC2 substrates, and regulated mTORC2 in 
vitro activity towards Akt/PKB. Conversely, mTOR-Ser2448 phosphorylation 
was observed in both mTORC1 and mTORC2. mTOR-Ser2448 
phosphorylation in mTORC1 was regulated by both rapamycin treatment and 
Raptor knockout, whereas mTOR-Ser2448 phosphorylation in mTORC2 was 
insensitive to rapamycin treatment or Rictor knockout. Future work is required 
to reveal the in vivo function of both mTOR-Ser2448 and mTOR-Ser2481 
phosphorylation. 
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Figure 8: Insulin-stimulated mTORC2 autophosphorylation temporally 
occurs after the phosphorylation of Akt/PKB. A. HeLa cells were serum 
starved overnight in 0.1% FBS, then restimulated with 100nM insulin for the 
indicated time point. B. HA-mTOR, HA-mTOR kinase dead (KD), HA-mTOR 
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Ser-2481-Ala, or HA-mTOR Ser-2481-Asp were expressed in HEK293 cells. 
48 hours post-transfection, cells were lysed and HA-mTOR constructs were 
immunoprecipitated with HA antibodies coupled to protein-A sepharose. C.  
Immunoprecipitations from Figure 9B were split into two equal tubes: one tube 
was used to assess total protein, and one for mTOR in vitro kinase assay. D. 
HA-mTOR Ser-2481-Ala or HA-mTOR Ser-2481-Asp were expressed in 
HEK293 cells. 48 hours post-transfection, cells were either serum starved 
overnight in 0.1% FBS or serum starved overnight in 0.1% FBS and then 
restimulated with 100nM insulin. In vitro kinases assays were preformed as 
described in Figure 9C. E. HEK293 cells were pretreated with 100nM 
rapamycin for 1h, then stimulated with 100nM insulin for 15min prior to lysis. 
mTORC1 or mTORC2 immunocomplexes were purified via Raptor or Rictor 
antibodies. F. A schematic of mTORC1 and mTORC2 phosphorylation sites 
and the kinases responsible for their phosphorylation are shown. Repressor 
domain (RD). Images were generated with Prosite’s MyDomains Image 
Creator. 
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4.0: Discussion 
 
4.1: Identification of the mTOR regulated phosphoproteome 
 To identify novel mTORC1 or mTORC2 substrates, we used a 
quantitative and functional phosphoproteomic approach. We quantified the 
phosphorylation of 1398 unique proteins, which represents 52% coverage of 
the known mTORC1 and mTORC2 signaling networks. First, we performed a 
large-scale analysis of the mTORC1 and mTORC2 regulated 
phosphoproteomes by inducible knockout of essential mTORC1 or mTORC2 
components, followed by phosphopeptide enrichment and high accuracy 
mass spectrometry. Then we analyzed which phosphopeptides identified by 
mass spectrometry could be phosphorylated by mTOR in vitro. This workflow 
allowed us to obtain a global view of the mTORC1 and mTORC2 regulated 
phosphoproteomes. A major challenge encountered by many 
phosphoproteomic datasets is the inability to distinguish between direct and 
indirect effectors. Our peptide array in vitro kinase assay provided the 
functional data necessary to identify potential direct mTOR substrates from 
indirect effectors. Using the inducible gene knockout of other kinases or 
phosphatases, followed by peptide array in vitro kinase or phosphase assay, 
this workflow could be more broadly applied to study the downstream 
functions of additional kinases and phosphatases.  
 In yeast, rapamycin sensitive phosphoproteomes have identified 
several novel TORC1 effectors (Huber et al., 2009; Soulard et al., 2010). 
However in mammals, rapamycin treatment incompletely mimics Raptor 
deletion, as mTORC1 has rapamycin-resistant functions (Feldman et al., 
2009; Thoreen et al., 2009). Additionally, prolonged rapamycin treatment 
inhibits mTORC1 and mTORC2 (Sarbassov et al., 2006). Thus rapamycin will 
only identify a subset of mTORC1 substrates, where our approach to delete 
Raptor avoids the above stated limitations. Recently, ATP-competitive 
inhibitors of mTOR have revealed portions of the larger mTOR regulated 
phosphoproteome (Hsu et al., 2011; Yu et al., 2011). However ATP-
competitive inhibitors of mTOR target both mTORC1 and mTORC2 (reviewed 
in (Sparks and Guertin, 2010). Thus these studies cannot distinguish 
mTORC1 substrates from mTORC2 substrates. Inducible deletion of Raptor 
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or Rictor allowed us to overcome the above stated challenge and reveal the 
specific mTORC1 or mTORC2 regulated phosphoproteome. Additionally, 
these studies and our own incompletely identified the known mTOR effectors, 
suggesting additional novel mTORC1 or mTORC2 substrates remain to be 
revealed. Thus all three datasets are likely sampling different parts of the 
global mTOR regulated phosphoproteome. Currently, mTOR has been 
implicated to directly or indirectly regulate the phosphorylation of 803 distinct 
proteins. This corresponds to 3.9% of all mammalian genes. Given the broad 
role of mTOR in regulating cell physiology, many mTOR targets are expected 
and many may remain to be characterized. 
 Quantitatively defining the mTORC1 and mTORC2 regulated 
phosphoproteomes revealed that mTORC1 phosphorylates CAD to positively 
regulate de novo pyrimidine synthesis. Thus we identified a novel biological 
function of mTORC1, and identified 335 novel substrates or indirect effectors 
of mTORC1 or mTORC2, central controllers of cell growth. 
For appropriate cell growth to occur, cells needs to coordinate the 
production of essential building block such as proteins, lipids, sugars, 
nucleotides and other metabolites. mTORC1 and mTORC2, as central 
controllers of cell growth, have well established roles in regulating protein 
synthesis, translation, and an emerging role in lipid and glucose homeostasis 
(reviewed in (Laplante and Sabatini, 2009a; Polak and Hall, 2009). Here we 
have revealed a novel finding that mTORC1 directly phosphorylates CAD to 
positively regulate growth factor stimulated de novo pyrimidine synthesis, and 
thereby cell proliferation. There are several key findings in the literature which 
hinted that CAD may function downstream of mTORC1. In flies, mutations 
within the CAD gene, rudimentary, have smaller cell size (Fausto-Sterling and 
Hsieh, 1976). Furthermore, de novo pyrimidine synthesis is known to be 
positively regulated by growth factors (Smith and Buchanan, 1979). 
Pyrimidines, in addition to being essential components of DNA and 
RNA, are used as an energy source to drive specific cellular functions. UTP is 
the source of energy for activating glucose and galactose, while CTP is an 
energy source in lipid metabolism. Thus mTORC1 likely regulates de novo 
pyrimidine synthesis to both promote cell proliferation, and as part of a larger 
role in controlling lipid and glucose homeostasis in vivo. Furthermore, in 
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contrast to purines, which are synthesized in the mitochondria, pyrimidines 
are synthesized in cytoplasm providing a spatial localization where regulation 
of de novo pyrimidine synthesis would be accessible to direct mTOR 
phosphorylation. We showed that mTORC1 regulates CAD phosphorylation, 
oligomerization, and function. mTORC1 mediated phosphorylation of CAD 
promotes CAD oligomerization, and increased de novo pyrimidine synthesis in 
vivo. This data suggests that mTORC1 mediated CAD oligomerization may 
facilitate steric channeling of CAD synthesized metabolites, and thus explain 
the increase the rate of de novo pyrimidine synthesis. 
De novo pyrimidine synthesis requires PRPP (5-phosphoribosyl-1-
pyrophosphate), which is produced via the pentose phosphate pathway. Thus 
it is likely that regulation of the de novo pyrimidine synthesis pathway and the 
pentose phosphate pathway are coordinated. Interestingly, TSC1 -/- MEFs, 
which have hyperactive mTORC1 signaling, display an increase flux through 
the oxidative branch of the pentose phosphate that is partially dependent on 
SREBP-1 (Duvel et al., 2010). Our data demonstrates that mTORC1 acutely 
(1 hour) regulates the production of pyrimidines by directly phosphorylating 
and activating CAD, the initial and rate limiting step of de novo pyrimidine 
synthesis. Separately and in a prolonged manner (12-20 hours), mTORC1 
regulates the production of PRPP via SREBP-1 dependent transcriptional 
activity. Thus it is likely that mTORC1 controls de novo pyrimidine synthesis 
through a combination of direct and indirect effectors to properly regulate cell 
proliferation.  
 
4.2: Regulation of mTOR phosphorylation 
 Separately, we investigated the regulation of mTOR phosphorylation at 
two sties, mTOR-Ser2481 and mTOR-Ser2448. Here we report that mTOR 
autophosphorylation at Ser2481 is specific to mTORC2, requires an intact 
complex, and is stimulated by growth factors. Growth factor activation of 
mTORC2 leads to the rapid phosphorylation of Akt/PKB and SGK1 substrate 
NDGR1. If mTOR-Ser2481phosphorylation was a marker of active mTORC2, 
we hypothesize that mTORC2 autophosphorylation would precede the 
phosphorylation of mTORC2 substrates. However, in vivo mTORC2 activity 
towards Akt/PKB-Ser473 phosphorylation preceded mTORC2 
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autophosphorylation at Ser2481. This data suggests mTOR-Ser2481 
phosphorylation may contribute to inhibition of mTOR activity towards 
Akt/PKB. Furthermore, mTOR-Ser2481 is within a repressor domain of 
mTOR. The repressor domain is 95% conserved in vertebrates, yet poorly 
conserved in invertebrates. This data suggests the repressor domain may be 
required for vertebrate specific functions of mTOR. Interesting, other 
regulatory sites in the mTOR signaling network are also solely conversed in 
vertebrates, such as ERK (Ma et al., 2005) and IKKβ (Lee et al., 2007) 
phosphorylation of TSC2. Addition of an antibody (mTAB1) that recognizes 
the repressor domain (RD) (Brunn et al., 1997), or partial deletion of the 
repressor domain (amino acids 2430-2450) increases mTOR in vitro kinase 
activity (Edinger and Thompson, 2004). We identified that mTORC2 
autophosphorylation at Ser2481 inhibits mTORC2 in vitro kinase activity. One 
possible mechanism could be that mTOR-Ser2481 phosphorylation blocks 
substrate presentation. Alternatively, mutation of mTOR-Ser2481 to aspartic 
acid may not properly mimic the functional role of phosphorylation at this site. 
Furthermore, as the expression of mTOR-Ser2481 mutated to aspartic acid 
did not alter mTORC2 signaling in vivo, there are likely additional regulatory 
mechanisms that inactivate grow factor regulated mTORC2 activity. Many 
phosphorylations sites have recently been discovered in mTOR and mTOR 
interaction proteins (Gwinn et al., 2008; Hayashi et al., 2007; Wang et al., 
2009b). mTOR can phosphorylate Raptor, Rictor, and Sin1 at multiple sites in 
vivo (Acosta-Jaquez et al., 2009; Foster et al., 2009; Wang et al., 2009a). 
Thus multiple phosphorylations may each contribute a small portion to the 
regulation of mTOR activity. It is likely that certain phosphorylations will 
positively regulate mTOR activity, while others may contribute to a feedback 
inhibition mTOR activity. Therefore it will be important to examine these 
phosphorylations under specific physiological conditions to determine their 
function role. 
We also characterized the phosphorylation of mTOR at Ser2448. 
mTOR-Ser2448 phosphorylation was first proposed to be an Akt/PKB site 
(Sekulic et al., 2000). Subsequent work demonstrated phosphorylation of 
mTOR-Ser2448 was mediated by S6K (Chiang and Abraham, 2005; Holz and 
Blenis, 2005). Our data suggest S6K phosphorylates mTORC1, but an 
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unidentified Raptor and Rictor independent-kinase phosphorylates Ser2448 in 
mTORC2 (Fig 2). A recent study showed that cytoplasmic mTOR-Ser2448 
phosphorylation correlated with tumor progression and poor survival in human 
gastric cancer. Interestingly, nuclear mTOR-Ser2448 phosphorylation was 
associated with better overall survival (Murayama et al., 2009). Thus mTOR-
Ser2448 phosphorylation may prove useful as a clinical biomarker. Similarly, 
while this work was in progress, another group published the observation that 
mTOR-Ser2481 phosphorylation was specific to mTORC2, and can be utilized 
as a biomarker for mTORC2 sensitively to rapamycin (Copp et al., 2009). 
Although the functional significance of mTOR-Ser2448 and mTOR-Ser2481 
phosphorylation remains to be clarified, our results suggests that further 
investigation of mTOR phosphorylation may identify important functional roles 
and/or prove useful as clinical biomarkers. 
 
4.3: Closing remarks 
 The mTORC1 and mTORC2 signaling networks have emerged as 
central controllers of cell growth and proliferation that are important for 
development, aging, and diseases such as cancer and diabetes. Future work 
to identify direct substrates of mTOR may reveal new cellular processes that 
mTORC1 and mTORC2 regulate to ultimately determine cell size and 
positively regulate proliferation. 
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5.0: Experimental Procedures 
 
Antibodies: CAD antibody for western/IP (#A301-374A), and CAD antibody for 
IF/ImmunoEM (#IHC-00280) from Bethyl. Anti-Akt/PKB and Anti-mTOR (for 
endogenous IP) from Santa Cruz Biotechnology. Alexa Fluor 488 anti-rabbit 
and Alexa Fluor 594 anti-mouse secondary antibodies from Invitrogen. HRP-
coupled anti-mouse and anti-rabbit secondary antibodies from Pierce; HRP-
coupled anti-IgG, light chain specific, anti-rabbit secondary antibody from 
Jackson Immunoresearch; HRP-coupled anti-rabbit IgM from Abcam; Ten-
nanometer gold particles coupled to goat anti-rabbit IgG from BBInternational; 
Anti-Rictor and anti-Raptor antibodies were produced as previously described 
(Jacinto et al., 2004). All other commercial antibodies from Cell Signaling 
Technology.  
 
Antibody production: CAD-Ser1859 phospho-specific, rabbit polyclonal 
antibodies were raised against a KLH-coupled peptide (RIHRApSDPGLPAE), 
which corresponds to residues 1854–1866 of human CAD. Antibodies were 
generated and affinity purified by Eurogentec.  
 
Bioinformatics: In vivo kinase motif analysis was performed with Motif-X 
(Schwartz and Gygi, 2005). In vitro kinase motif analysis was performed with 
WebLogo (Crooks et al., 2004). We searched for human, fish, fly, worm, and 
yeast orthologs of our novel mouse mTOR effectors using g-profiler (Reimand 
et al., 2007). KEGG pathway analysis was done using the Benjamini-
Hochberg FDR in g-profiler. Using the previously identified TOS motifs found 
in PRAS40, S6K, and 4E-BP, (Lee et al., 2008) we developed a consensus 
TOS motif corresponding to: F-[DEV]-[MLI]-[DEV]-[LIE]. We then searched for 
putative TOS motifs using ScanProsite (Gattiker et al., 2002). Sequence 
alignments were done with ClustalW2 (Larkin et al., 2007). Venn diagrams 
were created with VENNY (Oliveros, 2007). HeLa cell volume was calculated 
from BioNumbers (Milo et al., 2010). Previously identified growth factor 
regulated phosphorylations were searched for in PhosphositePlus (Hornbeck 
et al., 2004). 
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Cell culture: Cells were maintained in D-MEM containing 10% dialyzed fetal 
bovine serum (D-FCS). For overnight serum deprivation, cells were grown for 
16 hours in D-MEM containing with 0.1% D-FCS. iRapKO and iRicKO are 
inducible Raptor and Rictor, respectively, knockout MEF cell lines. Generation 
of the iRapKO and iRicKO cell lines was previously described (Cybulski et al., 
2012; Patursky-Polischuk et al., 2009). Briefly, immortalized MEFs contain 
floxed Raptor or Rictor alleles, and 4-hydroxytamoxifen (4-OHT) inducible Cre 
recombinase. iRapKO (Raptor knockout) cells or iRicKO (Rictor knockout) 
cells were compared to control cells treated with 1 µM 4-OHT. 72 hours after 
4-OHT treatment, the deletion of Raptor and inhibition of mTORC1 signaling 
or deletion of Rictor and inhibition of mTORC2 signaling was confirmed by 
western blot. For SILAC experiments, MEFs or HeLa cells were culture for 7 
passages in SILAC media + 10% D-FCS. Cells were then subjected to 4-OHT 
treatment (MEFs) or cell harvest (HeLa). HeLa cells were transfected with 
Lipofectamine 2000 following the manufacture’s instructions. Wild-type and 
mutant CAD was transfected into G9c cells with FuGene, following the 
manufacture’s instructions. G9c cells lack functional CAD activity, and require 
the addition of 30µM uridine to the media to maintain cell growth and 
proliferation (Qiu and Davidson, 2000). Cell proliferation was measured using 
Crystal Violet staining or an AlamarBlue assay as previously described 
(Colombi et al., 2010). 
 
Chemicals: SILAC media and D-FCS from DundeeCellProducts; Glutamine 
and Pen/Strep from Invitrogen. N15-amide glutamine from Cambridge Isotope 
Labs. Lipofectamine 2000, and recombinant mTOR from Invitrogen. PALA 
was a kind gift from the NCI/DTP Open Chemical Repository. Protein A-
agarose from Zymed. Soluble peptides were synthesized by GenScript. CAD 
siRNA and Non-targeting siRNA SMARTpools from Dharmacon. Additional 
cell culture reagents including D-MEM, insulin, and rapamycin, wortmannin, 
and PP242 from Sigma.  
 
Flow cytometry: HeLa cells were arrested in early S-phase using a double 
thymidine block. 40% confluent cells were subsequently grown in complete 
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media + 2.5mM thymidine for 18h, released in complete media for 9h, and 
arrested in S-phase with a second 16 hour incubation in complete media + 
2.5mM thymidine. Cells were then released, ± 30µM uridine, in DMEM 
(starved) or DMEM + 10% D-FCS + 2x AA (stimulated) or DMEM + 10% D-
FCS + 2x AA + 100nM rapamycin (rapamycin). Cells were trypsinized and 
washed 2x in 1xPBS + 0.1% BSA.  Cells were fixed in 75% ice-cold EtOH for 
1h at 4C. After washing 2x 1xPBS, cells were permeabilized with 0.25% 
Trition-100 in 1x PBS for 5min at 4C. Cells were washed, and then treated 
with 30ug/mL RNase A for 15min at 37C. After washing, cells were 
resuspended at 1x10^6 cells/mL in PI staining buffer (1xPBS + 3.8mM 
NaCitrate + 50 ug/mL propidium iodide + 10ug/mL RNase A) and incubated in 
the dark for 2h at 4C. The PI staining was then measured with a Beckman 
Coulter Cell Lab Quanta SC Flow cytometer. 
 
Fluorescence Microscopy: HeLa cells were grown on cover slips to 60% 
confluence. Cells were serum starved for 16h hours in D-MEM containing with 
0.1% D-FCS, followed by 30min AA starvation in 1xPBS. Cells were 
restimulated with 10% D-FCS and double the concentration of AAs in D-MEM 
for 1h. Cells were then washed 3x 1xPBS, and fixed with 4% 
paraformaldehyde in 1xPBS for 15min at 24C. After washing 2x 1xPBS, cells 
were quenched with 50mM ammonium chloride in 1xPBS for 10min at 24C. 
Cells were washed 2x 1xPBS and permeabilized with 0.1% Trition-100 in 
1xPBS for 5min. After washing 2x 1xPBS, cells were blocked in 2% BSA in 
1xPBS for 1h at 24C. Cells were washed 2x 1xPBS and incubated with 
primary antibody in 1xPBS + 0.3% BSA (1:200 dilution) for 2h at 24C. After 
washing 3x 1xPBS, cells were incubated with secondary antibodies in 1xPBS 
+ 0.3% BSA (1:200 dilution) and keep in the dark for 1h at 24C. Cells were 
washed 3x 1xPBS, stained 3min with DAPI (1:1000 dilution) in 1xPBS, before 
mounting on microscope slides. Images were taken with a 40x objective on a 
Zeiss AxioImager Z1 microscope and an AxioCam MRm camera (150-300ms 
exposure time). Inducible knockout of Raptor was performed as previously 
described, and MEFs were images as described above.  
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Glycerol Gradient Ultracentrifugation: Cells (1x107) were suspended in 250µL 
of lysis buffer containing 100mM Tris-HCL pH 8.0, 100mM KCL, 25 mM 
MgCl2, 1 mM DTT, 7.5% (vol/vol) DMSO, and 2.5% (vol/vol) glycerol. CAD 
oligomers were then isolated on 10–35% (vol/vol) glycerol gradients as 
previously described (Lee et al., 1985). 
 
Immunoelectron microscopy: HeLa cells were serum starved for 16h hours in 
D-MEM containing with 0.1% D-FCS, followed by 30min AA starvation in 
1xPBS. Cells were restimulated with 10% D-FCS and double the 
concentration of AAs in D-MEM for 1h. Cells were then fixed and treated for 
immunoelectron microscopy as previously described (Stettler et al., 2009). 
Ten-nanometer gold particles coupled to goat anti-rabbit IgG were used to 
detect rabbit anti-CAD antibodies. 
 
Immunoprecipitations: Cells were rinsed twice with ice-cold PBS before lysis. 
Lysis buffer contained 40mM HEPES pH 7.4, 150mM NaCl, 0.3% CHAPS 
supplemented with protease and phosphatase inhibitors (1x Roche complete 
protease inhibitor cocktail, 1 µg/ml Aprotinin, 1 µg/ml Pepstatin, 10 mM NaF, 
10 mM β-glycerophosphate, 0.5mM ortho-vanadate).  Cells were harvested 
and incubated on ice for 5 minutes. Cells suspensions were then gently 
sonicated for 5 seconds on ice. Cell debris was removed by centrifugation for 
10 minutes at 10000g. The protein concentration was determined with a Bio-
Rad assay. For immunoprecipitations (IP), 5 µg of antibody was incubated 
with 1mL of cleared cell lysate from a 10 cm plate, and rotated for 2 hours (HA 
IP) or overnight (mTOR IP) at 4°C. Normal rabbit IgG was used for mock IPs.  
50 µl of a 50% slurry of protein A-agarose was added and then additionally 
incubated for one hour. Beads were collected by centrifugation, and 
immunoprecipitations were washed three times in lysis buffer before being 
resuspended in 2x SDS-PAGE sample buffer.  
 
Metabolic Measurements: Prior to metabolic labeling, HeLa cells were serum 
starved for 16h hours in D-MEM containing with 0.1% D-FCS, followed by 
30min AA starvation in 1xPBS. Cells were restimulated with 10% D-FCS and 
2x AA (minus glutamine) + 4mM N15-amide labeled glutamine. Cells were 
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washed 2x with ice-cold 1xPBS. Cells were then quenched by flash freezing 
the plates in liquid nitrogen. Metabolites were extracted with 75% EtOH in 
10mM ammonium acetate, pH 7.5 for 5min at 80C. Cell debris was removed 
via centrifugation at 3000g for 5min at 4C. Samples were then dried in a 
speed-vac at stored at -80C until measurement. Metabolites were then 
measured using a targeted approach with uHPLC-MS/MS as previously 
described (Buescher et al., 2010). Total cellular concentrations of metabolites 
were calculated using a HeLa cell volume of 2425 µM3, and then comparing 
the relative amount of metabolites in cells to a heavy isotope labeled internal 
standard and exogenous metabolite standard curves.  
 
mTOR endogenous in vitro kinase assay: In vitro kinase protocol was 
modified from (Sarbassov et al., 2005). Briefly, immunoprecipitations of 
mTOR or HA-mTOR were prepared as previously described. After three 
washes in lysis buffer, immunoprecipitations were split into two equal tubes: 
one tube was used to assess mTOR phosphorylation at Ser-2481, and one for 
in vitro kinase assay. Immunoprecipitations for in vitro kinase assay were 
resuspended in kinase reaction buffer (25 mM Hepes pH 7.4, 50mM NaCl, 1 
mM MgCl2, and 1mM ATP) at 37C for 30min plus inactive 1µg Akt/PKB1 
(Upstate Biotechnology) as a substrate.  
 
mTOR recombinant in vitro kinase assay: Cells were rinsed three times with 
ice-cold 1xPBS before lysis. Cells were then lysed in RIPA buffer (50mM Tris, 
pH 7.4, 150mM NaCl, 1mM EDTA, 1.0% NP-40, and 0.1% Deoxycholate with 
protease and phosphatase inhibitors: 1x Roche complete protease inhibitor 
cocktail, 1µg/ml Aprotinin, 1µg/ml Pepstatin, 10mM NaF, 10mM β-
glycerophosphate, 0.5mM ortho-vanadate). Cells were harvested by 
scrapping and incubated on ice for 20 minutes. Cell debris was removed by 
centrifugation for 10 minutes at 1000g. The protein concentration was 
determined with a BCA assay. 5µg of antibody was incubated with 1mg of 
cleared cell lysate and rotated for 3 hours at 4°C. Normal rabbit IgG was used 
for mock IPs. 40µl of a 50% slurry of protein A-agarose was added and then 
incubated for one additional hour. Beads were collected by centrifugation, and 
immunoprecipitations were washed four times in lysis buffer before being 
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resuspended in kinase reaction buffer (25mM HEPES pH 7.4, 50mM NaCl, 
0.01% Tween, 1mM MnCl2, 1mM DTT, and 1mM ATP + 10uCi 32P-ATP) at 
37C for 30min with 100ng mTOR (Invitrogen) +/- 200nM PP242.  
 
Peptide array spotting: An array of 600 peptides was synthesized on cellulose 
paper using an intavis AG MultiPep robotic spotter following the 
manufacture’s instructions. 12-mer peptides (6aa-pS/T-5aa) of each pSer/Thr 
site identified as mTOR regulated in 2/3 SILAC labels were spotted in 
duplicate. Additionally, Ala was substituted for each pSer/Thr identified via MS 
and spotted in duplicate (6aa-A-5aa). 
 
Peptide array in vitro kinase assay: The printed peptide array was moistened 
in 95% EtOH, and blocked overnight at 24C in peptide kinase buffer (25mM 
HEPES pH 7.2, 50mM NaCL, 0.01% Tween-20, 10mM MnCl2, 1mM EDTA) 
supplemented with 0.2 mg/mL BSA. The array was then additionally blocked 
with a cold-kinase assay (peptide kinase buffer + 1.0mg/mL BSA + 1mM ATP 
and incubated at 37C for 30min). The mTOR kinase reaction was carried out 
with peptide kinase buffer + 0.1mg/mL BSA + 500uM ATP + 500uCi 32P-ATP 
+ 100ng mTOR (Invitrogen) for 3h at 37C. After extensive washing (3x for 
10min in [50mM Tris, pH 6.8, 8M urea, 1% SDS, 0.5% B-ME], 2x ddH20, 3x 
for 10min in [50mM Tris, pH 6.8, 1M NaCL], 2x ddH20, 3x for 10min in [5% 
phosphoric acid, pH 1.5], 2x ddH20, 2min in 95% EtOH) the array was air 
dried and incorporation of 32P into the peptides was measured with a 
PhosphorScreen (Molecular Dynamics) and a STORM scanner 
(Amersham/GE).  
 
Peptide in vitro kinase assay: Soluble peptides were incubated in peptide 
kinase buffer (25mM HEPES pH 7.2, 50mM NaCL, 0.01% Tween-20, 10mM 
MnCl2, 1mM EDTA + 0.1mg/mL BSA + 500uM ATP + 500uCi 32P-ATP + 
100ng mTOR (Invitrogen) +/- 500nM PP242) for 30min at 37C. Peptides were 
then spotted and air dried on Whatman P81 paper. After washing 3x [0.5% 
phosphoric acid, pH 1.5] and 1x 100% acetone, the incorporation of 32P into 
the peptides was measured with a liquid scintillation counter. 
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Phosphoproteomics: Protein extraction, SDS-PAGE protein fractionation, in-
gel digestion, peptide desalting, phosphopeptide enrichment, nano-LC-
MS/MS analysis, database search, and quantitation were previously 
described (Soulard et al., 2010) with the following changes: 2mg of each 
SILAC labeled protein extract was mixed together prior to SDS-PAGE 
fractionation. Identification of phosphopeptides was done with MaxQuant 
1.13.13 against the mouse or human Swiss-Prot/TrEMB database 
downloaded from Uniprot on June 30th, 2009. The databases contained 
forward and reverse mouse or human sequences as well as common 
contaminants. 
 
Plasmids: HA-mTOR, and HA-mTOR kinase dead (KD) were described 
previously (Dennis et al., 2001). Human CAD cloned into pCMV-SPORT6 was 
obtained from Open Biosystems (accession# BC065510). CAD-Ser-1859-Ala, 
HA-mTOR Ser-2481-Ala, and HA-mTOR Ser-2481-Asp were produced via 
site-directed mutagenesis and verified by DNA sequencing. 
 
Quantification and statistics: Quantification of immunoblot signals was 
performed with ImageQuant v7 .0 using a STORM scanner and ECL Plus 
(from Amersham) or 32P-ATP via PhosphorScreens (Molecular Dynamics). 
Phosphospecific signals were normalized to the total amount of the 
corresponding protein. Statistical significance was determined using a 
Student’s t-Test. Data is presented as the mean ± standard deviation. 
 
TiO2 phosphopeptide enrichment: 0.40mg TiO2 spheres were used per 
1.00mg total peptides. TiO2 beads were primed with 100% acentronitrile 
(AcCN). TiO2 beads and total peptides were then combined in binding buffer 
(80% AcCN, 5% TFA, 1M Glycolic Acid), and incubated for 30min. TiO2 
beads were then washed 1x binding buffer, and 2x with washing buffer (80% 
AcCN, 1% TFA). Phosphopeptides were eluted with 30% AcCN, 300mM 
NH4OH. 
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Table 1: mTOR regulated phosphorylations identified by mass 
spectrometry. 
 
An excel version of the mTOR regulated phosphorylations is available online 
at: edoc.unibas.ch 
Uniprot Modified Sequence M/L Ratio H/L Ratio H/M Ratio Experiment iRapKO/Control iRicKO/Control iRicKO/iRapKO Peptide array +
Q3TIY5 AAAQYSS(ph)QKS(ph)VEER -1.0208 -2.4435 -1.3823 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q3TIY5 AAAQYSS(ph)QKS(ph)VEER -1.0208 -2.4435 -1.3823 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK -1.3058 -2.3894 -0.9600 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9QX47 ASES(ph)SS(ph)EEKDDYEIFVK -1.3385 -2.2782 -0.9944 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9QX47 ASES(ph)SS(ph)EEKDDYEIFVK -1.3385 -2.2782 -0.9944 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q71FD5 AYS(ph)GSDLPSGTGSGGGGADGAR -1.2952 -1.6083 -1.2142 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q71FD5 AYS(ph)GSDLPSGTGSGGGGADGAR -1.4600 -1.6083 -1.2126 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q8VDN3 GGVT(ph)GSPEAS(ph)ISGSK -6.3497 -14.0059 -6.1954 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q6ZPJ3 LIHGEDS(ph)DS(ph)EGDDDGR -1.3288 -2.4551 -2.0838 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q6ZPJ3 LIHGEDS(ph)DS(ph)EGDDDGR -1.3288 -2.4551 -2.0838 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q6ZPJ3 LIHGEDS(ph)DS(ph)EGDDDGR -1.3288 -2.4551 -2.0838 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q6ZPJ3 LIHGEDS(ph)DS(ph)EGDDDGR -1.3288 -2.4551 -2.0838 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9Z248 LSPLS(ph)PGS(ph)PGPAAR -1.4753 -2.5471 -0.9978 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9Z248 LSPLS(ph)PGS(ph)PGPAAR -1.4753 -2.5471 -0.9978 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9Z248 LSPLS(ph)PGS(ph)PGPAAR -1.4701 -2.5471 -0.9978 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q9Z248 LSPLS(ph)PGS(ph)PGPAAR -1.4701 -2.5471 -0.9978 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q09XV5 TAS(ph)PS(ph)PLRPDAPVEK -1.7390 -2.1830 -1.0616 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
Q09XV5 TAS(ph)PS(ph)PLRPDAPVEK -1.7390 -2.1830 -1.0616 SILAC 1 / Biological 1 Raptor down Rictor down H/M down
P70698 DTYSDRS(ph)GS(ph)SSPDSEITELK -2.0318 -2.0049 -1.1737 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
Q6PAM1 EQGVESPGAQPASS(ph)PR -1.0412 -1.1477 -1.3190 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
Q99LL5 GLSVS(ph)GPCGSRSPQQTPMES -1.1057 -1.8854 -1.1905 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -1.2125 -2.2311 -1.0687 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
Q6ZPH4 ILDPNSGEPAPVLSS(ph)PTPTDLSTFLSFPS(ph)PEK -1.4845 -2.1561 -1.0041 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
Q6A006 LSTT(ph)PS(ph)PT(ph)NSLHEDGVDDFRR -1.2757 -2.5851 -1.1479 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
Q0VAV8 NNPS(ph)PPPDSDLER -2.1403 -1.9313 -8.7199 SILAC 1 / Biological 2 Raptor down Rictor down H/M down
Q62433 LNIT(ph)PNSGATGNNAGPK -3.8290 -5.1105 -1.2929 SILAC 2 / Biological 3 Raptor down Rictor down H/M down
P70698 DTY(ph)SDRS(ph)GSSS(ph)PDSEITELK -1.3252 -1.4296 0.8984 SILAC 1 / Biological 1 Raptor down Rictor down H/M up
P62754 LSSLRASTSKS(ph)ESSQK -2.4280 -1.6802 1.6980 SILAC 1 / Biological 1 Raptor down Rictor down H/M up
P62754 LSSLRASTSKS(ph)ESSQK -2.4280 -1.6802 1.6980 SILAC 1 / Biological 1 Raptor down Rictor down H/M up
Q8K4Q0 ILDTSSLTQS(ph)APAS(ph)PTNK -2.2602 -1.1246 1.0442 SILAC 1 / Biological 2 Raptor down Rictor down H/M up
Q0VAV8 NNPS(ph)PPPDSDLER -2.4270 -1.9285 0.9745 SILAC 2 / Biological 3 Raptor down Rictor down H/M up
P14873 ES(ph)SPLYS(ph)PGFSDSTSAAK -1.4068 -1.9970 0.0463 SILAC 1 / Biological 1 Raptor down Rictor down  +
P14873 ES(ph)SPLYS(ph)PGFSDSTSAAK -1.4068 -1.9970 0.0463 SILAC 1 / Biological 1 Raptor down Rictor down  +
B2RQC6 IHRAS(ph)DPGLPAEEPK -1.8717 -1.1005 0.3325 SILAC 1 / Biological 2 Raptor down Rictor down  +
Q4VAC9 RFS(ph)FSPSAVS(ph)PR -1.5134 -1.3287 -0.6570 SILAC 1 / Biological 1 Raptor down Rictor down  +
Q4VAC9 RFS(ph)FSPSAVS(ph)PR -1.5134 -1.3243 -0.6570 SILAC 1 / Biological 1 Raptor down Rictor down  +
Q4VAC9 RFSFS(ph)PSAVS(ph)PR -2.7391 -1.4159 -0.6027 SILAC 1 / Biological 1 Raptor down Rictor down  +
Q4VAC9 RFSFS(ph)PSAVS(ph)PR -2.7427 -1.3971 -0.6009 SILAC 1 / Biological 1 Raptor down Rictor down  +
P20152 SLYSSS(ph)PGGAYVTR -1.3407 -1.7037 -0.3416 SILAC 1 / Biological 1 Raptor down Rictor down  +
P20152 SLYSSS(ph)PGGAYVTR -1.3760 -1.7586 -0.3318 SILAC 1 / Biological 1 Raptor down Rictor down  +
Q7TPV4 (ac)AEMKSPTKAEPAT(ph)PAEAAQSDR -1.7531 -1.6838 -0.0286 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 (ac)AEMKSPTKAEPAT(ph)PAEAAQSDR -1.7171 -1.6838 -0.0286 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 (ac)AEMKSPTKAEPATPAEAAQS(ph)DR -5.4894 -2.1025 -0.3886 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)S(ph)LQYGAEETPLAGSY(ph)GAADSFPK -1.3038 -1.6038 -0.0949 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)S(ph)LQYGAEETPLAGSY(ph)GAADSFPK -1.3038 -1.6038 -0.0949 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)S(ph)LQYGAEETPLAGSY(ph)GAADSFPK -1.3830 -1.6058 -0.0378 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)S(ph)LQYGAEETPLAGSY(ph)GAADSFPK -1.3830 -1.6058 -0.0378 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)S(ph)LQYGAEETPLAGSYGAADS(ph)FPK -1.3038 -1.6038 -0.0949 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)S(ph)LQYGAEETPLAGSYGAADS(ph)FPK -1.3038 -1.6038 -0.0949 SILAC 1 / Biological 1 Raptor down Rictor down
P43274 (ac)SETAPAAPAAPAPAEKT(ph)PVK -1.2670 -1.2922 0.0142 SILAC 1 / Biological 1 Raptor down Rictor down
P43274 (ac)SETAPAAPAAPAPAEKT(ph)PVK -1.2928 -1.1871 0.0286 SILAC 1 / Biological 1 Raptor down Rictor down
P43277 (ac)SETAPAAPAAPAPVEKT(ph)PVK -1.5823 -1.3274 0.1609 SILAC 1 / Biological 1 Raptor down Rictor down
P43277 (ac)SETAPAAPAAPAPVEKT(ph)PVK -1.6449 -1.2357 0.1965 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)SLQY(ph)GAEETPLAGS(ph)YGAADSFPK -1.3686 -1.7550 -0.4296 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)SLQY(ph)GAEETPLAGS(ph)YGAADSFPK -1.3686 -1.7550 -0.4296 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)SLQY(ph)GAEETPLAGS(ph)YGAADSFPK -1.3242 -1.7147 -0.4252 SILAC 1 / Biological 1 Raptor down Rictor down
Q99K70 (ac)SLQY(ph)GAEETPLAGS(ph)YGAADSFPK -1.3242 -1.7147 -0.4252 SILAC 1 / Biological 1 Raptor down Rictor down
Q9ERU9 ANT(ph)S(ph)SDLEKDDDAYK -1.3904 -1.1052 0.0193 SILAC 1 / Biological 1 Raptor down Rictor down
Q9ERU9 ANT(ph)S(ph)SDLEKDDDAYK -1.3904 -1.1052 0.0193 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK -1.2731 -2.5007 -0.9257 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK -1.3058 -2.3894 -0.8688 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK -1.2731 -2.5007 -0.7432 SILAC 1 / Biological 1 Raptor down Rictor down
Q68FG5 ATAPQT(ph)QHVSPM(ox)R -1.3847 -1.3766 -0.0445 SILAC 1 / Biological 1 Raptor down Rictor down
Q68FG5 ATAPQT(ph)QHVSPM(ox)R -1.3703 -1.4140 0.0000 SILAC 1 / Biological 1 Raptor down Rictor down
Q68FG5 ATAPQTQHVS(ph)PMR -1.5757 -1.4973 0.0004 SILAC 1 / Biological 1 Raptor down Rictor down
Q68FG5 ATAPQTQHVS(ph)PMR -1.5701 -1.4621 0.0012 SILAC 1 / Biological 1 Raptor down Rictor down
Q80XU3 ATVT(ph)PS(ph)PVKGK -1.9394 -1.8396 0.2152 SILAC 1 / Biological 1 Raptor down Rictor down
Q80XU3 ATVT(ph)PS(ph)PVKGK -1.9525 -1.8432 0.2193 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 DIPSDT(ph)QSPVSTK -2.5724 -2.3683 -0.1291 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 DIPSDT(ph)QSPVSTK -2.9066 -2.3760 -0.1150 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BTI8 DKFSPTQDRPESS(ph)TVLK -3.8443 -2.8118 -0.4546 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BTI8 DKFSPTQDRPESS(ph)TVLK -3.8443 -2.8250 -0.4523 SILAC 1 / Biological 1 Raptor down Rictor down
P70698 DTYSDRS(ph)GS(ph)SSPDSEITELK -1.2843 -1.7695 -0.3905 SILAC 1 / Biological 1 Raptor down Rictor down
P70698 DTYSDRS(ph)GS(ph)SSPDSEITELK -1.5271 -1.7717 -0.3666 SILAC 1 / Biological 1 Raptor down Rictor down
P70698 DTYSDRS(ph)GS(ph)SSPDSEITELK -1.2530 -1.6272 -0.2432 SILAC 1 / Biological 1 Raptor down Rictor down
P70698 DTYSDRS(ph)GS(ph)SSPDSEITELK -1.2032 -1.4203 -0.2224 SILAC 1 / Biological 1 Raptor down Rictor down
P13864 EADDDEEADDDVSEMPS(ph)PK -1.6517 -1.1035 0.0638 SILAC 1 / Biological 1 Raptor down Rictor down
P13864 EADDDEEADDDVSEMPS(ph)PK -1.6517 -1.1015 0.0723 SILAC 1 / Biological 1 Raptor down Rictor down
Q99NH0 EHYPVS(ph)SPSS(ph)PSPPAQPGGVSR -1.7719 -1.7854 -0.4115 SILAC 1 / Biological 1 Raptor down Rictor down
Q99NH0 EHYPVS(ph)SPSS(ph)PSPPAQPGGVSR -1.7719 -1.7758 -0.4115 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BP27 ENPPS(ph)PPT(ph)SPAAPQPR -2.2444 -2.3596 -0.2269 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BP27 ENPPS(ph)PPT(ph)SPAAPQPR -2.2496 -2.3687 -0.2145 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BP27 ENPPS(ph)PPT(ph)SPAAPQPR -1.1809 -1.2699 -0.0911 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BP27 ENPPS(ph)PPT(ph)SPAAPQPR -1.2326 -1.3131 -0.0667 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BP27 ENPPS(ph)PPTS(ph)PAAPQPR -1.1292 -1.2266 -0.1154 SILAC 1 / Biological 1 Raptor down Rictor down
Q6PAM1 EQGVESPGAQPAS(ph)SPR -1.7594 -1.1115 -0.4826 SILAC 1 / Biological 1 Raptor down Rictor down
Q6PAM1 EQGVESPGAQPAS(ph)SPR -1.7541 -1.0906 -0.4462 SILAC 1 / Biological 1 Raptor down Rictor down
Q6PAM1 EQGVESPGAQPASS(ph)PR -1.3066 -1.0687 -0.0787 SILAC 1 / Biological 1 Raptor down Rictor down
Q62261 ESS(ph)PVPS(ph)PTLDR -1.3178 -1.6312 -0.2389 SILAC 1 / Biological 1 Raptor down Rictor down
Q62261 ESS(ph)PVPS(ph)PTLDR -1.3178 -1.6312 -0.2389 SILAC 1 / Biological 1 Raptor down Rictor down
B2RUB9 GPPDFS(ph)S(ph)DEEREPTPVLGSGASVGR -2.1577 -1.9798 -0.3201 SILAC 1 / Biological 1 Raptor down Rictor down
B2RUB9 GPPDFS(ph)S(ph)DEEREPTPVLGSGASVGR -2.1577 -1.9798 -0.3201 SILAC 1 / Biological 1 Raptor down Rictor down
B2RUB9 GPPDFS(ph)S(ph)DEEREPTPVLGSGASVGR -2.1354 -1.9814 -0.2983 SILAC 1 / Biological 1 Raptor down Rictor down
B2RUB9 GPPDFS(ph)S(ph)DEEREPTPVLGSGASVGR -2.1354 -1.9814 -0.2800 SILAC 1 / Biological 1 Raptor down Rictor down
B2RUB9 GPPDFS(ph)SDEEREPTPVLGS(ph)GASVGR -3.3970 -2.2233 -0.4160 SILAC 1 / Biological 1 Raptor down Rictor down
B2RUB9 GPPDFS(ph)SDEEREPTPVLGS(ph)GASVGR -3.3970 -2.2233 -0.4160 SILAC 1 / Biological 1 Raptor down Rictor down
Q9ESV0 KAQAVS(ph)EEEEEEEGQSSS(ph)PK -1.7200 -1.5679 0.1735 SILAC 1 / Biological 1 Raptor down Rictor down
Q9ESV0 KAQAVS(ph)EEEEEEEGQSSS(ph)PK -1.7200 -1.5679 0.1735 SILAC 1 / Biological 1 Raptor down Rictor down
Q9ESV0 KAQAVS(ph)EEEEEEEGQSSS(ph)PK -1.7063 -1.5679 0.2009 SILAC 1 / Biological 1 Raptor down Rictor down
Q9ESV0 KAQAVS(ph)EEEEEEEGQSSS(ph)PK -1.7063 -1.5679 0.2009 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPH4 KILDPNSGEPAPVLSS(ph)PTPTDLSTFLSFPS(ph)PEK -1.8564 -2.1857 -0.1584 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPH4 KILDPNSGEPAPVLSS(ph)PTPTDLSTFLSFPS(ph)PEK -1.8564 -2.1857 -0.1443 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPH4 KILDPNSGEPAPVLSS(ph)PTPTDLSTFLSFPS(ph)PEK -1.8938 -2.4445 -0.1211 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPH4 KILDPNSGEPAPVLSS(ph)PTPTDLSTFLSFPS(ph)PEK -1.8938 -2.4445 -0.0930 SILAC 1 / Biological 1 Raptor down Rictor down
Q52KI8 KPPAPPS(ph)PVQS(ph)QS(ph)PSTNWSPAVPAK -1.1642 -1.1553 0.3125 SILAC 1 / Biological 1 Raptor down Rictor down
Q52KI8 KPPAPPS(ph)PVQS(ph)QS(ph)PSTNWSPAVPAK -1.1642 -1.1553 0.4950 SILAC 1 / Biological 1 Raptor down Rictor down
Q52KI8 KPPAPPS(ph)PVQSQS(ph)PSTNWS(ph)PAVPAK -1.1412 -1.3577 0.4378 SILAC 1 / Biological 1 Raptor down Rictor down
Q52KI8 KPPAPPS(ph)PVQSQS(ph)PSTNWS(ph)PAVPAK -1.1412 -1.3577 0.4378 SILAC 1 / Biological 1 Raptor down Rictor down
O88379 KRQS(ph)TES(ph)SPVPLNR -2.2271 -1.2854 -0.3048 SILAC 1 / Biological 1 Raptor down Rictor down
O88379 KRQS(ph)TES(ph)SPVPLNR -2.2271 -1.2854 -0.2980 SILAC 1 / Biological 1 Raptor down Rictor down
A2RSX9 KWS(ph)LNTYK -2.2451 -1.4787 0.4208 SILAC 1 / Biological 1 Raptor down Rictor down
P48678 LRLSPS(ph)PTSQR -2.1351 -2.1629 -0.0024 SILAC 1 / Biological 1 Raptor down Rictor down
P48678 LRLSPS(ph)PTSQR -2.1066 -2.1190 0.0852 SILAC 1 / Biological 1 Raptor down Rictor down
P20152 MFGGS(ph)GTSSRPSSNR -1.8489 -1.7250 -0.1068 SILAC 1 / Biological 1 Raptor down Rictor down
P20152 MFGGS(ph)GTSSRPSSNR -1.8204 -1.7250 -0.0954 SILAC 1 / Biological 1 Raptor down Rictor down
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Q6ZPJ3 NMTVEQLLTGS(ph)PT(ph)SPTVEPEKPTR -1.4182 -2.2210 -0.5973 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PT(ph)SPTVEPEKPTR -1.4179 -2.2261 -0.5908 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PTS(ph)PTVEPEKPTR -1.5780 -2.3971 -0.6898 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PTS(ph)PTVEPEKPTR -1.5780 -2.3971 -0.6898 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PTS(ph)PTVEPEKPTR -1.4981 -2.3090 -0.6436 SILAC 1 / Biological 1 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PTS(ph)PTVEPEKPTR -1.4979 -2.3116 -0.6403 SILAC 1 / Biological 1 Raptor down Rictor down
Q0VAV8 NNPS(ph)PPPDSDLER -1.5170 -1.8763 0.1276 SILAC 1 / Biological 1 Raptor down Rictor down
Q0VAV8 NNPS(ph)PPPDSDLER -1.5250 -1.8077 0.1474 SILAC 1 / Biological 1 Raptor down Rictor down
Q61234 NSAGGTSVGWDS(ph)PPAS(ph)PLQR -1.4830 -1.1411 0.1535 SILAC 1 / Biological 1 Raptor down Rictor down
Q61234 NSAGGTSVGWDS(ph)PPAS(ph)PLQR -1.4830 -1.1411 0.1535 SILAC 1 / Biological 1 Raptor down Rictor down
Q61234 NSAGGTSVGWDS(ph)PPAS(ph)PLQR -1.4830 -1.1411 0.1658 SILAC 1 / Biological 1 Raptor down Rictor down
Q61234 NSAGGTSVGWDS(ph)PPAS(ph)PLQR -1.4830 -1.1411 0.1658 SILAC 1 / Biological 1 Raptor down Rictor down
Q9Z277 RDS(ph)SSLSS(ph)PLNPK -1.7719 -2.2856 -0.5820 SILAC 1 / Biological 1 Raptor down Rictor down
Q9Z277 RDS(ph)SSLSS(ph)PLNPK -1.7719 -2.2856 -0.5820 SILAC 1 / Biological 1 Raptor down Rictor down
P97496 RKPS(ph)PSPPPPTATES(ph)R -1.3043 -1.1455 -0.7488 SILAC 1 / Biological 1 Raptor down Rictor down
P97496 RKPS(ph)PSPPPPTATES(ph)R -1.3043 -1.1455 -0.7488 SILAC 1 / Biological 1 Raptor down Rictor down
Q3TIY5 RLEIS(ph)PDS(ph)SPER -1.1571 -1.8649 -0.3022 SILAC 1 / Biological 1 Raptor down Rictor down
Q3TIY5 RLEIS(ph)PDS(ph)SPER -1.1571 -1.8614 -0.3015 SILAC 1 / Biological 1 Raptor down Rictor down
Q9JJZ4 RPS(ph)TSPDVLQGQPPR -1.2746 -1.1853 -0.0072 SILAC 1 / Biological 1 Raptor down Rictor down
Q9JJZ4 RPS(ph)TSPDVLQGQPPR -1.2746 -1.1379 -0.0072 SILAC 1 / Biological 1 Raptor down Rictor down
Q4VAC9 RS(ph)S(ph)LAIEDGK -1.7097 -1.4793 -0.2996 SILAC 1 / Biological 1 Raptor down Rictor down
Q4VAC9 RS(ph)S(ph)LAIEDGK -1.7097 -1.4793 -0.2996 SILAC 1 / Biological 1 Raptor down Rictor down
Q4VAC9 RS(ph)S(ph)LAIEDGK -1.7097 -1.4793 -0.2996 SILAC 1 / Biological 1 Raptor down Rictor down
Q4VAC9 RS(ph)S(ph)LAIEDGK -1.7097 -1.4793 -0.2996 SILAC 1 / Biological 1 Raptor down Rictor down
Q9WU62 RTS(ph)S(ph)AVWNS(ph)PPLK -1.4518 -2.4221 -0.8667 SILAC 1 / Biological 1 Raptor down Rictor down
Q9WU62 RTS(ph)S(ph)AVWNS(ph)PPLK -1.4518 -2.4221 -0.8667 SILAC 1 / Biological 1 Raptor down Rictor down
Q9WU62 RTS(ph)S(ph)AVWNS(ph)PPLK -1.4518 -2.4221 -0.8667 SILAC 1 / Biological 1 Raptor down Rictor down
Q9WU62 RTS(ph)S(ph)AVWNS(ph)PPLK -1.4518 -2.4221 -0.8667 SILAC 1 / Biological 1 Raptor down Rictor down
Q9WU62 RTS(ph)S(ph)AVWNS(ph)PPLK -1.4518 -2.4221 -0.8667 SILAC 1 / Biological 1 Raptor down Rictor down
Q9WU62 RTS(ph)S(ph)AVWNS(ph)PPLK -1.4518 -2.4221 -0.8667 SILAC 1 / Biological 1 Raptor down Rictor down
Q5SSI6 RTSS(ph)DDES(ph)EEDEDDLLQR -1.3066 -1.1204 -0.2750 SILAC 1 / Biological 1 Raptor down Rictor down
Q5SSI6 RTSS(ph)DDES(ph)EEDEDDLLQR -1.2496 -1.1204 -0.2522 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 S(ph)EGTTPEKNAASQQDAVTEGAMPAATGK -1.0014 -1.3611 -0.3876 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 S(ph)EGTTPEKNAASQQDAVTEGAMPAATGK -1.0014 -1.3611 -0.3876 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QXS1 S(ph)SSVGSSS(ph)SYPISSAGPR -1.2222 -1.5649 -0.2019 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QXS1 S(ph)SSVGSSS(ph)SYPISSAGPR -1.2222 -1.5552 -0.2019 SILAC 1 / Biological 1 Raptor down Rictor down
P43276 SETAPAET(ph)AAPAPVEKSPAKK -2.1406 -1.3635 -0.1432 SILAC 1 / Biological 1 Raptor down Rictor down
P43276 SETAPAET(ph)AAPAPVEKSPAKK -2.1406 -1.3635 -0.1432 SILAC 1 / Biological 1 Raptor down Rictor down
P48678 SGAQASST(ph)PLSPT(ph)R -1.6801 -1.3909 -0.0564 SILAC 1 / Biological 1 Raptor down Rictor down
P48678 SGAQASST(ph)PLSPT(ph)R -1.6801 -1.3909 -0.0069 SILAC 1 / Biological 1 Raptor down Rictor down
P48678 SGAQASSTPLS(ph)PTR -1.9304 -2.0748 -0.3348 SILAC 1 / Biological 1 Raptor down Rictor down
P48678 SGAQASSTPLS(ph)PTR -1.9304 -2.0748 -0.3348 SILAC 1 / Biological 1 Raptor down Rictor down
Q99L45 SGDEM(ox)IFDPTMS(ph)K -1.3521 -1.1090 0.2504 SILAC 1 / Biological 1 Raptor down Rictor down
Q99L45 SGDEM(ox)IFDPTMS(ph)K -1.3586 -1.1107 0.2524 SILAC 1 / Biological 1 Raptor down Rictor down
O70310 SGLS(ph)PANDTGAK -1.2357 -1.5624 -0.1658 SILAC 1 / Biological 1 Raptor down Rictor down
O70310 SGLS(ph)PANDTGAK -1.3317 -1.5203 0.0124 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 SPAPSNPT(ph)LSPSTPAK -3.4423 -2.9839 0.3659 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 SPAPSNPT(ph)LSPSTPAK -3.1742 -2.4928 0.4877 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 SPAPSNPTLSPS(ph)TPAK -2.2764 -2.0548 0.2665 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 SPAPSNPTLSPS(ph)TPAK -2.2764 -2.0548 0.2665 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 SPAPSNPTLSPST(ph)PAK -3.3990 -2.6348 -0.3990 SILAC 1 / Biological 1 Raptor down Rictor down
Q7TPV4 SPAPSNPTLSPST(ph)PAK -3.3942 -2.7300 -0.2717 SILAC 1 / Biological 1 Raptor down Rictor down
Q64337 SRLT(ph)PTT(ph)PESSSTGTEDK -2.1821 -1.6472 -0.0194 SILAC 1 / Biological 1 Raptor down Rictor down
Q64337 SRLTPT(ph)T(ph)PESSSTGTEDK -1.9882 -1.5303 0.0093 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QYG0 SRT(ph)AS(ph)LTSAASIDGSR -0.9994 -1.7238 -0.7768 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QYG0 SRT(ph)AS(ph)LTSAASIDGSR -0.9994 -1.7238 -0.7768 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QYG0 SRT(ph)AS(ph)LTSAASIDGSR -1.2912 -1.4822 -0.7332 SILAC 1 / Biological 1 Raptor down Rictor down
Q9QYG0 SRT(ph)AS(ph)LTSAASIDGSR -1.2912 -1.4822 -0.7332 SILAC 1 / Biological 1 Raptor down Rictor down
Q8VCV2 SRT(ph)HS(ph)TSSSIGSGESPFSR -1.2770 -1.2237 -0.4068 SILAC 1 / Biological 1 Raptor down Rictor down
Q8VCV2 SRT(ph)HS(ph)TSSSIGSGESPFSR -1.2770 -1.2237 -0.4068 SILAC 1 / Biological 1 Raptor down Rictor down
P26231 SRTS(ph)VQT(ph)EDDQLIAGQSAR -1.5235 -1.7041 -0.2995 SILAC 1 / Biological 1 Raptor down Rictor down
P26231 SRTS(ph)VQT(ph)EDDQLIAGQSAR -1.5235 -1.7041 -0.2995 SILAC 1 / Biological 1 Raptor down Rictor down
P26231 SRTS(ph)VQT(ph)EDDQLIAGQSAR -1.4353 -1.7041 -0.0809 SILAC 1 / Biological 1 Raptor down Rictor down
P26231 SRTS(ph)VQT(ph)EDDQLIAGQSAR -1.4353 -1.7041 -0.0809 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BTI8 SSS(ph)PVTELTARS(ph)PVK -1.2129 -1.1554 0.5848 SILAC 1 / Biological 1 Raptor down Rictor down
Q09XV5 T(ph)ASPS(ph)PLRPDAPVEK -1.0960 -1.7757 -0.4142 SILAC 1 / Biological 1 Raptor down Rictor down
Q09XV5 T(ph)ASPS(ph)PLRPDAPVEK -1.0960 -1.7459 -0.4142 SILAC 1 / Biological 1 Raptor down Rictor down
Q80YV2 T(ph)WGSVVRSPEGT(ph)PQK -4.4457 -1.2636 -0.0153 SILAC 1 / Biological 1 Raptor down Rictor down
Q80YV2 T(ph)WGSVVRSPEGT(ph)PQK -4.3911 -1.2567 -0.0022 SILAC 1 / Biological 1 Raptor down Rictor down
Q09XV5 TAS(ph)PS(ph)PLRPDAPVEK -1.3285 -1.8399 -0.4830 SILAC 1 / Biological 1 Raptor down Rictor down
Q09XV5 TAS(ph)PS(ph)PLRPDAPVEK -1.3285 -1.8548 -0.4783 SILAC 1 / Biological 1 Raptor down Rictor down
B2RT41 TSSSS(ph)PANS(ph)DVEMDGIGR -3.8809 -1.6616 -0.2912 SILAC 1 / Biological 1 Raptor down Rictor down
B2RT41 TSSSS(ph)PANS(ph)DVEMDGIGR -3.8809 -1.6616 -0.2912 SILAC 1 / Biological 1 Raptor down Rictor down
B2RT41 TSSSS(ph)PANS(ph)DVEMDGIGR -3.8809 -1.6519 -0.2912 SILAC 1 / Biological 1 Raptor down Rictor down
B2RT41 TSSSS(ph)PANS(ph)DVEMDGIGR -3.8809 -1.6519 -0.2912 SILAC 1 / Biological 1 Raptor down Rictor down
Q4JIM5 TVS(ph)TSS(ph)QPEENVDR -2.8967 -1.3384 0.1638 SILAC 1 / Biological 1 Raptor down Rictor down
Q4JIM5 TVS(ph)TSS(ph)QPEENVDR -2.8967 -1.3384 0.1638 SILAC 1 / Biological 1 Raptor down Rictor down
Q4JIM5 TVS(ph)TSS(ph)QPEENVDR -2.8845 -1.3384 0.1707 SILAC 1 / Biological 1 Raptor down Rictor down
Q4JIM5 TVS(ph)TSS(ph)QPEENVDR -2.8845 -1.3384 0.1707 SILAC 1 / Biological 1 Raptor down Rictor down
Q921K9 VDSSTNSSPS(ph)PQQSESLSPAHTS(ph)DFR -3.1617 -2.1517 0.2994 SILAC 1 / Biological 1 Raptor down Rictor down
Q921K9 VDSSTNSSPS(ph)PQQSESLSPAHTS(ph)DFR -3.1617 -2.1517 0.2994 SILAC 1 / Biological 1 Raptor down Rictor down
Q921K9 VDSSTNSSPS(ph)PQQSESLSPAHTS(ph)DFR -3.2573 -2.1534 0.4034 SILAC 1 / Biological 1 Raptor down Rictor down
Q921K9 VDSSTNSSPS(ph)PQQSESLSPAHTS(ph)DFR -3.2573 -2.1534 0.4034 SILAC 1 / Biological 1 Raptor down Rictor down
O88792 VIYSQPS(ph)T(ph)RSEGEFK -1.6996 -1.5759 -0.2401 SILAC 1 / Biological 1 Raptor down Rictor down
O88792 VIYSQPS(ph)T(ph)RSEGEFK -1.7408 -1.6366 -0.2399 SILAC 1 / Biological 1 Raptor down Rictor down
O88792 VIYSQPS(ph)TRS(ph)EGEFK -1.4110 -2.2099 -0.3085 SILAC 1 / Biological 1 Raptor down Rictor down
O88792 VIYSQPS(ph)TRS(ph)EGEFK -1.4110 -2.2072 -0.3085 SILAC 1 / Biological 1 Raptor down Rictor down
O88792 VIYSQPS(ph)TRS(ph)EGEFK -1.5168 -1.9212 -0.2808 SILAC 1 / Biological 1 Raptor down Rictor down
O88792 VIYSQPS(ph)TRS(ph)EGEFK -1.5126 -1.9212 -0.2808 SILAC 1 / Biological 1 Raptor down Rictor down
Q8BTI8 AQSGTDS(ph)S(ph)PEHKIPAPR -1.6663 -1.0702 -0.5927 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 ARLS(ph)LVSRS(ph)PS(ph)LLQSGVK -1.9154 -2.7675 -0.4854 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 DIPSDT(ph)QSPVSTK -2.0056 -1.7452 -0.3245 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 DIPSDTQS(ph)PVSTK -1.6784 -1.5943 -0.0815 SILAC 1 / Biological 2 Raptor down Rictor down
P70698 DTYSDRS(ph)GS(ph)SSPDSEITELK -1.6887 -1.7155 -0.6943 SILAC 1 / Biological 2 Raptor down Rictor down
Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR -1.1744 -1.1631 -0.5906 SILAC 1 / Biological 2 Raptor down Rictor down
Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR -1.1744 -1.1631 -0.5906 SILAC 1 / Biological 2 Raptor down Rictor down
Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR -1.1744 -1.1631 -0.5906 SILAC 1 / Biological 2 Raptor down Rictor down
Q3UHX0 FQDSS(ph)S(ph)EEEDIAEEADHS(ph)KPSPGEAVPENEAIR -2.8238 -1.0673 0.0164 SILAC 1 / Biological 2 Raptor down Rictor down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -1.1975 -2.1966 -0.9280 SILAC 1 / Biological 2 Raptor down Rictor down
Q64337 IALESVGQPEEQM(ox)ESGNCSGGDDDWT(ph)HLSSK -1.3213 -1.2917 0.0744 SILAC 1 / Biological 2 Raptor down Rictor down
Q6ZPH4 KILDPNSGEPAPVLS(ph)SPTPTDLSTFLSFPS(ph)PEK -1.3189 -2.1561 -0.5925 SILAC 1 / Biological 2 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PTS(ph)PTVEPEKPTR -1.0648 -2.1352 -0.9279 SILAC 1 / Biological 2 Raptor down Rictor down
P97496 RKPS(ph)PSPPPPT(ph)ATESR -1.3333 -1.8731 -0.4831 SILAC 1 / Biological 2 Raptor down Rictor down
Q80V30 RRS(ph)S(ph)TLAPAQPDGTESEWTDVETR -1.4411 -2.0960 -0.8788 SILAC 1 / Biological 2 Raptor down Rictor down
Q80V30 RRS(ph)S(ph)TLAPAQPDGTESEWTDVETR -1.4411 -2.0960 -0.8788 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 S(ph)PSLLQS(ph)GVK -1.8072 -1.4743 -0.1512 SILAC 1 / Biological 2 Raptor down Rictor down
Q99K70 SCSHQT(ph)SAPSLK -1.0506 -1.5572 -0.4472 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 SPAPSNPT(ph)LSPSTPAK -1.7662 -1.9940 0.2804 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 SPAPSNPTLS(ph)PS(ph)TPAK -1.9774 -1.8247 0.2295 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 SPAPSNPTLS(ph)PST(ph)PAK -1.8267 -1.4232 0.2113 SILAC 1 / Biological 2 Raptor down Rictor down
Q7TPV4 SPAPSNPTLSPST(ph)PAKT(ph)PK -1.9700 -1.7445 -0.3353 SILAC 1 / Biological 2 Raptor down Rictor down
Q8K2D3 SQDVAISPQQQQCSKS(ph)Y(ph)VDR -4.1726 -1.8244 0.3744 SILAC 1 / Biological 2 Raptor down Rictor down
O08582 SRS(ph)PVDSPVPASMFAPEPSS(ph)PGAAR -1.4421 -1.3662 -0.4334 SILAC 1 / Biological 2 Raptor down Rictor down
B2RWS6 TDGKEEEEQPSTSATQSS(ph)PAPGQSK -1.0391 -1.5543 -0.3796 SILAC 1 / Biological 2 Raptor down Rictor down
Q9QWY8 TLS(ph)DPPS(ph)PLPHGPPNK -0.9997 -1.2212 -0.3388 SILAC 1 / Biological 2 Raptor down Rictor down
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Q6ZQ58 VEPAWHDQDETS(ph)SVKSDGAGGAR -1.2710 -1.2034 -0.0910 SILAC 1 / Biological 2 Raptor down Rictor down
Q8BRB8 LPSGSGPASPTTGS(ph)AVDIR -1.2917 -1.6384 -0.7607 SILAC 2 / Biological 3 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGSPTS(ph)PTVEPEKPTR -1.7222 -1.1166 0.5952 SILAC 2 / Biological 3 Raptor down Rictor down
Q8C1D8 RLS(ph)STGGQTPR -1.5340 -1.2621 0.4308 SILAC 2 / Biological 3 Raptor down Rictor down
Q8C1D8 RLS(ph)STGGQTPR -1.5340 -1.2621 0.4308 SILAC 2 / Biological 3 Raptor down Rictor down
Q64337 SRLT(ph)PTT(ph)PESSSTGTEDK -1.5096 -1.1779 0.1344 SILAC 2 / Biological 3 Raptor down Rictor down
Q6P9R2 TEDGGWEWS(ph)DDEFDEESEEGR -1.1166 -1.2850 -0.3453 SILAC 2 / Biological 3 Raptor down Rictor down
Q6PAM1 EQGVES(ph)PGAQPASS(ph)PR -1.0430 -1.0779 -0.5360 SILAC 3 / Biological 4 Raptor down Rictor down
Q9ESL4 NFSS(ph)LNLSSR -1.2187 -1.0739 0.0485 SILAC 3 / Biological 4 Raptor down Rictor down
Q6ZPJ3 NMTVEQLLTGSPTSPT(ph)VEPEKPTR -1.4983 -1.0981 0.2703 SILAC 3 / Biological 4 Raptor down Rictor down
P52293 NVS(ph)SFPDDATSPLQENR -1.0461 -1.7328 -0.3149 SILAC 3 / Biological 4 Raptor down Rictor down
P52293 NVS(ph)SFPDDATSPLQENR -1.0461 -1.7328 -0.3149 SILAC 3 / Biological 4 Raptor down Rictor down
Q9JIK5 S(ph)NSSDAPGEES(ph)SSETEKEIPVEQK -1.9674 -1.3842 0.5995 SILAC 3 / Biological 4 Raptor down Rictor down
P97825 S(ph)NSSEASSGDFLDLK -1.3346 -1.3024 0.3219 SILAC 3 / Biological 4 Raptor down Rictor down
Q71FD5 AY(ph)SGSDLPSGT(ph)GSGGGGADGARAAR -2.5113 4.9569 5.4858 SILAC 1 / Biological 1 Raptor down Rictor up H/M up
Q99P31 LLQTCFSS(ph)PTDDSM(ox)DR -1.1476 1.2658 2.6584 SILAC 2 / Biological 3 Raptor down Rictor up H/M up
O08784 ASAVS(ph)PEKAPMTSK -1.0616 0.8497 2.3783 SILAC 3 / Biological 4 Raptor down Rictor up H/M up
Q61892 GGDYALAPGSQSS(ph)EMS(ph)LR -7.4230 1.7893 3.5858 SILAC 3 / Biological 4 Raptor down Rictor up H/M up
Q61892 GGDYALAPGSQSS(ph)EMS(ph)LR -7.4230 1.7893 3.5858 SILAC 3 / Biological 4 Raptor down Rictor up H/M up
P52293 RNVSSFPDDAT(ph)SPLQENR -1.2570 -0.3598 -1.5897 SILAC 1 / Biological 2 Raptor down H/M down
Q80U93 STQTAPSSAPS(ph)TGQKSPR -1.1887 -1.0647 -1.8365 SILAC 1 / Biological 2 Raptor down H/M down
B2RT41 TSS(ph)SSPANS(ph)DVEMDGIGR -1.0474 -0.7850 -2.8847 SILAC 1 / Biological 2 Raptor down H/M down
B2RQC6 IHRAS(ph)DPGLPAEEPK -1.7037 -0.9627 0.9493 SILAC 2 / Biological 3 Raptor down H/M up  +
B2RQC6 IHRAS(ph)DPGLPAEEPK -1.4514 -0.5579 0.9843 SILAC 3 / Biological 4 Raptor down H/M up  +
P43274 (ac)SETAPAAPAAPAPAEKT(ph)PVK -1.3114 -0.3112 1.2136 SILAC 1 / Biological 1 Raptor down H/M up
P43277 (ac)SETAPAAPAAPAPVEKT(ph)PVK -1.2643 -0.2017 1.2677 SILAC 1 / Biological 1 Raptor down H/M up
Q8BX17 APS(ph)QPPSPT(ph)EER -1.3355 -0.9756 1.0834 SILAC 1 / Biological 1 Raptor down H/M up
Q8BX17 APS(ph)QPPSPT(ph)EER -1.3355 -0.9756 1.0834 SILAC 1 / Biological 1 Raptor down H/M up
Q7TPV4 DIPSDTQS(ph)PVSTK -1.0487 -0.4267 0.7564 SILAC 1 / Biological 1 Raptor down H/M up
Q3UGP0 DLYRPLS(ph)SDDLDS(ph)VGDSV -1.0266 0.5716 0.9443 SILAC 1 / Biological 1 Raptor down H/M up
Q3UGP0 DLYRPLS(ph)SDDLDS(ph)VGDSV -1.0266 0.5716 0.9443 SILAC 1 / Biological 1 Raptor down H/M up
Q3UGP0 DLYRPLS(ph)SDDLDS(ph)VGDSV -1.0759 0.5890 0.9540 SILAC 1 / Biological 1 Raptor down H/M up
Q3UGP0 DLYRPLS(ph)SDDLDS(ph)VGDSV -1.0759 0.5890 0.9540 SILAC 1 / Biological 1 Raptor down H/M up
P70698 DTY(ph)SDRS(ph)GSSS(ph)PDSEITELK -1.3252 -1.0159 0.8984 SILAC 1 / Biological 1 Raptor down H/M up
Q9QXS1 GYYSPY(ph)SVSGSGS(ph)TAGSR -1.0829 -0.0088 1.2185 SILAC 1 / Biological 1 Raptor down H/M up
Q9QXS1 GYYSPY(ph)SVSGSGS(ph)TAGSR -1.0829 -0.0088 1.2185 SILAC 1 / Biological 1 Raptor down H/M up
Q9QXS1 GYYSPY(ph)SVSGSGS(ph)TAGSR -1.0829 0.0009 1.2185 SILAC 1 / Biological 1 Raptor down H/M up
Q9QXS1 GYYSPY(ph)SVSGSGS(ph)TAGSR -1.0829 0.0009 1.2185 SILAC 1 / Biological 1 Raptor down H/M up
Q8K4Q0 ILDTSSLTQS(ph)APAS(ph)PTNK -2.0257 -0.4242 1.4214 SILAC 1 / Biological 1 Raptor down H/M up
Q8K4Q0 ILDTSSLTQS(ph)APAS(ph)PTNK -2.0476 -0.4242 1.4225 SILAC 1 / Biological 1 Raptor down H/M up
Q52KI8 KPPAPPS(ph)PVQS(ph)QSPST(ph)NWSPAVPAK -1.2771 -0.6614 0.9900 SILAC 1 / Biological 1 Raptor down H/M up
Q52KI8 KPPAPPS(ph)PVQS(ph)QSPST(ph)NWSPAVPAK -1.2567 -0.6074 1.0081 SILAC 1 / Biological 1 Raptor down H/M up
P20152 LRSS(ph)VPGVR -1.4467 -1.0186 0.7796 SILAC 1 / Biological 1 Raptor down H/M up
P20152 LRSS(ph)VPGVR -1.4467 -1.0186 0.7821 SILAC 1 / Biological 1 Raptor down H/M up
P62754 LSSLRAST(ph)SKSESS(ph)QK -1.0284 -0.1108 1.2598 SILAC 1 / Biological 1 Raptor down H/M up
P62754 LSSLRAST(ph)SKSESS(ph)QK -1.0284 -0.1108 1.2598 SILAC 1 / Biological 1 Raptor down H/M up
P14404 NFIGNSNHGSQS(ph)PR -1.8254 0.1349 2.5021 SILAC 1 / Biological 1 Raptor down H/M up
P14404 NFIGNSNHGSQS(ph)PR -1.8254 0.1349 2.5021 SILAC 1 / Biological 1 Raptor down H/M up
Q8K019 NTPS(ph)QHSHSIQHS(ph)PER -1.4011 -0.5820 0.8882 SILAC 1 / Biological 1 Raptor down H/M up
Q8K019 NTPS(ph)QHSHSIQHS(ph)PER -1.4011 -0.5820 0.8882 SILAC 1 / Biological 1 Raptor down H/M up
Q6NS46 QES(ph)ESEQELVNK -1.0622 -0.1720 0.8331 SILAC 1 / Biological 1 Raptor down H/M up
Q6NS46 QES(ph)ESEQELVNK -1.0622 -0.2099 0.8425 SILAC 1 / Biological 1 Raptor down H/M up
O35130 RFS(ph)VQEQDWETT(ph)PPKK -1.4961 -0.5209 1.0294 SILAC 1 / Biological 1 Raptor down H/M up
O35130 RFS(ph)VQEQDWETT(ph)PPKK -1.5025 -0.5209 1.0378 SILAC 1 / Biological 1 Raptor down H/M up
Q8CI59 RLVDS(ph)DGS(ph)LAEVPK -1.7651 0.5896 2.0451 SILAC 1 / Biological 1 Raptor down H/M up
Q8CI59 RLVDS(ph)DGS(ph)LAEVPK -1.7651 0.5896 2.0451 SILAC 1 / Biological 1 Raptor down H/M up
Q8CI59 RLVDS(ph)DGS(ph)LAEVPK -1.7718 0.6481 2.0451 SILAC 1 / Biological 1 Raptor down H/M up
Q8CI59 RLVDS(ph)DGS(ph)LAEVPK -1.7718 0.6481 2.0451 SILAC 1 / Biological 1 Raptor down H/M up
Q8K3X4 RNSSS(ph)PVS(ph)PASVPGQR -1.1324 -0.0650 0.8989 SILAC 1 / Biological 1 Raptor down H/M up
Q8K3X4 RNSSS(ph)PVS(ph)PASVPGQR -1.1324 -0.0671 1.0397 SILAC 1 / Biological 1 Raptor down H/M up
Q3UGP0 S(ph)GKSPSPSPT(ph)SPGSLR -1.1628 0.5785 1.2862 SILAC 1 / Biological 1 Raptor down H/M up
Q3UGP0 S(ph)GKSPSPSPT(ph)SPGSLR -1.1628 0.5785 1.2862 SILAC 1 / Biological 1 Raptor down H/M up
P31750 S(ph)GSPSDNSGAEEMEVSLAKPK -1.3492 0.5463 1.3840 SILAC 1 / Biological 1 Raptor down H/M up
P31750 S(ph)GSPSDNSGAEEMEVSLAKPK -1.3492 0.5463 1.3840 SILAC 1 / Biological 1 Raptor down H/M up
P31750 SGS(ph)PSDNS(ph)GAEEMEVSLAKPK -1.3354 0.5453 1.0685 SILAC 1 / Biological 1 Raptor down H/M up
P31750 SGS(ph)PSDNS(ph)GAEEMEVSLAKPK -1.3354 0.5453 1.0685 SILAC 1 / Biological 1 Raptor down H/M up
Q8BTI8 SMLQT(ph)PPDQNLSGS(ph)KSPCPQK -1.3245 -0.2164 0.9470 SILAC 1 / Biological 1 Raptor down H/M up
Q8BTI8 SMLQT(ph)PPDQNLSGS(ph)KSPCPQK -1.3156 -0.2721 0.9561 SILAC 1 / Biological 1 Raptor down H/M up
Q8BTI8 SMLQT(ph)PPDQNLSGSKS(ph)PCPQK -1.4783 -0.1167 0.8714 SILAC 1 / Biological 1 Raptor down H/M up
Q8BTI8 SMLQT(ph)PPDQNLSGSKS(ph)PCPQK -1.4757 -0.1155 0.8714 SILAC 1 / Biological 1 Raptor down H/M up
Q7TNL7 SNIS(ph)PNFNFMGQLLDFER -1.6747 -0.2397 0.7924 SILAC 1 / Biological 1 Raptor down H/M up
Q7TNL7 SNIS(ph)PNFNFMGQLLDFER -1.5082 -0.2537 0.7949 SILAC 1 / Biological 1 Raptor down H/M up
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -1.5644 -0.4083 1.0495 SILAC 1 / Biological 1 Raptor down H/M up
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -1.5592 -0.5792 1.0530 SILAC 1 / Biological 1 Raptor down H/M up
Q4VAC9 SSS(ph)VLS(ph)LEGSDK -1.5433 -0.4693 0.8899 SILAC 1 / Biological 1 Raptor down H/M up
Q4VAC9 SSS(ph)VLS(ph)LEGSDK -1.5433 -0.4693 0.8899 SILAC 1 / Biological 1 Raptor down H/M up
Q4VAC9 SSS(ph)VLS(ph)LEGSDK -1.4044 -0.4661 0.8926 SILAC 1 / Biological 1 Raptor down H/M up
Q4VAC9 SSS(ph)VLS(ph)LEGSDK -1.4044 -0.4661 0.8926 SILAC 1 / Biological 1 Raptor down H/M up
Q80X50 STSAPQMSPGS(ph)SDNQSSSPQPAQQK -1.4897 -0.6635 0.7946 SILAC 1 / Biological 1 Raptor down H/M up
Q80X50 STSAPQMSPGS(ph)SDNQSSSPQPAQQK -1.5073 -0.6635 0.8057 SILAC 1 / Biological 1 Raptor down H/M up
Q05D44 SVPTVDS(ph)GNEDDDSSFK -1.6196 -0.2193 0.9385 SILAC 1 / Biological 1 Raptor down H/M up
Q05D44 SVPTVDS(ph)GNEDDDSSFK -1.6370 -0.2047 0.9644 SILAC 1 / Biological 1 Raptor down H/M up
Q02248 T(ph)SMGGTQQQFVEGVR -1.0759 0.1367 1.2013 SILAC 1 / Biological 1 Raptor down H/M up
Q02248 T(ph)SMGGTQQQFVEGVR -1.0759 0.1367 1.2013 SILAC 1 / Biological 1 Raptor down H/M up
P49586 T(ph)SPSSS(ph)PASLSR -1.4725 -0.3417 0.8213 SILAC 1 / Biological 1 Raptor down H/M up
Q05D44 TARPNSEAPLS(ph)GS(ph)EDADDSNKLSK -3.6244 0.3873 2.4337 SILAC 1 / Biological 1 Raptor down H/M up
Q05D44 TARPNSEAPLS(ph)GS(ph)EDADDSNKLSK -3.6244 0.3873 2.4337 SILAC 1 / Biological 1 Raptor down H/M up
P70255 TEMDKS(ph)PFNSPSPQDS(ph)PR -1.1442 -0.7933 0.7586 SILAC 1 / Biological 1 Raptor down H/M up
P70255 TEMDKS(ph)PFNSPSPQDS(ph)PR -1.0895 -0.7863 0.7717 SILAC 1 / Biological 1 Raptor down H/M up
Q5NCR9 VLQKPSVFGS(ph)DSDDDETS(ph)VSESLQR -1.0121 -0.2641 1.6889 SILAC 1 / Biological 1 Raptor down H/M up
Q5NCR9 VLQKPSVFGS(ph)DSDDDETS(ph)VSESLQR -1.0121 0.1496 1.6889 SILAC 1 / Biological 1 Raptor down H/M up
Q6NS46 ERQES(ph)ESEQELVNK -1.6654 -0.7673 0.9625 SILAC 1 / Biological 2 Raptor down H/M up
Q8K4Q0 ILDTSSLTQS(ph)APAS(ph)PTNK -2.5867 -0.3083 2.0880 SILAC 1 / Biological 2 Raptor down H/M up
Q9ESV0 KAQAVS(ph)EEEEEEEGQSS(ph)SPK -1.2551 -0.1690 0.8016 SILAC 1 / Biological 2 Raptor down H/M up
P62754 LSS(ph)LRAST(ph)SK -2.0054 0.0081 2.2572 SILAC 1 / Biological 2 Raptor down H/M up
Q8BGD9 RES(ph)EKS(ph)LENETLNK -1.5509 -0.2064 0.7954 SILAC 1 / Biological 2 Raptor down H/M up
Q8BGD9 RES(ph)EKS(ph)LENETLNK -1.4798 -0.3377 1.0169 SILAC 1 / Biological 2 Raptor down H/M up
Q8BGD9 RES(ph)EKSLENET(ph)LNK -2.0600 -0.2064 0.7815 SILAC 1 / Biological 2 Raptor down H/M up
Q61083 RGS(ph)DIDNPTLTVTDISPPSRS(ph)PR -1.2190 -0.1638 1.0338 SILAC 1 / Biological 2 Raptor down H/M up
Q61083 RGS(ph)DIDNPTLTVTDISPPSRS(ph)PR -1.2190 -0.1638 1.0338 SILAC 1 / Biological 2 Raptor down H/M up
Q80V17 RKT(ph)VS(ph)FSAAEEAPVPEPSTAAPLQAK -1.4593 0.2202 1.1709 SILAC 1 / Biological 2 Raptor down H/M up
P62754 RLSS(ph)LRAS(ph)TSK -1.8269 -0.0945 1.9960 SILAC 1 / Biological 2 Raptor down H/M up
P62754 RRLS(ph)S(ph)LR -2.1369 -0.3083 1.8083 SILAC 1 / Biological 2 Raptor down H/M up
P62754 RRLS(ph)S(ph)LR -1.8373 -0.0430 1.8974 SILAC 1 / Biological 2 Raptor down H/M up
Q6NZJ6 S(ph)FSKEVEERS(ph)R -1.3236 -0.0408 1.3112 SILAC 1 / Biological 2 Raptor down H/M up
Q64337 S(ph)RLTPTT(ph)PESSSTGTEDK -1.5842 0.5629 1.7705 SILAC 1 / Biological 2 Raptor down H/M up
Q64337 SRLT(ph)PTT(ph)PESSSTGTEDK -1.8296 0.3203 1.8054 SILAC 1 / Biological 2 Raptor down H/M up
Q64337 SRLT(ph)PTTPES(ph)SSTGTEDK -1.5884 -0.1149 1.8425 SILAC 1 / Biological 2 Raptor down H/M up
Q64337 SRLT(ph)PTTPESS(ph)STGTEDK -1.4931 0.3128 1.8619 SILAC 1 / Biological 2 Raptor down H/M up
Q64337 SRLTPT(ph)T(ph)PESSSTGTEDK -2.4720 -1.0354 1.2383 SILAC 1 / Biological 2 Raptor down H/M up
Q64337 SRLTPT(ph)T(ph)PESSSTGTEDK -1.7525 0.4930 1.4868 SILAC 1 / Biological 2 Raptor down H/M up
Q60875 EAQELGS(ph)PEDR -1.1584 0.3655 1.7557 SILAC 2 / Biological 3 Raptor down H/M up
Q58A65 ERPIS(ph)LGIFPLPAGDGLLT(ph)PDTQK -1.3753 0.0937 1.6573 SILAC 2 / Biological 3 Raptor down H/M up
Q58A65 ERPIS(ph)LGIFPLPAGDGLLT(ph)PDTQK -1.3753 0.0937 1.6573 SILAC 2 / Biological 3 Raptor down H/M up
Q6NS46 ERQES(ph)ESEQELVNK -1.6859 -0.9569 0.9172 SILAC 2 / Biological 3 Raptor down H/M up
Page 3 mTOR regulated phosphorylations
Uniprot Modified Sequence M/L Ratio H/L Ratio H/M Ratio Experiment iRapKO/Control iRicKO/Control iRicKO/iRapKO Peptide array +
Q3TUQ5 GFS(ph)DSGGGPPAK -1.0228 -0.0781 1.2068 SILAC 2 / Biological 3 Raptor down H/M up
Q4VA53 GRTAS(ph)DSDEQQWPEEK -1.6809 -0.0808 1.0018 SILAC 2 / Biological 3 Raptor down H/M up
Q8K4Q0 ILDTSSLTQS(ph)APAS(ph)PTNK -2.1617 -0.4751 1.5640 SILAC 2 / Biological 3 Raptor down H/M up
Q8K4Q0 ILDTSSLTQS(ph)APAS(ph)PTNK -2.2461 -0.4625 1.8610 SILAC 2 / Biological 3 Raptor down H/M up
P09405 KEDS(ph)DEDEDEEDEDDS(ph)DEDEDDEEEDEFEPPIVK -1.2894 -0.8222 0.9409 SILAC 2 / Biological 3 Raptor down H/M up
P09405 KEDS(ph)DEDEDEEDEDDS(ph)DEDEDDEEEDEFEPPIVK -1.2894 -0.8222 0.9409 SILAC 2 / Biological 3 Raptor down H/M up
Q78WZ7 KHS(ph)EEANFES(ph)PK -1.1718 -0.3619 0.8207 SILAC 2 / Biological 3 Raptor down H/M up
Q78WZ7 KHS(ph)EEANFES(ph)PK -1.1718 -0.3619 0.8207 SILAC 2 / Biological 3 Raptor down H/M up
Q6NS46 KSGAAEEDDS(ph)GVEVYYR -1.0396 -0.1168 0.9163 SILAC 2 / Biological 3 Raptor down H/M up
Q8R1A4 MSS(ph)HTETSSFLQTLTGR -1.3905 -0.3514 0.8825 SILAC 2 / Biological 3 Raptor down H/M up
Q6ZQ61 RDS(ph)FDDRGPSLNPVLDYDHGSR -1.0379 0.0010 1.8104 SILAC 2 / Biological 3 Raptor down H/M up
Q6ZQ61 RDSFDDRGPS(ph)LNPVLDYDHGSR -1.3222 -0.6460 0.9216 SILAC 2 / Biological 3 Raptor down H/M up
Q80V17 RKT(ph)VS(ph)FSAAEEAPVPEPSTAAPLQAK -1.5239 -0.2853 1.5848 SILAC 2 / Biological 3 Raptor down H/M up
Q80V17 RKT(ph)VS(ph)FSAAEEAPVPEPSTAAPLQAK -1.4020 0.1829 1.7584 SILAC 2 / Biological 3 Raptor down H/M up
P62754 RLSS(ph)LRAST(ph)SK -2.8225 -0.8700 2.6290 SILAC 2 / Biological 3 Raptor down H/M up
P62754 RRLS(ph)S(ph)LR -2.7225 -0.7373 2.3364 SILAC 2 / Biological 3 Raptor down H/M up
P62754 RRLS(ph)S(ph)LR -3.2167 -0.7580 2.7071 SILAC 2 / Biological 3 Raptor down H/M up
Q6NZJ6 S(ph)FSKEVEERS(ph)R -2.0383 -0.6345 0.8465 SILAC 2 / Biological 3 Raptor down H/M up
Q7TNL7 SNIS(ph)PNFNFMGQLLDFER -1.2540 -0.4902 0.9667 SILAC 2 / Biological 3 Raptor down H/M up
Q9JIK5 SNSSDAPGEES(ph)SSETEKEIPVEQK -1.0071 -0.6198 0.9212 SILAC 2 / Biological 3 Raptor down H/M up
Q7TPV4 SPS(ph)LLQSGVK -1.2562 -0.7663 0.7777 SILAC 2 / Biological 3 Raptor down H/M up
Q64337 SRLT(ph)PTTPES(ph)SSTGTEDK -1.5971 -0.9126 0.7978 SILAC 2 / Biological 3 Raptor down H/M up
Q64337 SRLTPT(ph)TPES(ph)SSTGTEDK -1.6332 -0.8015 1.0754 SILAC 2 / Biological 3 Raptor down H/M up
Q3UMF0 T(ph)LS(ph)SPTGTETNPPKAPR -1.6083 0.7887 2.4277 SILAC 2 / Biological 3 Raptor down H/M up
Q3UMF0 T(ph)LSSPTGTET(ph)NPPKAPR -1.1552 -0.2944 0.9358 SILAC 2 / Biological 3 Raptor down H/M up
Q8BT07 VKAT(ph)SPKS(ph)PSAALNDSLVECPK -1.1399 0.3483 1.9089 SILAC 2 / Biological 3 Raptor down H/M up
Q7TPV4 (ac)AEM(ox)KSPT(ph)KAEPATPAEAAQSDR -1.1612 0.0955 1.0591 SILAC 3 / Biological 4 Raptor down H/M up
Q7TPV4 (ac)AEM(ox)KSPTKAEPAT(ph)PAEAAQSDR -1.0882 -0.1585 0.8468 SILAC 3 / Biological 4 Raptor down H/M up
Q8BX17 APS(ph)QPPSPT(ph)EER -1.1503 -0.0605 1.2653 SILAC 3 / Biological 4 Raptor down H/M up
P27546 DMS(ph)PSAETEAPLAK -1.0284 0.1922 1.1627 SILAC 3 / Biological 4 Raptor down H/M up
Q9D1F4 EDEEEDEDEPTETETS(ph)GER -1.5365 -0.0402 1.5813 SILAC 3 / Biological 4 Raptor down H/M up
Q9JIK5 EIITEEPS(ph)EEEADM(ox)PKPK -1.2601 0.1656 1.5098 SILAC 3 / Biological 4 Raptor down H/M up
Q6NS46 ERQES(ph)ESEQELVNK -1.7747 -0.6957 0.9368 SILAC 3 / Biological 4 Raptor down H/M up
Q99P72 ES(ph)ETFS(ph)DSSPIEIIDEFPTFVSAK -1.0267 -0.2564 0.9316 SILAC 3 / Biological 4 Raptor down H/M up
Q6ZQ58 ES(ph)PRPPAAAEAPAGSDGEDGGRR -1.7201 -0.1962 1.2691 SILAC 3 / Biological 4 Raptor down H/M up
Q99P72 ESETFS(ph)DS(ph)SPIEIIDEFPTFVSAK -1.1033 -0.1358 0.9316 SILAC 3 / Biological 4 Raptor down H/M up
Q99P72 ESETFSDS(ph)S(ph)PIEIIDEFPTFVSAK -1.1438 -0.0786 0.9328 SILAC 3 / Biological 4 Raptor down H/M up
Q3UMF0 EVQRDPQLS(ph)PEQHPSSLSER -1.5167 -0.0816 1.4031 SILAC 3 / Biological 4 Raptor down H/M up
Q8BTM8 FNEEHIPDSPFVVPVAS(ph)PSGDAR -0.9970 -0.2598 0.9142 SILAC 3 / Biological 4 Raptor down H/M up
Q5F2E7 GADNDGSGS(ph)ESGYTTPK -1.0222 0.1284 0.9845 SILAC 3 / Biological 4 Raptor down H/M up
O08539 GNKS(ph)PSPPPDGSPAATPEIR -2.1786 0.0382 1.9648 SILAC 3 / Biological 4 Raptor down H/M up
O08539 GNKSPS(ph)PPPDGSPAATPEIR -1.4336 0.2227 1.8893 SILAC 3 / Biological 4 Raptor down H/M up
Q8C2Q7 HTGPNS(ph)PDTANDGFVR -1.1118 -0.0962 1.0791 SILAC 3 / Biological 4 Raptor down H/M up
Q8C2Q7 HTGPNSPDT(ph)ANDGFVR -1.4794 0.1442 1.5274 SILAC 3 / Biological 4 Raptor down H/M up
Q78WZ7 KHS(ph)EEANFES(ph)PK -1.8123 -0.7128 1.0233 SILAC 3 / Biological 4 Raptor down H/M up
Q78WZ7 KHS(ph)EEANFES(ph)PK -1.8123 -0.7128 1.0233 SILAC 3 / Biological 4 Raptor down H/M up
Q8R1Q8 KPASVS(ph)PTT(ph)PTSPTEGEAS -1.2687 -0.1049 1.6443 SILAC 3 / Biological 4 Raptor down H/M up
Q8R1Q8 KPASVSPTTPTS(ph)PTEGEAS -1.0440 0.3046 1.6068 SILAC 3 / Biological 4 Raptor down H/M up
Q52KI8 KPPAPPS(ph)PVQSQSPS(ph)TNWSPAVPAKK -1.0498 0.3970 1.1421 SILAC 3 / Biological 4 Raptor down H/M up
Q52KI8 KPPAPPS(ph)PVQSQSPST(ph)NWSPAVPAKK -1.3520 0.0712 0.8752 SILAC 3 / Biological 4 Raptor down H/M up
Q99P31 LLQTCFSS(ph)PTDDSM(ox)DR -1.7566 0.6013 2.4466 SILAC 3 / Biological 4 Raptor down H/M up
Q3UQN2 LSGINEIPRPFS(ph)PPVTSNT(ph)SPPPTAPLAR -1.2324 0.6131 1.6629 SILAC 3 / Biological 4 Raptor down H/M up
P62754 LSS(ph)LRAS(ph)TSK -1.9155 -0.4387 1.4212 SILAC 3 / Biological 4 Raptor down H/M up
P16951 NDSVIVADQT(ph)PTPT(ph)R -1.2739 0.5304 1.4583 SILAC 3 / Biological 4 Raptor down H/M up
Q8R2M2 NMPNVSDSETYNS(ph)DFDDSSPR -2.4061 0.1393 1.2484 SILAC 3 / Biological 4 Raptor down H/M up
P28028 NNPKS(ph)PQKPIVR -1.0008 0.1938 1.1835 SILAC 3 / Biological 4 Raptor down H/M up
A2BH40 NPQMPQYTSPQPGS(ph)ALSPR -1.6090 -0.0757 1.0013 SILAC 3 / Biological 4 Raptor down H/M up
Q6ZQ61 RDS(ph)FDDRGPSLNPVLDYDHGSR -1.4214 -0.3700 0.8486 SILAC 3 / Biological 4 Raptor down H/M up
Q8BGD9 RES(ph)EKSLENET(ph)LNK -1.3050 -0.2476 1.2878 SILAC 3 / Biological 4 Raptor down H/M up
Q8BGD9 RES(ph)EKSLENET(ph)LNK -1.3050 -0.2476 1.2878 SILAC 3 / Biological 4 Raptor down H/M up
Q80V17 RKT(ph)VS(ph)FSAAEEAPVPEPSTAAPLQAK -1.7637 0.0887 2.4362 SILAC 3 / Biological 4 Raptor down H/M up
Q9JJZ4 RPS(ph)TSPDVLQGQPPR -1.0616 0.3192 1.1693 SILAC 3 / Biological 4 Raptor down H/M up
P62754 RRLS(ph)S(ph)LR -2.5771 -0.7352 1.6375 SILAC 3 / Biological 4 Raptor down H/M up
P62754 RRLS(ph)S(ph)LR -2.2363 -0.7420 1.6509 SILAC 3 / Biological 4 Raptor down H/M up
A2A6P4 RS(ph)PS(ph)PAAMSER -1.3479 -0.0063 1.2103 SILAC 3 / Biological 4 Raptor down H/M up
A2A6P4 RS(ph)PS(ph)PAAMSER -1.3479 -0.0063 1.2103 SILAC 3 / Biological 4 Raptor down H/M up
Q3U6N9 S(ph)AS(ph)GASEPPLR -1.4089 -0.2586 1.0591 SILAC 3 / Biological 4 Raptor down H/M up
Q3U6N9 S(ph)ASGASEPPLR -1.4089 -0.2586 1.0591 SILAC 3 / Biological 4 Raptor down H/M up
Q64337 S(ph)RLTPTTPES(ph)SSTGTEDK -1.7364 -0.2703 1.9186 SILAC 3 / Biological 4 Raptor down H/M up
Q9Z2B9 S(ph)S(ph)PPLRTPDVLESSGPAVR -1.2118 -0.2974 0.8358 SILAC 3 / Biological 4 Raptor down H/M up
Q9Z2B9 S(ph)S(ph)PPLRTPDVLESSGPAVR -1.2118 -0.2974 0.8358 SILAC 3 / Biological 4 Raptor down H/M up
Q9D1F4 S(ph)SDEENGPPSS(ph)PDLDR -0.9968 0.1280 0.9961 SILAC 3 / Biological 4 Raptor down H/M up
Q9JIK5 SNSSDAPGEESS(ph)S(ph)ETEKEIPVEQK -1.0621 -0.1021 0.8766 SILAC 3 / Biological 4 Raptor down H/M up
Q7TPV4 SPAPSNPTLS(ph)PS(ph)TPAKTPK -1.1420 -0.1806 1.0310 SILAC 3 / Biological 4 Raptor down H/M up
Q64337 SRLT(ph)PTT(ph)PESSSTGTEDK -1.8917 -0.5883 1.4039 SILAC 3 / Biological 4 Raptor down H/M up
Q64337 SRLT(ph)PTT(ph)PESSSTGTEDK -1.9121 -0.5312 1.4974 SILAC 3 / Biological 4 Raptor down H/M up
Q64337 SRLT(ph)PTTPES(ph)SSTGTEDK -2.0834 -0.4740 1.6482 SILAC 3 / Biological 4 Raptor down H/M up
O08784 STSS(ph)SPAPTQTLPNSITQR -1.6442 0.6044 2.1529 SILAC 3 / Biological 4 Raptor down H/M up
O08784 STSSS(ph)PAPTQTLPNSITQR -1.6793 0.6846 2.4327 SILAC 3 / Biological 4 Raptor down H/M up
Q3UMF0 T(ph)LSS(ph)PTGTETNPPK -1.4205 -0.6717 1.0042 SILAC 3 / Biological 4 Raptor down H/M up
Q3UMF0 T(ph)LSSPT(ph)GTETNPPKAPR -2.0392 -0.4695 1.4844 SILAC 3 / Biological 4 Raptor down H/M up
Q80YV2 TRS(ph)WES(ph)SSPVDRPELEAASPTTR -1.0736 -0.0535 0.9810 SILAC 3 / Biological 4 Raptor down H/M up
Q80YV2 TRS(ph)WESS(ph)SPVDRPELEAASPTTR -1.0511 0.0088 0.9647 SILAC 3 / Biological 4 Raptor down H/M up
Q80YV2 TRS(ph)WESS(ph)SPVDRPELEAASPTTR -1.0623 -0.0224 0.9728 SILAC 3 / Biological 4 Raptor down H/M up
Q8BT07 VKAT(ph)SPKSPS(ph)AALNDSLVECPK -1.8560 -0.5075 1.4937 SILAC 3 / Biological 4 Raptor down H/M up
Q8BT07 VKATS(ph)PKSPS(ph)AALNDSLVECPK -2.0289 -0.2575 1.5887 SILAC 3 / Biological 4 Raptor down H/M up
B2RQC6 IHRAS(ph)DPGLPAEEPK -1.0570 -0.6052 0.4149 SILAC 1 / Biological 1 Raptor down  +
B2RQC6 IHRAS(ph)DPGLPAEEPK -1.0542 -0.6022 0.4273 SILAC 1 / Biological 1 Raptor down  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK -1.1313 -0.6669 0.0183 SILAC 1 / Biological 1 Raptor down  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK -1.4118 -0.5687 0.0896 SILAC 1 / Biological 1 Raptor down  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK -1.6924 -0.3753 0.4047 SILAC 1 / Biological 1 Raptor down  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK -1.8064 -0.3546 0.5994 SILAC 1 / Biological 1 Raptor down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR -1.5567 -1.0142 0.7036 SILAC 1 / Biological 1 Raptor down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR -1.5567 -1.0142 0.7036 SILAC 1 / Biological 1 Raptor down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR -1.5068 -0.8074 0.7244 SILAC 1 / Biological 1 Raptor down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR -1.5068 -0.8074 0.7244 SILAC 1 / Biological 1 Raptor down  +
Q3UJN1 (ac)AESSESLSAS(ph)S(ph)PAR -1.0005 -0.8200 -0.8685 SILAC 1 / Biological 1 Raptor down
Q99P72 (ac)MEDIDQSSLVSSSADS(ph)PPRPPPAFK -2.2388 -1.0360 -0.2650 SILAC 1 / Biological 1 Raptor down
Q99P72 (ac)MEDIDQSSLVSSSADS(ph)PPRPPPAFK -2.2503 -1.0042 -0.2650 SILAC 1 / Biological 1 Raptor down
Q80ZA1 ALPT(ph)CTSASPPQK -1.1822 -0.5445 0.1412 SILAC 1 / Biological 1 Raptor down
Q9ERU9 ANTS(ph)S(ph)DLEKDDDAYK -1.6802 -1.0517 -0.0582 SILAC 1 / Biological 1 Raptor down
Q9ERU9 ANTS(ph)S(ph)DLEKDDDAYK -1.6510 -1.0047 0.0039 SILAC 1 / Biological 1 Raptor down
Q9ERU9 ANTS(ph)S(ph)DLEKDDDAYK -1.9701 -0.9507 0.5449 SILAC 1 / Biological 1 Raptor down
Q9ERU9 ANTS(ph)S(ph)DLEKDDDAYK -1.9116 -0.8566 0.6692 SILAC 1 / Biological 1 Raptor down
Q8VDN3 ASLGS(ph)LEGEVEAEAS(ph)SPK -8.5396 0.2490 -0.5802 SILAC 1 / Biological 1 Raptor down
Q8VDN3 ASLGS(ph)LEGEVEAEAS(ph)SPK -8.5396 0.2490 -0.5802 SILAC 1 / Biological 1 Raptor down
Q9JKV1 DKKDEEEDMS(ph)LD -1.2507 -0.9776 0.0344 SILAC 1 / Biological 1 Raptor down
Q9JKV1 DKKDEEEDMS(ph)LD -1.2507 -0.9776 0.0384 SILAC 1 / Biological 1 Raptor down
P46467 EEQSGPVDEKGNDS(ph)DGEAESDDPEKK -1.0342 -0.6029 0.2231 SILAC 1 / Biological 1 Raptor down
P46467 EEQSGPVDEKGNDS(ph)DGEAESDDPEKK -1.0342 -0.6029 0.2231 SILAC 1 / Biological 1 Raptor down
Q6PAM1 EQGVESPGAQPASS(ph)PR -1.2697 -1.0596 -0.0171 SILAC 1 / Biological 1 Raptor down
Q6ZQH8 GAPS(ph)SPAAGVLPS(ph)PQGK -1.2859 -0.5492 0.4793 SILAC 1 / Biological 1 Raptor down
Q6ZQH8 GAPS(ph)SPAAGVLPS(ph)PQGK -1.2968 -0.5419 0.4804 SILAC 1 / Biological 1 Raptor down
Q6ZQH8 GAPSS(ph)PAAGVLPS(ph)PQGK -1.2966 -0.4969 0.4513 SILAC 1 / Biological 1 Raptor down
Q6ZQH8 GAPSS(ph)PAAGVLPS(ph)PQGK -1.2997 -0.4953 0.4527 SILAC 1 / Biological 1 Raptor down
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Q99LL5 GKLQEEGGS(ph)EEEEAGNPSEDGMQSGPTQAPPR -1.0563 -0.9830 0.3843 SILAC 1 / Biological 1 Raptor down
Q99LL5 GKLQEEGGS(ph)EEEEAGNPSEDGMQSGPTQAPPR -1.0563 -0.5693 0.3843 SILAC 1 / Biological 1 Raptor down
Q52KE7 GLNLDGT(ph)PALSTLGGFSPASKPS(ph)SPR -1.0786 -0.5367 0.2552 SILAC 1 / Biological 1 Raptor down
Q52KE7 GLNLDGT(ph)PALSTLGGFSPASKPS(ph)SPR -1.0512 -0.7401 0.2617 SILAC 1 / Biological 1 Raptor down
Q52KE7 GLNLDGTPALSTLGGFSPASKPS(ph)S(ph)PR -1.0910 -0.9356 0.1503 SILAC 1 / Biological 1 Raptor down
Q52KE7 GLNLDGTPALSTLGGFSPASKPS(ph)S(ph)PR -1.0910 -0.5219 0.1503 SILAC 1 / Biological 1 Raptor down
Q99LL5 GLSVSGPCGSRS(ph)PQQTPM(ox)ES -1.0675 -0.8982 0.1824 SILAC 1 / Biological 1 Raptor down
O08539 GNKS(ph)PS(ph)PPPDGSPAATPEIR -1.3755 -0.6965 0.4333 SILAC 1 / Biological 1 Raptor down
O08539 GNKS(ph)PS(ph)PPPDGSPAATPEIR -1.3749 -0.6965 0.4639 SILAC 1 / Biological 1 Raptor down
O08539 GNKS(ph)PS(ph)PPPDGSPAATPEIR -1.5394 -0.7094 0.5887 SILAC 1 / Biological 1 Raptor down
O08539 GNKS(ph)PS(ph)PPPDGSPAATPEIR -1.5394 -0.7094 0.6629 SILAC 1 / Biological 1 Raptor down
O08539 GNKS(ph)PSPPPDGS(ph)PAATPEIR -0.9985 -0.6033 0.2648 SILAC 1 / Biological 1 Raptor down
O08539 GNKSPS(ph)PPPDGSPAATPEIR -1.6762 -0.2933 0.2999 SILAC 1 / Biological 1 Raptor down
A2BH40 GPS(ph)PS(ph)PVGSPASVAQSR -1.0954 -0.5318 0.1731 SILAC 1 / Biological 1 Raptor down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -1.0954 -0.5318 0.1731 SILAC 1 / Biological 1 Raptor down
Q3THK3 GTS(ph)RPGT(ph)PSAEAASTSSTLR -1.1742 -0.5198 0.0596 SILAC 1 / Biological 1 Raptor down
Q3THK3 GTS(ph)RPGT(ph)PSAEAASTSSTLR -1.1742 -0.5198 0.0596 SILAC 1 / Biological 1 Raptor down
Q8R457 HLLTDLPLPPELPGGDPS(ph)PPDS(ph)PEPK -1.3146 -0.4914 0.4127 SILAC 1 / Biological 1 Raptor down
Q8R457 HLLTDLPLPPELPGGDPS(ph)PPDS(ph)PEPK -1.3146 -0.4914 0.4127 SILAC 1 / Biological 1 Raptor down
Q8R457 HLLTDLPLPPELPGGDPS(ph)PPDS(ph)PEPK -1.3146 -0.4914 0.4127 SILAC 1 / Biological 1 Raptor down
Q8R457 HLLTDLPLPPELPGGDPS(ph)PPDS(ph)PEPK -1.3146 -0.4914 0.4127 SILAC 1 / Biological 1 Raptor down
Q52KI8 KPPAPPS(ph)PVQSQS(ph)PSTNWSPAVPAK -1.1412 -0.8509 0.2904 SILAC 1 / Biological 1 Raptor down
Q52KI8 KPPAPPS(ph)PVQSQS(ph)PSTNWSPAVPAK -1.1412 -0.8509 0.2904 SILAC 1 / Biological 1 Raptor down
Q60598 KQT(ph)PPASPSPQPIEDRPPS(ph)SPIYEDAAPFK -1.1264 -0.0548 0.6567 SILAC 1 / Biological 1 Raptor down
Q60598 KQT(ph)PPASPSPQPIEDRPPS(ph)SPIYEDAAPFK -1.1264 -0.0548 0.6567 SILAC 1 / Biological 1 Raptor down
O88379 KRQS(ph)TESS(ph)PVPLNR -1.1512 -0.9839 -0.1524 SILAC 1 / Biological 1 Raptor down
O88379 KRQS(ph)TESS(ph)PVPLNR -1.1512 -0.9839 -0.1490 SILAC 1 / Biological 1 Raptor down
Q64337 LTPTTPESS(ph)STGTEDK -1.1219 -0.1608 0.2738 SILAC 1 / Biological 1 Raptor down
Q64337 LTPTTPESS(ph)STGTEDK -1.1219 -0.1633 0.2805 SILAC 1 / Biological 1 Raptor down
Q8R457 NNS(ph)PAPPQPAPVK -1.0148 -0.7411 0.1342 SILAC 1 / Biological 1 Raptor down
Q8R457 NNS(ph)PAPPQPAPVK -1.0296 -0.7430 0.1577 SILAC 1 / Biological 1 Raptor down
Q3UK83 NQGGYGGSSSSS(ph)SYGSGR -1.2273 -0.2790 0.3898 SILAC 1 / Biological 1 Raptor down
Q3UK83 NQGGYGGSSSSS(ph)SYGSGR -1.2313 -0.2266 0.3988 SILAC 1 / Biological 1 Raptor down
Q571F6 NTETQPT(ph)SPQLGTK -2.4909 -0.6939 0.2051 SILAC 1 / Biological 1 Raptor down
Q571F6 NTETQPT(ph)SPQLGTK -2.4909 -0.6939 0.2051 SILAC 1 / Biological 1 Raptor down
P24788 RDS(ph)LEEGELR -1.1242 -0.4698 0.2995 SILAC 1 / Biological 1 Raptor down
P24788 RDS(ph)LEEGELR -1.0787 -0.4673 0.3135 SILAC 1 / Biological 1 Raptor down
O35130 RFS(ph)VQEQDWET(ph)TPPK -1.7674 -0.3557 0.6845 SILAC 1 / Biological 1 Raptor down
O35130 RFS(ph)VQEQDWET(ph)TPPK -1.6226 -0.3518 0.7420 SILAC 1 / Biological 1 Raptor down
Q5SSI6 RTSS(ph)DDES(ph)EEDEDDLLQR -1.4072 -0.9225 -0.1027 SILAC 1 / Biological 1 Raptor down
Q5SSI6 RTSS(ph)DDES(ph)EEDEDDLLQR -1.3787 -0.9225 -0.0913 SILAC 1 / Biological 1 Raptor down
Q8BTI8 S(ph)GTPPRPGSVTNMQADECTAT(ph)PQR -1.2648 -1.0047 -0.0955 SILAC 1 / Biological 1 Raptor down
Q8BTI8 S(ph)GTPPRPGSVTNMQADECTAT(ph)PQR -1.2648 -1.0047 -0.0955 SILAC 1 / Biological 1 Raptor down
Q52KI8 S(ph)PS(ph)PAPPPPPPPPPPR -1.0113 -0.8095 -0.0068 SILAC 1 / Biological 1 Raptor down
Q52KI8 S(ph)PS(ph)PAPPPPPPPPPPR -1.0113 -0.8095 -0.0068 SILAC 1 / Biological 1 Raptor down
Q64337 S(ph)RLTPTTPESSSTGTEDK -1.9392 -0.8649 0.6237 SILAC 1 / Biological 1 Raptor down
Q9QZQ1 S(ph)SPNVANQPPS(ph)PGGK -1.3425 -0.3977 0.3970 SILAC 1 / Biological 1 Raptor down
Q9QZQ1 S(ph)SPNVANQPPS(ph)PGGK -1.3720 -0.3977 0.4438 SILAC 1 / Biological 1 Raptor down
Q6AW69 S(ph)YGSQPNSPT(ph)SEDLAK -1.0652 -0.4720 0.0104 SILAC 1 / Biological 1 Raptor down
Q6AW69 S(ph)YGSQPNSPT(ph)SEDLAK -1.0652 -0.4555 0.0104 SILAC 1 / Biological 1 Raptor down
P70255 SGSMEEDVDTS(ph)PGGDYYTSPNS(ph)PTSSSR -1.1958 -0.6522 0.5237 SILAC 1 / Biological 1 Raptor down
P70255 SGSMEEDVDTS(ph)PGGDYYTSPNS(ph)PTSSSR -1.1994 -0.6242 0.5237 SILAC 1 / Biological 1 Raptor down
P70255 SGSMEEDVDTSPGGDY(ph)YTSPNSPTS(ph)SSR -1.1958 -0.6522 0.5237 SILAC 1 / Biological 1 Raptor down
P70255 SGSMEEDVDTSPGGDY(ph)YTSPNSPTS(ph)SSR -1.1958 -0.6522 0.5237 SILAC 1 / Biological 1 Raptor down
P70255 SGSMEEDVDTSPGGDY(ph)YTSPNSPTS(ph)SSR -1.1994 -0.6242 0.5237 SILAC 1 / Biological 1 Raptor down
P70255 SGSMEEDVDTSPGGDY(ph)YTSPNSPTS(ph)SSR -1.1994 -0.6242 0.5237 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SMLQT(ph)PPDQNLSGSKS(ph)PCPQK -1.5833 -0.1174 0.6721 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SMLQT(ph)PPDQNLSGSKS(ph)PCPQK -1.5833 -0.1170 0.6939 SILAC 1 / Biological 1 Raptor down
Q80WJ7 SQEPISNDQKVS(ph)DDDKEK -1.2670 -0.4556 0.6216 SILAC 1 / Biological 1 Raptor down
Q80WJ7 SQEPISNDQKVS(ph)DDDKEK -1.2670 -0.4556 0.6216 SILAC 1 / Biological 1 Raptor down
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -1.1484 -0.4241 0.7272 SILAC 1 / Biological 1 Raptor down
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -1.1484 -0.3925 0.7272 SILAC 1 / Biological 1 Raptor down
Q68FE6 SQS(ph)FAGVLGSHER -1.1756 -0.2180 -0.3636 SILAC 1 / Biological 1 Raptor down
Q05D44 SRVNS(ph)S(ph)GES(ph)GGESDEFLQSR -2.5406 -0.8387 0.5435 SILAC 1 / Biological 1 Raptor down
Q05D44 SRVNS(ph)S(ph)GES(ph)GGESDEFLQSR -2.5406 -0.8387 0.5435 SILAC 1 / Biological 1 Raptor down
Q05D44 SRVNS(ph)S(ph)GES(ph)GGESDEFLQSR -2.5406 -0.8387 0.5435 SILAC 1 / Biological 1 Raptor down
Q05D44 SRVNS(ph)S(ph)GES(ph)GGESDEFLQSR -2.5370 -0.8387 0.5435 SILAC 1 / Biological 1 Raptor down
Q05D44 SRVNS(ph)S(ph)GES(ph)GGESDEFLQSR -2.5370 -0.8387 0.5435 SILAC 1 / Biological 1 Raptor down
Q05D44 SRVNS(ph)S(ph)GES(ph)GGESDEFLQSR -2.5370 -0.8387 0.5435 SILAC 1 / Biological 1 Raptor down
Q9D1F4 SS(ph)DEENGPPS(ph)SPDLDR -0.9979 -0.2495 0.4649 SILAC 1 / Biological 1 Raptor down
Q9D1F4 SS(ph)DEENGPPS(ph)SPDLDR -0.9979 -0.2495 0.4649 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SSS(ph)PVTELTARS(ph)PVK -1.4224 -1.0670 0.4308 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SSS(ph)PVTELTARS(ph)PVK -1.2315 -0.9866 0.4374 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SSS(ph)PVTELTARS(ph)PVK -1.1248 -0.9269 0.4439 SILAC 1 / Biological 1 Raptor down
Q6ZPE9 SSSDS(ph)VEEETVDS(ph)DTPPVLEK -1.0961 -0.9546 -0.0129 SILAC 1 / Biological 1 Raptor down
Q6ZPE9 SSSDS(ph)VEEETVDS(ph)DTPPVLEK -1.0961 -0.9546 -0.0129 SILAC 1 / Biological 1 Raptor down
Q6ZPE9 SSSDS(ph)VEEETVDS(ph)DTPPVLEK -1.3157 -0.7731 0.1683 SILAC 1 / Biological 1 Raptor down
Q6ZPE9 SSSDS(ph)VEEETVDS(ph)DTPPVLEK -1.3305 -0.7750 0.1917 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SSSPVT(ph)ELTARS(ph)PVKQDK -1.1248 -0.5591 0.4439 SILAC 1 / Biological 1 Raptor down
Q8BTI8 SSSPVT(ph)ELTARS(ph)PVKQDK -1.1248 -0.5591 0.4439 SILAC 1 / Biological 1 Raptor down
Q80U93 STQTAPSSAPSTGQKS(ph)PR -1.1150 -0.7479 0.3733 SILAC 1 / Biological 1 Raptor down
Q80U93 STQTAPSSAPSTGQKS(ph)PR -1.1017 -0.8254 0.3802 SILAC 1 / Biological 1 Raptor down
Q8CD14 T(ph)GAS(ph)QGRDSDSDDGEFEIQAEDDAR -1.0061 -0.5663 0.1391 SILAC 1 / Biological 1 Raptor down
Q8CD14 T(ph)GAS(ph)QGRDSDSDDGEFEIQAEDDAR -1.0061 -0.5663 0.1391 SILAC 1 / Biological 1 Raptor down
Q8CD14 T(ph)GAS(ph)QGRDSDSDDGEFEIQAEDDAR -1.0061 -0.5663 0.1391 SILAC 1 / Biological 1 Raptor down
Q8CD14 T(ph)GAS(ph)QGRDSDSDDGEFEIQAEDDAR -1.0061 -0.5663 0.1391 SILAC 1 / Biological 1 Raptor down
P49586 T(ph)SPSSS(ph)PASLSR -1.3147 -0.5974 0.6067 SILAC 1 / Biological 1 Raptor down
Q05D44 TARPNS(ph)EAPLS(ph)GSEDADDSNKLSK -3.0078 0.2536 0.6944 SILAC 1 / Biological 1 Raptor down
Q05D44 TARPNS(ph)EAPLS(ph)GSEDADDSNKLSK -3.0078 0.2536 0.6944 SILAC 1 / Biological 1 Raptor down
P70255 TEMDKS(ph)PFNSPSPQDS(ph)PR -1.0733 -0.8945 0.2812 SILAC 1 / Biological 1 Raptor down
P70255 TEMDKS(ph)PFNSPSPQDS(ph)PR -1.0539 -0.8908 0.3317 SILAC 1 / Biological 1 Raptor down
Q8CD14 TGASQGRDS(ph)DS(ph)DDGEFEIQAEDDAR -1.2277 -0.6845 0.0566 SILAC 1 / Biological 1 Raptor down
Q8CD14 TGASQGRDS(ph)DS(ph)DDGEFEIQAEDDAR -1.2277 -0.6845 0.0566 SILAC 1 / Biological 1 Raptor down
Q8CD14 TGASQGRDS(ph)DS(ph)DDGEFEIQAEDDAR -1.2277 -0.6845 0.0566 SILAC 1 / Biological 1 Raptor down
Q8CD14 TGASQGRDS(ph)DS(ph)DDGEFEIQAEDDAR -1.2277 -0.6845 0.0566 SILAC 1 / Biological 1 Raptor down
Q03141 TPVAS(ph)THS(ph)ISSATTPDR -1.1883 -0.6449 0.4524 SILAC 1 / Biological 1 Raptor down
Q03141 TPVAS(ph)THS(ph)ISSATTPDR -1.1883 -0.6449 0.4524 SILAC 1 / Biological 1 Raptor down
Q03141 TPVAS(ph)THS(ph)ISSATTPDR -1.1883 -0.6449 0.4527 SILAC 1 / Biological 1 Raptor down
Q03141 TPVAS(ph)THS(ph)ISSATTPDR -1.1883 -0.6449 0.4527 SILAC 1 / Biological 1 Raptor down
Q03141 TPVAS(ph)THSIS(ph)SATTPDR -1.6968 -0.5844 0.3436 SILAC 1 / Biological 1 Raptor down
Q03141 TPVAS(ph)THSIS(ph)SATTPDR -1.6968 -0.5844 0.3436 SILAC 1 / Biological 1 Raptor down
P49586 TSPSSS(ph)PAS(ph)LSR -1.2191 -0.5958 -0.0418 SILAC 1 / Biological 1 Raptor down
P49586 TSPSSS(ph)PAS(ph)LSR -1.3147 -0.5974 0.0621 SILAC 1 / Biological 1 Raptor down
Q9ESX5 TVLES(ph)GGETGDGDNDTTK -1.0860 -0.9023 0.1197 SILAC 1 / Biological 1 Raptor down
Q9ESX5 TVLES(ph)GGETGDGDNDTTK -1.0846 -0.8109 0.1197 SILAC 1 / Biological 1 Raptor down
Q80YV2 TWGSVVRS(ph)PEGT(ph)PQK -1.8677 -0.5361 -0.3340 SILAC 1 / Biological 1 Raptor down
Q80YV2 TWGSVVRS(ph)PEGT(ph)PQK -3.1040 -0.8964 -0.1681 SILAC 1 / Biological 1 Raptor down
Q80YV2 TWGSVVRS(ph)PEGT(ph)PQK -2.4570 -0.4120 -0.1383 SILAC 1 / Biological 1 Raptor down
Q80YV2 TWGSVVRS(ph)PEGT(ph)PQK -4.3403 -0.5361 -0.0153 SILAC 1 / Biological 1 Raptor down
P49586 WPFSGKT(ph)SPSSS(ph)PASLSR -1.7529 -0.9566 0.4637 SILAC 1 / Biological 1 Raptor down
P49586 WPFSGKT(ph)SPSSS(ph)PASLSR -1.2407 -0.5980 0.5353 SILAC 1 / Biological 1 Raptor down
P35822 YLCEGT(ph)ESPYQT(ph)GQLHPAIR -1.3581 -0.9693 0.0875 SILAC 1 / Biological 1 Raptor down
P35822 YLCEGT(ph)ESPYQT(ph)GQLHPAIR -1.3826 -0.9665 0.0880 SILAC 1 / Biological 1 Raptor down
P35822 YLCEGTES(ph)PYQT(ph)GQLHPAIR -1.3772 -0.9052 0.1045 SILAC 1 / Biological 1 Raptor down
P35822 YLCEGTES(ph)PYQT(ph)GQLHPAIR -1.3894 -0.9038 0.1049 SILAC 1 / Biological 1 Raptor down
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Q7TPV4 (ac)AEM(ox)KS(ph)PTKAEPATPAEAAQSDR -1.6759 -0.4963 0.4274 SILAC 1 / Biological 2 Raptor down
P43276 (ac)SETAPAETAAPAPVEKS(ph)PAK -0.9964 -0.4514 0.3590 SILAC 1 / Biological 2 Raptor down
Q3V1V3 ALAEEDS(ph)EDELPS(ph)DVDFNDPYFAEEVKK -1.2488 -0.8622 0.2183 SILAC 1 / Biological 2 Raptor down
Q3V1V3 ALAEEDS(ph)EDELPS(ph)DVDFNDPYFAEEVKK -1.2488 -0.8622 0.2183 SILAC 1 / Biological 2 Raptor down
Q71FD5 AYS(ph)GSDLPSGTGSGGGGADGAR -1.0607 -0.3580 0.3391 SILAC 1 / Biological 2 Raptor down
Q8K019 GRADGDWDDQEVLDYFSDKES(ph)AK -1.1523 0.0751 -0.0033 SILAC 1 / Biological 2 Raptor down
Q76KJ5 KGTDASS(ph)DTQEAVNR -1.1874 -0.6906 0.5966 SILAC 1 / Biological 2 Raptor down
Q8R1Q8 KPASVS(ph)PTTPT(ph)SPTEGEAS -1.0287 -1.0275 0.0414 SILAC 1 / Biological 2 Raptor down
Q6ZPJ3 LIHGEDS(ph)DS(ph)EGDDDGR -1.1731 -0.8702 0.0138 SILAC 1 / Biological 2 Raptor down
Q6ZPJ3 LIHGEDS(ph)DS(ph)EGDDDGR -1.1731 -0.8702 0.0138 SILAC 1 / Biological 2 Raptor down
Q6ZPE9 RETVVESQS(ph)SQSPS(ph)PK -1.2767 -0.0569 -0.7487 SILAC 1 / Biological 2 Raptor down
Q9Z248 RGSLEMS(ph)S(ph)DGEPLSR -1.1945 0.0862 0.5769 SILAC 1 / Biological 2 Raptor down
Q9Z248 RGSLEMS(ph)S(ph)DGEPLSR -1.1945 0.0862 0.5769 SILAC 1 / Biological 2 Raptor down
Q80V17 RKT(ph)VS(ph)FSAAEEAPVPEPSTAAPLQAK -1.6147 -0.5721 0.6509 SILAC 1 / Biological 2 Raptor down
Q80V17 RKT(ph)VSFS(ph)AAEEAPVPEPSTAAPLQAK -1.6361 -0.6438 0.6781 SILAC 1 / Biological 2 Raptor down
A2A6P4 RS(ph)PS(ph)PAAMSER -1.1047 -0.6951 0.7011 SILAC 1 / Biological 2 Raptor down
A2A6P4 RS(ph)PS(ph)PAAMSER -1.1047 -0.6951 0.7011 SILAC 1 / Biological 2 Raptor down
Q3U6N9 S(ph)ASGASEPPLR -1.3692 -0.0600 -0.4126 SILAC 1 / Biological 2 Raptor down
Q8R1A4 SNS(ph)WVNTGPK -1.2645 -0.7868 -0.1356 SILAC 1 / Biological 2 Raptor down
O08582 SRS(ph)PVDSPVPASMFAPEPSS(ph)PGAAR -1.1453 -0.3944 0.5134 SILAC 1 / Biological 2 Raptor down
Q6P5B5 T(ph)DGS(ph)ISGDRQPVTVADYISR -0.9961 -1.0045 -0.5435 SILAC 1 / Biological 2 Raptor down
Q68EF0 TLVLSSS(ph)PTS(ph)PTQEPLAAAK -1.1149 -0.7533 0.0101 SILAC 1 / Biological 2 Raptor down
Q68EF0 TLVLSSS(ph)PTS(ph)PTQEPLAAAK -1.0345 -0.5381 0.1027 SILAC 1 / Biological 2 Raptor down
Q3U6N9 S(ph)AS(ph)GASEPPLR -1.0389 -0.5219 0.4978 SILAC 2 / Biological 3 Raptor down
Q99LH1 S(ph)DSITEKEPEGDCSQDR -1.1478 -0.5564 0.1098 SILAC 2 / Biological 3 Raptor down
Q7TNL7 S(ph)NISPNFNFMGQLLDFER -1.1804 -0.8599 0.1855 SILAC 2 / Biological 3 Raptor down
P58871 SLS(ph)SGFSPEEAQQQDEEFEKK -1.2089 -0.6332 0.1909 SILAC 2 / Biological 3 Raptor down
Q64337 SRLT(ph)PTTPES(ph)SSTGTEDK -1.5410 -1.0238 0.5201 SILAC 2 / Biological 3 Raptor down
Q9CXF4 DDSPTQTLAS(ph)PNACR -1.0462 -0.1629 0.7205 SILAC 3 / Biological 4 Raptor down
O88379 DLDPDVVT(ph)EDEDDPGSHKR -1.1044 -0.3794 0.6839 SILAC 3 / Biological 4 Raptor down
Q6PAM1 EQGVESPGAQPAS(ph)SPR -1.0892 -0.9432 -0.0422 SILAC 3 / Biological 4 Raptor down
Q6PAM1 EQGVESPGAQPASS(ph)PR -1.0063 -0.7846 0.1412 SILAC 3 / Biological 4 Raptor down
Q6NS46 ERQES(ph)ESEQELVNK -1.6293 -0.5860 0.6986 SILAC 3 / Biological 4 Raptor down
Q99P72 ESETFSDS(ph)S(ph)PIEIIDEFPTFVSAK -1.1843 -0.1358 0.4522 SILAC 3 / Biological 4 Raptor down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -1.6096 -0.8180 0.5669 SILAC 3 / Biological 4 Raptor down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -1.6096 -0.8180 0.5669 SILAC 3 / Biological 4 Raptor down
Q6NS46 KSGAAEEDDS(ph)GVEVYYR -1.2533 -0.4689 0.6812 SILAC 3 / Biological 4 Raptor down
Q80Y32 KSS(ph)PQS(ph)PDTAMDLLK -4.7353 0.4020 0.5947 SILAC 3 / Biological 4 Raptor down
Q80Y32 KSS(ph)PQS(ph)PDTAMDLLK -4.7353 0.4020 0.5947 SILAC 3 / Biological 4 Raptor down
P14404 NFIGNSNHGSQS(ph)PR -1.1355 -0.2552 0.6318 SILAC 3 / Biological 4 Raptor down
Q571F6 NTETQPT(ph)SPQLGTK -1.0832 -0.4668 0.6810 SILAC 3 / Biological 4 Raptor down
Q6ZQK6 RAS(ph)S(ph)PFRR -1.4974 -0.9069 0.4377 SILAC 3 / Biological 4 Raptor down
Q6ZQ61 RDSFDDRGPS(ph)LNPVLDYDHGSR -1.2925 -0.7288 0.3661 SILAC 3 / Biological 4 Raptor down
Q61083 RGS(ph)DIDNPTLTVTDISPPSRS(ph)PR -1.0409 -0.3917 0.3970 SILAC 3 / Biological 4 Raptor down
Q61083 RGS(ph)DIDNPTLTVTDISPPSRS(ph)PR -1.0409 -0.3917 0.3970 SILAC 3 / Biological 4 Raptor down
Q80V17 RKT(ph)VS(ph)FSAAEEAPVPEPSTAAPLQAK -1.7637 -0.9819 0.5447 SILAC 3 / Biological 4 Raptor down
Q99LH1 S(ph)DSITEKEPEGDCSQDR -1.3487 -0.6608 0.3612 SILAC 3 / Biological 4 Raptor down
P70698 S(ph)GS(ph)SSPDSEITELKFPSISQD -1.2231 -0.9352 0.5223 SILAC 3 / Biological 4 Raptor down
Q05A74 S(ph)PLIESTANMENNQPQK -1.1850 -0.1592 0.6707 SILAC 3 / Biological 4 Raptor down
Q8BT07 S(ph)PSAALNDSLVECPK -1.0305 -0.0007 0.7495 SILAC 3 / Biological 4 Raptor down
Q9QWY8 SHTGDLS(ph)PNVQSR -1.0030 -0.8318 0.5718 SILAC 3 / Biological 4 Raptor down
P97825 SNS(ph)SEASSGDFLDLK -1.0174 -0.6773 0.2852 SILAC 3 / Biological 4 Raptor down
Q3UMF0 T(ph)LS(ph)SPTGTETNPPKAPR -1.2474 -0.7398 0.3792 SILAC 3 / Biological 4 Raptor down
Q8K3Z9 T(ph)SSVS(ph)SLASACTGGIPSSSR -1.1420 -0.1896 0.6845 SILAC 3 / Biological 4 Raptor down
Q8K3Z9 T(ph)SSVS(ph)SLASACTGGIPSSSR -1.1420 -0.1896 0.6845 SILAC 3 / Biological 4 Raptor down
Q80U72 TTEAPCS(ph)PGSQQPPS(ph)PDELPANVK -1.2772 -0.7606 0.6842 SILAC 3 / Biological 4 Raptor down
Q6ZQ58 VEPAWHDQDETSSVKS(ph)DGAGGAR -1.0359 -0.4040 0.6377 SILAC 3 / Biological 4 Raptor down
Q62433 TASGS(ph)SVT(ph)SLEGTR 1.2023 -1.1253 -2.3064 SILAC 1 / Biological 1 Raptor up Rictor down H/M down
Q62433 TASGS(ph)SVT(ph)SLEGTR 1.2023 -1.1253 -2.3064 SILAC 1 / Biological 1 Raptor up Rictor down H/M down
Q62433 TASGS(ph)SVT(ph)SLEGTR 1.2023 -1.1239 -2.3064 SILAC 1 / Biological 1 Raptor up Rictor down H/M down
Q62433 TASGS(ph)SVT(ph)SLEGTR 1.2023 -1.1239 -2.3064 SILAC 1 / Biological 1 Raptor up Rictor down H/M down
Q9WTQ5 QAQS(ph)STEIPLQAESGQGTEEEAAKDGEENR 1.3542 -2.1083 -2.7074 SILAC 1 / Biological 2 Raptor up Rictor down H/M down
Q62433 TAS(ph)GSSVTS(ph)LEGTR 1.2629 -1.1389 -2.6397 SILAC 1 / Biological 2 Raptor up Rictor down H/M down
Q6Y7W8 ALSSGGS(ph)ITSPPLS(ph)PALPK 1.4616 -1.0739 -2.3876 SILAC 2 / Biological 3 Raptor up Rictor down H/M down
Q8BK67 CSSSS(ph)GGGS(ph)SGDEDGPELDGAPGGGKR 1.0888 -1.1157 -2.0780 SILAC 2 / Biological 3 Raptor up Rictor down H/M down
Q9WTQ5 QAQS(ph)STEIPLQAESGQGTEEEAAKDGEENR 1.3535 -1.3818 -3.1059 SILAC 2 / Biological 3 Raptor up Rictor down H/M down
B2RUR8 S(ph)TPES(ph)GES(ph)DKESVGS(ph)S(ph)S(ph)LGNEGS(ph)R 4.4281 1.8675 -3.4847 SILAC 1 / Biological 1 Raptor up Rictor up H/M down
B2RUR8 S(ph)TPES(ph)GES(ph)DKESVGS(ph)S(ph)S(ph)LGNEGS(ph)R 4.4281 1.8675 -3.4847 SILAC 1 / Biological 1 Raptor up Rictor up H/M down
B2RUR8 S(ph)TPES(ph)GES(ph)DKESVGS(ph)S(ph)S(ph)LGNEGS(ph)R 4.4281 1.8675 -3.4847 SILAC 1 / Biological 1 Raptor up Rictor up H/M down
B2RUR8 S(ph)TPES(ph)GES(ph)DKESVGS(ph)S(ph)S(ph)LGNEGS(ph)R 4.4281 1.8675 -3.4847 SILAC 1 / Biological 1 Raptor up Rictor up H/M down
B2RUR8 S(ph)TPES(ph)GES(ph)DKESVGS(ph)S(ph)S(ph)LGNEGS(ph)R 4.4281 1.8675 -3.4847 SILAC 1 / Biological 1 Raptor up Rictor up H/M down
P10923 ISHELESS(ph)SSEVN 3.1262 1.0308 -1.6529 SILAC 3 / Biological 4 Raptor up Rictor up H/M down
Q6NZJ6 ITKPGS(ph)IDSNNQLFAPGGR 1.9968 1.1495 -1.1532 SILAC 3 / Biological 4 Raptor up Rictor up H/M down
Q8BHS6 RAS(ph)PNSDDTVLSPQELQK 2.3339 0.9020 -1.2567 SILAC 3 / Biological 4 Raptor up Rictor up H/M down
P10711 KKEPAIS(ph)SQNSPEAR 1.0859 2.8614 1.3761 SILAC 2 / Biological 3 Raptor up Rictor up H/M up  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK 1.2323 2.1405 0.9247 SILAC 1 / Biological 2 Raptor up Rictor up H/M up  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK 1.2323 2.1405 0.9247 SILAC 1 / Biological 2 Raptor up Rictor up H/M up  +
Q9JIX8 SQS(ph)PS(ph)PPPLPEDLEK 1.0768 1.9974 0.9988 SILAC 2 / Biological 3 Raptor up Rictor up H/M up  +
Q3TZZ7 DLGRS(ph)S(ph)SSLLASPSHIAAK 1.1073 1.6943 1.0992 SILAC 1 / Biological 1 Raptor up Rictor up H/M up
Q3TZZ7 DLGRS(ph)S(ph)SSLLASPSHIAAK 1.1073 1.8189 1.0992 SILAC 1 / Biological 1 Raptor up Rictor up H/M up
Q64511 VKAS(ph)PITNDGEDEFVPS(ph)DGLDKDEYAFSSGK 1.7073 0.8656 0.9615 SILAC 1 / Biological 1 Raptor up Rictor up H/M up
Q69ZN8 KQETAAVCGET(ph)DEEAGES(ph)GGEGIFR 1.4164 1.4221 0.7801 SILAC 1 / Biological 2 Raptor up Rictor up H/M up
Q69ZN8 KQETAAVCGET(ph)DEEAGES(ph)GGEGIFR 1.4164 1.4221 0.7801 SILAC 1 / Biological 2 Raptor up Rictor up H/M up
Q3UJN1 RADALTS(ph)SPGR 1.1191 2.2712 0.8801 SILAC 1 / Biological 2 Raptor up Rictor up H/M up
Q63918 RGNNS(ph)AVGS(ph)NADLT(ph)IEEDEEEEPVALQQAQQVR 1.5310 2.8320 1.7972 SILAC 1 / Biological 2 Raptor up Rictor up H/M up
Q8BTI8 RS(ph)S(ph)SELS(ph)PEVVEK 1.0078 2.2006 0.8597 SILAC 1 / Biological 2 Raptor up Rictor up H/M up
Q58A65 SAS(ph)QSS(ph)LDKLDQELKEQQK 0.9783 2.2779 0.9100 SILAC 1 / Biological 2 Raptor up Rictor up H/M up
Q61206 (ac)S(ph)QGDSNPAAIPHAAEDIQGDDR 1.1507 2.9543 1.8669 SILAC 2 / Biological 3 Raptor up Rictor up H/M up
O08784 ASAVS(ph)PEKAPMTSK 1.2313 1.8892 0.7857 SILAC 2 / Biological 3 Raptor up Rictor up H/M up
Q9D6Z1 KS(ph)SPKEEVAS(ph)EPEEAASPTTPK 1.0220 1.4860 1.2461 SILAC 2 / Biological 3 Raptor up Rictor up H/M up
Q9JIX8 S(ph)QSPS(ph)PPPLPEDLEK 1.0805 2.2622 1.0775 SILAC 2 / Biological 3 Raptor up Rictor up H/M up
P97311 FNGS(ph)S(ph)EDAS(ph)QETVSKPSLR 2.2253 3.0771 1.3233 SILAC 3 / Biological 4 Raptor up Rictor up H/M up
Q8VE94 ENFSAGS(ph)DCVTLK 1.0053 1.0625 0.2789 SILAC 2 / Biological 3 Raptor up Rictor up  +
Q3TUD7 KAENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK 2.5541 2.6164 0.0846 SILAC 1 / Biological 1 Raptor up Rictor up  +
Q3TUD7 KAENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK 2.5541 2.6164 0.0846 SILAC 1 / Biological 1 Raptor up Rictor up  +
Q3TUD7 KAENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK 2.5541 2.6164 0.2671 SILAC 1 / Biological 1 Raptor up Rictor up  +
Q3TUD7 KAENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK 2.5541 2.6164 0.2671 SILAC 1 / Biological 1 Raptor up Rictor up  +
Q8R1A4 S(ph)RSLS(ph)NSNPDISGTPTSPDDEVR 2.2928 1.5509 -0.8701 SILAC 3 / Biological 4 Raptor up Rictor up  +
P43276 (ac)S(ph)ETAPAETAAPAPVEK 1.6427 1.7866 0.0625 SILAC 1 / Biological 1 Raptor up Rictor up
P43276 (ac)S(ph)ETAPAETAAPAPVEK 1.6427 1.7866 0.0625 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 0.9551 1.6385 0.1703 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 0.9551 1.6385 0.1703 SILAC 1 / Biological 1 Raptor up Rictor up
O54724 ATEEPS(ph)GTGSDELIK 1.2914 0.8306 -0.3345 SILAC 1 / Biological 1 Raptor up Rictor up
O54724 ATEEPS(ph)GTGSDELIK 1.2914 0.8281 -0.3278 SILAC 1 / Biological 1 Raptor up Rictor up
O54988 ATLEQPETDEVEQVS(ph)ESNS(ph)IEELER 1.7321 1.0678 -0.1241 SILAC 1 / Biological 1 Raptor up Rictor up
O54988 ATLEQPETDEVEQVS(ph)ESNS(ph)IEELER 1.7321 1.0678 -0.1241 SILAC 1 / Biological 1 Raptor up Rictor up
O54988 ATLEQPETDEVEQVS(ph)ESNS(ph)IEELER 1.7321 1.0687 -0.1241 SILAC 1 / Biological 1 Raptor up Rictor up
O54988 ATLEQPETDEVEQVS(ph)ESNS(ph)IEELER 1.7321 1.0687 -0.1241 SILAC 1 / Biological 1 Raptor up Rictor up
Q8R5F7 DSGTMGS(ph)DSDESVIQTK 1.1844 1.3297 0.5642 SILAC 1 / Biological 1 Raptor up Rictor up
Q8R5F7 DSGTMGS(ph)DSDESVIQTK 1.1844 1.3297 0.5642 SILAC 1 / Biological 1 Raptor up Rictor up
Q9ERU9 EDALDDSVS(ph)SSSVHAS(ph)PLASS(ph)PVRK 1.9948 1.9415 0.1555 SILAC 1 / Biological 1 Raptor up Rictor up
Q9ERU9 EDALDDSVS(ph)SSSVHAS(ph)PLASS(ph)PVRK 1.9948 1.9415 0.1555 SILAC 1 / Biological 1 Raptor up Rictor up
Q9ERU9 EDALDDSVSSS(ph)SVHAS(ph)PLASS(ph)PVRK 2.4042 1.6001 -0.4181 SILAC 1 / Biological 1 Raptor up Rictor up
Q9ERU9 EDALDDSVSSS(ph)SVHAS(ph)PLASS(ph)PVRK 2.4042 1.6001 -0.4135 SILAC 1 / Biological 1 Raptor up Rictor up
Q9ERU9 EDALDDSVSSS(ph)SVHAS(ph)PLASS(ph)PVRK 1.9948 1.9415 0.1555 SILAC 1 / Biological 1 Raptor up Rictor up
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Q9ERU9 EDALDDSVSSS(ph)SVHAS(ph)PLASS(ph)PVRK 1.9948 1.9415 0.1555 SILAC 1 / Biological 1 Raptor up Rictor up
P53986 EGKEDEAST(ph)DVDEKPK 1.4814 1.5512 0.0980 SILAC 1 / Biological 1 Raptor up Rictor up
P53986 EGKEDEAST(ph)DVDEKPK 1.4634 1.5159 0.2079 SILAC 1 / Biological 1 Raptor up Rictor up
Q3UMF0 EQT(ph)ASAPATPLVS(ph)K 3.4182 2.4464 -0.6522 SILAC 1 / Biological 1 Raptor up Rictor up
Q3UMF0 EQT(ph)ASAPATPLVS(ph)K 3.4182 2.4464 -0.6522 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 ET(ph)NVSKEDTDQEEKAS(ph)NEDVTK 1.6427 1.9218 0.4652 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 ET(ph)NVSKEDTDQEEKAS(ph)NEDVTK 1.6427 1.9218 0.4652 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 ETNVSKEDT(ph)DQEEKAS(ph)NEDVTK 1.4159 1.3219 -0.0580 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 ETNVSKEDT(ph)DQEEKAS(ph)NEDVTK 1.4159 1.3219 -0.0580 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 ETNVSKEDT(ph)DQEEKAS(ph)NEDVTK 1.5636 1.9041 0.4066 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 ETNVSKEDT(ph)DQEEKAS(ph)NEDVTK 1.5636 1.9691 0.4066 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 GDRGEES(ph)NES(ph)AEASSNWEK 1.7577 2.3142 0.4634 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 GDRGEES(ph)NES(ph)AEASSNWEK 1.7577 2.3142 0.4634 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 GDRGEES(ph)NES(ph)AEASSNWEK 1.7577 2.3142 0.4634 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 GDRGEES(ph)NES(ph)AEASSNWEK 1.7577 2.3142 0.4634 SILAC 1 / Biological 1 Raptor up Rictor up
Q3TUD7 KAENAEGQTPAIGPDGEPLDET(ph)S(ph)QMSDLPVK 2.0897 3.0763 0.5896 SILAC 1 / Biological 1 Raptor up Rictor up
Q3TUD7 KAENAEGQTPAIGPDGEPLDET(ph)S(ph)QMSDLPVK 2.0897 3.0763 0.5896 SILAC 1 / Biological 1 Raptor up Rictor up
P43277 KAS(ph)GPPVSELITK 1.0424 1.2124 -0.0497 SILAC 1 / Biological 1 Raptor up Rictor up
P43277 KAS(ph)GPPVSELITK 1.0465 1.2593 -0.0497 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D6Z1 KS(ph)SPKEEVAS(ph)EPEEAASPTTPK 2.1319 1.8929 -0.1376 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D6Z1 KS(ph)SPKEEVAS(ph)EPEEAASPTTPK 2.1258 1.9071 -0.1306 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D6Z1 KSS(ph)PKEEVAS(ph)EPEEAASPTTPK 2.1892 1.8929 -0.2933 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D6Z1 KSS(ph)PKEEVAS(ph)EPEEAASPTTPK 2.1832 1.9070 -0.2864 SILAC 1 / Biological 1 Raptor up Rictor up
Q80Y32 KSS(ph)PQS(ph)PDTAMDLLK 1.9427 1.1367 -0.1602 SILAC 1 / Biological 1 Raptor up Rictor up
Q80Y32 KSS(ph)PQS(ph)PDTAMDLLK 1.9427 1.1367 -0.1602 SILAC 1 / Biological 1 Raptor up Rictor up
Q80Y32 KSS(ph)PQS(ph)PDTAMDLLK 1.9307 1.1588 -0.0750 SILAC 1 / Biological 1 Raptor up Rictor up
Q80Y32 KSS(ph)PQS(ph)PDTAMDLLK 1.9307 1.1588 -0.0750 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 LQGS(ph)GVS(ph)LASK 1.1289 1.0356 0.3042 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 LQGS(ph)GVS(ph)LASK 1.1289 1.0356 0.3042 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 LQGS(ph)GVS(ph)LASK 1.1289 1.0356 0.3042 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 LQGS(ph)GVS(ph)LASK 1.1289 1.0356 0.3042 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK 1.0228 1.2771 -0.1668 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK 1.0228 1.2771 -0.1668 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK 1.1616 1.2804 -0.1641 SILAC 1 / Biological 1 Raptor up Rictor up
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK 1.1616 1.2804 -0.1641 SILAC 1 / Biological 1 Raptor up Rictor up
Q9WV92 QLEYQQFEDDKLS(ph)QR 1.7011 1.0621 -0.5710 SILAC 1 / Biological 1 Raptor up Rictor up
Q9WV92 QLEYQQFEDDKLS(ph)QR 1.7120 1.0691 -0.5710 SILAC 1 / Biological 1 Raptor up Rictor up
Q3UH59 QLHIEGAS(ph)LELS(ph)DDDTESK 1.0835 0.9678 -0.3981 SILAC 1 / Biological 1 Raptor up Rictor up
Q3UH59 QLHIEGAS(ph)LELS(ph)DDDTESK 1.1130 0.9678 -0.3981 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 QSNAS(ph)SDVEVEEK 1.0862 0.9958 0.1230 SILAC 1 / Biological 1 Raptor up Rictor up
Q99JF8 QSNAS(ph)SDVEVEEK 1.0989 1.0006 0.1258 SILAC 1 / Biological 1 Raptor up Rictor up
Q6P4S8 RDS(ph)TEAPKPESS(ph)PEPPPGQGR 1.7212 0.8460 -0.1838 SILAC 1 / Biological 1 Raptor up Rictor up
Q6P4S8 RDS(ph)TEAPKPESS(ph)PEPPPGQGR 1.7212 0.8460 -0.1838 SILAC 1 / Biological 1 Raptor up Rictor up
O70475 RIPYT(ph)PGEIPK 1.5772 1.8788 0.4074 SILAC 1 / Biological 1 Raptor up Rictor up
O70475 RIPYT(ph)PGEIPK 1.5772 1.8788 0.4074 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 RNDS(ph)S(ph)ELEDLSELEDLKDAK 1.5396 1.1021 0.0266 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 RNDS(ph)S(ph)ELEDLSELEDLKDAK 1.5396 1.1021 0.0266 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 RNDS(ph)S(ph)ELEDLSELEDLKDAK 1.3967 1.1372 0.0266 SILAC 1 / Biological 1 Raptor up Rictor up
Q04692 RNDS(ph)S(ph)ELEDLSELEDLKDAK 1.3967 1.1372 0.0266 SILAC 1 / Biological 1 Raptor up Rictor up
Q9Z277 RQS(ph)LELQK 1.0572 0.8411 -0.1313 SILAC 1 / Biological 1 Raptor up Rictor up
Q9Z277 RQS(ph)LELQK 1.0572 0.8416 -0.1313 SILAC 1 / Biological 1 Raptor up Rictor up
Q3UK83 S(ph)ESPKEPEQLR 1.0211 0.8303 0.0386 SILAC 1 / Biological 1 Raptor up Rictor up
Q62318 SRS(ph)GEGEVSGLLR 1.6115 2.0591 0.4813 SILAC 1 / Biological 1 Raptor up Rictor up
Q62318 SRS(ph)GEGEVSGLLR 1.5990 2.0628 0.4813 SILAC 1 / Biological 1 Raptor up Rictor up
B2RUB9 SSTPLPT(ph)VSSSAENTR 1.4738 1.5350 0.1477 SILAC 1 / Biological 1 Raptor up Rictor up
B2RUB9 SSTPLPT(ph)VSSSAENTR 1.4548 1.5369 0.1538 SILAC 1 / Biological 1 Raptor up Rictor up
B2RUB9 SSTPLPT(ph)VSSSAENTR 1.3935 1.4560 0.1570 SILAC 1 / Biological 1 Raptor up Rictor up
B2RUB9 SSTPLPT(ph)VSSSAENTR 1.3900 1.4839 0.1570 SILAC 1 / Biological 1 Raptor up Rictor up
B2RUB9 SSTPLPTVSSS(ph)AENTR 1.3550 1.4080 0.1268 SILAC 1 / Biological 1 Raptor up Rictor up
B2RUB9 SSTPLPTVSSS(ph)AENTR 1.2593 1.4080 0.2051 SILAC 1 / Biological 1 Raptor up Rictor up
P35486 Y(ph)HGHSMSDPGVS(ph)YR 1.8680 1.1117 -0.5506 SILAC 1 / Biological 1 Raptor up Rictor up
P35486 Y(ph)HGHSMSDPGVS(ph)YR 1.8677 1.1466 -0.5365 SILAC 1 / Biological 1 Raptor up Rictor up
P35486 YHGHS(ph)MSDPGVSYR 1.1140 1.3004 -0.3974 SILAC 1 / Biological 1 Raptor up Rictor up
P35486 YHGHS(ph)MSDPGVSYR 1.1219 1.3017 -0.3974 SILAC 1 / Biological 1 Raptor up Rictor up
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 1.5418 1.1890 -0.8507 SILAC 1 / Biological 2 Raptor up Rictor up
P14873 ASLS(ph)PMDEPVPDSES(ph)PVEK 0.9517 1.9436 0.5759 SILAC 1 / Biological 2 Raptor up Rictor up
Q3TZZ7 DLGRS(ph)SS(ph)SLLASPSHIAAK 1.1272 1.6804 0.5602 SILAC 1 / Biological 2 Raptor up Rictor up
Q3UMF0 ITVEKDPDSALGIS(ph)DGETSPS(ph)SK 0.9593 1.1835 0.3465 SILAC 1 / Biological 2 Raptor up Rictor up
Q6P9Q4 KPVS(ph)PPS(ph)PK 0.9807 0.8662 0.5674 SILAC 1 / Biological 2 Raptor up Rictor up
Q6P9Q4 KPVS(ph)PPS(ph)PK 0.9807 0.8662 0.5674 SILAC 1 / Biological 2 Raptor up Rictor up
Q3U4X8 KQS(ph)QIQNQQSS(ph)DLDSDVEDY 1.2738 1.4284 0.1437 SILAC 1 / Biological 2 Raptor up Rictor up
Q3U4X8 KQSQIQNQQSS(ph)DLDS(ph)DVEDY 1.1911 0.9739 -0.0343 SILAC 1 / Biological 2 Raptor up Rictor up
Q3U4X8 KQSQIQNQQSS(ph)DLDS(ph)DVEDY 1.2337 1.2003 0.0443 SILAC 1 / Biological 2 Raptor up Rictor up
Q9D6Z1 KS(ph)SPKEEVAS(ph)EPEEAASPTTPK 1.4938 1.4392 0.2407 SILAC 1 / Biological 2 Raptor up Rictor up
Q9D6Z1 KSS(ph)PKEEVAS(ph)EPEEAASPTTPK 1.4322 1.0405 0.1668 SILAC 1 / Biological 2 Raptor up Rictor up
Q5U3K5 NIS(ph)LSS(ph)EEEAEGLAGHPR 1.3504 1.0927 -0.3883 SILAC 1 / Biological 2 Raptor up Rictor up
Q3UJN1 RADALTSS(ph)PGR 1.9490 2.7297 0.3902 SILAC 1 / Biological 2 Raptor up Rictor up
Q63918 RGNNS(ph)AVGS(ph)NADLTIEEDEEEEPVALQQAQQVR 1.0743 1.6475 0.5996 SILAC 1 / Biological 2 Raptor up Rictor up
Q63918 RGNNS(ph)AVGS(ph)NADLTIEEDEEEEPVALQQAQQVR 1.0743 1.6475 0.5996 SILAC 1 / Biological 2 Raptor up Rictor up
Q9CT10 SAGSSS(ph)PEAGEDS(ph)DHEDGNYCPPVKR 0.9449 1.6851 0.6997 SILAC 1 / Biological 2 Raptor up Rictor up
Q6A065 TEEDSKS(ph)IKS(ph)DVPVYLK 2.1318 1.3417 0.0537 SILAC 1 / Biological 2 Raptor up Rictor up
Q6A065 TEEDSKS(ph)IKS(ph)DVPVYLK 2.1318 1.3417 0.0537 SILAC 1 / Biological 2 Raptor up Rictor up
Q4VA53 AES(ph)PETSAVES(ph)TQS(ph)TPQK 0.9836 1.0733 -0.4172 SILAC 2 / Biological 3 Raptor up Rictor up
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 1.3114 1.0238 -0.2315 SILAC 2 / Biological 3 Raptor up Rictor up
Q8BP27 ENPPSPPT(ph)SPAAPQPR 1.0161 1.0304 -0.1078 SILAC 2 / Biological 3 Raptor up Rictor up
Q99JF8 ETNVSKEDTDQEEKASNEDVT(ph)K 1.1257 1.4422 -0.7881 SILAC 2 / Biological 3 Raptor up Rictor up
Q8CHU3 GS(ph)SQPNLSTSYSEQEYGK 1.1511 1.7862 0.6926 SILAC 2 / Biological 3 Raptor up Rictor up
Q8CHU3 GS(ph)SQPNLSTSYSEQEYGK 1.1511 1.7862 0.6926 SILAC 2 / Biological 3 Raptor up Rictor up
Q8K1N2 KYS(ph)GSSLSNMGAYSR 1.9824 1.8591 0.0858 SILAC 2 / Biological 3 Raptor up Rictor up
Q05A74 LAS(ph)TSDIEEKENR 1.5569 0.8752 -0.0332 SILAC 2 / Biological 3 Raptor up Rictor up
Q3UQN2 LSGINEIPRPFS(ph)PPVTSNT(ph)SPPPTAPLAR 1.1874 1.9954 0.6587 SILAC 2 / Biological 3 Raptor up Rictor up
Q3UQN2 LSGINEIPRPFS(ph)PPVTSNT(ph)SPPPTAPLAR 1.1061 1.5142 0.6661 SILAC 2 / Biological 3 Raptor up Rictor up
Q3THK3 MDTGPQS(ph)LS(ph)GKSTPSSGDVQVTEDAVR 1.8160 1.4428 -0.1409 SILAC 2 / Biological 3 Raptor up Rictor up
Q3THK3 MDTGPQSLS(ph)GKS(ph)TPSSGDVQVTEDAVR 1.6602 1.1871 -0.2909 SILAC 2 / Biological 3 Raptor up Rictor up
Q3THK3 MDTGPQSLS(ph)GKS(ph)TPSSGDVQVTEDAVR 1.6602 1.1871 -0.2909 SILAC 2 / Biological 3 Raptor up Rictor up
Q8K1N2 NFS(ph)CGS(ph)MELDDSDLESLR 1.5935 0.8705 -0.2811 SILAC 2 / Biological 3 Raptor up Rictor up
Q8K1N2 NFS(ph)CGS(ph)MELDDSDLESLR 1.5935 0.8705 -0.2811 SILAC 2 / Biological 3 Raptor up Rictor up
Q8BYC6 NGPLNES(ph)QEEEEDGEQGSNLNR 0.9501 1.1289 0.3103 SILAC 2 / Biological 3 Raptor up Rictor up
Q8CI95 S(ph)FSLASSGNSPISQR 1.0045 1.1072 0.3084 SILAC 2 / Biological 3 Raptor up Rictor up
O08784 STSS(ph)SPAPTQTLPNSITQR 1.8283 2.3423 0.4150 SILAC 2 / Biological 3 Raptor up Rictor up
Q8K1N2 T(ph)ASESNVYLNSFHYPDR 1.2541 1.3463 0.4672 SILAC 2 / Biological 3 Raptor up Rictor up
O55091 TEEVEVES(ph)EEDPILEHPPENPVK 1.6694 1.3399 -0.0622 SILAC 2 / Biological 3 Raptor up Rictor up
Q9QYB5 TEEVLSPDGS(ph)PSKS(ph)PSK 1.3259 1.1289 0.2024 SILAC 2 / Biological 3 Raptor up Rictor up
Q9QYB5 TEEVLSPDGS(ph)PSKS(ph)PSK 1.3259 1.1289 0.2024 SILAC 2 / Biological 3 Raptor up Rictor up
Q9WV92 VESTSVGSIS(ph)PGGAK 1.3211 0.9892 -0.3468 SILAC 2 / Biological 3 Raptor up Rictor up
Q68G59 YGLQDS(ph)DEEEEEHPPK 1.0401 2.1138 0.5482 SILAC 2 / Biological 3 Raptor up Rictor up
P08775 YSPTS(ph)PTY(ph)SPTTPK 1.8460 1.6107 -0.0144 SILAC 2 / Biological 3 Raptor up Rictor up
O54724 ATEEPS(ph)GT(ph)GSDELIK 1.2571 1.0316 -0.4853 SILAC 3 / Biological 4 Raptor up Rictor up
O54724 ATEEPSGTGS(ph)DELIK 1.4642 1.0732 -0.4203 SILAC 3 / Biological 4 Raptor up Rictor up
Q6PHZ2 ESTES(ph)SNT(ph)TIEDEDVK 0.9994 1.3369 0.1355 SILAC 3 / Biological 4 Raptor up Rictor up
Q6PHZ2 ESTES(ph)SNT(ph)TIEDEDVK 0.9994 1.3369 0.1355 SILAC 3 / Biological 4 Raptor up Rictor up
Q8BYJ6 HASAPS(ph)HVQPSDSEK 1.0575 0.8874 -0.3666 SILAC 3 / Biological 4 Raptor up Rictor up
Q6ZPV6 IKT(ph)EPS(ph)SPLSDPSDIIR 0.9755 0.9200 -0.1866 SILAC 3 / Biological 4 Raptor up Rictor up
Q6ZPV6 IKT(ph)EPS(ph)SPLSDPSDIIR 0.9695 0.9138 0.0293 SILAC 3 / Biological 4 Raptor up Rictor up
Q8K1N2 KSS(ph)IS(ph)SISGR 1.2993 0.9839 -0.2097 SILAC 3 / Biological 4 Raptor up Rictor up
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Q8K1N2 KSS(ph)ISS(ph)ISGR 1.2186 0.9577 -0.4554 SILAC 3 / Biological 4 Raptor up Rictor up
Q8K1N2 KYS(ph)GSSLSNMGAYSR 0.9719 1.1522 -0.0223 SILAC 3 / Biological 4 Raptor up Rictor up
Q61687 LTPVS(ph)LSNS(ph)PIK 1.4571 1.1670 -0.4440 SILAC 3 / Biological 4 Raptor up Rictor up
Q61687 LTPVSLS(ph)NS(ph)PIK 2.2061 0.9761 -0.6679 SILAC 3 / Biological 4 Raptor up Rictor up
Q6DIC7 S(ph)NLDITVGSR 1.6315 1.2235 -0.7427 SILAC 3 / Biological 4 Raptor up Rictor up
Q3UHP6 SES(ph)LSNCSIGK 1.0122 0.9045 -0.5925 SILAC 3 / Biological 4 Raptor up Rictor up
Q8K2R0 SPDEATAADQES(ph)EDDLS(ph)AS(ph)RTSLER 1.3024 2.2134 0.3906 SILAC 3 / Biological 4 Raptor up Rictor up
Q8K2R0 SPDEATAADQES(ph)EDDLS(ph)ASRTS(ph)LER 1.3323 2.0393 0.4390 SILAC 3 / Biological 4 Raptor up Rictor up
Q9CQ20 T(ph)TPAPS(ph)PGSANESFFAPSR 1.0639 1.7173 0.5459 SILAC 3 / Biological 4 Raptor up Rictor up
Q9CQ20 T(ph)TPAPS(ph)PGSANESFFAPSR 1.0639 1.7173 0.5459 SILAC 3 / Biological 4 Raptor up Rictor up
Q9Z277 LADDEGDS(ph)DSES(ph)VGQSR 1.4127 -0.1407 -1.6659 SILAC 3 / Biological 4 Raptor up H/M down  +
Q6NZJ6 S(ph)FSKEVEER 1.1093 0.1417 -1.6174 SILAC 2 / Biological 3 Raptor up H/M down  +
Q6NZJ6 S(ph)FSKEVEER 1.4983 0.0013 -1.5476 SILAC 3 / Biological 4 Raptor up H/M down  +
P20152 SLYSSS(ph)PGGAYVTR 1.3648 -1.0318 -2.4054 SILAC 3 / Biological 4 Raptor up H/M down  +
Q62433 SRT(ph)AS(ph)GSSVTSLEGTR 1.1111 -0.4206 -1.5735 SILAC 1 / Biological 1 Raptor up H/M down  +
Q62433 SRT(ph)AS(ph)GSSVTSLEGTR 1.1123 -0.4206 -1.5620 SILAC 1 / Biological 1 Raptor up H/M down  +
Q61892 GGDYALAPGSQSS(ph)EMS(ph)LR 1.2061 -0.5857 -1.9813 SILAC 1 / Biological 1 Raptor up H/M down
Q61892 GGDYALAPGSQSS(ph)EMS(ph)LR 1.2599 -0.5865 -1.9293 SILAC 1 / Biological 1 Raptor up H/M down
Q61892 GGDYALAPGSQSS(ph)EMS(ph)LR 1.3327 -0.3776 -1.5728 SILAC 1 / Biological 1 Raptor up H/M down
Q61892 GGDYALAPGSQSS(ph)EMS(ph)LR 1.2370 -0.3792 -1.4689 SILAC 1 / Biological 1 Raptor up H/M down
Q9WTQ5 GPSEAPQEAEAEEGAT(ph)SDGEK 0.9630 -0.8121 -1.4206 SILAC 1 / Biological 1 Raptor up H/M down
B9EKC2 KENEEAEPST(ph)APGT(ph)PTLR 1.7267 0.2599 -1.3351 SILAC 1 / Biological 1 Raptor up H/M down
B9EKC2 KENEEAEPST(ph)APGT(ph)PTLR 1.7161 0.3377 -1.3351 SILAC 1 / Biological 1 Raptor up H/M down
Q60953 LAT(ph)S(ph)SPEQSWPSTFK 1.8623 0.5601 -1.0919 SILAC 1 / Biological 1 Raptor up H/M down
Q60953 LAT(ph)S(ph)SPEQSWPSTFK 1.8623 0.5767 -1.0919 SILAC 1 / Biological 1 Raptor up H/M down
Q9QZQ1 LDSDRVS(ph)S(ph)ASSTAER 1.6775 -0.8567 -2.5317 SILAC 1 / Biological 1 Raptor up H/M down
Q9QZQ1 LDSDRVS(ph)S(ph)ASSTAER 1.2428 -0.4428 -1.7716 SILAC 1 / Biological 1 Raptor up H/M down
P39447 S(ph)REDLSAQPVQTK 0.9695 0.2211 -1.1303 SILAC 1 / Biological 1 Raptor up H/M down
P39447 S(ph)REDLSAQPVQTK 0.9800 0.1435 -1.1234 SILAC 1 / Biological 1 Raptor up H/M down
Q9WTQ5 SATLSSTES(ph)TAS(ph)GMQDEVR 1.4330 -0.2014 -1.0825 SILAC 1 / Biological 1 Raptor up H/M down
Q9WTQ5 SATLSSTES(ph)TAS(ph)GMQDEVR 1.4330 -0.2014 -1.0825 SILAC 1 / Biological 1 Raptor up H/M down
Q9WTQ5 SATLSSTES(ph)TAS(ph)GMQDEVR 1.0799 -0.1686 -1.0825 SILAC 1 / Biological 1 Raptor up H/M down
Q9WTQ5 SATLSSTES(ph)TAS(ph)GMQDEVR 1.0799 -0.1686 -1.0825 SILAC 1 / Biological 1 Raptor up H/M down
P14873 SLMS(ph)S(ph)PEDLTKDFEELKAEEIDVAK 1.6442 -0.0287 -1.3435 SILAC 1 / Biological 1 Raptor up H/M down
P14873 SLMS(ph)S(ph)PEDLTKDFEELKAEEIDVAK 1.6442 -0.0287 -1.3435 SILAC 1 / Biological 1 Raptor up H/M down
Q62433 TASGSS(ph)VTS(ph)LEGTR 1.0494 -0.7012 -1.7608 SILAC 1 / Biological 1 Raptor up H/M down
Q62433 TASGSS(ph)VTS(ph)LEGTR 1.0494 -0.7313 -1.7535 SILAC 1 / Biological 1 Raptor up H/M down
Q62433 TASGSS(ph)VTS(ph)LEGTR 1.0479 -0.6071 -1.7461 SILAC 1 / Biological 1 Raptor up H/M down
Q62433 TASGSS(ph)VTS(ph)LEGTR 1.0944 -0.6079 -1.6941 SILAC 1 / Biological 1 Raptor up H/M down
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 1.4615 0.0875 -1.5858 SILAC 1 / Biological 2 Raptor up H/M down
Q8VDN3 ASLGS(ph)LEGEVEAEAS(ph)SPKGK 1.1557 -0.8363 -1.9782 SILAC 1 / Biological 2 Raptor up H/M down
Q61609 EVKSS(ph)PS(ph)ESPLMEK 2.0863 -0.2044 -2.0593 SILAC 1 / Biological 2 Raptor up H/M down
O55131 ILEQQNSSRT(ph)LEK 1.0542 -0.8268 -1.6570 SILAC 1 / Biological 2 Raptor up H/M down
Q6A065 LGS(ph)LSARS(ph)DSEATISR 1.0680 0.0000 -1.2175 SILAC 1 / Biological 2 Raptor up H/M down
Q6A065 LGS(ph)LSARS(ph)DSEATISR 1.1037 0.0845 -1.0730 SILAC 1 / Biological 2 Raptor up H/M down
Q99K70 M(ox)SPNETLFLES(ph)TNK 1.0892 -0.0002 -1.3642 SILAC 1 / Biological 2 Raptor up H/M down
O35144 NS(ph)PMTISR 1.1587 0.1090 -1.0260 SILAC 1 / Biological 2 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPS(ph)PTR 2.2446 -0.2072 -1.7573 SILAC 1 / Biological 2 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPS(ph)PTR 2.2446 -0.2072 -1.7573 SILAC 1 / Biological 2 Raptor up H/M down
Q99J21 SELQAYIEQCQDSPT(ph)SGK 1.4010 0.1177 -1.2767 SILAC 1 / Biological 2 Raptor up H/M down
Q9ET54 SRS(ph)RDS(ph)GDENEPIQER 1.4394 -0.2296 -1.4689 SILAC 1 / Biological 2 Raptor up H/M down
Q9ET54 SRS(ph)RDS(ph)GDENEPIQER 1.4394 -0.2296 -1.4689 SILAC 1 / Biological 2 Raptor up H/M down
Q62433 SRT(ph)AS(ph)GS(ph)SVTSLEGTR 1.2308 -0.9788 -1.9311 SILAC 1 / Biological 2 Raptor up H/M down
Q62433 TASGSS(ph)VTS(ph)LEGTR 1.0888 -0.1922 -0.9895 SILAC 1 / Biological 2 Raptor up H/M down
Q8BHS6 YNDWS(ph)DDDDDS(ph)NESK 2.3784 0.4139 -1.8850 SILAC 1 / Biological 2 Raptor up H/M down
Q8BTI8 AQSGT(ph)DSS(ph)PEHKIPAPR 1.5888 0.2357 -4.4392 SILAC 2 / Biological 3 Raptor up H/M down
Q8BTI8 AQSGTDS(ph)S(ph)PEHKIPAPR 1.2690 0.1949 -4.4475 SILAC 2 / Biological 3 Raptor up H/M down
Q8BTI8 AQSGTDS(ph)S(ph)PEHKIPAPR 1.2390 0.2418 -3.9531 SILAC 2 / Biological 3 Raptor up H/M down
Q8VDN3 ASLGS(ph)LEGEVEAEAS(ph)SPKGK 1.4220 0.1425 -1.2321 SILAC 2 / Biological 3 Raptor up H/M down
Q8VDN3 EFS(ph)APSTPTGT(ph)LEFAGGDAK 1.3621 -0.2182 -1.5484 SILAC 2 / Biological 3 Raptor up H/M down
Q8VDN3 EFS(ph)APSTPTGT(ph)LEFAGGDAK 1.3621 -0.2182 -1.5484 SILAC 2 / Biological 3 Raptor up H/M down
Q8VDN3 EFSAPS(ph)T(ph)PTGTLEFAGGDAK 1.2632 -0.4212 -3.0991 SILAC 2 / Biological 3 Raptor up H/M down
Q8VDN3 GGVTGSPEASISGS(ph)K 2.8236 0.3273 -2.3241 SILAC 2 / Biological 3 Raptor up H/M down
Q9ESL4 GSVSLNS(ph)SPK 1.2174 -0.3476 -1.0976 SILAC 2 / Biological 3 Raptor up H/M down
Q8R457 HSS(ph)IS(ph)PVRLPLNSSLGAELSR 0.9641 -0.0186 -1.5372 SILAC 2 / Biological 3 Raptor up H/M down
Q8R457 HSS(ph)IS(ph)PVRLPLNSSLGAELSR 0.9641 -0.0186 -1.5372 SILAC 2 / Biological 3 Raptor up H/M down
O55131 ILEQQNSSRT(ph)LEK 1.0593 -0.0096 -1.0042 SILAC 2 / Biological 3 Raptor up H/M down
Q6NZJ6 ITKPGS(ph)IDSNNQLFAPGGR 1.5985 0.5869 -0.9920 SILAC 2 / Biological 3 Raptor up H/M down
Q6NZJ6 ITKPGSIDSNNQLFAPGGRLS(ph)WGK 1.7651 -0.2260 -2.4539 SILAC 2 / Biological 3 Raptor up H/M down
Q6NZJ6 KAAS(ph)LTEDR 1.0273 -0.7671 -1.3234 SILAC 2 / Biological 3 Raptor up H/M down
B1AR17 KLDS(ph)EEEFGS(ph)ERDEYR 1.1929 0.1950 -1.1016 SILAC 2 / Biological 3 Raptor up H/M down
B1AR17 KLDS(ph)EEEFGS(ph)ERDEYR 1.1929 0.1950 -1.1016 SILAC 2 / Biological 3 Raptor up H/M down
P52927 KPAQETEETSSQES(ph)AEED 1.0155 -0.3158 -1.5340 SILAC 2 / Biological 3 Raptor up H/M down
Q6PHZ2 KPDGVKESTES(ph)SNTTIEDEDVK 1.1221 0.1539 -1.5106 SILAC 2 / Biological 3 Raptor up H/M down
Q923J1 KPSAVNTLSSS(ph)LPQGDR 0.9582 -0.0010 -1.0888 SILAC 2 / Biological 3 Raptor up H/M down
Q3U4X8 KQS(ph)QIQNQQSSDLDSDVEDY 1.0428 -0.4110 -1.5533 SILAC 2 / Biological 3 Raptor up H/M down
Q3U4X8 KQSQIQNQQSSDLDS(ph)DVEDY 1.0899 -0.0946 -1.3060 SILAC 2 / Biological 3 Raptor up H/M down
Q4VA53 LDS(ph)SEMDHS(ph)ENEDYTMSSPLPGK 1.2708 0.4889 -1.1729 SILAC 2 / Biological 3 Raptor up H/M down
P10923 LEHSKES(ph)QES(ph)ADQSDVIDSQASSK 1.3959 -0.5567 -2.0938 SILAC 2 / Biological 3 Raptor up H/M down
P10923 LEHSKES(ph)QES(ph)ADQSDVIDSQASSK 1.3959 -0.5567 -2.0938 SILAC 2 / Biological 3 Raptor up H/M down
P05627 LQALKEEPQTVPEMPGET(ph)PPLS(ph)PIDMESQER 1.8185 0.3884 -1.2192 SILAC 2 / Biological 3 Raptor up H/M down
P05627 LQALKEEPQTVPEMPGET(ph)PPLS(ph)PIDMESQER 1.8185 0.3884 -1.2192 SILAC 2 / Biological 3 Raptor up H/M down
Q8K2Z4 LQPLTS(ph)VDSDNDFVTPKPR 1.1608 -0.4040 -2.6178 SILAC 2 / Biological 3 Raptor up H/M down
Q99K70 M(ox)SPNETLFLES(ph)TNK 1.3395 0.7082 -1.1215 SILAC 2 / Biological 3 Raptor up H/M down
Q99K70 M(ox)SPNETLFLEST(ph)NK 1.0718 0.1376 -1.0585 SILAC 2 / Biological 3 Raptor up H/M down
P98203 NFDT(ph)LDLPK 0.9710 -0.9738 -2.0138 SILAC 2 / Biological 3 Raptor up H/M down
Q3U4X8 NQVVPESDS(ph)PVKR 0.9891 -0.7733 -1.5089 SILAC 2 / Biological 3 Raptor up H/M down
Q8BHS6 RAS(ph)PNSDDTVLSPQELQK 1.7677 -0.0530 -1.6795 SILAC 2 / Biological 3 Raptor up H/M down
Q8BHS6 RASPNS(ph)DDTVLSPQELQK 1.7792 0.1889 -1.5724 SILAC 2 / Biological 3 Raptor up H/M down
Q9Z277 RCDVQEDS(ph)EGS(ph)ETDDNKDSTPFEDNEVQDEFLEK 1.0062 -0.7057 -1.3149 SILAC 2 / Biological 3 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPS(ph)PTR 1.8596 -0.0831 -2.4109 SILAC 2 / Biological 3 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPS(ph)PTR 1.8596 -0.0831 -2.4109 SILAC 2 / Biological 3 Raptor up H/M down
Q8BTI8 RS(ph)S(ph)SELSPEVVEK 1.1626 -0.0035 -1.3200 SILAC 2 / Biological 3 Raptor up H/M down
Q8BTI8 S(ph)GSSQELDGKPSASPQER 1.4416 -0.6348 -1.2830 SILAC 2 / Biological 3 Raptor up H/M down
Q8BYJ6 S(ph)LTS(ph)SLENIFSR 1.3649 -0.1316 -2.1948 SILAC 2 / Biological 3 Raptor up H/M down
Q8BYJ6 S(ph)LTS(ph)SLENIFSR 1.3851 -0.1758 -1.9130 SILAC 2 / Biological 3 Raptor up H/M down
Q8BYJ6 S(ph)LTSS(ph)LENIFSR 1.4055 -0.2202 -1.6312 SILAC 2 / Biological 3 Raptor up H/M down
Q9R0L6 S(ph)NRPVSADGNYRPLAK 1.0529 -0.5111 -1.9519 SILAC 2 / Biological 3 Raptor up H/M down
Q8VDN3 S(ph)NSFSDEREFSAPS(ph)TPTGTLEFAGGDAK 1.1381 -0.3810 -1.8598 SILAC 2 / Biological 3 Raptor up H/M down
A2AI52 S(ph)YSSPDITQALQEEEKR 1.0789 -0.6785 -1.7067 SILAC 2 / Biological 3 Raptor up H/M down
Q99J21 SELQAYIEQCQDS(ph)PTSGK 1.2660 0.0343 -1.1188 SILAC 2 / Biological 3 Raptor up H/M down
Q3UHP6 SES(ph)LSNCSIGK 1.2144 -0.4473 -1.4783 SILAC 2 / Biological 3 Raptor up H/M down
Q9EPC1 SPLVPKS(ph)PT(ph)PKSPPSR 1.1404 -0.6923 -1.9805 SILAC 2 / Biological 3 Raptor up H/M down
Q9EPC1 SPLVPKS(ph)PT(ph)PKSPPSR 1.0262 -0.7561 -1.9764 SILAC 2 / Biological 3 Raptor up H/M down
Q9EPC1 SPTPKS(ph)PPSR 1.0637 0.4579 -1.0060 SILAC 2 / Biological 3 Raptor up H/M down
Q9CZJ2 SPVPS(ph)PPGS(ph)PR 1.0166 -0.4429 -1.6486 SILAC 2 / Biological 3 Raptor up H/M down
Q9CZJ2 SPVPS(ph)PPGS(ph)PR 1.0166 -0.4429 -1.6486 SILAC 2 / Biological 3 Raptor up H/M down
Q8R1A4 SRSLS(ph)NS(ph)NPDISGTPTSPDDEVR 1.8338 0.4733 -1.2260 SILAC 2 / Biological 3 Raptor up H/M down
Q80X50 STSAPQMS(ph)PGSSDNQSSS(ph)PQPAQQK 1.4036 -0.7651 -2.1139 SILAC 2 / Biological 3 Raptor up H/M down
Q80X50 STSAPQMSPGS(ph)SDNQSSS(ph)PQPAQQK 1.3423 -1.0393 -2.2776 SILAC 2 / Biological 3 Raptor up H/M down
Q5FWX6 SVFPATVSAVLPAPS(ph)PCS(ph)SPK 1.0286 -0.3914 -1.5776 SILAC 2 / Biological 3 Raptor up H/M down
Q5FWX6 SVFPATVSAVLPAPS(ph)PCSS(ph)PK 1.0147 -0.2796 -1.7325 SILAC 2 / Biological 3 Raptor up H/M down
Q6ZQ61 SYSPDGKES(ph)PSDKK 1.3428 -0.3811 -1.5578 SILAC 2 / Biological 3 Raptor up H/M down
Q6PDH0 T(ph)RSPS(ph)PTLGESLAPR 1.0206 -0.1180 -1.1786 SILAC 2 / Biological 3 Raptor up H/M down
Q6PDH0 T(ph)RSPSPT(ph)LGESLAPR 1.1965 -0.5591 -1.7324 SILAC 2 / Biological 3 Raptor up H/M down
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P59808 TCS(ph)FGGFDLTNR 1.7255 -0.6500 -2.1416 SILAC 2 / Biological 3 Raptor up H/M down
Q3TYK4 TDSREDEIS(ph)PPPPNPVVK 1.1686 0.1777 -1.2012 SILAC 2 / Biological 3 Raptor up H/M down
Q9WU62 VLS(ph)PILLNNILPTTAKS(ph)PLGNIR 1.4005 0.6081 -1.3794 SILAC 2 / Biological 3 Raptor up H/M down
Q9WU62 VLS(ph)PILLNNILPTTAKS(ph)PLGNIR 1.4005 0.6081 -1.3794 SILAC 2 / Biological 3 Raptor up H/M down
Q8BTI8 VSSPVLETVQQRT(ph)PS(ph)RER 0.9431 -1.0014 -2.8966 SILAC 2 / Biological 3 Raptor up H/M down
Q3TIY5 AAAQYSS(ph)QKS(ph)VEER 1.3744 -0.9067 -2.1635 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 1.5314 0.1824 -1.3087 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 ASLGS(ph)LEGEVEAEASSPK 1.3078 0.1731 -1.1660 SILAC 3 / Biological 4 Raptor up H/M down
Q8BVR6 DDS(ph)GAEDNVDTHQQQAENSTVPTADSR 0.9514 -0.4679 -1.4195 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 EFS(ph)APST(ph)PTGTLEFAGGDAK 1.7792 -0.5075 -2.4034 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 EFS(ph)APST(ph)PTGTLEFAGGDAK 1.5600 -0.2612 -2.1172 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 EFS(ph)APSTPTGT(ph)LEFAGGDAK 2.0212 -0.9098 -2.6628 SILAC 3 / Biological 4 Raptor up H/M down
Q3UMF0 EQT(ph)ASAPAT(ph)PLVSK 1.3448 0.3922 -1.0964 SILAC 3 / Biological 4 Raptor up H/M down
Q3UMF0 EQTAS(ph)APAT(ph)PLVSK 1.3820 0.0653 -1.1597 SILAC 3 / Biological 4 Raptor up H/M down
Q3UMF0 EQTAS(ph)APAT(ph)PLVSK 1.3823 0.0281 -1.1573 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 FKAEAPLPS(ph)PK 1.2332 -0.6840 -1.8452 SILAC 3 / Biological 4 Raptor up H/M down
P10923 FRIS(ph)HELESS(ph)SSEVN 2.1796 0.7327 -1.5980 SILAC 3 / Biological 4 Raptor up H/M down
Q01320 FT(ph)VDLDS(ph)DEDFSGLDEKDEDEDFLPLDAT(ph)PPK 1.0188 0.1157 -1.0621 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 GDLGASS(ph)PSMK 2.0058 0.0796 -2.0789 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 GDLGASSPS(ph)MK 2.3393 0.0768 -2.4559 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 GGVTGS(ph)PEASIS(ph)GSKGDLK 3.3593 0.0524 -3.2963 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 GGVTGS(ph)PEASISGS(ph)KGDLK 3.2839 0.5007 -3.2737 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDN3 GHYEVTGS(ph)DDEAGK 1.1595 -0.1253 -1.6330 SILAC 3 / Biological 4 Raptor up H/M down
Q9WTQ5 GPSEAPQEAEAEEGAT(ph)SDGEK 1.6075 -0.8866 -2.3635 SILAC 3 / Biological 4 Raptor up H/M down
Q9ESL4 GSVS(ph)LNSS(ph)PK 1.4175 -0.5454 -1.8885 SILAC 3 / Biological 4 Raptor up H/M down
Q9ESL4 GSVS(ph)LNSS(ph)PK 1.4175 -0.5454 -1.8885 SILAC 3 / Biological 4 Raptor up H/M down
Q8VDD5 GT(ph)GDCSDEEVDGKADGADAK 1.1925 -0.4283 -1.4174 SILAC 3 / Biological 4 Raptor up H/M down
Q61687 IKPVTENLVLPSHTGFCQS(ph)S(ph)GDEALSK 1.0664 -0.2610 -1.0526 SILAC 3 / Biological 4 Raptor up H/M down
Q61687 IKPVTENLVLPSHTGFCQS(ph)S(ph)GDEALSK 1.0664 -0.2610 -1.0526 SILAC 3 / Biological 4 Raptor up H/M down
Q8C1D8 IS(ph)DSES(ph)EELPKPR 2.5445 0.5147 -2.0644 SILAC 3 / Biological 4 Raptor up H/M down
P10923 ISHELES(ph)SS(ph)SEVN 2.0685 0.6219 -1.4107 SILAC 3 / Biological 4 Raptor up H/M down
P10923 ISHELESSS(ph)SEVN 2.4074 0.4347 -1.9308 SILAC 3 / Biological 4 Raptor up H/M down
Q6NZJ6 ITKPGSIDSNNQLFAPGGRLS(ph)WGK 2.4443 0.5222 -2.1859 SILAC 3 / Biological 4 Raptor up H/M down
Q6NZJ6 KAAS(ph)LTEDR 1.6783 -0.0651 -1.6782 SILAC 3 / Biological 4 Raptor up H/M down
P09405 KEDS(ph)DEDEDEEDEDDS(ph)DEDEDDEEEDEFEPPIVK 1.4757 -0.2905 -1.5710 SILAC 3 / Biological 4 Raptor up H/M down
P09405 KEDS(ph)DEDEDEEDEDDS(ph)DEDEDDEEEDEFEPPIVK 1.4757 -0.2905 -1.5710 SILAC 3 / Biological 4 Raptor up H/M down
Q64511 KIVETINS(ph)DS(ph)DSEFGIPK 1.2928 0.1836 -1.2327 SILAC 3 / Biological 4 Raptor up H/M down
P17095 KLEKEEEEGISQES(ph)S(ph)EEEQ 1.1576 -0.1237 -1.1601 SILAC 3 / Biological 4 Raptor up H/M down
P17095 KLEKEEEEGISQES(ph)S(ph)EEEQ 1.1068 -0.1237 -1.1463 SILAC 3 / Biological 4 Raptor up H/M down
P52927 KPAQETEETSSQES(ph)AEED 1.6141 0.1616 -1.5193 SILAC 3 / Biological 4 Raptor up H/M down
Q6PHZ2 KPDGVKES(ph)TESSNTT(ph)IEDEDVK 1.6793 0.6613 -1.4441 SILAC 3 / Biological 4 Raptor up H/M down
Q6PHZ2 KPDGVKES(ph)TESSNTT(ph)IEDEDVK 1.6793 0.6613 -1.4441 SILAC 3 / Biological 4 Raptor up H/M down
Q6PHZ2 KPDGVKESTES(ph)S(ph)NTTIEDEDVK 1.5706 0.6701 -1.3017 SILAC 3 / Biological 4 Raptor up H/M down
Q52KI8 KVELS(ph)ES(ph)EEDKGSK 1.1345 -0.1450 -1.3033 SILAC 3 / Biological 4 Raptor up H/M down
Q0P678 LGVSVS(ph)PSR 1.1528 -0.1386 -1.3883 SILAC 3 / Biological 4 Raptor up H/M down
Q8BRB8 LPSGS(ph)GPAS(ph)PTTGSAVDIR 1.2866 -0.0498 -1.2598 SILAC 3 / Biological 4 Raptor up H/M down
Q99K70 M(ox)SPNETLFLES(ph)TNK 1.5506 0.2242 -1.2202 SILAC 3 / Biological 4 Raptor up H/M down
P98203 NFDT(ph)LDLPK 1.5790 0.1395 -1.5527 SILAC 3 / Biological 4 Raptor up H/M down
Q69ZN8 NLETLPS(ph)FS(ph)SDEEDSVAK 0.9533 -0.3387 -1.3436 SILAC 3 / Biological 4 Raptor up H/M down
Q61687 QNYSESSNYDS(ph)ELER 1.2980 0.0708 -1.0693 SILAC 3 / Biological 4 Raptor up H/M down
Q3U4X8 QSQIQNQQS(ph)SDLDSDVEDY(ph) 1.3192 0.2929 -1.0935 SILAC 3 / Biological 4 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPS(ph)PTR 1.4133 -0.3089 -1.6485 SILAC 3 / Biological 4 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPSPT(ph)R 1.3016 -0.1915 -1.6440 SILAC 3 / Biological 4 Raptor up H/M down
Q6NZE7 RIDFTPVS(ph)PAPSPT(ph)R 1.3016 -0.1915 -1.5951 SILAC 3 / Biological 4 Raptor up H/M down
Q9Z0R4 S(ph)GSGMSVISSSSVDQR 1.0397 -0.6194 -2.1742 SILAC 3 / Biological 4 Raptor up H/M down
O08784 S(ph)T(ph)SSSPAPTQTLPNSITQR 0.9673 -0.3116 -1.3735 SILAC 3 / Biological 4 Raptor up H/M down
Q61127 SFS(ph)PKS(ph)PLELGEK 0.9996 0.1140 -1.2061 SILAC 3 / Biological 4 Raptor up H/M down
Q61127 SFS(ph)PKS(ph)PLELGEK 0.9996 0.1140 -1.2061 SILAC 3 / Biological 4 Raptor up H/M down
Q61823 SGVAVPT(ph)SPK 2.8611 -0.1578 -2.9481 SILAC 3 / Biological 4 Raptor up H/M down
Q8BYJ6 SLT(ph)SS(ph)LENIFSR 2.2631 -0.4157 -2.4795 SILAC 3 / Biological 4 Raptor up H/M down
Q8BYJ6 SLT(ph)SS(ph)LENIFSR 2.2631 -0.4157 -2.4795 SILAC 3 / Biological 4 Raptor up H/M down
Q8R1A4 SPSGSAFGS(ph)QENLR 1.6420 0.4705 -1.3774 SILAC 3 / Biological 4 Raptor up H/M down
Q9QYG0 SRT(ph)AS(ph)LTSAASIDGSR 6.1261 -0.7115 -6.8085 SILAC 3 / Biological 4 Raptor up H/M down
P26231 SRTS(ph)VQT(ph)EDDQLIAGQSAR 1.0253 0.0630 -1.0941 SILAC 3 / Biological 4 Raptor up H/M down
Q9QXS1 SSS(ph)VGSSSSYPISSAGPR 1.0696 -0.7074 -1.6728 SILAC 3 / Biological 4 Raptor up H/M down
Q9QYG0 T(ph)ASLTSAAS(ph)IDGSR 1.4608 0.3663 -1.3899 SILAC 3 / Biological 4 Raptor up H/M down
P59808 TCS(ph)FGGFDLTNR 1.9226 -0.0254 -2.1360 SILAC 3 / Biological 4 Raptor up H/M down
O88792 VIYSQPS(ph)TRS(ph)EGEFK 1.1793 0.0091 -1.2227 SILAC 3 / Biological 4 Raptor up H/M down
Q8BHS6 YNDWS(ph)DDDDDS(ph)NESK 1.9760 0.3744 -1.5891 SILAC 3 / Biological 4 Raptor up H/M down
Q8BHS6 YNDWS(ph)DDDDDS(ph)NESK 1.9760 0.3744 -1.5891 SILAC 3 / Biological 4 Raptor up H/M down
Q8R1A4 S(ph)RSLS(ph)NSNPDISGTPTSPDDEVR 1.0862 0.2424 -0.4929 SILAC 2 / Biological 3 Raptor up  +
Q8R1A4 S(ph)RSLS(ph)NSNPDISGTPTSPDDEVR 1.1285 0.3288 -0.4271 SILAC 2 / Biological 3 Raptor up  +
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 0.9450 0.3702 -0.4076 SILAC 1 / Biological 1 Raptor up
Q8VDN3 AS(ph)LGS(ph)LEGEVEAEASSPK 0.9551 0.3702 -0.4076 SILAC 1 / Biological 1 Raptor up
Q8BGU5 AS(ph)TIFLSKS(ph)QTDVR 1.0459 0.7560 -0.1234 SILAC 1 / Biological 1 Raptor up
O54724 ATEEPSGTGS(ph)DELIK 1.3810 0.6183 -0.0372 SILAC 1 / Biological 1 Raptor up
O54724 ATEEPSGTGS(ph)DELIK 1.3810 0.6183 -0.0372 SILAC 1 / Biological 1 Raptor up
Q80YV2 DTAATFQSVDGS(ph)PQAEQSPLESTSK 0.9612 0.6481 0.0919 SILAC 1 / Biological 1 Raptor up
Q80YV2 DTAATFQSVDGS(ph)PQAEQSPLESTSK 0.9612 0.6481 0.0919 SILAC 1 / Biological 1 Raptor up
Q9D6Z1 EEVAS(ph)EPEEAASPTTPK 1.0432 0.2748 -0.4931 SILAC 1 / Biological 1 Raptor up
Q9D6Z1 EEVAS(ph)EPEEAASPTTPK 1.0183 0.2420 -0.4667 SILAC 1 / Biological 1 Raptor up
P47713 HIVSNDSS(ph)DSDDEAQGPK 0.9507 0.2045 -0.8425 SILAC 1 / Biological 1 Raptor up
P47713 HIVSNDSS(ph)DSDDEAQGPK 0.9512 0.1995 -0.8074 SILAC 1 / Biological 1 Raptor up
Q9ET54 IASDEEIQGT(ph)K 1.5475 0.7309 -0.3895 SILAC 1 / Biological 1 Raptor up
Q5U4B1 KDS(ph)EEGEESFSSVQDDLSK 1.2136 0.6289 -0.7910 SILAC 1 / Biological 1 Raptor up
Q5U4B1 KDS(ph)EEGEESFSSVQDDLSK 1.2340 0.6829 -0.7728 SILAC 1 / Biological 1 Raptor up
Q9Z277 KSDGACDS(ph)PS(ph)SDKENSSQMAQDLQK 1.6696 0.0035 0.0772 SILAC 1 / Biological 1 Raptor up
Q9Z277 KSDGACDS(ph)PS(ph)SDKENSSQMAQDLQK 1.6696 0.0035 0.0772 SILAC 1 / Biological 1 Raptor up
Q9Z277 KSDGACDS(ph)PS(ph)SDKENSSQMAQDLQK 1.6696 0.0035 0.0772 SILAC 1 / Biological 1 Raptor up
Q64511 KTSFDQDS(ph)DVDIFPSDFTSEPPALPR 1.0353 0.7987 0.0025 SILAC 1 / Biological 1 Raptor up
Q60953 LATS(ph)S(ph)PEQSWPSTFK 1.4371 0.5730 -0.8491 SILAC 1 / Biological 1 Raptor up
Q60953 LATS(ph)S(ph)PEQSWPSTFK 1.4232 0.5739 -0.8436 SILAC 1 / Biological 1 Raptor up
Q60953 LATS(ph)S(ph)PEQSWPSTFK 1.4393 0.5998 -0.7794 SILAC 1 / Biological 1 Raptor up
Q60953 LATS(ph)S(ph)PEQSWPSTFK 1.4410 0.5998 -0.7683 SILAC 1 / Biological 1 Raptor up
Q8BRB8 LPSGSGPAS(ph)PTTGSAVDIR 1.3702 0.5839 -0.7964 SILAC 1 / Biological 1 Raptor up
Q8BRB8 LPSGSGPAS(ph)PTTGSAVDIR 1.3702 0.5927 -0.7964 SILAC 1 / Biological 1 Raptor up
Q8BRB8 LRS(ph)EDGVEGDLGETQSR 1.0805 0.5103 -0.5819 SILAC 1 / Biological 1 Raptor up
Q8BRB8 LRS(ph)EDGVEGDLGETQSR 1.0775 0.3528 -0.5061 SILAC 1 / Biological 1 Raptor up
Q4VA53 METVSNASSSS(ph)NPSS(ph)PGR 1.5274 0.4998 -0.6198 SILAC 1 / Biological 1 Raptor up
Q4VA53 METVSNASSSS(ph)NPSS(ph)PGR 1.5274 0.4998 -0.6198 SILAC 1 / Biological 1 Raptor up
Q9JMH9 NKLEGDS(ph)DVDS(ph)ELEDRVDGVK 0.9838 -0.1614 -0.9037 SILAC 1 / Biological 1 Raptor up
Q9JMH9 NKLEGDS(ph)DVDS(ph)ELEDRVDGVK 0.9838 -0.1614 -0.9037 SILAC 1 / Biological 1 Raptor up
Q8R2M2 NMPNVS(ph)DSETYNSDFDDSS(ph)PR 1.0130 0.1822 -0.1275 SILAC 1 / Biological 1 Raptor up
Q8R2M2 NMPNVS(ph)DSETYNSDFDDSS(ph)PR 1.0130 0.1822 -0.1275 SILAC 1 / Biological 1 Raptor up
Q8R2M2 NMPNVS(ph)DSETYNSDFDDSS(ph)PR 1.0130 0.1822 -0.1275 SILAC 1 / Biological 1 Raptor up
Q8R2M2 NMPNVS(ph)DSETYNSDFDDSS(ph)PR 1.0130 0.1822 -0.1275 SILAC 1 / Biological 1 Raptor up
Q9Z277 RCDVQEDS(ph)EGS(ph)ETDDNKDSTPFEDNEVQDEFLEK 1.1993 0.1384 -0.8392 SILAC 1 / Biological 1 Raptor up
Q6P4S8 RDS(ph)TEAPKPESS(ph)PEPPPGQGR 1.0535 0.6838 -0.3615 SILAC 1 / Biological 1 Raptor up
Q6P4S8 RDS(ph)TEAPKPESS(ph)PEPPPGQGR 1.0535 0.6838 -0.3546 SILAC 1 / Biological 1 Raptor up
Q8BTI8 RVPS(ph)PTPVPK 1.0754 -0.2289 -0.9310 SILAC 1 / Biological 1 Raptor up
Q8BTI8 RVPS(ph)PTPVPK 1.0754 -0.2289 -0.9309 SILAC 1 / Biological 1 Raptor up
Q9Z277 S(ph)DGACDSPSSDKENSSQMAQDLQK 1.1826 0.2339 -0.4585 SILAC 1 / Biological 1 Raptor up
Q9Z277 S(ph)DGACDSPSSDKENSSQMAQDLQK 1.1826 0.2339 -0.4585 SILAC 1 / Biological 1 Raptor up
Q3UK83 S(ph)ESPKEPEQLR 1.0238 0.7668 0.0108 SILAC 1 / Biological 1 Raptor up
Q8CI95 S(ph)FSLASS(ph)GNSPISQR 0.9645 0.4989 -0.5896 SILAC 1 / Biological 1 Raptor up
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Q8CI95 S(ph)FSLASS(ph)GNSPISQR 0.9645 0.4989 -0.5896 SILAC 1 / Biological 1 Raptor up
Q8CI95 S(ph)FSLASS(ph)GNSPISQR 1.3538 -0.0921 -0.4994 SILAC 1 / Biological 1 Raptor up
Q8CI95 S(ph)FSLASS(ph)GNSPISQR 1.3538 -0.0921 -0.4994 SILAC 1 / Biological 1 Raptor up
Q69ZM0 S(ph)QSQAS(ph)LTGLAFMSPSNR 1.2938 0.4555 -0.7330 SILAC 1 / Biological 1 Raptor up
Q69ZM0 S(ph)QSQAS(ph)LTGLAFMSPSNR 1.2938 0.4555 -0.7330 SILAC 1 / Biological 1 Raptor up
Q8R1A4 S(ph)RSLSNS(ph)NPDISGTPTSPDDEVR 1.3435 0.7837 -0.4816 SILAC 1 / Biological 1 Raptor up
Q8R1A4 S(ph)RSLSNS(ph)NPDISGTPTSPDDEVR 1.3435 0.7881 -0.4816 SILAC 1 / Biological 1 Raptor up
P58871 S(ph)S(ph)GSLSPGLETEDPLEAR 0.9555 0.4438 -0.2451 SILAC 1 / Biological 1 Raptor up
P58871 S(ph)S(ph)GSLSPGLETEDPLEAR 0.9615 0.4438 -0.2416 SILAC 1 / Biological 1 Raptor up
Q8CI95 SFS(ph)LASSGNS(ph)PISQR 1.2588 0.5078 -0.8228 SILAC 1 / Biological 1 Raptor up
Q8CI95 SFS(ph)LASSGNS(ph)PISQR 1.2466 0.5091 -0.8225 SILAC 1 / Biological 1 Raptor up
Q8CI95 SFSLASSGNS(ph)PISQR 1.1702 0.7453 -0.3167 SILAC 1 / Biological 1 Raptor up
Q8CI95 SFSLASSGNS(ph)PISQR 1.1752 0.7453 -0.3158 SILAC 1 / Biological 1 Raptor up
Q9JIX8 SLSPLS(ph)GTTDTKAES(ph)PAGR 1.0322 0.7091 0.2501 SILAC 1 / Biological 1 Raptor up
Q9JIX8 SLSPLS(ph)GTTDTKAES(ph)PAGR 1.0322 0.7096 0.2640 SILAC 1 / Biological 1 Raptor up
Q8R1A4 SRS(ph)LS(ph)NSNPDISGTPTSPDDEVR 0.9859 0.5736 -0.2414 SILAC 1 / Biological 1 Raptor up
Q8R1A4 SRS(ph)LS(ph)NSNPDISGTPTSPDDEVR 0.9859 0.5736 -0.2414 SILAC 1 / Biological 1 Raptor up
Q9QXS1 SS(ph)SVGSSSSYPISSAGPR 0.9772 0.0000 -0.9199 SILAC 1 / Biological 1 Raptor up
Q9QXS1 SS(ph)SVGSSSSYPISSAGPR 0.9772 0.0000 -0.9199 SILAC 1 / Biological 1 Raptor up
P58871 SSGS(ph)LS(ph)PGLETEDPLEAR 1.1788 0.4099 -0.4469 SILAC 1 / Biological 1 Raptor up
P58871 SSGS(ph)LS(ph)PGLETEDPLEAR 1.1788 0.4099 -0.4469 SILAC 1 / Biological 1 Raptor up
P58871 SSGS(ph)LS(ph)PGLETEDPLEAR 0.9797 0.4867 -0.3803 SILAC 1 / Biological 1 Raptor up
P58871 SSGS(ph)LS(ph)PGLETEDPLEAR 0.9797 0.4867 -0.3803 SILAC 1 / Biological 1 Raptor up
A6X919 SSPPPLS(ph)GASEVDAGELGSER 1.0048 0.4754 0.0339 SILAC 1 / Biological 1 Raptor up
A6X919 SSPPPLS(ph)GASEVDAGELGSER 0.9667 0.4791 0.0463 SILAC 1 / Biological 1 Raptor up
Q64511 VKAS(ph)PITNDGEDEFVPS(ph)DGLDKDEYAFSSGK 1.1158 0.7917 0.5124 SILAC 1 / Biological 1 Raptor up
Q0P678 VQSQEETRS(ph)DEEDRAS(ph)EPK 1.1266 0.3138 0.2349 SILAC 1 / Biological 1 Raptor up
Q0P678 VQSQEETRS(ph)DEEDRAS(ph)EPK 1.1266 0.3138 0.2417 SILAC 1 / Biological 1 Raptor up
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 1.0845 0.6547 -0.2748 SILAC 1 / Biological 2 Raptor up
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 1.0845 0.6547 -0.2748 SILAC 1 / Biological 2 Raptor up
Q3UMF0 ITVEKDPDSALGIS(ph)DGETS(ph)PSSK 1.0911 0.7205 0.0761 SILAC 1 / Biological 2 Raptor up
Q3UMF0 ITVEKDPDSALGIS(ph)DGETSPS(ph)SK 0.9697 0.7375 0.1630 SILAC 1 / Biological 2 Raptor up
Q6NZJ6 KAAS(ph)LTEDR 1.3844 0.3249 -0.6179 SILAC 1 / Biological 2 Raptor up
B9EKC2 KENEEAEPS(ph)TAPGT(ph)PTLR 1.5609 -0.0011 -0.8269 SILAC 1 / Biological 2 Raptor up
B9EKC2 KENEEAEPST(ph)APGT(ph)PTLR 0.9956 0.0926 -0.8291 SILAC 1 / Biological 2 Raptor up
B9EKC2 KENEEAEPST(ph)APGT(ph)PTLR 1.1140 0.0367 -0.7785 SILAC 1 / Biological 2 Raptor up
B2RUB9 LREQGTES(ph)RSS(ph)TPLPTVSSSAENTR 1.0441 0.6211 -0.1599 SILAC 1 / Biological 2 Raptor up
B9EHJ7 LS(ph)TSPATRDEAAS(ph)PGAK 0.9410 0.7262 0.2482 SILAC 1 / Biological 2 Raptor up
Q5U3K5 NISLS(ph)S(ph)EEEAEGLAGHPR 0.9917 0.4706 -0.4110 SILAC 1 / Biological 2 Raptor up
Q5U3K5 NISLS(ph)S(ph)EEEAEGLAGHPR 0.9917 0.4706 -0.3883 SILAC 1 / Biological 2 Raptor up
O70475 RIPYT(ph)PGEIPK 1.1099 -0.1938 -0.4202 SILAC 1 / Biological 2 Raptor up
Q61823 SGVAVPT(ph)SPK 1.0513 -0.2061 -0.6524 SILAC 1 / Biological 2 Raptor up
P14602 SPS(ph)WEPFR 1.2723 0.6509 -0.1950 SILAC 1 / Biological 2 Raptor up
O54724 ATEEPSGTGS(ph)DELIK 1.1076 0.3103 -0.9017 SILAC 2 / Biological 3 Raptor up
Q60953 ATS(ph)PPHLDGTSNPESTVPEKK 1.0151 0.6046 -0.3697 SILAC 2 / Biological 3 Raptor up
Q99P72 ESET(ph)FSDSS(ph)PIEIIDEFPTFVSAK 0.9694 -0.2493 -0.8766 SILAC 2 / Biological 3 Raptor up
P51859 GSAEGS(ph)SDEEGKLVIDEPAKEK 1.0956 0.4991 0.0693 SILAC 2 / Biological 3 Raptor up
Q9WU62 ISVDDYGMDLNS(ph)DDS(ph)T(ph)DDESHPR 0.9998 0.3404 -0.5683 SILAC 2 / Biological 3 Raptor up
Q9WU62 ISVDDYGMDLNS(ph)DDS(ph)T(ph)DDESHPR 0.9998 0.3404 -0.5683 SILAC 2 / Biological 3 Raptor up
Q8R1Q8 KPASVS(ph)PTTPTSPTEGEAS 1.3076 0.5863 -0.3362 SILAC 2 / Biological 3 Raptor up
Q9D6Z1 KSS(ph)PKEEVASEPEEAAS(ph)PTTPK 1.0726 0.7436 -0.1279 SILAC 2 / Biological 3 Raptor up
Q05D44 KTARPNSEAPLSGS(ph)EDADDS(ph)NK 1.3567 0.4219 -0.5781 SILAC 2 / Biological 3 Raptor up
P49586 MLQAIS(ph)PKQS(ph)PSSS(ph)PTHER 1.1768 0.1063 -0.7294 SILAC 2 / Biological 3 Raptor up
Q8BTI8 MVQASSQSLLPPAQDRPRS(ph)PVPSAFSDQSR 1.1687 0.5881 -0.5359 SILAC 2 / Biological 3 Raptor up
Q99JF8 NLAKPGVTS(ph)TSDS(ph)EDEDDQEGEK 0.9893 0.2333 -0.4364 SILAC 2 / Biological 3 Raptor up
P09450 S(ph)RDAT(ph)PPVS(ph)PINMEDQER 0.9392 0.2529 -0.5762 SILAC 2 / Biological 3 Raptor up
A6X919 S(ph)SPPPLSGASEVDAGELGSER 0.9706 0.3245 -0.3977 SILAC 2 / Biological 3 Raptor up
Q3UHP6 SPS(ph)FASEWDEIEK 1.1139 -0.4037 -0.7677 SILAC 2 / Biological 3 Raptor up
Q80YV2 SQDATVSPGS(ph)EQSEK 1.0754 0.4721 -0.2375 SILAC 2 / Biological 3 Raptor up
Q6A065 TEEDSKS(ph)IKS(ph)DVPVYLK 1.1620 0.5789 -0.2575 SILAC 2 / Biological 3 Raptor up
Q6A065 TEEDSKS(ph)IKS(ph)DVPVYLK 1.1620 0.5789 -0.2575 SILAC 2 / Biological 3 Raptor up
O35243 TETDITTVEQSS(ph)PSGK 1.0008 0.3832 -0.5278 SILAC 2 / Biological 3 Raptor up
Q9DBJ3 TPISTPVSGT(ph)PQPS(ph)PMIER 1.0093 0.0910 -0.8316 SILAC 2 / Biological 3 Raptor up
Q9WU62 TPS(ph)PPCPANK 1.3976 0.5451 -0.7531 SILAC 2 / Biological 3 Raptor up
Q61687 TTSTS(ph)NPSS(ph)PAPDWYK 1.0119 0.4008 -0.5711 SILAC 2 / Biological 3 Raptor up
A2AIV2 VISHDRDS(ph)PPPPPPPPPPPQPQPTLK 1.3528 0.7180 -0.8335 SILAC 2 / Biological 3 Raptor up
O88792 VIYSQPS(ph)TR 0.9868 0.4242 -0.5978 SILAC 2 / Biological 3 Raptor up
Q64511 VKASPIT(ph)NDGEDEFVPSDGLDKDEY(ph)AFSSGK 0.9846 0.7303 -0.1376 SILAC 2 / Biological 3 Raptor up
Q5DTP7 WGQPPS(ph)PTPVPRPPDADPNT(ph)PSPK 0.9394 0.3459 -0.6068 SILAC 2 / Biological 3 Raptor up
Q5DTP7 WGQPPS(ph)PTPVPRPPDADPNT(ph)PSPK 0.9394 0.3459 -0.6068 SILAC 2 / Biological 3 Raptor up
Q5DTP7 WGQPPS(ph)PTPVPRPPDADPNT(ph)PSPK 1.0654 0.4699 -0.5198 SILAC 2 / Biological 3 Raptor up
P08775 YSPT(ph)SPT(ph)YSPTSPK 1.1541 0.8104 -0.0944 SILAC 2 / Biological 3 Raptor up
P08775 YSPTS(ph)PTYSPTS(ph)PK 1.0874 0.1929 -0.6544 SILAC 2 / Biological 3 Raptor up
O54724 ATEEPS(ph)GT(ph)GSDELIK 1.1680 0.7682 -0.4853 SILAC 3 / Biological 4 Raptor up
Q80YV2 DTAATFQSVDGS(ph)PQAEQSPLESTSK 1.0158 0.3619 -0.2609 SILAC 3 / Biological 4 Raptor up
Q923J1 FSVST(ph)PSQPSCK 1.1862 0.5833 -0.6579 SILAC 3 / Biological 4 Raptor up
Q64511 IVETINS(ph)DS(ph)DSEFGIPK 1.0088 0.2010 -0.7276 SILAC 3 / Biological 4 Raptor up
B9EKC2 KENEEAEPS(ph)TAPGT(ph)PTLR 1.3197 0.6204 -0.7642 SILAC 3 / Biological 4 Raptor up
Q8R1Q8 KPASVS(ph)PTTPTSPTEGEAS 0.9399 0.8177 0.0627 SILAC 3 / Biological 4 Raptor up
Q3U4X8 KQSQIQNQQSS(ph)DLDSDVEDY(ph) 1.2652 0.2349 -0.9270 SILAC 3 / Biological 4 Raptor up
Q3U4X8 KQSQIQNQQSSDLDS(ph)DVEDY 1.1432 0.3816 -0.9244 SILAC 3 / Biological 4 Raptor up
Q99JF8 NLAKPGVT(ph)STSDS(ph)EDEDDQEGEK 1.1824 0.5465 -0.5284 SILAC 3 / Biological 4 Raptor up
Q99JF8 NLAKPGVTSTS(ph)DS(ph)EDEDDQEGEK 1.3916 0.2894 -0.7704 SILAC 3 / Biological 4 Raptor up
Q99JF8 NLAKPGVTSTS(ph)DS(ph)EDEDDQEGEK 1.0339 0.3358 -0.6964 SILAC 3 / Biological 4 Raptor up
O35144 NS(ph)PMTISR 1.0078 0.2242 -0.8891 SILAC 3 / Biological 4 Raptor up
Q3UH59 QLHIEGAS(ph)LELS(ph)DDDTESK 1.2918 0.5415 -0.8537 SILAC 3 / Biological 4 Raptor up
Q3UHJ0 REQGSSGLGSGSS(ph)GGGGSSSGLGSGYIGR 0.9746 -0.1730 -0.8536 SILAC 3 / Biological 4 Raptor up
Q8R1A4 S(ph)PSGSAFGS(ph)QENLR 0.9679 0.3381 -0.8749 SILAC 3 / Biological 4 Raptor up
P26231 S(ph)RTS(ph)VQTEDDQLIAGQSAR 1.0710 0.0523 -0.8802 SILAC 3 / Biological 4 Raptor up
P26231 S(ph)RTS(ph)VQTEDDQLIAGQSAR 0.9678 0.1582 -0.8257 SILAC 3 / Biological 4 Raptor up
Q8R1A4 SPS(ph)GSAFGS(ph)QENLR 1.1300 0.5032 -0.6117 SILAC 3 / Biological 4 Raptor up
P27546 VGS(ph)LDNVGHLPAGGAVK 1.1136 0.3233 -0.8890 SILAC 3 / Biological 4 Raptor up
P14873 ES(ph)SPLYS(ph)PGFSDSTSAAK -0.7384 -2.2190 -1.3762 SILAC 1 / Biological 2 Rictor down H/M down  +
Q4VAC9 RFS(ph)FSPSAVS(ph)PR -0.2030 -1.3975 -1.8523 SILAC 1 / Biological 2 Rictor down H/M down  +
Q4VAC9 RFSFS(ph)PSAVS(ph)PR -0.2669 -1.3544 -1.1151 SILAC 1 / Biological 2 Rictor down H/M down  +
Q4VAC9 RFSFS(ph)PSAVS(ph)PR -0.3308 -1.3112 -1.0905 SILAC 1 / Biological 2 Rictor down H/M down  +
P20152 SLYSSS(ph)PGGAYVTR -0.3939 -1.6695 -1.4205 SILAC 1 / Biological 2 Rictor down H/M down  +
Q62433 SRT(ph)AS(ph)GSSVTSLEGTR -0.0804 -2.1199 -2.1936 SILAC 3 / Biological 4 Rictor down H/M down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR 0.0089 -1.1991 -1.2688 SILAC 2 / Biological 3 Rictor down H/M down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR -0.1399 -1.6403 -1.1215 SILAC 2 / Biological 3 Rictor down H/M down  +
Q3TIY5 AAAQYS(ph)SQKS(ph)VEER -0.6827 -3.1759 -1.9843 SILAC 1 / Biological 1 Rictor down H/M down
Q3TIY5 AAAQYS(ph)SQKS(ph)VEER -0.5378 -3.1720 -1.9267 SILAC 1 / Biological 1 Rictor down H/M down
Q8BQM4 ECLSGLDSNEMS(ph)PQEK -0.2134 -1.2846 -1.6344 SILAC 1 / Biological 1 Rictor down H/M down
Q8BQM4 ECLSGLDSNEMS(ph)PQEK -0.2007 -1.2798 -1.6316 SILAC 1 / Biological 1 Rictor down H/M down
Q62261 ES(ph)SPVPS(ph)PTLDRK -0.9424 -2.1667 -0.9927 SILAC 1 / Biological 1 Rictor down H/M down
Q62261 ES(ph)SPVPS(ph)PTLDRK -0.9424 -2.1667 -0.9788 SILAC 1 / Biological 1 Rictor down H/M down
Q99K70 MSPNETLFLEST(ph)NK 0.0698 -1.2725 -1.5416 SILAC 1 / Biological 1 Rictor down H/M down
Q99K70 MSPNETLFLEST(ph)NK 0.1142 -1.2322 -1.5372 SILAC 1 / Biological 1 Rictor down H/M down
Q6QI06 NDS(ph)GEENVPLDLTR 0.7235 -1.2831 -1.2978 SILAC 1 / Biological 1 Rictor down H/M down
Q6QI06 NDS(ph)GEENVPLDLTR 0.7235 -1.2831 -1.2978 SILAC 1 / Biological 1 Rictor down H/M down
Q91YM2 NEEENIY(ph)SVPHDSTQGK 0.2399 -2.0151 -1.0839 SILAC 1 / Biological 1 Rictor down H/M down
Q91YM2 NEEENIY(ph)SVPHDSTQGK 0.2399 -2.0151 -1.0839 SILAC 1 / Biological 1 Rictor down H/M down
Q09XV5 NTSS(ph)DNS(ph)DVEVMPAQSPR -0.4994 -1.7650 -3.5300 SILAC 1 / Biological 1 Rictor down H/M down
Q09XV5 NTSS(ph)DNS(ph)DVEVMPAQSPR -0.4994 -1.7650 -3.5283 SILAC 1 / Biological 1 Rictor down H/M down
Q09XV5 NTSS(ph)DNS(ph)DVEVMPAQSPR -0.3475 -1.6764 -2.1586 SILAC 1 / Biological 1 Rictor down H/M down
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Q09XV5 NTSS(ph)DNS(ph)DVEVMPAQSPR -0.3475 -1.6764 -2.1577 SILAC 1 / Biological 1 Rictor down H/M down
Q9Z248 RGS(ph)LEMSS(ph)DGEPLSR -0.7395 -1.2506 -1.2389 SILAC 1 / Biological 1 Rictor down H/M down
Q9Z248 RGS(ph)LEMSS(ph)DGEPLSR -0.7395 -1.2506 -1.2389 SILAC 1 / Biological 1 Rictor down H/M down
Q9Z248 RGS(ph)LEMSS(ph)DGEPLSR -0.8444 -1.2438 -1.2376 SILAC 1 / Biological 1 Rictor down H/M down
Q9Z248 RGS(ph)LEMSS(ph)DGEPLSR -0.8444 -1.2438 -1.2376 SILAC 1 / Biological 1 Rictor down H/M down
P14602 SPS(ph)WEPFR 0.8615 -1.3112 -2.0037 SILAC 1 / Biological 1 Rictor down H/M down
P14602 SPS(ph)WEPFR 0.4199 -1.1068 -1.7460 SILAC 1 / Biological 1 Rictor down H/M down
P14602 SPS(ph)WEPFR 0.4201 -1.1081 -1.7426 SILAC 1 / Biological 1 Rictor down H/M down
O08784 STSS(ph)SPAPTQTLPNSITQR -0.7178 -1.6642 -2.0973 SILAC 1 / Biological 1 Rictor down H/M down
O08784 STSS(ph)SPAPTQTLPNSITQR -0.8812 -1.6477 -2.0781 SILAC 1 / Biological 1 Rictor down H/M down
Q9CQ20 T(ph)TPAPS(ph)PGSANESFFAPSR -0.2303 -1.4213 -1.0849 SILAC 1 / Biological 1 Rictor down H/M down
Q9CQ20 T(ph)TPAPS(ph)PGSANESFFAPSR -0.2303 -1.4213 -1.0849 SILAC 1 / Biological 1 Rictor down H/M down
Q9CQ20 T(ph)TPAPS(ph)PGSANESFFAPSR -0.2327 -1.4098 -1.0781 SILAC 1 / Biological 1 Rictor down H/M down
Q9CQ20 T(ph)TPAPS(ph)PGSANESFFAPSR -0.2327 -1.4098 -1.0781 SILAC 1 / Biological 1 Rictor down H/M down
Q3UJN1 (ac)AES(ph)SES(ph)LSASS(ph)PAR 0.0630 -1.3356 -1.3362 SILAC 1 / Biological 2 Rictor down H/M down
Q3UJN1 (ac)AES(ph)SES(ph)LSASS(ph)PAR 0.0630 -1.3356 -1.3362 SILAC 1 / Biological 2 Rictor down H/M down
Q9EPC1 (ac)ATS(ph)PQKSPLVPKSPT(ph)PK 0.2377 -1.1325 -1.7536 SILAC 1 / Biological 2 Rictor down H/M down
Q9WU62 ASWGLQDS(ph)PGS(ph)TDSPWQER -0.9149 -2.0182 -1.4568 SILAC 1 / Biological 2 Rictor down H/M down
Q9WU62 ASWGLQDS(ph)PGS(ph)TDSPWQER -0.7969 -1.8624 -1.0689 SILAC 1 / Biological 2 Rictor down H/M down
Q8C8U0 DFAARS(ph)PSAS(ph)ITDEDSNV -0.0735 -1.7724 -1.6014 SILAC 1 / Biological 2 Rictor down H/M down
Q8C8U0 DFAARS(ph)PSAS(ph)ITDEDSNV 0.2940 -1.2524 -1.5637 SILAC 1 / Biological 2 Rictor down H/M down
Q8K298 DSNLS(ph)AASPKPGK 0.0213 -1.2526 -1.0450 SILAC 1 / Biological 2 Rictor down H/M down
P13864 EADDDEEADDDVSEMPS(ph)PK -0.5043 -2.6560 -1.3109 SILAC 1 / Biological 2 Rictor down H/M down
Q8BQM4 ECLSGLDSNEMS(ph)PQEK -0.1472 -1.4165 -1.2964 SILAC 1 / Biological 2 Rictor down H/M down
Q8BIG4 EVMESAVGTSSGSGQSEES(ph)PR -0.4525 -1.9103 -1.1028 SILAC 1 / Biological 2 Rictor down H/M down
Q9ESL4 GSVS(ph)LNSS(ph)PK -0.0879 -1.0922 -1.3011 SILAC 1 / Biological 2 Rictor down H/M down
Q9ESL4 GSVS(ph)LNSS(ph)PK -0.0879 -1.0922 -1.3011 SILAC 1 / Biological 2 Rictor down H/M down
P47713 HIVSNDSSDS(ph)DDEAQGPK 0.1027 -1.1788 -1.2439 SILAC 1 / Biological 2 Rictor down H/M down
Q9ET54 IAS(ph)DEEIQGTK -0.4728 -1.6408 -1.2222 SILAC 1 / Biological 2 Rictor down H/M down
P52927 KQQQEPTCEPS(ph)PK -0.6529 -1.5057 -1.0189 SILAC 1 / Biological 2 Rictor down H/M down
Q60598 KQT(ph)PPAS(ph)PS(ph)PQPIEDRPPSSPIY(ph)EDAAPFK -0.7796 -1.9911 -1.2746 SILAC 1 / Biological 2 Rictor down H/M down
Q60598 KQT(ph)PPAS(ph)PSPQPIEDRPPS(ph)SPIYEDAAPFK -0.4044 -1.6938 -1.2123 SILAC 1 / Biological 2 Rictor down H/M down
Q60598 KQT(ph)PPASPSPQPIEDRPPS(ph)SPIYEDAAPFK -0.6374 -2.5885 -1.9313 SILAC 1 / Biological 2 Rictor down H/M down
Q60598 KQT(ph)PPASPSPQPIEDRPPSSPIY(ph)EDAAPFK -0.4009 -2.0620 -1.1826 SILAC 1 / Biological 2 Rictor down H/M down
Q60598 KQT(ph)PPASPSPQPIEDRPPSSPIY(ph)EDAAPFK -0.6346 -2.1240 -1.1502 SILAC 1 / Biological 2 Rictor down H/M down
Q3TIY5 LEIS(ph)PDSS(ph)PER -0.0569 -1.4125 -1.2012 SILAC 1 / Biological 2 Rictor down H/M down
Q9WU42 LEPVS(ph)PPS(ph)PPHADPELELAPSR -0.4046 -1.4835 -1.0999 SILAC 1 / Biological 2 Rictor down H/M down
Q9WU42 LEPVS(ph)PPS(ph)PPHADPELELAPSR -0.4046 -1.4835 -1.0999 SILAC 1 / Biological 2 Rictor down H/M down
Q8K2Z4 LQPLTS(ph)VDS(ph)DNDFVTPKPR -0.3559 -1.5155 -1.1893 SILAC 1 / Biological 2 Rictor down H/M down
Q8BRB8 LRS(ph)EDGVEGDLGETQSR -0.2895 -1.2584 -1.1645 SILAC 1 / Biological 2 Rictor down H/M down
Q6A006 LSTT(ph)PS(ph)PT(ph)NSLHEDGVDDFRR -0.4435 -1.4653 -0.9506 SILAC 1 / Biological 2 Rictor down H/M down
Q6QI06 NDS(ph)GEENVPLDLTR 0.5959 -1.3744 -1.8380 SILAC 1 / Biological 2 Rictor down H/M down
Q99JF8 QVDTEEAGMVTAATASNVKAS(ph)PK 0.0049 -1.5883 -1.1688 SILAC 1 / Biological 2 Rictor down H/M down
Q61127 S(ph)FSPKS(ph)PLELGEKLS(ph)PLPGGPGAGDPR 0.0283 -2.3369 -1.8199 SILAC 1 / Biological 2 Rictor down H/M down
P13864 S(ph)KSDSDTLSVETSPSS(ph)VATR -0.9576 -2.2193 -0.9938 SILAC 1 / Biological 2 Rictor down H/M down
Q8C8U0 S(ph)PS(ph)ASITDEDSNV 0.3506 -1.2524 -1.5637 SILAC 1 / Biological 2 Rictor down H/M down
Q6AW69 S(ph)YGSQPNS(ph)PTSEDLAK 0.2992 -1.3385 -1.6689 SILAC 1 / Biological 2 Rictor down H/M down
Q6AW69 S(ph)YGSQPNS(ph)PTSEDLAK 0.5129 -1.0931 -1.5316 SILAC 1 / Biological 2 Rictor down H/M down
P60330 SFEILRGS(ph)DGEDS(ph)ASGEK -0.4651 -2.1134 -1.9206 SILAC 1 / Biological 2 Rictor down H/M down
P60330 SFEILRGS(ph)DGEDS(ph)ASGEK -0.4651 -2.1134 -1.9206 SILAC 1 / Biological 2 Rictor down H/M down
Q9EPC1 SPLVPKSPT(ph)PKS(ph)PPSR 0.2377 -1.5084 -1.7702 SILAC 1 / Biological 2 Rictor down H/M down
Q8VCV2 SRT(ph)HST(ph)SSSIGSGESPFSR 0.0828 -1.2997 -1.3459 SILAC 1 / Biological 2 Rictor down H/M down
Q8VCV2 SRT(ph)HSTS(ph)SSIGSGESPFSR -0.1575 -1.4233 -1.7829 SILAC 1 / Biological 2 Rictor down H/M down
Q8VCV2 SRT(ph)HSTS(ph)SSIGSGESPFSR -0.0373 -1.3615 -1.5644 SILAC 1 / Biological 2 Rictor down H/M down
Q3UAI4 SSLGQS(ph)AS(ph)ETEEDTVSISK -0.2432 -1.1957 -0.9518 SILAC 1 / Biological 2 Rictor down H/M down
Q3UAI4 SSLGQS(ph)ASET(ph)EEDTVSISK -0.2432 -1.1957 -0.9518 SILAC 1 / Biological 2 Rictor down H/M down
Q05A74 STGVSFWTQDS(ph)DENEQERQS(ph)DTEDGSSKR -0.7538 -1.6448 -1.1971 SILAC 1 / Biological 2 Rictor down H/M down
Q9WU42 TDDT(ph)S(ph)GEDNDEKEAVASK -0.4154 -1.5015 -1.0105 SILAC 1 / Biological 2 Rictor down H/M down
Q9WU42 TDDT(ph)S(ph)GEDNDEKEAVASK -0.4154 -1.5015 -1.0105 SILAC 1 / Biological 2 Rictor down H/M down
O35243 TETDITTVEQSS(ph)PSGK -0.4500 -2.5231 -2.7436 SILAC 1 / Biological 2 Rictor down H/M down
Q9DBJ3 TPISTPVSGT(ph)PQPS(ph)PMIER 0.0249 -1.0717 -0.9579 SILAC 1 / Biological 2 Rictor down H/M down
Q80U72 TTEAPCS(ph)PGSQQPPS(ph)PDELPANVK -0.6828 -1.1728 -1.1176 SILAC 1 / Biological 2 Rictor down H/M down
Q3UYI5 VIEPPAAS(ph)CPSS(ph)PR 0.2600 -1.7364 -2.0160 SILAC 1 / Biological 2 Rictor down H/M down
Q3UYI5 VIEPPAAS(ph)CPSS(ph)PR 0.2600 -1.7364 -2.0160 SILAC 1 / Biological 2 Rictor down H/M down
A2AJI0 AAEEKEPAAPAS(ph)PAPS(ph)PVPSPT(ph)PAQPQK 0.3865 -1.5860 -1.4234 SILAC 2 / Biological 3 Rictor down H/M down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK 0.7125 -1.1435 -1.6425 SILAC 2 / Biological 3 Rictor down H/M down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK 0.7125 -1.1435 -1.6425 SILAC 2 / Biological 3 Rictor down H/M down
Q9QX47 ASES(ph)SS(ph)EEKDDYEIFVK 0.8682 -1.1047 -1.4597 SILAC 2 / Biological 3 Rictor down H/M down
Q8C8U0 DFAARS(ph)PS(ph)ASITDEDSNV 0.3432 -1.1853 -1.4605 SILAC 2 / Biological 3 Rictor down H/M down
P98203 DIPSYGS(ph)LSR 0.9092 -1.1985 -1.8269 SILAC 2 / Biological 3 Rictor down H/M down
Q61823 DSGRGDS(ph)VSDNGSEAVR -0.3680 -1.2028 -1.2877 SILAC 2 / Biological 3 Rictor down H/M down
P13864 EADDDEEADDDVSEMPS(ph)PK 0.0049 -1.1956 -1.5763 SILAC 2 / Biological 3 Rictor down H/M down
Q3UMF0 EQT(ph)AS(ph)APATPLVSK -0.0793 -1.1465 -1.3272 SILAC 2 / Biological 3 Rictor down H/M down
Q6ZPE9 ET(ph)VVESQSSQSPS(ph)PKR -0.1460 -1.2971 -1.5160 SILAC 2 / Biological 3 Rictor down H/M down
Q6ZPE9 ETVVESQSS(ph)QSPS(ph)PKR 0.0441 -1.1393 -1.8915 SILAC 2 / Biological 3 Rictor down H/M down
Q6ZPE9 ETVVESQSSQS(ph)PS(ph)PK -0.0007 -1.1964 -1.3654 SILAC 2 / Biological 3 Rictor down H/M down
Q5F2E7 GADNDGSGSES(ph)GY(ph)TTPK -0.0230 -1.1763 -1.6797 SILAC 2 / Biological 3 Rictor down H/M down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -0.2243 -1.3827 -1.6635 SILAC 2 / Biological 3 Rictor down H/M down
A2BH40 GPS(ph)PSPVGS(ph)PASVAQSR -0.2243 -1.3827 -1.6635 SILAC 2 / Biological 3 Rictor down H/M down
Q9WTQ5 GPSEAPQEAEAEEGAT(ph)SDGEK 0.4017 -1.1440 -1.8382 SILAC 2 / Biological 3 Rictor down H/M down
Q9WU62 ISVDDYGMDLNS(ph)DDS(ph)T(ph)DDESHPR -0.5025 -1.2065 -0.9950 SILAC 2 / Biological 3 Rictor down H/M down
P52927 KQQQEPTCEPS(ph)PK 0.0840 -1.1473 -1.3806 SILAC 2 / Biological 3 Rictor down H/M down
A2RSX9 KWS(ph)LNTYK -0.3400 -1.3529 -0.9539 SILAC 2 / Biological 3 Rictor down H/M down
Q9WU62 LDSVTVNSLKAT(ph)PQS(ph)PK -0.3405 -1.5834 -1.0799 SILAC 2 / Biological 3 Rictor down H/M down
Q9WU62 LDSVTVNSLKAT(ph)PQS(ph)PK -0.3405 -1.5834 -1.0799 SILAC 2 / Biological 3 Rictor down H/M down
Q3TIY5 LEIS(ph)PDSS(ph)PER 0.5467 -1.2336 -1.7152 SILAC 2 / Biological 3 Rictor down H/M down
Q3TIY5 LEIS(ph)PDSS(ph)PER 0.5467 -1.2336 -1.7152 SILAC 2 / Biological 3 Rictor down H/M down
B1AWD9 LQS(ph)EPESIR -0.2156 -1.3745 -1.8556 SILAC 2 / Biological 3 Rictor down H/M down
Q8BRB8 LRS(ph)EDGVEGDLGETQSR -0.3310 -1.4048 -1.0287 SILAC 2 / Biological 3 Rictor down H/M down
B9EHJ7 LSTS(ph)PATRDEAAS(ph)PGAK 0.1906 -1.1394 -1.3962 SILAC 2 / Biological 3 Rictor down H/M down
Q8CI59 LVDS(ph)DGS(ph)LAEVPK -0.4032 -1.2117 -1.1717 SILAC 2 / Biological 3 Rictor down H/M down
Q8CI59 LVDS(ph)DGS(ph)LAEVPK -0.4032 -1.2117 -1.1717 SILAC 2 / Biological 3 Rictor down H/M down
Q9JMH9 NKLEGDS(ph)DVDS(ph)ELEDRVDGVK 0.5611 -1.5613 -2.0604 SILAC 2 / Biological 3 Rictor down H/M down
Q9JMH9 NKLEGDS(ph)DVDS(ph)ELEDRVDGVK 0.5611 -1.5613 -2.0604 SILAC 2 / Biological 3 Rictor down H/M down
Q6ZPJ3 NMTVEQLLTGS(ph)PT(ph)SPTVEPEKPTR -0.9149 -1.8203 -1.3602 SILAC 2 / Biological 3 Rictor down H/M down
Q3U4X8 NQVVPES(ph)DSPVKR 0.6987 -1.1086 -2.0049 SILAC 2 / Biological 3 Rictor down H/M down
Q61234 NSAGGTSVGWDS(ph)PPAS(ph)PLQR -0.1557 -1.0829 -1.1413 SILAC 2 / Biological 3 Rictor down H/M down
Q571F6 NTETQPTS(ph)PQLGTK 0.0402 -1.1238 -1.1620 SILAC 2 / Biological 3 Rictor down H/M down
Q9Z277 RDS(ph)SSLSS(ph)PLNPK 0.4813 -2.1902 -2.6515 SILAC 2 / Biological 3 Rictor down H/M down
P97496 RKPSPS(ph)PPPPT(ph)ATESR -0.5130 -1.3367 -1.1046 SILAC 2 / Biological 3 Rictor down H/M down
Q9QYG0 S(ph)RT(ph)LSQSSESGTLPSGPPGHTMEVSC 0.1077 -1.6380 -2.4603 SILAC 2 / Biological 3 Rictor down H/M down
Q9QXS1 S(ph)SSVGSSSSYPISSAGPR 0.1938 -1.1773 -1.2719 SILAC 2 / Biological 3 Rictor down H/M down
Q99K70 SCSHQT(ph)SAPSLK -0.6339 -1.8889 -1.2327 SILAC 2 / Biological 3 Rictor down H/M down
Q6QI06 SNS(ph)VSLVPPGSSHTLPR 0.1373 -1.2527 -4.3362 SILAC 2 / Biological 3 Rictor down H/M down
Q8VCV2 SRT(ph)HS(ph)TSSSIGSGESPFSR 0.2551 -1.5845 -2.2734 SILAC 2 / Biological 3 Rictor down H/M down
Q6ZPE9 SSSDS(ph)VEEETVDS(ph)DTPPVLEK 0.1217 -1.2116 -1.1879 SILAC 2 / Biological 3 Rictor down H/M down
Q8VCV2 SVT(ph)SNQSDGTQESCESPDVLDR -0.1766 -1.7765 -1.7676 SILAC 2 / Biological 3 Rictor down H/M down
Q9QYG0 T(ph)LSQS(ph)SESGTLPSGPPGHTMEVSC 0.5832 -1.9554 -3.2102 SILAC 2 / Biological 3 Rictor down H/M down
A2AQB0 TEQIVNEDS(ph)QAAALAPNPK 0.4818 -1.1702 -1.7237 SILAC 2 / Biological 3 Rictor down H/M down
Q62261 TSS(ph)KESS(ph)PVPS(ph)PTLDR -0.0043 -1.3285 -1.6142 SILAC 2 / Biological 3 Rictor down H/M down
Q5DTM8 ALVVPEPEPDSDS(ph)NQER -0.2581 -1.4147 -1.3700 SILAC 3 / Biological 4 Rictor down H/M down
Q9ERU9 ANT(ph)S(ph)SDLEKDDDAYK 0.0054 -1.8632 -1.0363 SILAC 3 / Biological 4 Rictor down H/M down
Q9ERU9 ANT(ph)S(ph)SDLEKDDDAYK 0.0054 -1.8632 -1.0363 SILAC 3 / Biological 4 Rictor down H/M down
Q9ERU9 ANT(ph)S(ph)SDLEKDDDAYK 0.0054 -1.8632 -1.0363 SILAC 3 / Biological 4 Rictor down H/M down
Q6QI06 NDS(ph)GEENVPLDLTR 0.3346 -1.7133 -2.0243 SILAC 3 / Biological 4 Rictor down H/M down
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Q6ZPJ3 NMTVEQLLTGSPT(ph)SPTVEPEKPTR -0.7755 -1.8459 -0.9747 SILAC 3 / Biological 4 Rictor down H/M down
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK -0.1278 -1.2167 -1.1617 SILAC 3 / Biological 4 Rictor down H/M down
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK -0.1278 -1.2167 -1.1617 SILAC 3 / Biological 4 Rictor down H/M down
Q62433 S(ph)RTAS(ph)GSSVTSLEGTR 0.4496 -1.8688 -2.4402 SILAC 3 / Biological 4 Rictor down H/M down
Q9QYG0 SRT(ph)AS(ph)LTSAASIDGSR 0.4206 -1.2076 -1.6295 SILAC 3 / Biological 4 Rictor down H/M down
Q6ZQ58 VEPAWHDQDETS(ph)S(ph)VKSDGAGGAR 0.0359 -1.3551 -1.3307 SILAC 3 / Biological 4 Rictor down H/M down
Q3TUD7 KAENAEGQTPAIGPDGEPLDETS(ph)QMS(ph)DLPVK -0.8274 -1.1630 -0.4662 SILAC 2 / Biological 3 Rictor down  +
Q4VAC9 RFS(ph)FSPSAVS(ph)PR -0.7417 -1.3116 -0.6570 SILAC 1 / Biological 1 Rictor down  +
Q4VAC9 RFS(ph)FSPSAVS(ph)PR -0.7417 -1.3073 -0.6570 SILAC 1 / Biological 1 Rictor down  +
Q9R0L6 VTNAIS(ph)PES(ph)SPGVGR -0.8833 -1.3849 -0.3253 SILAC 1 / Biological 1 Rictor down  +
Q9R0L6 VTNAIS(ph)PES(ph)SPGVGR -0.8833 -1.3801 -0.3244 SILAC 1 / Biological 1 Rictor down  +
Q9R0L6 VTNAIS(ph)PES(ph)SPGVGR -0.1750 -1.1896 -0.8446 SILAC 1 / Biological 2 Rictor down  +
Q9R0L6 VTNAIS(ph)PES(ph)SPGVGR -0.1750 -1.1896 -0.8446 SILAC 1 / Biological 2 Rictor down  +
Q80ZA1 AFQALIKEES(ph)PNC -0.4573 -1.1224 -0.4738 SILAC 1 / Biological 1 Rictor down
Q80ZA1 AFQALIKEES(ph)PNC -0.3814 -1.1219 -0.4282 SILAC 1 / Biological 1 Rictor down
P14873 AS(ph)LSPMDEPVPDSESPVEK -0.2794 -1.1369 -0.0117 SILAC 1 / Biological 1 Rictor down
P14873 AS(ph)LSPMDEPVPDSESPVEK -0.2794 -1.1369 -0.0117 SILAC 1 / Biological 1 Rictor down
P14873 AS(ph)LSPMDEPVPDSESPVEK -0.2794 -1.1369 -0.0117 SILAC 1 / Biological 1 Rictor down
P14873 AS(ph)LSPMDEPVPDSESPVEK -0.2794 -1.1369 -0.0117 SILAC 1 / Biological 1 Rictor down
Q62261 ESS(ph)PVPS(ph)PTLDR -0.8792 -1.6304 -0.8060 SILAC 1 / Biological 1 Rictor down
Q62261 ESS(ph)PVPS(ph)PTLDR -0.9157 -1.4822 -0.8060 SILAC 1 / Biological 1 Rictor down
Q01320 FTVDLDS(ph)DEDFS(ph)GLDEKDEDEDFLPLDAT(ph)PPK -0.7591 -1.2570 -0.0274 SILAC 1 / Biological 1 Rictor down
Q01320 FTVDLDS(ph)DEDFS(ph)GLDEKDEDEDFLPLDAT(ph)PPK -0.7578 -1.1743 -0.0274 SILAC 1 / Biological 1 Rictor down
Q52KI8 GAS(ph)ASPQGRQS(ph)PSPS(ph)TRPIR 0.2248 -1.3058 -0.4901 SILAC 1 / Biological 1 Rictor down
Q52KI8 GAS(ph)ASPQGRQS(ph)PSPS(ph)TRPIR 0.1826 -1.3105 -0.4182 SILAC 1 / Biological 1 Rictor down
Q8VDN3 GGVT(ph)GSPEASISGSK -0.3051 -1.2945 -0.7403 SILAC 1 / Biological 1 Rictor down
Q8VDN3 GGVT(ph)GSPEASISGSK -0.2925 -1.2861 -0.7261 SILAC 1 / Biological 1 Rictor down
Q61990 GVTIPYRPKPS(ph)SSPVIFAGGQDR -0.9032 -1.4879 -0.6618 SILAC 1 / Biological 1 Rictor down
Q61990 GVTIPYRPKPS(ph)SSPVIFAGGQDR -0.8784 -1.4879 -0.6406 SILAC 1 / Biological 1 Rictor down
A2RSX9 KWS(ph)LNTYK -0.6493 -1.7644 0.2699 SILAC 1 / Biological 1 Rictor down
Q9WU62 LDSVTVNS(ph)LKAT(ph)PQS(ph)PK -0.9312 -3.3334 -0.2197 SILAC 1 / Biological 1 Rictor down
Q9WU62 LDSVTVNS(ph)LKAT(ph)PQS(ph)PK -0.9312 -3.3334 -0.2197 SILAC 1 / Biological 1 Rictor down
Q9WU62 LDSVTVNSLKAT(ph)PQS(ph)PK -0.8825 -1.2408 -0.3324 SILAC 1 / Biological 1 Rictor down
Q9WU62 LDSVTVNSLKAT(ph)PQS(ph)PK -0.8825 -1.2408 -0.3324 SILAC 1 / Biological 1 Rictor down
Q9WU62 LDSVTVNSLKAT(ph)PQS(ph)PK -0.8722 -1.2141 -0.3237 SILAC 1 / Biological 1 Rictor down
Q9WU62 LDSVTVNSLKAT(ph)PQS(ph)PK -0.8722 -1.2141 -0.3237 SILAC 1 / Biological 1 Rictor down
Q9ERU9 LNQSGAS(ph)VGT(ph)DEESDVTQEEER -0.8085 -1.0910 -0.0742 SILAC 1 / Biological 1 Rictor down
Q9ERU9 LNQSGAS(ph)VGT(ph)DEESDVTQEEER -0.8085 -1.0910 -0.0724 SILAC 1 / Biological 1 Rictor down
Q9ESC8 NSYSNSQAPS(ph)PGLGSK -0.4018 -1.4821 -0.6384 SILAC 1 / Biological 1 Rictor down
Q9ESC8 NSYSNSQAPS(ph)PGLGSK -0.4018 -1.4821 -0.6384 SILAC 1 / Biological 1 Rictor down
Q64337 S(ph)RLTPTT(ph)PESSSTGTEDK -0.6846 -1.6829 -0.6306 SILAC 1 / Biological 1 Rictor down
Q64337 S(ph)RLTPTT(ph)PESSSTGTEDK -0.6846 -1.6829 -0.6305 SILAC 1 / Biological 1 Rictor down
Q8VCV2 S(ph)RTHSTS(ph)SSIGSGESPFSR -0.7545 -1.1342 -0.3073 SILAC 1 / Biological 1 Rictor down
Q8VCV2 S(ph)RTHSTS(ph)SSIGSGESPFSR -0.7545 -1.1342 -0.3073 SILAC 1 / Biological 1 Rictor down
P60330 SFEILRGS(ph)DGEDS(ph)ASGEK 0.1517 -1.2225 -0.6596 SILAC 1 / Biological 1 Rictor down
P60330 SFEILRGS(ph)DGEDS(ph)ASGEK 0.1517 -1.2225 -0.6596 SILAC 1 / Biological 1 Rictor down
P60330 SFEILRGS(ph)DGEDS(ph)ASGEK 0.1517 -1.2225 -0.6596 SILAC 1 / Biological 1 Rictor down
P60330 SFEILRGS(ph)DGEDS(ph)ASGEK 0.1517 -1.2225 -0.6596 SILAC 1 / Biological 1 Rictor down
Q61127 SFSPKS(ph)PLELGEK -0.6023 -1.6364 -0.0213 SILAC 1 / Biological 1 Rictor down
Q61127 SFSPKS(ph)PLELGEK -0.6023 -1.6364 -0.0213 SILAC 1 / Biological 1 Rictor down
Q99N57 SHSESASPSALSSS(ph)PNNLS(ph)PTGWSQPK -0.4609 -1.9104 -0.7925 SILAC 1 / Biological 1 Rictor down
Q99N57 SHSESASPSALSSS(ph)PNNLS(ph)PTGWSQPK -0.4784 -1.9104 -0.7814 SILAC 1 / Biological 1 Rictor down
Q3UAI4 SSLGQS(ph)AS(ph)ETEEDTVSISK -0.8395 -1.7083 -0.9350 SILAC 1 / Biological 1 Rictor down
Q3UAI4 SSLGQS(ph)AS(ph)ETEEDTVSISK -0.8395 -1.7083 -0.9350 SILAC 1 / Biological 1 Rictor down
Q3UAI4 SSLGQS(ph)AS(ph)ETEEDTVSISK -0.7876 -1.7156 -0.8448 SILAC 1 / Biological 1 Rictor down
Q3UAI4 SSLGQS(ph)AS(ph)ETEEDTVSISK -0.7876 -1.7156 -0.8448 SILAC 1 / Biological 1 Rictor down
Q9QXS1 SSS(ph)VGS(ph)SSSYPISSAGPR -0.3143 -1.2868 -0.5813 SILAC 1 / Biological 1 Rictor down
Q9QXS1 SSS(ph)VGS(ph)SSSYPISSAGPR -0.3185 -1.2892 -0.5700 SILAC 1 / Biological 1 Rictor down
P14873 SVS(ph)PGVTQAVVEEHCAS(ph)PEEK -0.8468 -1.3370 -0.2394 SILAC 1 / Biological 1 Rictor down
P14873 SVS(ph)PGVTQAVVEEHCAS(ph)PEEK -0.8468 -1.3370 -0.2394 SILAC 1 / Biological 1 Rictor down
Q9R0L6 VTNAIS(ph)PESS(ph)PGVGR -0.8833 -1.3992 -0.3109 SILAC 1 / Biological 1 Rictor down
Q9R0L6 VTNAIS(ph)PESS(ph)PGVGR -0.8833 -1.3992 -0.3100 SILAC 1 / Biological 1 Rictor down
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPT(ph)SPK -0.8181 -1.0826 -0.3620 SILAC 1 / Biological 1 Rictor down
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPT(ph)SPK -0.8181 -1.0826 -0.3620 SILAC 1 / Biological 1 Rictor down
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPT(ph)SPK -0.8181 -1.0826 -0.3620 SILAC 1 / Biological 1 Rictor down
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPT(ph)SPK -0.8181 -1.0826 -0.3620 SILAC 1 / Biological 1 Rictor down
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPT(ph)SPK -0.7746 -1.3877 -0.1022 SILAC 1 / Biological 1 Rictor down
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPT(ph)SPK -0.7746 -1.3877 -0.1022 SILAC 1 / Biological 1 Rictor down
Q6DFZ1 ADAPDAGAQS(ph)DSELPSYHQNDVSLDR -0.4040 -1.1711 -0.4221 SILAC 1 / Biological 2 Rictor down
Q4VA53 AESPETS(ph)AVESTQS(ph)TPQK -0.7305 -1.1547 -0.8686 SILAC 1 / Biological 2 Rictor down
Q9DBE9 ALDISLS(ph)S(ph)EEEEEGDEEEAVAETK -0.6729 -1.7067 -0.8788 SILAC 1 / Biological 2 Rictor down
Q8CD14 ALPSFPTSECVS(ph)DVEPDTR -0.8448 -1.1945 -0.1767 SILAC 1 / Biological 2 Rictor down
Q5DTM8 ALVVPEPEPDS(ph)DSNQER -0.1786 -1.1415 -0.7521 SILAC 1 / Biological 2 Rictor down
Q52KI8 APQTS(ph)SPPPVR -0.9506 -1.1209 -0.0751 SILAC 1 / Biological 2 Rictor down
Q80YR5 APTAALS(ph)PEPQDSK -0.7058 -1.4274 -0.4801 SILAC 1 / Biological 2 Rictor down
Q80YR5 APTAALSPEPQDS(ph)KEDVKK -0.8879 -1.1900 -0.5726 SILAC 1 / Biological 2 Rictor down
Q61083 AQS(ph)YPDNHQEFTDYDNPIFEK -0.2053 -1.5316 -0.7496 SILAC 1 / Biological 2 Rictor down
Q8BTI8 AQSGTDS(ph)S(ph)PEHKIPAPR -0.4300 -1.0828 -0.5918 SILAC 1 / Biological 2 Rictor down
Q8BGU5 AST(ph)IFLSKS(ph)QTDVR 0.6476 -1.0808 -0.7373 SILAC 1 / Biological 2 Rictor down
Q8BGU5 AST(ph)IFLSKS(ph)QTDVR 0.6476 -1.0808 -0.7373 SILAC 1 / Biological 2 Rictor down
Q9WU42 ASTS(ph)PQKPLDLK -0.7876 -1.2637 -0.5593 SILAC 1 / Biological 2 Rictor down
Q68FG5 ATAPQTQHVS(ph)PMR -0.5356 -1.3520 -0.6401 SILAC 1 / Biological 2 Rictor down
Q8BK67 CSSS(ph)S(ph)GGGSSGDEDGPELDGAPGGGKR -0.2013 -1.7810 -0.4760 SILAC 1 / Biological 2 Rictor down
Q8BK67 CSSS(ph)S(ph)GGGSSGDEDGPELDGAPGGGKR -0.2013 -1.7810 -0.4760 SILAC 1 / Biological 2 Rictor down
A2AFQ0 DGGS(ph)GNS(ph)TIIVSR -0.4142 -1.1972 -0.4785 SILAC 1 / Biological 2 Rictor down
P07901 DKEVS(ph)DDEAEEKEEK -0.3989 -1.1202 -0.0904 SILAC 1 / Biological 2 Rictor down
Q91YE7 DYDS(ph)PERER -0.1820 -1.1235 -0.6340 SILAC 1 / Biological 2 Rictor down
P48755 DYGEPGPSSGAGS(ph)PYGRPAQPPQAQAQTAQQQK -0.5412 -1.1826 -0.5384 SILAC 1 / Biological 2 Rictor down
Q8BP27 ENPPS(ph)PPTS(ph)PAAPQPR -0.8053 -1.2671 -0.4693 SILAC 1 / Biological 2 Rictor down
Q8BP27 ENPPSPPT(ph)S(ph)PAAPQPR -0.7699 -1.1115 -0.0855 SILAC 1 / Biological 2 Rictor down
P14873 EVSSKEEQS(ph)PVKAEVAEK -0.7510 -3.0928 -0.1159 SILAC 1 / Biological 2 Rictor down
Q1HFZ0 FQQPPQPEGEEDAS(ph)DGGR -0.6013 -1.4645 -0.4908 SILAC 1 / Biological 2 Rictor down
Q68FE6 FSTYSQS(ph)PPDTPSLR -0.0658 -1.0997 -0.7315 SILAC 1 / Biological 2 Rictor down
Q01320 FTVDLDS(ph)DEDFS(ph)GLDEKDEDEDFLPLDATPPK -0.5913 -1.6356 -0.2232 SILAC 1 / Biological 2 Rictor down
Q01320 FTVDLDS(ph)DEDFS(ph)GLDEKDEDEDFLPLDATPPK -0.8429 -1.6267 -0.1462 SILAC 1 / Biological 2 Rictor down
Q5F2E7 GADNDGS(ph)GS(ph)ESGYTTPK -0.4276 -1.0693 -0.5201 SILAC 1 / Biological 2 Rictor down
Q9ERU9 GGEDEDGS(ph)DEDVVHNEDIHFEPIVSLPEVEVK -0.4660 -1.6390 -0.5006 SILAC 1 / Biological 2 Rictor down
Q8VHR5 GRLT(ph)PS(ph)PDIIVLS(ph)DNEASS(ph)PR -0.6113 -1.2960 -0.1770 SILAC 1 / Biological 2 Rictor down
Q8VHR5 GRLT(ph)PS(ph)PDIIVLS(ph)DNEASS(ph)PR -0.6113 -1.2960 -0.1770 SILAC 1 / Biological 2 Rictor down
Q8K019 KAEGEPQEES(ph)PLK -0.8596 -1.3319 -0.4775 SILAC 1 / Biological 2 Rictor down
Q8K019 KAEGEPQEESPLKS(ph)K -0.9461 -1.4086 -0.4023 SILAC 1 / Biological 2 Rictor down
Q52KI8 KPPAPPSPVQS(ph)QS(ph)PST(ph)NWSPAVPAK -0.6837 -1.4683 -0.5325 SILAC 1 / Biological 2 Rictor down
A2AR02 KS(ph)PS(ph)S(ph)ESEAENVDAQPQSTVRPEEIPPIPENR -0.7522 -1.3047 -0.2562 SILAC 1 / Biological 2 Rictor down
Q9ERU9 LNQSGAS(ph)VGT(ph)DEESDVTQEEER -0.7708 -1.2649 -0.5968 SILAC 1 / Biological 2 Rictor down
Q9ERU9 LNQSGAS(ph)VGT(ph)DEESDVTQEEER -0.7708 -1.2649 -0.5968 SILAC 1 / Biological 2 Rictor down
Q6A006 LSTTPS(ph)PT(ph)NSLHEDGVDDFRR -0.3038 -1.2946 -0.7709 SILAC 1 / Biological 2 Rictor down
Q4VA53 METVSNASSSSNPSS(ph)PGR -0.4893 -1.2401 -0.6391 SILAC 1 / Biological 2 Rictor down
Q8BTI8 MSCFSRPS(ph)MSPT(ph)PLDR -0.5783 -1.2799 -0.6091 SILAC 1 / Biological 2 Rictor down
Q6ZPJ3 NMTVEQLLTGS(ph)PTSPT(ph)VEPEKPTR -0.7142 -2.1278 -0.8844 SILAC 1 / Biological 2 Rictor down
Q8C9B9 NTTKPETIPDMEDS(ph)PPVS(ph)DSEEQQESVR -0.2055 -1.0784 -0.5339 SILAC 1 / Biological 2 Rictor down
P97496 RKPS(ph)PSPPPPTAT(ph)ESR -0.7308 -1.0944 -0.4064 SILAC 1 / Biological 2 Rictor down
Q8K3X4 RNSS(ph)SPVS(ph)PASVPGQR -0.9318 -1.2758 -0.1261 SILAC 1 / Biological 2 Rictor down
Q8K3X4 RNSSS(ph)PVS(ph)PASVPGQR -0.9318 -1.1711 -0.2106 SILAC 1 / Biological 2 Rictor down
Q5SSI6 RTSS(ph)DDES(ph)EEDEDDLLQR -0.5233 -1.1894 -0.4843 SILAC 1 / Biological 2 Rictor down
Q5SSI6 RTSS(ph)DDES(ph)EEDEDDLLQR -0.6278 -1.2432 -0.4247 SILAC 1 / Biological 2 Rictor down
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Q8BTI8 RVPS(ph)PTPVPK -0.8388 -1.5843 -0.6587 SILAC 1 / Biological 2 Rictor down
P28028 S(ph)ASEPSLNR -0.7167 -1.2270 -0.1706 SILAC 1 / Biological 2 Rictor down
O70310 S(ph)GLSPANDTGAK -0.9855 -1.7498 -0.8965 SILAC 1 / Biological 2 Rictor down
P13864 S(ph)KSDSDTLSVETS(ph)PSSVATR -0.8136 -1.6960 -0.7785 SILAC 1 / Biological 2 Rictor down
B1AQD9 SAEPTREPGAEAES(ph)GS(ph)ESEPEPGPGPR -0.1634 -1.1877 -0.5033 SILAC 1 / Biological 2 Rictor down
B1AQD9 SAEPTREPGAEAES(ph)GS(ph)ESEPEPGPGPR -0.1634 -1.1877 -0.5033 SILAC 1 / Biological 2 Rictor down
Q99N57 SHSESASPSALSSS(ph)PNNLS(ph)PTGWSQPK -0.5695 -3.0034 -0.5524 SILAC 1 / Biological 2 Rictor down
Q99N57 SHSESASPSALSSS(ph)PNNLS(ph)PTGWSQPK -0.5695 -3.0034 -0.5524 SILAC 1 / Biological 2 Rictor down
Q9JIX8 SLS(ph)PLSGTTDTKAES(ph)PAGR -0.2376 -1.2498 -0.2990 SILAC 1 / Biological 2 Rictor down
Q9JIX8 SLSPLSGTT(ph)DTKAES(ph)PAGR -0.3857 -1.2427 -0.5935 SILAC 1 / Biological 2 Rictor down
Q9JIX8 SLSPLSGTT(ph)DTKAES(ph)PAGR -0.2376 -1.2427 -0.4736 SILAC 1 / Biological 2 Rictor down
A2AJI0 SSQPS(ph)PTTVPASDS(ph)PPAKQDVK -0.0360 -1.2366 -0.7864 SILAC 1 / Biological 2 Rictor down
Q8BTI8 SSSPVT(ph)ELT(ph)ARSPVKQDK -0.3809 -1.3509 -0.3790 SILAC 1 / Biological 2 Rictor down
Q8BTI8 SSSPVT(ph)ELT(ph)ARSPVKQDK -0.3809 -1.3509 -0.3790 SILAC 1 / Biological 2 Rictor down
Q7TSC1 T(ph)ASETRS(ph)EGSEY(ph)EEIPK -0.4594 -1.0854 -0.5187 SILAC 1 / Biological 2 Rictor down
Q7TSC1 T(ph)ASETRS(ph)EGSEY(ph)EEIPK -0.4594 -1.0854 -0.5187 SILAC 1 / Biological 2 Rictor down
Q8BKC8 T(ph)ASNPKVENEDEPVR -0.0777 -1.1463 -0.3228 SILAC 1 / Biological 2 Rictor down
Q7TSC1 TAS(ph)ETRS(ph)EGS(ph)EYEEIPK -0.3281 -1.1249 -0.6334 SILAC 1 / Biological 2 Rictor down
Q7TSC1 TAS(ph)ETRS(ph)EGS(ph)EYEEIPK -0.2991 -1.0854 -0.6073 SILAC 1 / Biological 2 Rictor down
A2AQB0 TEQIVNEDS(ph)QAAALAPNPK -0.5306 -1.3817 -0.9269 SILAC 1 / Biological 2 Rictor down
A2AAE1 VVFENEQDNNS(ph)LTK -0.6581 -1.0824 -0.7787 SILAC 1 / Biological 2 Rictor down
Q8K2Z4 VVFLS(ph)DES(ph)S(ph)EDELSAEMTEEETPKR -0.3672 -1.3796 -0.7671 SILAC 1 / Biological 2 Rictor down
Q8K2Z4 VVFLS(ph)DES(ph)S(ph)EDELSAEMTEEETPKR -0.3672 -1.3796 -0.7671 SILAC 1 / Biological 2 Rictor down
Q8K2Z4 VVFLS(ph)DES(ph)S(ph)EDELSAEMTEEETPKR -0.3672 -1.3796 -0.7671 SILAC 1 / Biological 2 Rictor down
Q5DTP7 WGQPPS(ph)PTPVPRPPDADPNT(ph)PSPK -0.9924 -1.6074 -0.6618 SILAC 1 / Biological 2 Rictor down
Q5DTP7 WGQPPS(ph)PTPVPRPPDADPNT(ph)PSPK -0.9924 -1.6074 -0.6618 SILAC 1 / Biological 2 Rictor down
Q5DTP7 WGQPPS(ph)PTPVPRPPDADPNT(ph)PSPK -0.9924 -1.6074 -0.6618 SILAC 1 / Biological 2 Rictor down
Q80V30 YMLTHQELAS(ph)DGEIQTK -0.4459 -1.2847 -0.5096 SILAC 1 / Biological 2 Rictor down
Q6ZQK6 AAKES(ph)EEEEEEEETEEK -0.9077 -1.3346 -0.2460 SILAC 2 / Biological 3 Rictor down
O54988 AKDSGS(ph)VSLQETR -0.2951 -1.1710 -0.8940 SILAC 2 / Biological 3 Rictor down
Q9DBE9 ALDIS(ph)LSS(ph)EEEEEGDEEEAVAETK -0.7949 -1.9950 -0.7337 SILAC 2 / Biological 3 Rictor down
Q68FG5 ATAPQTQHVS(ph)PMR -0.7405 -1.4905 -0.8245 SILAC 2 / Biological 3 Rictor down
A2AFQ0 DGGS(ph)GNST(ph)IIVSR -0.6544 -1.3220 -0.6824 SILAC 2 / Biological 3 Rictor down
O54988 DS(ph)GSVSLQETR -0.8216 -1.0798 -0.4224 SILAC 2 / Biological 3 Rictor down
Q04692 DTVIIVS(ph)EPSEDEESHDLPSVT(ph)R -0.7909 -1.1770 -0.3190 SILAC 2 / Biological 3 Rictor down
Q1HFZ0 EGVILT(ph)NENAASPEQPGDEDAK -0.6282 -1.3680 -0.6838 SILAC 2 / Biological 3 Rictor down
Q3UMF0 EQTAS(ph)APAT(ph)PLVSK -0.3434 -1.0711 -0.7616 SILAC 2 / Biological 3 Rictor down
Q68FE6 FSTYS(ph)QSPPDTPSLR -0.7114 -1.4453 -0.9499 SILAC 2 / Biological 3 Rictor down
Q6ZQK6 GGSISVQVNSVKFDS(ph)E -0.9606 -1.2993 -0.6492 SILAC 2 / Biological 3 Rictor down
Q3UMF0 ITVEKDPDSALGIS(ph)DGET(ph)SPSSK -0.3651 -1.1500 -0.5507 SILAC 2 / Biological 3 Rictor down
Q3UMF0 ITVEKDPDSALGISDGET(ph)S(ph)PSSK -0.3637 -1.7292 -0.6946 SILAC 2 / Biological 3 Rictor down
Q3TUD7 KAENAEGQTPAIGPDGEPLDET(ph)S(ph)QMSDLPVK -0.6786 -1.3543 -0.5273 SILAC 2 / Biological 3 Rictor down
Q8BRB8 LPS(ph)GSGPAS(ph)PTTGSAVDIR -0.7426 -1.3601 -0.8771 SILAC 2 / Biological 3 Rictor down
B9EHJ7 LS(ph)TSPATRDEAAS(ph)PGAK -0.2295 -1.3124 -0.7546 SILAC 2 / Biological 3 Rictor down
B9EHJ7 LSTS(ph)PATRDEAAS(ph)PGAK 0.0516 -1.1394 -0.7546 SILAC 2 / Biological 3 Rictor down
Q8BTI8 MSCFSRPSMS(ph)PT(ph)PLDR -0.8036 -1.1263 -0.6075 SILAC 2 / Biological 3 Rictor down
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK -0.7324 -1.2647 -0.6130 SILAC 2 / Biological 3 Rictor down
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK -0.7324 -1.2647 -0.6130 SILAC 2 / Biological 3 Rictor down
P60330 S(ph)FEILRGSDGEDS(ph)ASGEK -0.0679 -1.3001 -0.7110 SILAC 2 / Biological 3 Rictor down
Q7TPV4 S(ph)PSLLQSGVK -0.5524 -1.0752 -0.2754 SILAC 2 / Biological 3 Rictor down
O70310 SGLS(ph)PANDTGAK -0.4550 -1.5060 -0.9139 SILAC 2 / Biological 3 Rictor down
Q9JIK5 SNSSDAPGEES(ph)SSETEKEIPVEQK -0.9778 -1.1319 0.1255 SILAC 2 / Biological 3 Rictor down
Q8K2D3 SQDVAIS(ph)PQQQQCSK -0.5845 -1.2177 -0.1175 SILAC 2 / Biological 3 Rictor down
Q9QXS1 SSS(ph)VGSSSS(ph)YPISSAGPR -0.1495 -1.0836 -0.5426 SILAC 2 / Biological 3 Rictor down
B2RUR8 STPES(ph)GES(ph)DKESVGSSSLGNEGSR -0.1881 -1.0835 -0.8755 SILAC 2 / Biological 3 Rictor down
B2RUR8 STPES(ph)GES(ph)DKESVGSSSLGNEGSR -0.2051 -1.1063 -0.8579 SILAC 2 / Biological 3 Rictor down
Q6ZQ58 VEPAWHDQDETSS(ph)VKS(ph)DGAGGAR -0.2418 -1.1092 -0.9100 SILAC 2 / Biological 3 Rictor down
Q6ZQ58 VEPAWHDQDETSS(ph)VKS(ph)DGAGGAR -0.3278 -1.1443 -0.7769 SILAC 2 / Biological 3 Rictor down
A2AQB0 VSDSSLS(ph)PEKFTQVECQHK -0.5791 -1.3162 -0.5798 SILAC 2 / Biological 3 Rictor down
Q80V30 YMLTHQELAS(ph)DGEIQTK -0.9625 -1.3592 -0.7941 SILAC 2 / Biological 3 Rictor down
P08775 YSPTSPTY(ph)SPT(ph)TPK -0.6280 -1.5569 -0.6920 SILAC 2 / Biological 3 Rictor down
Q3UZ39 AGS(ph)REPVEDPQSGSSGK -0.6436 -1.1033 -0.6549 SILAC 3 / Biological 4 Rictor down
A2RSX9 KWS(ph)LNTYK -0.4545 -1.1687 -0.8713 SILAC 3 / Biological 4 Rictor down
P48678 SGAQASSTPLS(ph)PTR -0.0763 -1.0795 -0.7012 SILAC 3 / Biological 4 Rictor down
P48678 SGAQASSTPLSPT(ph)R -0.1770 -1.0966 -0.9041 SILAC 3 / Biological 4 Rictor down
O70310 SGLS(ph)PANDTGAK -0.2519 -1.1099 -0.7991 SILAC 3 / Biological 4 Rictor down
Q05A74 DKKS(ph)PLIESTANMENNQPQK -0.6783 1.0643 1.7984 SILAC 2 / Biological 3 Rictor up H/M up  +
O54774 HSSLPTES(ph)DEDIAPAQR 0.1971 1.0222 1.2423 SILAC 1 / Biological 1 Rictor up H/M up  +
O54774 HSSLPTES(ph)DEDIAPAQR 0.2055 1.0250 1.2429 SILAC 1 / Biological 1 Rictor up H/M up  +
P10711 KKEPAIS(ph)SQNSPEAR 0.4401 1.8652 1.5305 SILAC 3 / Biological 4 Rictor up H/M up  +
Q6NZJ6 S(ph)FSKEVEER 0.3621 0.9005 0.7551 SILAC 1 / Biological 1 Rictor up H/M up  +
Q9JIX8 SQS(ph)PS(ph)PPPLPEDLEK 0.1454 1.3182 0.9276 SILAC 1 / Biological 2 Rictor up H/M up  +
Q9JIX8 SQS(ph)PS(ph)PPPLPEDLEK 0.5529 2.8551 1.5614 SILAC 1 / Biological 2 Rictor up H/M up  +
Q9JIX8 SQS(ph)PS(ph)PPPLPEDLEK 0.9109 1.9643 0.9421 SILAC 2 / Biological 3 Rictor up H/M up  +
P27546 DMS(ph)PLPESEVTLGK 0.4919 0.9968 0.8658 SILAC 1 / Biological 1 Rictor up H/M up
P27546 DMS(ph)PLPESEVTLGK 0.4919 0.9968 0.8658 SILAC 1 / Biological 1 Rictor up H/M up
Q60598 KQT(ph)PPAS(ph)PSPQPIEDRPPS(ph)SPIYEDAAPFK -0.6048 0.9702 2.2679 SILAC 1 / Biological 1 Rictor up H/M up
Q60598 KQT(ph)PPAS(ph)PSPQPIEDRPPS(ph)SPIYEDAAPFK -0.6048 0.9702 2.2679 SILAC 1 / Biological 1 Rictor up H/M up
Q99JF8 NLAKPGVTST(ph)SDS(ph)EDEDDQEGEKK 0.7146 1.0716 0.8328 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 RGNNS(ph)AVGS(ph)NADLTIEEDEEEEPVALQQAQQVR 0.7983 2.3883 3.5633 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 RGNNS(ph)AVGS(ph)NADLTIEEDEEEEPVALQQAQQVR 0.7983 2.3883 3.5633 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 RGNNS(ph)AVGS(ph)NADLTIEEDEEEEPVALQQAQQVR 0.7983 2.3970 3.5633 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 RGNNS(ph)AVGS(ph)NADLTIEEDEEEEPVALQQAQQVR 0.7983 2.3970 3.5633 SILAC 1 / Biological 1 Rictor up H/M up
Q6NZJ6 S(ph)FSKEVEERS(ph)R 0.0308 1.0986 1.1885 SILAC 1 / Biological 1 Rictor up H/M up
Q6NZJ6 S(ph)FSKEVEERS(ph)R 0.0348 1.0986 1.1928 SILAC 1 / Biological 1 Rictor up H/M up
Q3UGP0 S(ph)PSPSPTSPGS(ph)LRK -0.4455 1.4403 1.4157 SILAC 1 / Biological 1 Rictor up H/M up
Q3UGP0 S(ph)PSPSPTSPGS(ph)LRK -0.4444 1.4430 1.4900 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 S(ph)SPFKVS(ph)PLSFGR 0.2046 0.9870 0.8868 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 S(ph)SPFKVS(ph)PLSFGR 0.2460 1.0464 0.9076 SILAC 1 / Biological 1 Rictor up H/M up
Q3UGP0 SPS(ph)PS(ph)PTSPGSLRK 0.0994 0.9875 1.3787 SILAC 1 / Biological 1 Rictor up H/M up
Q3UGP0 SPS(ph)PS(ph)PTSPGSLRK 0.1100 0.9937 1.3787 SILAC 1 / Biological 1 Rictor up H/M up
Q3UGP0 SPS(ph)PSPT(ph)SPGSLR -0.1199 0.9969 1.3664 SILAC 1 / Biological 1 Rictor up H/M up
Q3UGP0 SPS(ph)PSPT(ph)SPGSLR -0.2215 0.9947 1.3847 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 SS(ph)PFKVS(ph)PLSFGR 0.2031 1.2332 0.9446 SILAC 1 / Biological 1 Rictor up H/M up
Q63918 SS(ph)PFKVS(ph)PLSFGR 0.2256 1.2297 0.9589 SILAC 1 / Biological 1 Rictor up H/M up
Q3TZZ7 SSS(ph)S(ph)LLASPSHIAAK 0.4093 1.0760 0.7626 SILAC 1 / Biological 1 Rictor up H/M up
Q80YV2 T(ph)RSWES(ph)SSPVDRPELEAASPTTR 0.8333 1.1006 0.8721 SILAC 1 / Biological 1 Rictor up H/M up
Q80YV2 T(ph)RSWES(ph)SSPVDRPELEAASPTTR 0.8284 1.1333 0.8800 SILAC 1 / Biological 1 Rictor up H/M up
Q64511 VKAS(ph)PITNDGEDEFVPS(ph)DGLDKDEYAFSSGK 0.1214 0.8692 0.8843 SILAC 1 / Biological 1 Rictor up H/M up
Q99P72 (ac)MEDIDQSSLVSSSADS(ph)PPRPPPAFK -0.1694 1.5710 1.6119 SILAC 1 / Biological 2 Rictor up H/M up
Q80TM9 ACSDS(ph)LES(ph)IPAGQVASDDLR 0.2208 1.2992 0.9280 SILAC 1 / Biological 2 Rictor up H/M up
Q80TM9 ACSDS(ph)LES(ph)IPAGQVASDDLR 0.2208 1.2992 0.9280 SILAC 1 / Biological 2 Rictor up H/M up
Q99KK9 DLS(ph)PQQMVVR 0.1928 0.8817 0.8800 SILAC 1 / Biological 2 Rictor up H/M up
P27546 DMS(ph)PSAETEAPLAK 0.8640 2.5359 1.1024 SILAC 1 / Biological 2 Rictor up H/M up
Q8R5F7 DSGTMGS(ph)DS(ph)DESVIQTK 0.2164 1.6409 1.2468 SILAC 1 / Biological 2 Rictor up H/M up
Q8R5F7 DSGTMGSDS(ph)DESVIQTK 0.3798 1.8374 1.3586 SILAC 1 / Biological 2 Rictor up H/M up
P14873 DVMSDETNNEETES(ph)PSQEFVNITK 0.4363 2.1911 0.9796 SILAC 1 / Biological 2 Rictor up H/M up
P53986 EGKEDEAST(ph)DVDEKPK 0.0585 1.3534 1.3631 SILAC 1 / Biological 2 Rictor up H/M up
Q9WTQ5 EKEPTKPLESPT(ph)S(ph)PVSNETTSSFK -0.6042 2.0101 2.7153 SILAC 1 / Biological 2 Rictor up H/M up
Q9WTQ5 EKEPTKPLESPT(ph)S(ph)PVSNETTSSFK -0.6042 2.0101 2.7153 SILAC 1 / Biological 2 Rictor up H/M up
Q8C2Q7 HTGPNS(ph)PDTANDGFVR 0.0731 0.9025 1.1369 SILAC 1 / Biological 2 Rictor up H/M up
Q8C2Q7 HTGPNS(ph)PDTANDGFVR 0.0298 0.9894 1.3471 SILAC 1 / Biological 2 Rictor up H/M up
Q8C0D4 IQQDS(ph)ES(ph)GDELSSSSTEQMR 0.5098 1.0401 0.8285 SILAC 1 / Biological 2 Rictor up H/M up
Q8C0D4 IQQDS(ph)ES(ph)GDELSSSSTEQMR 0.5098 1.0401 0.8285 SILAC 1 / Biological 2 Rictor up H/M up
P09405 KEDS(ph)DEDEDEEDEDDS(ph)DEDEDDEEEDEFEPPIVK -0.3516 1.5401 1.4422 SILAC 1 / Biological 2 Rictor up H/M up
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P09405 KEDS(ph)DEDEDEEDEDDS(ph)DEDEDDEEEDEFEPPIVK -0.3516 1.5401 1.4422 SILAC 1 / Biological 2 Rictor up H/M up
O08784 KSAEPLANTVLAS(ph)ET(ph)EEEGNAQALGPTAK 0.1697 1.0799 0.7565 SILAC 1 / Biological 2 Rictor up H/M up
O08784 KSAEPLANTVLAS(ph)ET(ph)EEEGNAQALGPTAK 0.1697 1.0799 0.7565 SILAC 1 / Biological 2 Rictor up H/M up
Q5F2E7 NDS(ph)WGSFDLR 0.2622 1.9788 1.3008 SILAC 1 / Biological 2 Rictor up H/M up
P16951 NDSVIVADQT(ph)PT(ph)PTR 0.7961 1.6650 1.0075 SILAC 1 / Biological 2 Rictor up H/M up
P16951 NDSVIVADQT(ph)PT(ph)PTR 0.7961 1.6650 1.0075 SILAC 1 / Biological 2 Rictor up H/M up
P09405 NLS(ph)FNITEDELK 0.0182 2.0545 1.9696 SILAC 1 / Biological 2 Rictor up H/M up
Q8C0N2 NSAS(ph)VGIIQR 0.2046 1.8150 2.0731 SILAC 1 / Biological 2 Rictor up H/M up
Q80Y35 QAASSQEPS(ph)ELEELR -0.4785 2.0086 4.5674 SILAC 1 / Biological 2 Rictor up H/M up
Q6P4S8 RDS(ph)TEAPKPESS(ph)PEPPPGQGR 0.0000 0.8653 0.8316 SILAC 1 / Biological 2 Rictor up H/M up
Q3UFM5 S(ph)RSS(ph)S(ph)EDDIEQQESHSVESGEK 0.0618 0.9172 0.8045 SILAC 1 / Biological 2 Rictor up H/M up
Q9QZQ1 S(ph)SPNVANQPPS(ph)PGGK 0.4791 1.7841 1.0263 SILAC 1 / Biological 2 Rictor up H/M up
P28028 SAS(ph)EPSLNR -0.9132 0.9157 1.0149 SILAC 1 / Biological 2 Rictor up H/M up
Q3UFM5 SRS(ph)S(ph)S(ph)EDDIEQQESHSVESGEK 0.0068 0.8215 0.8494 SILAC 1 / Biological 2 Rictor up H/M up
Q3UFM5 SRS(ph)S(ph)S(ph)EDDIEQQESHSVESGEK 0.0068 0.8215 0.8494 SILAC 1 / Biological 2 Rictor up H/M up
Q9QZQ1 SSPNVANQPPS(ph)PGGK -0.1040 1.5100 1.2118 SILAC 1 / Biological 2 Rictor up H/M up
B2RUB9 SSTPLPTVSSS(ph)AENTR 0.3386 1.2214 0.9293 SILAC 1 / Biological 2 Rictor up H/M up
Q3UQN6 VSEGCLTSS(ph)QDGVENDGLHR 0.3633 1.6936 1.1860 SILAC 1 / Biological 2 Rictor up H/M up
P35486 YGMGT(ph)SVER 0.1595 1.5070 1.5360 SILAC 1 / Biological 2 Rictor up H/M up
Q6Y7W8 AGAEASEEVPQTSLSSARPGT(ph)PSDHQPQEATQFER -0.7111 1.4124 2.5206 SILAC 2 / Biological 3 Rictor up H/M up
P14873 ASLS(ph)PMDEPVPDSES(ph)PVEK 0.0525 0.9061 0.8230 SILAC 2 / Biological 3 Rictor up H/M up
Q8K1N2 ASYSGTS(ph)PSHSFISGEPDR 0.3720 1.5043 0.8250 SILAC 2 / Biological 3 Rictor up H/M up
Q8BTI8 DKFSPT(ph)QDRPESSTVLK -0.1165 1.2715 1.7264 SILAC 2 / Biological 3 Rictor up H/M up
P27546 DMS(ph)PSAETEAPLAK -0.0060 1.1446 1.3083 SILAC 2 / Biological 3 Rictor up H/M up
P27546 DMS(ph)PSAETEAPLAK 0.2143 2.0311 1.7965 SILAC 2 / Biological 3 Rictor up H/M up
P14873 DVMSDETNNEETES(ph)PSQEFVNITK -0.3204 1.9357 2.2031 SILAC 2 / Biological 3 Rictor up H/M up
Q3UMF0 EVQRDPQLS(ph)PEQHPSSLSER -0.5567 1.1375 1.4691 SILAC 2 / Biological 3 Rictor up H/M up
P97311 FNGSSEDAS(ph)QETVSKPSLR 0.4708 1.7254 1.3295 SILAC 2 / Biological 3 Rictor up H/M up
Q6ZPV6 IKTEPS(ph)S(ph)PLSDPSDIIR 0.2953 0.8305 0.8713 SILAC 2 / Biological 3 Rictor up H/M up
Q8BTM8 IPEISIQDMTAQVTS(ph)PSGK -0.1919 1.0776 1.2315 SILAC 2 / Biological 3 Rictor up H/M up
Q8C0D4 IQQDS(ph)ES(ph)GDELSSSSTEQMR 0.2590 0.9838 0.7537 SILAC 2 / Biological 3 Rictor up H/M up
O08784 KSAEPLANTVLAS(ph)ET(ph)EEEGNAQALGPTAK 0.0644 0.8956 1.0233 SILAC 2 / Biological 3 Rictor up H/M up
O08784 KSAEPLANTVLAS(ph)ET(ph)EEEGNAQALGPTAK 0.0644 0.8956 1.0233 SILAC 2 / Biological 3 Rictor up H/M up
Q9QZQ1 LFS(ph)QGQDVSDKVK 0.4715 1.3815 1.3003 SILAC 2 / Biological 3 Rictor up H/M up
Q3UH27 LLHEDLDES(ph)DDDVDEK 0.1580 1.8494 1.8854 SILAC 2 / Biological 3 Rictor up H/M up
Q99P31 LLQTCFSSPT(ph)DDSM(ox)DR -0.8630 1.4973 2.3276 SILAC 2 / Biological 3 Rictor up H/M up
Q8R2M2 NMPNVSDSETYNS(ph)DFDDSSPR 0.0994 1.0299 1.1302 SILAC 2 / Biological 3 Rictor up H/M up
Q8C0N2 NSAS(ph)VGIIQR 0.0366 0.9662 1.6490 SILAC 2 / Biological 3 Rictor up H/M up
Q3TUQ5 QQDS(ph)QPEEVMDVLEMVESVK 0.5220 1.6372 1.3175 SILAC 2 / Biological 3 Rictor up H/M up
Q3UJN1 RADALTSS(ph)PGR 0.2558 0.9382 0.8510 SILAC 2 / Biological 3 Rictor up H/M up
Q62388 S(ph)ATPANSDS(ph)ESENFLR 0.0973 1.4827 0.9039 SILAC 2 / Biological 3 Rictor up H/M up
Q62388 S(ph)ATPANSDS(ph)ESENFLR 0.0893 1.1595 0.9102 SILAC 2 / Biological 3 Rictor up H/M up
B2RRF1 S(ph)DSAPPTPVNR -0.7139 1.0305 1.5001 SILAC 2 / Biological 3 Rictor up H/M up
Q8K019 S(ph)KSQEEPKDTFEHDPSESIDEFNK 0.7875 1.8339 0.8349 SILAC 2 / Biological 3 Rictor up H/M up
Q8R457 S(ph)LSRS(ph)PIPSR -0.3007 1.0028 1.5735 SILAC 2 / Biological 3 Rictor up H/M up
Q8R457 S(ph)LSRS(ph)PIPSR -0.2849 1.0071 1.6658 SILAC 2 / Biological 3 Rictor up H/M up
Q5SXY1 S(ph)SKGSPTGS(ph)SPNNASELSLASLTEK -0.3255 1.0343 1.2893 SILAC 2 / Biological 3 Rictor up H/M up
Q8BTI8 S(ph)SRRSS(ph)SELS(ph)PEVVEK 0.2634 2.2576 2.0552 SILAC 2 / Biological 3 Rictor up H/M up
O88665 SLQDLDMS(ph)S(ph)PEDEGQTR -0.1991 1.7520 2.1223 SILAC 2 / Biological 3 Rictor up H/M up
O88665 SLQDLDMS(ph)S(ph)PEDEGQTR -0.1991 1.7520 2.1223 SILAC 2 / Biological 3 Rictor up H/M up
Q9JIX8 SLS(ph)PLSGTTDTK 0.0896 1.6006 0.8467 SILAC 2 / Biological 3 Rictor up H/M up
Q9JIX8 SLS(ph)PLSGTTDTKAES(ph)PAGR 0.2891 0.8746 0.9779 SILAC 2 / Biological 3 Rictor up H/M up
Q8R457 SLS(ph)RS(ph)PIPSR -0.2692 1.0114 1.7580 SILAC 2 / Biological 3 Rictor up H/M up
Q8K2R0 SPDEATAADQES(ph)EDDLSASR 0.9027 1.9037 1.2030 SILAC 2 / Biological 3 Rictor up H/M up
Q69ZM0 SQS(ph)QAS(ph)LTGLAFMSPSNR 0.3031 0.8280 0.8729 SILAC 2 / Biological 3 Rictor up H/M up
Q6Y7W8 SQS(ph)WEER -0.5920 0.9542 2.2594 SILAC 2 / Biological 3 Rictor up H/M up
Q3UAM3 SSS(ph)LDMNR -0.1665 1.0131 1.3530 SILAC 2 / Biological 3 Rictor up H/M up
Q9JIX8 SSSFS(ph)EEKGESDDEKPR 0.2793 1.4408 1.6516 SILAC 2 / Biological 3 Rictor up H/M up
Q9JIX8 SSSFSEEKGES(ph)DDEKPR 0.4452 1.6570 1.1995 SILAC 2 / Biological 3 Rictor up H/M up
Q80X50 STSAPQMS(ph)PGSSDNQSSS(ph)PQPAQQK -0.3132 1.3363 1.7577 SILAC 2 / Biological 3 Rictor up H/M up
P14873 SVS(ph)PGVTQAVVEEHCAS(ph)PEEK -0.2393 1.0100 1.4248 SILAC 2 / Biological 3 Rictor up H/M up
Q8BYJ6 T(ph)SSTCS(ph)NES(ph)LNAGGTPVTPR 0.4727 1.5590 1.1463 SILAC 2 / Biological 3 Rictor up H/M up
Q8BYJ6 T(ph)SSTCS(ph)NES(ph)LNAGGTPVTPR 0.4727 1.5590 1.1463 SILAC 2 / Biological 3 Rictor up H/M up
O08784 TVVHLLSGKS(ph)PK 0.1499 1.0218 1.0122 SILAC 2 / Biological 3 Rictor up H/M up
Q3UHJ0 VGSLT(ph)PPS(ph)SPK 0.5402 1.4233 0.9743 SILAC 2 / Biological 3 Rictor up H/M up
Q3UQN6 VSEGCLTSS(ph)QDGVENDGLHR -0.0065 2.7210 2.8843 SILAC 2 / Biological 3 Rictor up H/M up
Q61206 (ac)S(ph)QGDSNPAAIPHAAEDIQGDDR 0.0708 1.9302 2.0167 SILAC 3 / Biological 4 Rictor up H/M up
A2AU91 AETTEKDAVTEDS(ph)PQPPLPSVR -0.1947 0.9964 1.3717 SILAC 3 / Biological 4 Rictor up H/M up
A2AU91 AS(ph)QEPFS(ph)PAEDVMETDLLEGLAANQDRPSK -0.1211 1.6730 2.0679 SILAC 3 / Biological 4 Rictor up H/M up
A2AU91 AS(ph)QEPFS(ph)PAEDVMETDLLEGLAANQDRPSK -0.1211 1.6730 2.0679 SILAC 3 / Biological 4 Rictor up H/M up
Q8R5F7 DSGTMGS(ph)DSDESVIQTK -0.0478 2.4371 2.2154 SILAC 3 / Biological 4 Rictor up H/M up
P97311 FNGS(ph)SEDAS(ph)QETVSKPSLR -0.6535 1.5211 1.6667 SILAC 3 / Biological 4 Rictor up H/M up
P97311 FNGSSEDAS(ph)QETVSKPSLR 0.1455 1.5512 1.3422 SILAC 3 / Biological 4 Rictor up H/M up
O35280 FSSS(ph)QPEPR -0.0310 1.2381 1.0660 SILAC 3 / Biological 4 Rictor up H/M up
Q64511 KIVET(ph)INS(ph)DSDSEFGIPK 0.8735 1.1198 0.9745 SILAC 3 / Biological 4 Rictor up H/M up
P10711 KKEPAISS(ph)QNSPEAR 0.6347 1.6297 1.2583 SILAC 3 / Biological 4 Rictor up H/M up
Q8C9B9 KNTTKPETIPDMEDS(ph)PPVSDS(ph)EEQQESVR -0.1050 0.9880 1.0700 SILAC 3 / Biological 4 Rictor up H/M up
Q8C9B9 KNTTKPETIPDMEDS(ph)PPVSDS(ph)EEQQESVR -0.0802 0.8542 1.1344 SILAC 3 / Biological 4 Rictor up H/M up
O08784 KSAEPLANTVLAS(ph)ET(ph)EEEGNAQALGPTAK -0.7608 1.4442 2.7095 SILAC 3 / Biological 4 Rictor up H/M up
Q05D44 KTS(ph)FDENDSEELEDKDSK 0.1961 1.8680 1.8034 SILAC 3 / Biological 4 Rictor up H/M up
P05627 LQALKEEPQTVPEMPGET(ph)PPLS(ph)PIDMESQER 0.1990 1.3565 0.9923 SILAC 3 / Biological 4 Rictor up H/M up
P05627 LQALKEEPQTVPEMPGET(ph)PPLS(ph)PIDMESQER 0.1990 1.3565 0.9923 SILAC 3 / Biological 4 Rictor up H/M up
Q8C9B9 NTTKPETIPDM(ox)EDS(ph)PPVS(ph)DSEEQQESVR -0.1297 1.1219 1.0057 SILAC 3 / Biological 4 Rictor up H/M up
Q3UAM3 PSAEQQEPVSPVVSPQQS(ph)PPT(ph)SPHTWR -0.2948 0.9314 1.0790 SILAC 3 / Biological 4 Rictor up H/M up
Q80Y35 QAASS(ph)QEPSELEELR -0.3867 2.3479 2.6601 SILAC 3 / Biological 4 Rictor up H/M up
Q3TUQ5 QQDS(ph)QPEEVMDVLEMVESVK -0.0203 1.0438 0.9582 SILAC 3 / Biological 4 Rictor up H/M up
Q80X50 RYPSSISSS(ph)PQK -0.3996 1.6505 1.8822 SILAC 3 / Biological 4 Rictor up H/M up
P30999 S(ph)GDLGDMEPLK -0.5564 0.9904 0.9736 SILAC 3 / Biological 4 Rictor up H/M up
Q02248 S(ph)PQMVSAIVR -0.3052 0.8408 0.9287 SILAC 3 / Biological 4 Rictor up H/M up
Q80WJ7 SETNWES(ph)PK -0.5272 1.3414 1.2576 SILAC 3 / Biological 4 Rictor up H/M up
P49586 T(ph)SPSSS(ph)PASLSR -0.3132 0.8716 0.8931 SILAC 3 / Biological 4 Rictor up H/M up
Q9ESX5 T(ph)VLESGGETGDGDNDTTKK 0.0514 0.9746 1.3858 SILAC 3 / Biological 4 Rictor up H/M up
Q05D44 TSFDENDS(ph)EELEDKDSK -0.2597 1.0729 1.0982 SILAC 3 / Biological 4 Rictor up H/M up
Q921K9 VDSSTNSSPS(ph)PQQSESLS(ph)PAHTSDFR -0.4026 0.8323 1.0661 SILAC 3 / Biological 4 Rictor up H/M up
Q3UHJ0 VGSLT(ph)PPS(ph)SPK -0.1328 0.9318 1.0458 SILAC 3 / Biological 4 Rictor up H/M up
A2AIV2 VISHDRDS(ph)PPPPPPPPPPPQPQPTLK 0.3290 1.5384 1.0679 SILAC 3 / Biological 4 Rictor up H/M up
Q3UQN6 VSEGCLTSS(ph)QDGVENDGLHR -0.1105 1.0122 1.3004 SILAC 3 / Biological 4 Rictor up H/M up
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPTS(ph)PK -0.3480 0.8274 0.9390 SILAC 3 / Biological 4 Rictor up H/M up
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPTS(ph)PK -0.3480 0.8274 0.9390 SILAC 3 / Biological 4 Rictor up H/M up
P08775 Y(ph)TPTSPSYSPSSPEY(ph)TPASPK -0.0945 1.0433 1.0433 SILAC 3 / Biological 4 Rictor up H/M up
P08775 Y(ph)TPTSPSYSPSSPEY(ph)TPASPK -0.0945 1.0433 1.0433 SILAC 3 / Biological 4 Rictor up H/M up
P08775 YS(ph)PTSPTYS(ph)PTSPK -0.7247 1.0686 1.4518 SILAC 3 / Biological 4 Rictor up H/M up
P08775 YTPTS(ph)PSYSPSS(ph)PEYTPASPK -0.0945 1.0433 1.0433 SILAC 3 / Biological 4 Rictor up H/M up
Q8VE94 ENFSAGS(ph)DCVTLK 0.7199 1.3201 0.6003 SILAC 3 / Biological 4 Rictor up  +
O54774 HSSLPTES(ph)DEDIAPAQR 0.4266 3.2945 -0.3993 SILAC 2 / Biological 3 Rictor up  +
Q6NZJ6 S(ph)FSKEVEER 0.4672 0.9179 0.5961 SILAC 1 / Biological 1 Rictor up  +
P43274 (ac)S(ph)ETAPAAPAAPAPAEK 0.4796 0.8249 0.0000 SILAC 1 / Biological 1 Rictor up
P43274 (ac)S(ph)ETAPAAPAAPAPAEK 0.4796 0.8249 0.0000 SILAC 1 / Biological 1 Rictor up
Q80TC1 DAPTS(ph)PASVASSSSTPSSK 0.1881 0.9049 0.3012 SILAC 1 / Biological 1 Rictor up
Q80TC1 DAPTS(ph)PASVASSSSTPSSK 0.2141 0.9049 0.3012 SILAC 1 / Biological 1 Rictor up
Q99JF8 ETNVS(ph)KEDT(ph)DQEEKASNEDVTK 0.6837 0.8863 0.1469 SILAC 1 / Biological 1 Rictor up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR 0.8713 1.2882 0.2040 SILAC 1 / Biological 1 Rictor up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR 0.8713 1.2882 0.2040 SILAC 1 / Biological 1 Rictor up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR 0.8197 1.2112 0.4042 SILAC 1 / Biological 1 Rictor up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR 0.8197 1.2112 0.4042 SILAC 1 / Biological 1 Rictor up
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A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR 0.8197 1.2112 0.4042 SILAC 1 / Biological 1 Rictor up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR 0.8197 1.2112 0.4042 SILAC 1 / Biological 1 Rictor up
O54774 HSSLPT(ph)ESDEDIAPAQR -0.3581 1.0598 0.4110 SILAC 1 / Biological 1 Rictor up
O54774 HSSLPT(ph)ESDEDIAPAQR -0.3599 1.0598 0.7038 SILAC 1 / Biological 1 Rictor up
Q64511 KAS(ph)GSENEGDYNPGR 0.7479 1.1907 0.6673 SILAC 1 / Biological 1 Rictor up
Q64511 KAS(ph)GSENEGDYNPGR 0.7403 1.1349 0.6897 SILAC 1 / Biological 1 Rictor up
Q64511 KASGS(ph)ENEGDYNPGR 0.7404 0.9843 0.2615 SILAC 1 / Biological 1 Rictor up
Q64511 KASGS(ph)ENEGDYNPGR 0.7404 1.0151 0.2641 SILAC 1 / Biological 1 Rictor up
P53986 LKS(ph)KES(ph)LQEAGK 0.6678 0.8358 0.3609 SILAC 1 / Biological 1 Rictor up
Q3UZ39 NMPSLSAATLASLGGTSS(ph)R 0.6976 0.8783 0.5429 SILAC 1 / Biological 1 Rictor up
Q3UZ39 NMPSLSAATLASLGGTSS(ph)R 0.6976 0.8783 0.5429 SILAC 1 / Biological 1 Rictor up
Q60875 QILS(ph)QSTDSLNMR 0.6811 1.0463 0.6482 SILAC 1 / Biological 1 Rictor up
Q60875 QILS(ph)QSTDSLNMR 0.4864 1.0463 0.6826 SILAC 1 / Biological 1 Rictor up
Q60875 QILSQS(ph)TDSLNMR 0.7091 0.8669 0.1184 SILAC 1 / Biological 1 Rictor up
Q8K1N2 RLS(ph)AGTTVADVQK 0.6837 0.8441 0.2916 SILAC 1 / Biological 1 Rictor up
Q8K1N2 RLS(ph)AGTTVADVQK 0.6837 0.8446 0.3054 SILAC 1 / Biological 1 Rictor up
Q8K1N2 RLS(ph)AGTTVADVQK 0.5314 0.9499 0.3452 SILAC 1 / Biological 1 Rictor up
Q3UJN1 RRIS(ph)DPLT(ph)SSPGR 0.8951 1.3929 0.5597 SILAC 1 / Biological 1 Rictor up
Q3UJN1 RRIS(ph)DPLT(ph)SSPGR 0.8383 1.3138 0.5630 SILAC 1 / Biological 1 Rictor up
Q58A65 S(ph)ASQSS(ph)LDKLDQELK 0.7156 0.8386 0.1817 SILAC 1 / Biological 1 Rictor up
P53986 S(ph)KESLQEAGKSDANTDLIGGSPK 0.6377 1.0424 0.7262 SILAC 1 / Biological 1 Rictor up
P53986 S(ph)KESLQEAGKSDANTDLIGGSPK 0.6377 1.0424 0.7262 SILAC 1 / Biological 1 Rictor up
Q63918 S(ph)SPFKVSPLS(ph)FGR 0.2813 1.1250 0.6059 SILAC 1 / Biological 1 Rictor up
Q63918 S(ph)SPFKVSPLS(ph)FGR 0.2813 1.1250 0.6059 SILAC 1 / Biological 1 Rictor up
O88665 SLQDLDMS(ph)S(ph)PEDEGQTR 0.1653 1.0512 0.6800 SILAC 1 / Biological 1 Rictor up
O88665 SLQDLDMS(ph)S(ph)PEDEGQTR 0.1653 1.0512 0.6800 SILAC 1 / Biological 1 Rictor up
O88665 SLQDLDMS(ph)S(ph)PEDEGQTR 0.1653 1.0512 0.6800 SILAC 1 / Biological 1 Rictor up
O88665 SLQDLDMS(ph)S(ph)PEDEGQTR 0.1653 1.0512 0.6800 SILAC 1 / Biological 1 Rictor up
Q3TZZ7 SSS(ph)S(ph)LLASPSHIAAK 0.5343 0.9620 0.7286 SILAC 1 / Biological 1 Rictor up
Q9WV92 VESTSVGSIS(ph)PGGAK 0.4950 0.8641 0.3276 SILAC 1 / Biological 1 Rictor up
Q9DBR0 ADS(ph)DGDLS(ph)ENDDGAGDLRS(ph)GDEEFRGEDDLCDSR 0.7276 1.4092 0.5643 SILAC 1 / Biological 2 Rictor up
P30999 APS(ph)RQDVYGPQPQVR 0.5613 0.8781 0.0351 SILAC 1 / Biological 2 Rictor up
Q3UMU9 AQEDGQDS(ph)EDGPRGGS(ph)S(ph)EELHDSPR 0.1654 1.1683 0.5017 SILAC 1 / Biological 2 Rictor up
P14873 ASLS(ph)PMDEPVPDSES(ph)PVEK 0.7459 1.5249 0.4420 SILAC 1 / Biological 2 Rictor up
Q8BT07 ATS(ph)PKSPS(ph)AALNDSLVECPK -0.3909 0.9896 0.2627 SILAC 1 / Biological 2 Rictor up
P47713 DFS(ph)SQDSFDDELDAAVADPDEFER 0.8080 1.2008 0.2823 SILAC 1 / Biological 2 Rictor up
P47713 DFS(ph)SQDSFDDELDAAVADPDEFER 0.8080 1.2008 0.2823 SILAC 1 / Biological 2 Rictor up
P47713 DFS(ph)SQDSFDDELDAAVADPDEFER 0.8080 1.2008 0.2823 SILAC 1 / Biological 2 Rictor up
P27546 DMS(ph)PLPESEVTLGK 0.4427 1.9102 0.7490 SILAC 1 / Biological 2 Rictor up
P46467 EEQSGPVDEKGNDS(ph)DGEAESDDPEKK 0.2070 1.3115 0.1451 SILAC 1 / Biological 2 Rictor up
Q3UJN1 GLLY(ph)DS(ph)SEEDEERPAR 0.6616 1.1345 0.3183 SILAC 1 / Biological 2 Rictor up
P51859 GSAEGS(ph)S(ph)DEEGKLVIDEPAKEK 0.8124 1.2437 0.2399 SILAC 1 / Biological 2 Rictor up
Q3THK3 IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGSR 0.2754 0.9822 0.5986 SILAC 1 / Biological 2 Rictor up
Q3THK3 IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGSR 0.2754 0.9822 0.5986 SILAC 1 / Biological 2 Rictor up
Q3THK3 IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGSR 0.2754 0.9822 0.5986 SILAC 1 / Biological 2 Rictor up
Q3THK3 IHDLEDDLEMS(ph)S(ph)DAS(ph)DAS(ph)GEEGSR 0.2754 0.9822 0.5986 SILAC 1 / Biological 2 Rictor up
P51859 KGSAEGS(ph)S(ph)DEEGKLVIDEPAK 0.7469 1.2295 0.2444 SILAC 1 / Biological 2 Rictor up
Q8CI11 KLEVS(ph)PGDEQSNVETR -0.2016 1.3362 0.7230 SILAC 1 / Biological 2 Rictor up
Q810V0 KSPVFS(ph)DEDS(ph)DLDFDIGKLEQQTK 0.4768 1.1673 0.2717 SILAC 1 / Biological 2 Rictor up
Q810V0 KSPVFS(ph)DEDS(ph)DLDFDIGKLEQQTK 0.4768 1.1673 0.2717 SILAC 1 / Biological 2 Rictor up
Q60953 LAT(ph)S(ph)SPEQSWPSTFK 0.4442 0.8202 0.0037 SILAC 1 / Biological 2 Rictor up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.0015 0.8965 0.3354 SILAC 1 / Biological 2 Rictor up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.0015 0.8965 0.3354 SILAC 1 / Biological 2 Rictor up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.0015 0.8965 0.3354 SILAC 1 / Biological 2 Rictor up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.0015 0.8965 0.3354 SILAC 1 / Biological 2 Rictor up
P14873 LSPAKSPS(ph)LS(ph)PSPPS(ph)PIEK 0.8256 1.2192 -0.1357 SILAC 1 / Biological 2 Rictor up
Q68EF0 NKS(ph)TSSAMGGSHQDLSVIQPIVK -0.3383 1.3026 0.6463 SILAC 1 / Biological 2 Rictor up
Q99JF8 NLAKPGVTST(ph)SDS(ph)EDEDDQEGEK 0.3703 1.3628 0.1902 SILAC 1 / Biological 2 Rictor up
P24788 RGT(ph)S(ph)PRPPEGGLGYSQLGDDDLK 0.1355 0.8494 0.4618 SILAC 1 / Biological 2 Rictor up
P24788 RGT(ph)S(ph)PRPPEGGLGYSQLGDDDLK 0.1355 0.8494 0.4618 SILAC 1 / Biological 2 Rictor up
A5D6P2 RS(ph)SDPALTGLSTSVSDNNFSSEEPSR 0.4000 1.0472 0.4530 SILAC 1 / Biological 2 Rictor up
Q69ZM0 S(ph)QSQAS(ph)LTGLAFMSPSNR 0.2610 1.1168 0.6076 SILAC 1 / Biological 2 Rictor up
P58871 S(ph)SGSLS(ph)PGLETEDPLEAR 0.8201 1.1378 0.3400 SILAC 1 / Biological 2 Rictor up
Q3UAI4 S(ph)SLGQSAS(ph)ETEEDTVSISK 0.6401 1.3339 0.1884 SILAC 1 / Biological 2 Rictor up
P14873 S(ph)VSPGVTQAVVEEHCAS(ph)PEEK 0.5790 1.1094 0.0999 SILAC 1 / Biological 2 Rictor up
Q9CT10 SAGSSS(ph)PEAGEDS(ph)DHEDGNYCPPVKR 0.3102 1.6851 0.3599 SILAC 1 / Biological 2 Rictor up
Q8R1A4 SPSGSAFGS(ph)QENLR 0.2085 0.9822 0.6508 SILAC 1 / Biological 2 Rictor up
Q3UAI4 SSLGQS(ph)ASET(ph)EEDTVSISK 0.8481 0.8791 0.1519 SILAC 1 / Biological 2 Rictor up
Q3UAM3 SSS(ph)LDMNR 0.4230 1.1446 0.4116 SILAC 1 / Biological 2 Rictor up
P14873 SVS(ph)PGVTQAVVEEHCAS(ph)PEEK 0.6166 1.1163 0.1499 SILAC 1 / Biological 2 Rictor up
Q3UMF0 T(ph)LSSPTGTET(ph)NPPKAPR 0.4578 1.1995 0.6573 SILAC 1 / Biological 2 Rictor up
Q9CZJ2 TQESCGIAPLT(ph)PSQS(ph)PKPEAR -0.0305 1.2396 -0.3734 SILAC 1 / Biological 2 Rictor up
Q8BT07 VKAT(ph)S(ph)PKSPSAALNDSLVECPK 0.5006 1.3598 0.5040 SILAC 1 / Biological 2 Rictor up
Q8K298 AASPSKPPISNAS(ph)ATPVGR 0.4564 0.8530 0.6440 SILAC 2 / Biological 3 Rictor up
Q8VDN3 ASLGS(ph)LEGEVEAEASSPK 0.9272 0.8593 0.1842 SILAC 2 / Biological 3 Rictor up
P47713 DFS(ph)S(ph)QDSFDDELDAAVADPDEFER 0.5647 1.1058 0.6231 SILAC 2 / Biological 3 Rictor up
P47713 DFS(ph)S(ph)QDSFDDELDAAVADPDEFER 0.5647 1.1058 0.6231 SILAC 2 / Biological 3 Rictor up
B9EKC2 ENEEAEPSTAPGT(ph)PTLR 0.8345 0.8983 0.0634 SILAC 2 / Biological 3 Rictor up
O35280 FSSS(ph)QPEPR 0.4487 0.9722 0.4070 SILAC 2 / Biological 3 Rictor up
Q3UMU9 GGS(ph)S(ph)GEELEDEEPVKK 0.2203 1.2879 0.5677 SILAC 2 / Biological 3 Rictor up
Q9Z1D1 GIPLPTGDT(ph)SPEPELLPGDPLPPPK 0.7634 1.4051 0.5570 SILAC 2 / Biological 3 Rictor up
Q69ZM0 HS(ph)QSPDSGKESLLK 0.7549 0.9588 0.1845 SILAC 2 / Biological 3 Rictor up
Q62130 ICTEQSNS(ph)PPPIR 0.6387 1.1551 -0.7555 SILAC 2 / Biological 3 Rictor up
Q6ZPV6 IKT(ph)EPSS(ph)PLSDPSDIIR 0.8290 1.2310 0.6075 SILAC 2 / Biological 3 Rictor up
Q8C9B9 NTTKPETIPDMEDS(ph)PPVS(ph)DSEEQQESVR 0.9206 0.9156 0.1894 SILAC 2 / Biological 3 Rictor up
Q9Z1X4 RPMEEDGEEKS(ph)PSK 0.3736 0.9280 0.4053 SILAC 2 / Biological 3 Rictor up
Q8R1A4 S(ph)LSNSNPDISGTPTS(ph)PDDEVR 0.3917 0.9366 0.4310 SILAC 2 / Biological 3 Rictor up
Q3TUQ5 S(ph)LSPGKENINSQEVEK 0.5046 0.8383 0.5950 SILAC 2 / Biological 3 Rictor up
Q6DIC7 S(ph)NLDITVGSR 0.5643 1.0222 0.2630 SILAC 2 / Biological 3 Rictor up
Q02248 S(ph)PQMVSAIVR 0.4783 0.8229 0.1041 SILAC 2 / Biological 3 Rictor up
Q80U93 STQTAPSSAPSTGQKS(ph)PR 0.6285 1.2640 0.6338 SILAC 2 / Biological 3 Rictor up
P49586 T(ph)SPSSSPASLSR 0.7532 1.3969 0.7454 SILAC 2 / Biological 3 Rictor up
Q3UHJ0 VGSLT(ph)PPS(ph)SPK 0.5240 1.4554 0.5089 SILAC 2 / Biological 3 Rictor up
P43276 (ac)S(ph)ETAPAETAAPAPVEK 0.2438 0.8875 0.6872 SILAC 3 / Biological 4 Rictor up
Q63918 DEEALEDS(ph)AEEK 0.5117 0.8649 0.6718 SILAC 3 / Biological 4 Rictor up
P47713 DFS(ph)S(ph)QDSFDDELDAAVADPDEFER 0.3645 0.8306 0.2388 SILAC 3 / Biological 4 Rictor up
Q9D6Z1 EEVASEPEEAAS(ph)PTTPK -0.1661 0.9516 0.5173 SILAC 3 / Biological 4 Rictor up
P70255 HKS(ph)GSMEEDVDTSPGGDYYTSPNS(ph)PTSSSR 0.4483 1.4312 0.5417 SILAC 3 / Biological 4 Rictor up
Q8C0D4 IQQDS(ph)ES(ph)GDELSSSSTEQMR 0.2343 0.8369 0.4660 SILAC 3 / Biological 4 Rictor up
Q8C0D4 IQQDS(ph)ES(ph)GDELSSSSTEQMR 0.2343 0.8369 0.4660 SILAC 3 / Biological 4 Rictor up
Q64511 KTS(ph)FDQDS(ph)DVDIFPSDFTSEPPALPR 0.4334 0.8300 0.3258 SILAC 3 / Biological 4 Rictor up
P43274 KTS(ph)GPPVSELITK 0.3148 0.8676 0.5569 SILAC 3 / Biological 4 Rictor up
Q8BYC6 NGPLNES(ph)QEEEEDGEQGSNLNR 0.9018 0.8252 -0.4019 SILAC 3 / Biological 4 Rictor up
Q62388 S(ph)ATPANS(ph)DSESENFLR 0.7630 1.3214 0.6578 SILAC 3 / Biological 4 Rictor up
Q62388 S(ph)ATPANS(ph)DSESENFLR 0.7630 1.3214 0.6578 SILAC 3 / Biological 4 Rictor up
B2RRF1 SDS(ph)APPTPVNR 0.4217 1.0040 0.6101 SILAC 3 / Biological 4 Rictor up
Q3TYK4 T(ph)DS(ph)REDEISPPPPNPVVK 0.2992 1.2002 0.5792 SILAC 3 / Biological 4 Rictor up
Q3TYK4 T(ph)DSREDEIS(ph)PPPPNPVVK 0.2090 0.9965 0.6031 SILAC 3 / Biological 4 Rictor up
O55091 TEEVEVES(ph)EEDPILEHPPENPVK 0.0546 0.9003 0.3353 SILAC 3 / Biological 4 Rictor up
P97792 TQYNQVPS(ph)EDFER 0.4598 0.8240 -0.2714 SILAC 3 / Biological 4 Rictor up
Q60953 VPAPPGS(ph)PCR 0.4567 0.9273 0.3051 SILAC 3 / Biological 4 Rictor up
Q3UQN6 VSEGCLT(ph)SSQDGVENDGLHR 0.0589 1.0933 0.4745 SILAC 3 / Biological 4 Rictor up
Q3UQN6 VSEGCLTS(ph)SQDGVENDGLHR 0.0382 1.1960 0.0828 SILAC 3 / Biological 4 Rictor up
Q99L90 GDQVLNFS(ph)DAEDLIDDSK -0.0832 -0.8920 -1.0363 SILAC 1 / Biological 2 H/M down  +
Q99L90 GDQVLNFS(ph)DAEDLIDDSK 0.6107 -0.2779 -1.1570 SILAC 3 / Biological 4 H/M down  +
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Q9Z277 LADDEGDS(ph)DSES(ph)VGQSR 0.3376 -0.6160 -1.4439 SILAC 2 / Biological 3 H/M down  +
Q4VAC9 RFSFS(ph)PSAVS(ph)PR 0.5315 -0.5325 -1.1757 SILAC 2 / Biological 3 H/M down  +
Q4VAC9 RFSFS(ph)PSAVS(ph)PR 0.5315 -0.5325 -1.1757 SILAC 2 / Biological 3 H/M down  +
Q6NZJ6 S(ph)FSKEVEER 0.4677 -0.3145 -1.2305 SILAC 1 / Biological 2 H/M down  +
Q62433 SRT(ph)AS(ph)GSSVTSLEGTR 0.8835 -0.6805 -1.1999 SILAC 1 / Biological 1 H/M down  +
Q62433 SRT(ph)AS(ph)GSSVTSLEGTR 0.8858 -0.6249 -1.1718 SILAC 1 / Biological 1 H/M down  +
Q6P5B5 T(ph)DGSIS(ph)GDRQPVTVADYISR 0.8709 -0.5895 -1.0106 SILAC 3 / Biological 4 H/M down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR 0.0459 -0.7991 -1.1115 SILAC 3 / Biological 4 H/M down  +
Q5NCR9 VLQKPSVFGS(ph)DS(ph)DDDETSVSESLQR 0.0459 -0.7991 -1.1115 SILAC 3 / Biological 4 H/M down  +
Q9R0L6 VTNAIS(ph)PES(ph)SPGVGR 0.6386 -0.0693 -1.2535 SILAC 2 / Biological 3 H/M down  +
Q52KI8 APQTSS(ph)PPPVR -0.2101 -0.2293 -1.3849 SILAC 1 / Biological 1 H/M down
Q52KI8 APQTSS(ph)PPPVR -0.2101 -0.2063 -1.3849 SILAC 1 / Biological 1 H/M down
Q8BTI8 AQSGTDS(ph)S(ph)PEHKIPAPR -0.4874 -0.7701 -2.1544 SILAC 1 / Biological 1 H/M down
Q8BTI8 AQSGTDS(ph)S(ph)PEHKIPAPR -0.4874 -0.7699 -2.1475 SILAC 1 / Biological 1 H/M down
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 0.8144 -0.0497 -2.8896 SILAC 1 / Biological 1 H/M down
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 0.8144 -0.0497 -2.8896 SILAC 1 / Biological 1 H/M down
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 0.2683 -0.2574 -1.6594 SILAC 1 / Biological 1 H/M down
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 0.2683 -0.2574 -1.6594 SILAC 1 / Biological 1 H/M down
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 0.2683 -0.2540 -1.6594 SILAC 1 / Biological 1 H/M down
Q60710 CDGS(ph)PRT(ph)PPS(ph)TPPATANLSADDDFQNTDLR 0.2683 -0.2540 -1.6594 SILAC 1 / Biological 1 H/M down
P09450 DAT(ph)PPVSPINMEDQER -0.3004 -0.3433 -1.4678 SILAC 1 / Biological 1 H/M down
P09450 DAT(ph)PPVSPINMEDQER -0.3961 -0.3449 -1.3638 SILAC 1 / Biological 1 H/M down
Q9D6Z1 EEVAS(ph)EPEEAASPTTPK 0.2676 -0.7486 -1.8720 SILAC 1 / Biological 1 H/M down
P14873 ESSPLYS(ph)PGFSDSTSAAK 0.5331 -0.6594 -1.0946 SILAC 1 / Biological 1 H/M down
Q9WTQ5 GPSEAPQEAEAEEGAT(ph)SDGEK 0.9048 -0.8352 -1.4257 SILAC 1 / Biological 1 H/M down
Q8K4Q0 ILDTSSLTQSAPAS(ph)PTNK 0.1450 -0.6053 -1.3381 SILAC 1 / Biological 1 H/M down
Q8K4Q0 ILDTSSLTQSAPAS(ph)PTNK 0.2031 -0.5823 -1.3330 SILAC 1 / Biological 1 H/M down
Q6PDH0 KNS(ph)ITEIS(ph)DNEDELLEYHR -0.3771 -1.0306 -1.1194 SILAC 1 / Biological 1 H/M down
Q6PDH0 KNS(ph)ITEIS(ph)DNEDELLEYHR -0.3771 -1.0306 -1.1194 SILAC 1 / Biological 1 H/M down
Q6PDH0 KNS(ph)ITEIS(ph)DNEDELLEYHR -0.3771 -1.0301 -1.1055 SILAC 1 / Biological 1 H/M down
Q6PDH0 KNS(ph)ITEIS(ph)DNEDELLEYHR -0.3771 -1.0301 -1.1055 SILAC 1 / Biological 1 H/M down
Q9QZQ1 LDSDRVS(ph)SAS(ph)STAER 0.8082 -0.0290 -1.0115 SILAC 1 / Biological 1 H/M down
Q6A065 LGSLS(ph)ARS(ph)DSEATISR 0.4564 -0.1065 -0.9562 SILAC 1 / Biological 1 H/M down
Q6A065 LGSLS(ph)ARS(ph)DSEATISR 0.4564 -0.1065 -0.9562 SILAC 1 / Biological 1 H/M down
B1AWD9 LQS(ph)EPESIR 0.4338 -0.2622 -1.2262 SILAC 1 / Biological 1 H/M down
B2RUB9 LSQSSYQDSESLS(ph)PPR -0.3956 -0.9057 -0.9606 SILAC 1 / Biological 1 H/M down
Q61687 LT(ph)LSDGES(ph)GEEKPTKPK 0.4866 -0.2294 -1.1957 SILAC 1 / Biological 1 H/M down
Q61687 LT(ph)LSDGES(ph)GEEKPTKPK 0.4866 -0.2271 -1.1957 SILAC 1 / Biological 1 H/M down
Q99K70 MSPNETLFLES(ph)TNK 0.8655 -0.5279 -1.2676 SILAC 1 / Biological 1 H/M down
Q99K70 MSPNETLFLES(ph)TNK 0.8655 -0.5279 -1.2676 SILAC 1 / Biological 1 H/M down
P52293 NVSS(ph)FPDDATSPLQENR -0.2925 -1.0153 -1.8144 SILAC 1 / Biological 1 H/M down
P52293 NVSS(ph)FPDDATSPLQENR -0.2925 -1.0153 -1.8144 SILAC 1 / Biological 1 H/M down
Q6PCY9 RGS(ph)LS(ph)PPSSAYER 0.5103 -0.0815 -1.0216 SILAC 1 / Biological 1 H/M down
Q6PCY9 RGS(ph)LS(ph)PPSSAYER 0.5103 -0.0771 -1.0216 SILAC 1 / Biological 1 H/M down
Q9D1F4 S(ph)SDEENGPPSS(ph)PDLDR -0.5009 -0.8773 -1.0030 SILAC 1 / Biological 1 H/M down
Q9D1F4 S(ph)SDEENGPPSS(ph)PDLDR -0.5009 -0.8773 -1.0030 SILAC 1 / Biological 1 H/M down
Q9D1F4 S(ph)SDEENGPPSS(ph)PDLDR -0.2977 -0.8773 -1.0030 SILAC 1 / Biological 1 H/M down
Q9D1F4 S(ph)SDEENGPPSS(ph)PDLDR -0.2977 -0.8773 -1.0030 SILAC 1 / Biological 1 H/M down
Q542W3 SAT(ph)PPPAEPASLPQEPPKPR -0.1000 -0.7575 -0.9743 SILAC 1 / Biological 1 H/M down
P14873 SLMS(ph)S(ph)PEDLTK 0.8546 -0.2856 -1.0431 SILAC 1 / Biological 1 H/M down
P14873 SLMS(ph)S(ph)PEDLTK 0.8493 -0.3557 -1.0182 SILAC 1 / Biological 1 H/M down
P14873 SLMS(ph)S(ph)PEDLTK 0.8620 -0.2847 -0.9965 SILAC 1 / Biological 1 H/M down
P14873 SLMS(ph)S(ph)PEDLTK 0.8465 -0.3517 -0.9949 SILAC 1 / Biological 1 H/M down
Q5BL07 SQS(ph)GEDESLNQPGPIK 0.3748 -0.6457 -1.7587 SILAC 1 / Biological 1 H/M down
Q5BL07 SQS(ph)GEDESLNQPGPIK 0.3748 -0.6457 -1.7587 SILAC 1 / Biological 1 H/M down
O08784 STSSS(ph)PAPTQTLPNSITQR -0.7952 -1.0289 -1.2636 SILAC 1 / Biological 1 H/M down
O08784 STSSS(ph)PAPTQTLPNSITQR -0.7952 -0.9882 -1.2596 SILAC 1 / Biological 1 H/M down
Q8BKC8 T(ph)ASNPKVENEDEPVR 0.7248 -0.0279 -1.1884 SILAC 1 / Biological 1 H/M down
Q8BKC8 T(ph)ASNPKVENEDEPVR 0.7381 -0.0243 -1.1378 SILAC 1 / Biological 1 H/M down
Q05CR3 T(ph)SSEDNLYLAVLR 0.0766 -0.7495 -0.9632 SILAC 1 / Biological 1 H/M down
Q05CR3 T(ph)SSEDNLYLAVLR 0.0849 -0.7520 -0.9553 SILAC 1 / Biological 1 H/M down
Q3TIY5 AAAQYSS(ph)QKS(ph)VEER 0.9027 -0.8661 -1.4583 SILAC 1 / Biological 2 H/M down
Q3TIY5 AAAQYSS(ph)QKS(ph)VEER 0.9027 -0.8661 -1.4583 SILAC 1 / Biological 2 H/M down
Q9QX47 ASES(ph)S(ph)SEEKDDYEIFVK -0.1396 -0.8460 -1.1748 SILAC 1 / Biological 2 H/M down
Q9QX47 ASESS(ph)S(ph)EEKDDYEIFVK 0.3509 0.0000 -1.3686 SILAC 1 / Biological 2 H/M down
Q60710 CDGS(ph)PRTPPST(ph)PPATANLSADDDFQNT(ph)DLR 0.3428 -0.3921 -1.5813 SILAC 1 / Biological 2 H/M down
Q80TC1 DAPTS(ph)PASVASSSSTPSSK -0.2855 -0.7552 -1.7588 SILAC 1 / Biological 2 H/M down
Q6A065 DNS(ph)IS(ph)PESDVDTASTISLVTGETER 0.5354 -0.9503 -1.5043 SILAC 1 / Biological 2 H/M down
Q6A065 DNS(ph)IS(ph)PESDVDTASTISLVTGETER 0.5354 -0.9503 -1.5043 SILAC 1 / Biological 2 H/M down
Q6A065 DNSIS(ph)PES(ph)DVDTASTISLVTGETER 0.3632 -1.0276 -1.1748 SILAC 1 / Biological 2 H/M down
Q99JF8 ETNVS(ph)KEDT(ph)DQEEKASNEDVTK 0.5360 -0.9662 -1.0624 SILAC 1 / Biological 2 H/M down
Q8VDN3 FKAEAPLPS(ph)PK -0.1506 -0.7536 -1.4217 SILAC 1 / Biological 2 H/M down
Q9Z0U1 GSYGS(ph)DPEEEEYRQQLAAHSK -0.2531 -0.4979 -1.4533 SILAC 1 / Biological 2 H/M down
P52927 KPAQETEETSSQES(ph)AEED 0.9362 -0.5917 -1.4630 SILAC 1 / Biological 2 H/M down
Q6A065 LGSLS(ph)ARS(ph)DSEATISR 0.9362 -0.0539 -1.0173 SILAC 1 / Biological 2 H/M down
A6PW47 LLSSSDDDANILSS(ph)PTDR -0.2127 -0.4201 -3.1923 SILAC 1 / Biological 2 H/M down
Q8BRB8 LPSGS(ph)GPASPTT(ph)GSAVDIR 0.2108 -0.8020 -1.0132 SILAC 1 / Biological 2 H/M down
Q8BRB8 LPSGSGPAS(ph)PTTGSAVDIR 0.1674 -0.9454 -1.0914 SILAC 1 / Biological 2 H/M down
B1AR17 MEAEVDSPS(ph)PAPS(ph)LGER -0.1207 -0.7786 -1.0839 SILAC 1 / Biological 2 H/M down
B1AR17 MEAEVDSPS(ph)PAPS(ph)LGER -0.1207 -0.7786 -1.0839 SILAC 1 / Biological 2 H/M down
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK 0.1219 -0.5865 -1.2610 SILAC 1 / Biological 2 H/M down
Q9D4H9 NSADDEELT(ph)NDS(ph)LTLSQSK 0.1130 -0.6586 -1.1510 SILAC 1 / Biological 2 H/M down
Q9ESC8 NSYSNSQAPS(ph)PGLGSK 0.0674 -0.0875 -4.0845 SILAC 1 / Biological 2 H/M down
O35130 RFS(ph)VQEQDWET(ph)TPPKK -0.5971 -0.8929 -1.0085 SILAC 1 / Biological 2 H/M down
Q9Z277 RQS(ph)LELQK 0.7641 -0.6600 -1.2033 SILAC 1 / Biological 2 H/M down
Q8BTI8 S(ph)GTPPRPGS(ph)VTNMQADECTATPQR -0.4662 -0.9178 -0.9877 SILAC 1 / Biological 2 H/M down
P97434 S(ph)KSVIEQVSWDN 0.2772 -1.0072 -1.0578 SILAC 1 / Biological 2 H/M down
Q8R1A4 S(ph)LSNSNPDISGTPTSPDDEVR 0.0259 -0.9572 -1.1305 SILAC 1 / Biological 2 H/M down
Q7TPV4 S(ph)PSLLQSGVK -0.2887 0.0952 -4.3543 SILAC 1 / Biological 2 H/M down
Q9QXS1 S(ph)SSVGSS(ph)SSYPISSAGPR 0.2635 -0.8560 -1.0019 SILAC 1 / Biological 2 H/M down
Q6AW69 S(ph)YGSQPNS(ph)PTSEDLAK 0.6043 -0.9223 -1.5791 SILAC 1 / Biological 2 H/M down
Q8BRB8 SSEVVLS(ph)GDDEDYQR 0.2614 -0.9738 -1.1911 SILAC 1 / Biological 2 H/M down
Q5SNZ0 SSS(ph)QENLLDEVMK -0.0781 -0.7377 -2.1205 SILAC 1 / Biological 2 H/M down
Q5FWX6 SVFPATVSAVLPAPS(ph)PCSS(ph)PK 0.7185 -0.6508 -1.4478 SILAC 1 / Biological 2 H/M down
Q5FWX6 SVFPATVSAVLPAPS(ph)PCSS(ph)PK 0.7185 -0.6508 -1.4478 SILAC 1 / Biological 2 H/M down
Q03141 TPVAST(ph)HS(ph)ISSATTPDR 0.3844 -0.3817 -1.0745 SILAC 1 / Biological 2 H/M down
Q03141 TPVAST(ph)HS(ph)ISSATTPDR 0.3844 -0.3817 -1.0745 SILAC 1 / Biological 2 H/M down
Q9CZJ2 TQESCGIAPLT(ph)PS(ph)QSPKPEAR 0.8573 -0.0864 -0.9753 SILAC 1 / Biological 2 H/M down
Q8K3Z9 TSS(ph)VS(ph)SLASACTGGIPSSSR -0.4085 -0.7313 -3.0363 SILAC 1 / Biological 2 H/M down
Q8K3Z9 TSS(ph)VS(ph)SLASACTGGIPSSSR -0.7027 -0.8425 -1.9931 SILAC 1 / Biological 2 H/M down
Q9WV60 TTS(ph)FAESCKPVQQPSAFGSMK 0.9070 -0.2587 -1.0081 SILAC 1 / Biological 2 H/M down
P27546 VGS(ph)LDNVGHLPAGGAVK -0.2454 -0.8167 -1.2256 SILAC 1 / Biological 2 H/M down
Q62130 YVSGS(ph)S(ph)PDLVTR 0.5118 -1.0071 -1.3076 SILAC 1 / Biological 2 H/M down
Q62130 YVSGS(ph)S(ph)PDLVTR 0.5118 -1.0071 -1.3076 SILAC 1 / Biological 2 H/M down
Q80ZA1 AFQALIKEES(ph)PNC 0.6633 -0.4850 -1.1726 SILAC 2 / Biological 3 H/M down
Q99NH0 APS(ph)PAPSSVPLGSEKPSSVSQDR 0.4500 -0.1740 -1.0247 SILAC 2 / Biological 3 H/M down
Q80YR5 APTAALSPEPQDS(ph)KEDVKK 0.4276 -0.8243 -1.5100 SILAC 2 / Biological 3 H/M down
Q7M739 DAVQAPLNVS(ph)LNEEGK 0.3359 -0.6166 -1.1558 SILAC 2 / Biological 3 H/M down
Q8BVR6 DDS(ph)GAEDNVDTHQQQAENSTVPTADSR 0.8316 -0.3579 -1.6160 SILAC 2 / Biological 3 H/M down
Q8C8U0 DFAARS(ph)PSAS(ph)ITDEDSNV 0.1315 -0.4396 -1.2743 SILAC 2 / Biological 3 H/M down
Q8C8U0 DFAARS(ph)PSAS(ph)ITDEDSNV 0.3432 -0.4396 -1.2743 SILAC 2 / Biological 3 H/M down
O35295 DSLGDFIEHYAQLGPS(ph)SPEQLAAGAEEGGGPR 0.2029 -0.8362 -1.2068 SILAC 2 / Biological 3 H/M down
O35295 DSLGDFIEHYAQLGPS(ph)SPEQLAAGAEEGGGPR 0.2029 -0.8362 -1.2068 SILAC 2 / Biological 3 H/M down
P48755 DYGEPGPSSGAGS(ph)PYGRPAQPPQAQAQTAQQQK 0.4366 -0.8154 -1.5935 SILAC 2 / Biological 3 H/M down
P48755 DYGEPGPSSGAGSPY(ph)GRPAQPPQAQAQTAQQQK 0.6020 -0.9517 -1.6794 SILAC 2 / Biological 3 H/M down
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Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR 0.6094 -0.6163 -1.2935 SILAC 2 / Biological 3 H/M down
Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR 0.6094 -0.6163 -1.2935 SILAC 2 / Biological 3 H/M down
Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR 0.6094 -0.6163 -1.2935 SILAC 2 / Biological 3 H/M down
Q61687 EQLAVNQVNS(ph)ES(ph)DS(ph)DSEESKKPR 0.5994 -0.3931 -1.2779 SILAC 2 / Biological 3 H/M down
Q99P72 ESETFSDS(ph)S(ph)PIEIIDEFPTFVSAK 0.4228 -0.7140 -1.1453 SILAC 2 / Biological 3 H/M down
Q99JF8 ETNVSKEDTDQEEKAS(ph)NEDVTK 0.7322 0.3314 -1.0696 SILAC 2 / Biological 3 H/M down
Q8BIG4 EVMESAVGTSSGSGQSEES(ph)PR 0.1691 -0.7596 -1.1289 SILAC 2 / Biological 3 H/M down
Q8VDN3 FKAEAPLPS(ph)PK 0.4240 -0.7107 -1.1894 SILAC 2 / Biological 3 H/M down
Q68FE6 FSTYSQS(ph)PPDTPSLR 0.4765 -0.2438 -1.0983 SILAC 2 / Biological 3 H/M down
Q5F2E7 GADNDGS(ph)GSESGYTTPK 0.1289 -0.9057 -1.0330 SILAC 2 / Biological 3 H/M down
Q5F2E7 GADNDGSGSES(ph)GY(ph)TTPK 0.1088 -1.0446 -1.3541 SILAC 2 / Biological 3 H/M down
Q3UMU9 GGSSEELHDS(ph)PRDNSDPAKPGNER 0.3058 -0.9152 -1.3492 SILAC 2 / Biological 3 H/M down
Q3UJN1 GLLY(ph)DSS(ph)EEDEERPAR -0.2021 -0.6859 -0.9569 SILAC 2 / Biological 3 H/M down
Q91YE7 GLVAAYS(ph)GDSDNEEELVER 0.4218 -0.5003 -1.4274 SILAC 2 / Biological 3 H/M down
Q91YE7 GLVAAYSGDS(ph)DNEEELVER 0.5335 -0.5961 -1.6938 SILAC 2 / Biological 3 H/M down
B2RUB9 GPPDFSSDEEREPT(ph)PVLGSGASVGR 0.0582 -0.7263 -1.1472 SILAC 2 / Biological 3 H/M down
Q8VHR5 GRLT(ph)PS(ph)PDIIVLSDNEAS(ph)S(ph)PR -0.0766 -0.3858 -1.1964 SILAC 2 / Biological 3 H/M down
Q09XV5 HFSTLKDDDLVEFS(ph)DLES(ph)EDDERPR 0.6386 -0.6933 -1.6141 SILAC 2 / Biological 3 H/M down
Q09XV5 HFSTLKDDDLVEFS(ph)DLES(ph)EDDERPR 0.6386 -0.6933 -1.6141 SILAC 2 / Biological 3 H/M down
P47713 HIVSNDSSDS(ph)DDEAQGPK 0.5470 -0.3893 -1.1478 SILAC 2 / Biological 3 H/M down
Q61687 IKPVTENLVLPS(ph)HTGFCQSS(ph)GDEALSK 0.3877 -0.3537 -0.9845 SILAC 2 / Biological 3 H/M down
Q61687 IKPVTENLVLPSHT(ph)GFCQSS(ph)GDEALSK 0.1267 -0.6241 -1.2778 SILAC 2 / Biological 3 H/M down
Q61687 IKPVTENLVLPSHT(ph)GFCQSS(ph)GDEALSK 0.3648 -0.6241 -0.9845 SILAC 2 / Biological 3 H/M down
P17095 KLEKEEEEGISQES(ph)S(ph)EEEQ 0.5608 -0.4363 -1.0222 SILAC 2 / Biological 3 H/M down
P17095 KLEKEEEEGISQES(ph)S(ph)EEEQ 0.5267 -0.4336 -1.0201 SILAC 2 / Biological 3 H/M down
Q6PDH0 KLS(ph)SGDLR 0.7047 -0.5464 -1.4214 SILAC 2 / Biological 3 H/M down
Q6PDH0 KLS(ph)SGDLR 0.7047 -0.5464 -1.4214 SILAC 2 / Biological 3 H/M down
Q6PHZ2 KPDGVKES(ph)TESSNTTIEDEDVK 0.5573 -0.0201 -1.4461 SILAC 2 / Biological 3 H/M down
A2AR02 KSPS(ph)S(ph)ES(ph)EAENVDAQPQSTVRPEEIPPIPENR 0.2670 -0.4459 -1.0226 SILAC 2 / Biological 3 H/M down
A2AR02 KSPS(ph)S(ph)ES(ph)EAENVDAQPQSTVRPEEIPPIPENR 0.2670 -0.4459 -1.0226 SILAC 2 / Biological 3 H/M down
A2AR02 KSPS(ph)S(ph)ES(ph)EAENVDAQPQSTVRPEEIPPIPENR 0.2670 -0.4459 -1.0226 SILAC 2 / Biological 3 H/M down
P39447 KVQIPVS(ph)HPDPEPVSDNEDDSY(ph)DEEVHDPR 0.2752 -0.5377 -1.2179 SILAC 2 / Biological 3 H/M down
Q9WU42 LEPVS(ph)PPS(ph)PPHADPELELAPSR 0.5296 -0.4014 -1.1106 SILAC 2 / Biological 3 H/M down
Q9WU42 LEPVS(ph)PPS(ph)PPHADPELELAPSR 0.5296 -0.4014 -1.1106 SILAC 2 / Biological 3 H/M down
Q80XU3 LKATVT(ph)PSPVKGK 0.4393 -0.3378 -1.3409 SILAC 2 / Biological 3 H/M down
Q9Z0R4 LPEEPS(ph)SEDEQQPEK 0.6080 -0.5212 -1.3377 SILAC 2 / Biological 3 H/M down
Q8BRB8 LPSGSGPAS(ph)PTT(ph)GSAVDIR 0.2599 -0.5176 -1.0139 SILAC 2 / Biological 3 H/M down
Q60875 LQDSSDPDTGSEEEVS(ph)S(ph)RLSPPHSPR 0.7497 -0.7299 -1.5067 SILAC 2 / Biological 3 H/M down
Q60875 LQDSSDPDTGSEEEVS(ph)S(ph)RLSPPHSPR 0.6235 -0.7112 -1.4001 SILAC 2 / Biological 3 H/M down
Q8K2Z4 LQPLTSVDS(ph)DNDFVTPKPR 0.3692 -0.8084 -1.2570 SILAC 2 / Biological 3 H/M down
Q61687 LT(ph)LSDGES(ph)GEEKPTKPK 0.3653 -0.8585 -0.9725 SILAC 2 / Biological 3 H/M down
Q80U72 MQS(ph)PELPAPER 0.4371 -0.2664 -1.0146 SILAC 2 / Biological 3 H/M down
Q91YM2 NEEENIY(ph)SVPHDSTQGK 0.3216 -0.5601 -1.0594 SILAC 2 / Biological 3 H/M down
Q9ESL4 NFS(ph)SLNLSSR 0.8456 -0.4782 -1.1136 SILAC 2 / Biological 3 H/M down
Q5U3K5 NISLS(ph)S(ph)EEEAEGLAGHPR -0.0108 -0.6866 -1.0437 SILAC 2 / Biological 3 H/M down
Q69ZN8 NLETLPS(ph)FS(ph)SDEEDSVAK 0.6522 -0.8574 -1.7044 SILAC 2 / Biological 3 H/M down
Q69ZN8 NLETLPSFS(ph)S(ph)DEEDSVAK 0.6051 -0.5508 -1.5111 SILAC 2 / Biological 3 H/M down
Q69ZN8 NLETLPSFS(ph)S(ph)DEEDSVAK 0.3479 -0.7041 -1.0691 SILAC 2 / Biological 3 H/M down
Q3UYI5 NREPPPPGS(ph)PPAS(ph)PGPQS(ph)PSTK 0.7283 -0.0503 -1.6469 SILAC 2 / Biological 3 H/M down
Q3UYI5 NREPPPPGS(ph)PPAS(ph)PGPQS(ph)PSTK 0.7283 -0.0503 -1.6469 SILAC 2 / Biological 3 H/M down
Q3UYI5 NREPPPPGS(ph)PPAS(ph)PGPQS(ph)PSTK 0.7283 -0.0503 -1.6469 SILAC 2 / Biological 3 H/M down
Q9ESC8 NSYSNSQAPS(ph)PGLGSK 0.2195 -0.4552 -1.2002 SILAC 2 / Biological 3 H/M down
Q09XV5 NTSS(ph)DNS(ph)DVEVMPAQSPR 0.9337 0.1076 -4.9241 SILAC 2 / Biological 3 H/M down
Q09XV5 NTSS(ph)DNS(ph)DVEVMPAQSPR 0.7894 -0.2662 -3.2383 SILAC 2 / Biological 3 H/M down
A2AU91 QSEQPVKPVGPVMDDAAPEDSAS(ph)PVSQQR 0.7791 -0.6718 -1.3705 SILAC 2 / Biological 3 H/M down
Q99JF8 QSNASSDVEVEEKET(ph)NVSKEDTDQEEK 0.4573 -0.4125 -1.0133 SILAC 2 / Biological 3 H/M down
Q3U4X8 QSQIQNQQSS(ph)DLDSDVEDY(ph) 0.7489 -0.3838 -1.2494 SILAC 2 / Biological 3 H/M down
Q9Z277 RCDVQEDS(ph)EGS(ph)ETDDNKDSTPFEDNEVQDEFLEK 0.4696 -0.5139 -1.2327 SILAC 2 / Biological 3 H/M down
Q9Z277 RCDVQEDS(ph)EGS(ph)ETDDNKDSTPFEDNEVQDEFLEK 0.7072 -0.6632 -1.1760 SILAC 2 / Biological 3 H/M down
P28028 RDS(ph)SDDWEIPDGQITVGQR -0.0380 -0.9865 -1.0773 SILAC 2 / Biological 3 H/M down
Q6ZPE9 RETVVESQSSQS(ph)PS(ph)PK -0.1122 -1.0184 -1.3654 SILAC 2 / Biological 3 H/M down
Q6PCY9 RGS(ph)LS(ph)PPSSAYER 0.3043 -1.0013 -1.2862 SILAC 2 / Biological 3 H/M down
Q6PCY9 RGS(ph)LS(ph)PPSSAYER 0.0412 -1.0013 -1.2819 SILAC 2 / Biological 3 H/M down
Q80U72 RNEAFVCKPDPSPPS(ph)PSEEEK 0.4474 -0.4287 -1.1194 SILAC 2 / Biological 3 H/M down
Q80U72 RNEAFVCKPDPSPPSPS(ph)EEEK 0.2391 -0.5146 -1.5787 SILAC 2 / Biological 3 H/M down
Q9Z277 RQS(ph)LELQK 0.6631 -0.5227 -1.0869 SILAC 2 / Biological 3 H/M down
Q8R457 RRSS(ph)SPFLS(ph)K 0.7125 -0.3966 -1.2696 SILAC 2 / Biological 3 H/M down
Q6PDH0 RTRS(ph)PS(ph)PTLGESLAPR 0.6274 0.0228 -1.0682 SILAC 2 / Biological 3 H/M down
O08582 S(ph)RSPVDSPVPASMFAPEPS(ph)SPGAAR 0.6610 -0.5468 -1.2457 SILAC 2 / Biological 3 H/M down
B1AQD9 SAEPTREPGAEAES(ph)GS(ph)ES(ph)EPEPGPGPR 0.4191 -0.3314 -1.0417 SILAC 2 / Biological 3 H/M down
Q3TUQ7 SGS(ph)ISNYR 0.1113 -1.0273 -1.3826 SILAC 2 / Biological 3 H/M down
Q9R0L6 SNRPVS(ph)ADGNYRPLAK 0.7239 -0.7097 -2.1771 SILAC 2 / Biological 3 H/M down
P14873 SPSLS(ph)PSPPS(ph)PIEK 0.6406 -0.0938 -1.0575 SILAC 2 / Biological 3 H/M down
Q80YV2 SQDATVSPGSEQSEKS(ph)PGPIVSR 0.9017 0.6886 -1.1774 SILAC 2 / Biological 3 H/M down
Q8BRB8 SSEVVLS(ph)GDDEDYQR -0.0352 -0.9050 -1.0952 SILAC 2 / Biological 3 H/M down
Q5FWX6 SVFPATVSAVLPAPS(ph)PCSS(ph)PK 0.9097 -0.3207 -1.6007 SILAC 2 / Biological 3 H/M down
Q8VCV2 SVTSNQS(ph)DGTQESCESPDVLDR 0.0838 -0.7480 -0.9548 SILAC 2 / Biological 3 H/M down
Q8VCV2 SVTSNQSDGT(ph)QESCESPDVLDR -0.1221 -0.6135 -1.3450 SILAC 2 / Biological 3 H/M down
A2AI52 SYS(ph)SPDITQALQEEEKR 0.8350 -0.0952 -1.1700 SILAC 2 / Biological 3 H/M down
Q09XV5 T(ph)ASPS(ph)PLRPDAPVEK 0.8484 -1.0180 -2.1379 SILAC 2 / Biological 3 H/M down
Q09XV5 T(ph)ASPS(ph)PLRPDAPVEK 0.8124 0.0393 -1.1557 SILAC 2 / Biological 3 H/M down
A2AQB0 T(ph)EQIVNEDSQAAALAPNPK 0.8783 0.5198 -0.9786 SILAC 2 / Biological 3 H/M down
Q9WV60 T(ph)TSFAESCKPVQQPSAFGSMK 0.7282 -0.1456 -1.4777 SILAC 2 / Biological 3 H/M down
Q8BKC8 TAS(ph)NPKVENEDEPVR 0.2041 -0.7646 -1.0213 SILAC 2 / Biological 3 H/M down
B2RWS6 TDGKEEEEQPSTSATQSS(ph)PAPGQSK -0.2830 -0.9211 -1.3984 SILAC 2 / Biological 3 H/M down
Q6PDG5 TLTDEVNSPDS(ph)DRR 0.0571 -0.8828 -1.3020 SILAC 2 / Biological 3 H/M down
Q9CZJ2 TQESCGIAPLT(ph)PS(ph)QSPKPEAR 0.9037 -0.4641 -1.7637 SILAC 2 / Biological 3 H/M down
Q9CZJ2 TQESCGIAPLT(ph)PS(ph)QSPKPEAR 0.8355 -0.5391 -1.7138 SILAC 2 / Biological 3 H/M down
Q9CZJ2 TQESCGIAPLT(ph)PSQS(ph)PKPEAR 0.7672 -0.6140 -1.6748 SILAC 2 / Biological 3 H/M down
P97792 TQYNQVPSEDFERAPQS(ph)PTLAPAK 0.3985 -0.3406 -1.1229 SILAC 2 / Biological 3 H/M down
Q8BRB8 TVIRLPSGS(ph)GPASPT(ph)TGSAVDIR 0.1669 -0.5746 -0.9574 SILAC 2 / Biological 3 H/M down
P27546 VGS(ph)LDNVGHLPAGGAVK 0.2924 -0.5135 -0.9551 SILAC 2 / Biological 3 H/M down
Q3UHJ0 VGSLTPPS(ph)S(ph)PK 0.5382 -0.7264 -1.2316 SILAC 2 / Biological 3 H/M down
P39447 VQIPVSHPDPEPVS(ph)DNEDDSY(ph)DEEVHDPR 0.2752 -0.4171 -1.0022 SILAC 2 / Biological 3 H/M down
Q6DFZ1 ADAPDAGAQS(ph)DSELPSYHQNDVSLDR 0.4460 -0.5670 -0.9628 SILAC 3 / Biological 4 H/M down
Q8BGU5 AST(ph)IFLSKS(ph)QTDVR 0.5506 -0.3764 -1.3324 SILAC 3 / Biological 4 H/M down
Q8BGU5 AST(ph)IFLSKS(ph)QTDVR 0.4072 -0.5340 -1.1515 SILAC 3 / Biological 4 H/M down
Q68FG5 ATAPQTQHVS(ph)PMR 0.2184 -0.9706 -1.1718 SILAC 3 / Biological 4 H/M down
A2AFQ0 DGGS(ph)GNS(ph)TIIVSR 0.4339 -0.6220 -0.9513 SILAC 3 / Biological 4 H/M down
Q3UMF0 DPDSALGIS(ph)DGETS(ph)PSSK 0.5374 -0.6465 -1.0447 SILAC 3 / Biological 4 H/M down
O54988 DSGS(ph)VSLQETR 0.8746 -0.2921 -1.4181 SILAC 3 / Biological 4 H/M down
Q80TC1 ESSTNNSVS(ph)PSESLR -0.0012 -1.0625 -1.0455 SILAC 3 / Biological 4 H/M down
Q6ZPE9 ETVVESQS(ph)SQSPS(ph)PKR 0.8306 -0.9567 -1.6318 SILAC 3 / Biological 4 H/M down
Q68FE6 FSTYS(ph)QSPPDTPSLR 0.2836 -0.7085 -1.1946 SILAC 3 / Biological 4 H/M down
Q5F2E7 GADNDGSGSES(ph)GY(ph)TTPK 0.8564 -0.5743 -1.6091 SILAC 3 / Biological 4 H/M down
Q5F2E7 GADNDGSGSES(ph)GY(ph)TTPK 0.8564 -0.5743 -1.6091 SILAC 3 / Biological 4 H/M down
Q9QXS1 GYYSPYSVSGSGS(ph)TAGS(ph)R 0.6071 -0.3826 -1.1254 SILAC 3 / Biological 4 H/M down
Q5U4B1 IINDS(ph)DS(ph)ESEETVQVK 0.8151 -0.1469 -0.9953 SILAC 3 / Biological 4 H/M down
Q5U4B1 IINDS(ph)DS(ph)ESEETVQVK 0.8151 -0.1074 -0.9953 SILAC 3 / Biological 4 H/M down
O55131 ILEQQNSSRT(ph)LEK 0.8900 -0.3537 -1.2729 SILAC 3 / Biological 4 H/M down
Q3UMF0 ITVEKDPDSALGIS(ph)DGET(ph)SPSSK 0.6519 -0.6094 -1.1616 SILAC 3 / Biological 4 H/M down
Q6PDH0 KNS(ph)ITEIS(ph)DNEDELLEYHR 0.6027 -0.2695 -0.9950 SILAC 3 / Biological 4 H/M down
Q6PDH0 KNS(ph)ITEIS(ph)DNEDELLEYHR 0.6027 -0.2695 -0.9950 SILAC 3 / Biological 4 H/M down
Q69ZN8 KQETAAVCGET(ph)DEEAGES(ph)GGEGIFR 0.7459 -0.2639 -1.0454 SILAC 3 / Biological 4 H/M down
Q69ZN8 KQETAAVCGET(ph)DEEAGES(ph)GGEGIFR 0.7459 -0.2639 -1.0454 SILAC 3 / Biological 4 H/M down
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Q9ESX5 KRDS(ph)ESES(ph)DETPTVPQLK 0.9246 -0.3753 -1.3203 SILAC 3 / Biological 4 H/M down
Q62318 LDLDLTSDS(ph)QPPVFK 0.5348 -0.3750 -1.0766 SILAC 3 / Biological 4 H/M down
Q3TIY5 LEIS(ph)PDSS(ph)PER 0.2451 -0.7004 -1.1380 SILAC 3 / Biological 4 H/M down
Q6A065 LGS(ph)LSARS(ph)DSEATISR 0.0982 -0.9877 -1.3055 SILAC 3 / Biological 4 H/M down
Q6A065 LGS(ph)LSARS(ph)DSEATISR 0.1489 -0.9374 -1.2488 SILAC 3 / Biological 4 H/M down
Q6A065 LGSLS(ph)ARS(ph)DSEATISR 0.0474 -1.0379 -1.3622 SILAC 3 / Biological 4 H/M down
Q5FWX6 LS(ph)NGS(ph)FSAPSLTNSR 0.8420 -0.0689 -1.1607 SILAC 3 / Biological 4 H/M down
Q5FWX6 LS(ph)NGS(ph)FSAPSLTNSR 0.8420 -0.0689 -1.1607 SILAC 3 / Biological 4 H/M down
Q8CI59 LVDS(ph)DGS(ph)LAEVPK 0.3618 -1.0629 -1.1895 SILAC 3 / Biological 4 H/M down
Q8CI59 LVDS(ph)DGS(ph)LAEVPK 0.3618 -1.0629 -1.1895 SILAC 3 / Biological 4 H/M down
Q99K70 MSPNETLFLEST(ph)NK 0.7960 0.5541 -0.9667 SILAC 3 / Biological 4 H/M down
Q91YM2 NEEENIY(ph)SVPHDSTQGK 0.8471 -0.3114 -1.1129 SILAC 3 / Biological 4 H/M down
Q9Z277 RQS(ph)LELQK 0.6889 -0.3910 -1.2086 SILAC 3 / Biological 4 H/M down
Q9Z277 S(ph)DGACDSPSSDKENSSQMAQDLQK 0.8269 -0.0862 -1.0550 SILAC 3 / Biological 4 H/M down
P97434 S(ph)KSVIEQVSWDN 0.4714 -0.8209 -1.3217 SILAC 3 / Biological 4 H/M down
Q8BTI8 S(ph)RS(ph)PLAIR 0.7528 -0.5906 -1.4854 SILAC 3 / Biological 4 H/M down
Q8BTI8 S(ph)RT(ph)SPAPWK 0.7389 -0.6556 -1.6739 SILAC 3 / Biological 4 H/M down
Q9QXS1 S(ph)SSVGSS(ph)SSYPISSAGPR 0.5119 -0.6021 -1.0895 SILAC 3 / Biological 4 H/M down
Q9QXS1 S(ph)SSVGSSSSYPISSAGPR 0.4021 -0.8457 -1.3503 SILAC 3 / Biological 4 H/M down
O08784 S(ph)TSSSPAPT(ph)QTLPNSITQR 0.7775 -0.4561 -1.5303 SILAC 3 / Biological 4 H/M down
A2AI52 S(ph)YSSPDITQALQEEEKR 0.7293 -0.9544 -1.6509 SILAC 3 / Biological 4 H/M down
Q99J21 SELQAYIEQCQDS(ph)PTSGK 0.8071 -0.0080 -1.1654 SILAC 3 / Biological 4 H/M down
Q3TUQ7 SIDDEITEAKS(ph)GTAT(ph)PQR 0.9305 -0.6759 -1.6230 SILAC 3 / Biological 4 H/M down
Q3TUQ7 SIDDEITEAKS(ph)GTAT(ph)PQR 0.9305 -0.6759 -1.6230 SILAC 3 / Biological 4 H/M down
P97434 SKS(ph)VIEQVSWDN 0.3398 -0.7487 -1.3073 SILAC 3 / Biological 4 H/M down
Q8C8U0 SPS(ph)AS(ph)ITDEDSNV 0.4242 -0.9432 -1.5470 SILAC 3 / Biological 4 H/M down
Q9QXS1 SS(ph)SVGS(ph)SSSYPISSAGPR 0.4823 -0.6061 -1.2009 SILAC 3 / Biological 4 H/M down
Q8BRB8 SSEVVLS(ph)GDDEDYQR 0.6827 -0.6365 -1.2719 SILAC 3 / Biological 4 H/M down
Q6AW69 SYGS(ph)QPNS(ph)PTSEDLAK 0.6409 -0.5516 -1.1827 SILAC 3 / Biological 4 H/M down
Q62433 TAS(ph)GSSVTS(ph)LEGTR 0.7120 -1.0084 -1.9414 SILAC 3 / Biological 4 H/M down
B2RWS6 TDGKEEEEQPSTSATQSS(ph)PAPGQSK 0.4212 -0.9661 -1.0922 SILAC 3 / Biological 4 H/M down
Q6P9R2 TEDGGWEWS(ph)DDEFDEESEEGR 0.5599 -0.4393 -1.2225 SILAC 3 / Biological 4 H/M down
A2AQB0 TEQIVNEDS(ph)QAAALAPNPK 0.7995 -0.9547 -1.6564 SILAC 3 / Biological 4 H/M down
Q9CZJ2 TQESCGIAPLT(ph)PS(ph)QSPKPEAR 0.7420 -0.0357 -0.9539 SILAC 3 / Biological 4 H/M down
Q9CZJ2 TQESCGIAPLT(ph)PSQS(ph)PKPEAR 0.7882 -0.0577 -1.4640 SILAC 3 / Biological 4 H/M down
Q6PDH0 TRS(ph)PS(ph)PTLGESLAPR 0.4462 -0.2089 -1.0012 SILAC 3 / Biological 4 H/M down
Q05CR3 TSS(ph)EDNLYLAVLR 0.7286 -0.3130 -1.2724 SILAC 3 / Biological 4 H/M down
Q4JIM5 TVS(ph)TSS(ph)QPEENVDR 0.4427 -0.4526 -1.2713 SILAC 3 / Biological 4 H/M down
Q3UYI5 VIEPPAAS(ph)CPSS(ph)PR 0.7197 -0.8388 -1.3700 SILAC 3 / Biological 4 H/M down
Q3UYI5 VIEPPAASCPS(ph)S(ph)PR 0.5459 -0.7952 -1.2669 SILAC 3 / Biological 4 H/M down
Q3UYI5 VIEPPAASCPS(ph)S(ph)PR 0.3721 -0.7517 -1.1638 SILAC 3 / Biological 4 H/M down
A2AAE1 VVFENEQDNNS(ph)LTK 0.6134 -0.4190 -1.3756 SILAC 3 / Biological 4 H/M down
Q62130 YVSGS(ph)S(ph)PDLVTR 0.7887 -0.1872 -1.2748 SILAC 3 / Biological 4 H/M down
Q62130 YVSGS(ph)S(ph)PDLVTR 0.7887 -0.1872 -1.2748 SILAC 3 / Biological 4 H/M down
P09411 ALES(ph)PERPFLAILGGAK -0.7927 -0.1574 0.8530 SILAC 1 / Biological 2 H/M up  +
P09411 ALES(ph)PERPFLAILGGAK -0.6877 -0.0885 0.8785 SILAC 3 / Biological 4 H/M up  +
Q05A74 DKKS(ph)PLIESTANMENNQPQK -0.3481 0.1582 1.3849 SILAC 1 / Biological 1 H/M up  +
Q05A74 DKKS(ph)PLIESTANMENNQPQK -0.3481 0.1582 1.3849 SILAC 1 / Biological 1 H/M up  +
O35130 RFS(ph)VQEQDWETTPPK -0.6077 0.2909 0.9290 SILAC 2 / Biological 3 H/M up  +
O35130 RFS(ph)VQEQDWETTPPK -0.8969 0.2998 1.2588 SILAC 3 / Biological 4 H/M up  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK -0.3613 0.5320 1.0711 SILAC 2 / Biological 3 H/M up  +
Q8BTI8 RSS(ph)SELS(ph)PEVVEK -0.4603 0.5459 1.1010 SILAC 2 / Biological 3 H/M up  +
Q9JIX8 SQS(ph)PS(ph)PPPLPEDLEK -0.7266 0.2373 0.7776 SILAC 1 / Biological 1 H/M up  +
Q9JIX8 SQS(ph)PS(ph)PPPLPEDLEK -0.7414 0.2340 0.8010 SILAC 1 / Biological 1 H/M up  +
Q6P5B5 T(ph)DGSIS(ph)GDRQPVTVADYISR -0.4448 0.2857 0.7638 SILAC 2 / Biological 3 H/M up  +
P43276 (ac)SETAPAETAAPAPVEKS(ph)PAK -0.7883 -0.0773 0.8576 SILAC 1 / Biological 1 H/M up
Q80ZA1 ALPTCTS(ph)ASPPQK -0.6361 0.5939 2.4801 SILAC 1 / Biological 1 H/M up
Q80ZA1 ALPTCTS(ph)ASPPQK -0.6361 0.5914 2.4868 SILAC 1 / Biological 1 H/M up
Q8R1Q8 DFQEYVEPGEDFPAS(ph)PQRR -0.5766 -0.4103 0.7854 SILAC 1 / Biological 1 H/M up
B2RRE7 EES(ph)S(ph)EDENEVSNILR -0.3356 -0.2503 0.7754 SILAC 1 / Biological 1 H/M up
B2RRE7 EES(ph)S(ph)EDENEVSNILR -0.3356 -0.2503 0.7754 SILAC 1 / Biological 1 H/M up
P07901 ES(ph)DDKPEIEDVGSDEEEEEKKDGDK -0.3788 0.3657 0.7868 SILAC 1 / Biological 1 H/M up
Q80TC1 ESSTNNSVS(ph)PSESLR -0.3566 0.2365 0.7958 SILAC 1 / Biological 1 H/M up
Q80TC1 ESSTNNSVS(ph)PSESLR -0.3321 0.2365 0.7958 SILAC 1 / Biological 1 H/M up
Q52KI8 KVELS(ph)ESEEDKGSK -0.2524 0.0503 1.1974 SILAC 1 / Biological 1 H/M up
Q52KI8 KVELS(ph)ESEEDKGSK -0.2524 0.0503 1.1974 SILAC 1 / Biological 1 H/M up
Q80Y44 LASGDGDEEQDEET(ph)EDEETEDHLGK -0.4674 0.2033 1.0081 SILAC 1 / Biological 1 H/M up
Q80Y44 LASGDGDEEQDEET(ph)EDEETEDHLGK -0.4691 0.2015 1.1211 SILAC 1 / Biological 1 H/M up
P58871 LDS(ph)PPPSPITEAS(ph)EAAEAAEADSWAVSGR 0.0777 0.3036 1.1949 SILAC 1 / Biological 1 H/M up
P58871 LDS(ph)PPPSPITEAS(ph)EAAEAAEADSWAVSGR 0.0777 0.3036 1.1949 SILAC 1 / Biological 1 H/M up
P62754 LSS(ph)LRASTSKSES(ph)SQK -0.3885 0.5545 1.2873 SILAC 1 / Biological 1 H/M up
P62754 LSS(ph)LRASTSKSES(ph)SQK -0.3885 0.5545 1.2873 SILAC 1 / Biological 1 H/M up
P49586 MLQAIS(ph)PK -0.2873 0.6119 0.8074 SILAC 1 / Biological 1 H/M up
Q8K019 NT(ph)PSQHSHSIQHS(ph)PER -0.8099 -0.5585 0.9975 SILAC 1 / Biological 1 H/M up
Q8K019 NT(ph)PSQHSHSIQHS(ph)PER -0.8099 -0.5585 0.9975 SILAC 1 / Biological 1 H/M up
Q8C9B9 NTTKPETIPDMEDS(ph)PPVS(ph)DSEEQQESVR -0.7690 -0.3289 0.8449 SILAC 1 / Biological 1 H/M up
Q8C9B9 NTTKPETIPDMEDS(ph)PPVS(ph)DSEEQQESVR -0.7690 -0.3289 0.8541 SILAC 1 / Biological 1 H/M up
Q8BGD9 RES(ph)EKS(ph)LENETLNK -0.9545 0.0019 0.9306 SILAC 1 / Biological 1 H/M up
Q8BGD9 RES(ph)EKS(ph)LENETLNK -0.9545 0.0019 0.9306 SILAC 1 / Biological 1 H/M up
Q8BGD9 RES(ph)EKS(ph)LENETLNK -0.9545 0.0019 0.9306 SILAC 1 / Biological 1 H/M up
Q8BGD9 RES(ph)EKS(ph)LENETLNK -0.9545 0.0019 0.9306 SILAC 1 / Biological 1 H/M up
Q8K3X4 RNS(ph)SS(ph)PVSPASVPGQR -0.2390 -0.5708 0.8436 SILAC 1 / Biological 1 H/M up
Q8K3X4 RNS(ph)SS(ph)PVSPASVPGQR -0.2166 -0.5751 0.9931 SILAC 1 / Biological 1 H/M up
Q9JIX8 S(ph)LSPLSGTTDTK -0.0071 0.5935 0.9314 SILAC 1 / Biological 1 H/M up
Q3UGP0 SGKS(ph)PSPSPTS(ph)PGSLR -0.6252 0.5808 0.8574 SILAC 1 / Biological 1 H/M up
Q3UGP0 SGKS(ph)PSPSPTS(ph)PGSLR -0.6169 0.5781 0.8577 SILAC 1 / Biological 1 H/M up
Q3UGP0 SGKS(ph)PSPSPTS(ph)PGSLR -0.5393 0.5811 1.0860 SILAC 1 / Biological 1 H/M up
Q3UGP0 SGKS(ph)PSPSPTS(ph)PGSLR -0.5913 0.5825 1.1231 SILAC 1 / Biological 1 H/M up
Q3UGP0 SGKSPS(ph)PSPT(ph)SPGSLR -0.7184 0.0770 0.8105 SILAC 1 / Biological 1 H/M up
Q3UGP0 SGKSPS(ph)PSPT(ph)SPGSLR -0.6766 0.0900 0.8105 SILAC 1 / Biological 1 H/M up
P31750 SGSPS(ph)DNS(ph)GAEEMEVSLAKPK -0.7516 0.5013 1.1311 SILAC 1 / Biological 1 H/M up
P31750 SGSPS(ph)DNS(ph)GAEEMEVSLAKPK -0.9437 0.5013 1.1448 SILAC 1 / Biological 1 H/M up
P31750 SGSPS(ph)DNS(ph)GAEEMEVSLAKPK -0.5566 0.2863 1.1511 SILAC 1 / Biological 1 H/M up
P31750 SGSPS(ph)DNS(ph)GAEEMEVSLAKPK -0.6527 0.3362 1.1579 SILAC 1 / Biological 1 H/M up
P97825 SNS(ph)SEASSGDFLDLK -0.0553 0.5811 0.8149 SILAC 1 / Biological 1 H/M up
P97825 SNS(ph)SEASSGDFLDLK -0.0553 0.5875 0.9165 SILAC 1 / Biological 1 H/M up
Q9QZQ1 SSPNVANQPPS(ph)PGGK -0.4903 0.1516 0.8819 SILAC 1 / Biological 1 H/M up
Q9QZQ1 SSPNVANQPPS(ph)PGGK -0.4612 0.1631 0.8845 SILAC 1 / Biological 1 H/M up
Q80X50 STSAPQMS(ph)PGSSDNQSSSPQPAQQK -0.3625 0.1192 0.8089 SILAC 1 / Biological 1 H/M up
Q80X50 STSAPQMS(ph)PGSSDNQSSSPQPAQQK -0.3690 0.1033 0.8105 SILAC 1 / Biological 1 H/M up
Q05D44 TARPNSEAPLS(ph)GSEDADDSNK -0.7133 -0.1286 0.8575 SILAC 1 / Biological 1 H/M up
Q05D44 TARPNSEAPLS(ph)GSEDADDSNK -0.7345 0.0269 0.8575 SILAC 1 / Biological 1 H/M up
Q6PDG5 TLT(ph)DEVNSPDSDRR 0.0263 0.1996 1.0129 SILAC 1 / Biological 1 H/M up
Q6PDG5 TLT(ph)DEVNSPDSDRR 0.0263 0.1996 1.0129 SILAC 1 / Biological 1 H/M up
Q6PDG5 TLTDEVNS(ph)PDSDRR -0.0517 0.3437 0.9185 SILAC 1 / Biological 1 H/M up
Q6PDG5 TLTDEVNS(ph)PDSDRR -0.0517 0.3437 0.9185 SILAC 1 / Biological 1 H/M up
Q8BKT7 ALFKPPEDS(ph)QDDES(ph)DS(ph)DAEEEQTTKR -0.9033 0.7466 1.3601 SILAC 1 / Biological 2 H/M up
Q9JIK5 EIITEEPS(ph)EEEADMPKPK -0.7013 0.4695 0.9921 SILAC 1 / Biological 2 H/M up
Q8CI11 ELS(ph)PEQSTAGKPSDGSSALDR -0.2684 0.7180 0.7632 SILAC 1 / Biological 2 H/M up
Q6ZPE9 ETVVESQSS(ph)QSPS(ph)PKR -0.7283 0.2274 1.2393 SILAC 1 / Biological 2 H/M up
Q61609 EVKSS(ph)PSES(ph)PLMEK -0.9234 0.3680 1.5248 SILAC 1 / Biological 2 H/M up
Q52KE7 GLNLDGTPALSTLGGFS(ph)PAS(ph)KPSSPR -0.7265 0.6103 0.7624 SILAC 1 / Biological 2 H/M up
Q52KE7 GLNLDGTPALSTLGGFS(ph)PAS(ph)KPSSPR -0.6841 0.0933 0.7858 SILAC 1 / Biological 2 H/M up
Q5SSI6 GQLHGS(ph)S(ph)DESEVENEAK -0.0716 0.5993 0.7583 SILAC 1 / Biological 2 H/M up
Q9ERU9 HSTPS(ph)PTKY(ph)SLSPSK -0.2168 0.5594 0.7585 SILAC 1 / Biological 2 H/M up
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Q9ERU9 HSTPS(ph)PTKY(ph)SLSPSK -0.2168 0.5594 0.7585 SILAC 1 / Biological 2 H/M up
Q64337 IALESVGQPEEQMESGNCS(ph)GGDDDWTHLSSK -0.8283 -0.0414 1.2000 SILAC 1 / Biological 2 H/M up
Q64337 KIALESVGQPEEQMESGNCS(ph)GGDDDWTHLSSK -0.7174 0.1442 1.3095 SILAC 1 / Biological 2 H/M up
Q64337 KIALESVGQPEEQMESGNCS(ph)GGDDDWTHLSSK -0.7174 0.1442 1.3095 SILAC 1 / Biological 2 H/M up
Q8R1Q8 KPASVS(ph)PTTPT(ph)SPTEGEAS -0.3553 0.4950 0.8792 SILAC 1 / Biological 2 H/M up
P53986 LKS(ph)KES(ph)LQEAGK -0.2598 0.6188 0.7925 SILAC 1 / Biological 2 H/M up
P53986 LKS(ph)KES(ph)LQEAGK -0.2598 0.6188 0.7925 SILAC 1 / Biological 2 H/M up
Q3UAM3 PSAEQQEPVS(ph)PVVS(ph)PQQS(ph)PPT(ph)SPHTWR -0.1367 0.5994 1.0119 SILAC 1 / Biological 2 H/M up
A2A5R2 QS(ph)LSS(ph)ADNLEPDVQGHQVAAR -0.4000 0.4509 0.7966 SILAC 1 / Biological 2 H/M up
A2A5R2 QSLS(ph)S(ph)ADNLEPDVQGHQVAAR -0.4564 0.5659 0.9747 SILAC 1 / Biological 2 H/M up
A2A5R2 QSLS(ph)S(ph)ADNLEPDVQGHQVAAR -0.5128 0.6810 1.1528 SILAC 1 / Biological 2 H/M up
O35295 RGGGSGGGDES(ph)EGEEVDED -0.2366 0.5886 0.8811 SILAC 1 / Biological 2 H/M up
Q9Z1X4 RPMEEDGEEKS(ph)PSK 0.0860 0.7287 0.7982 SILAC 1 / Biological 2 H/M up
P31750 SGS(ph)PSDNSGAEEMEVSLAKPK -0.0798 0.4603 1.1794 SILAC 1 / Biological 2 H/M up
P31750 SGSPS(ph)DNSGAEEMEVSLAKPK -0.0169 0.4816 1.1264 SILAC 1 / Biological 2 H/M up
Q9JIK5 SNSSDAPGEES(ph)SSETEKEIPVEQK -0.5756 0.2878 1.1418 SILAC 1 / Biological 2 H/M up
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -0.0509 0.7766 0.9886 SILAC 1 / Biological 2 H/M up
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -0.0509 0.7766 0.9886 SILAC 1 / Biological 2 H/M up
Q3UFM5 SRS(ph)S(ph)S(ph)EDDIEQQESHSVESGEK -0.0484 0.7258 0.8942 SILAC 1 / Biological 2 H/M up
Q7TPV4 (ac)AEMKSPTKAEPAT(ph)PAEAAQSDR -0.9639 -0.3308 1.1457 SILAC 2 / Biological 3 H/M up
Q3UJN1 (ac)AESSESLSAS(ph)S(ph)PAR -0.3870 0.2107 0.7563 SILAC 2 / Biological 3 H/M up
Q9DBR0 ADS(ph)DGDLS(ph)ENDDGAGDLRS(ph)GDEEFRGEDDLCDSR -0.9418 -0.1121 0.8953 SILAC 2 / Biological 3 H/M up
Q8BKT7 ALFKPPEDS(ph)QDDESDS(ph)DAEEEQTTKR -0.7365 0.4784 1.6334 SILAC 2 / Biological 3 H/M up
Q52KI8 APQT(ph)SSPPPVRR -0.5666 0.4118 1.1250 SILAC 2 / Biological 3 H/M up
P14873 AS(ph)LSPMDEPVPDS(ph)ESPVEK -0.4779 0.6146 1.8246 SILAC 2 / Biological 3 H/M up
Q8BT07 ATS(ph)PKS(ph)PSAALNDSLVECPK -0.9627 0.0264 1.2675 SILAC 2 / Biological 3 H/M up
Q9CXF4 DDSPTQTLAS(ph)PNACR -0.7869 0.2010 0.9706 SILAC 2 / Biological 3 H/M up
Q9JKV1 DKKDEEEDMS(ph)LD -0.2882 0.2455 0.8931 SILAC 2 / Biological 3 H/M up
Q99KK9 DLS(ph)PQQMVVR -0.4121 0.1163 0.8723 SILAC 2 / Biological 3 H/M up
A2A5R2 ELEKPMQS(ph)KPQSPVIQAT(ph)AGSPK -0.2151 0.5246 1.1888 SILAC 2 / Biological 3 H/M up
Q8CI11 ELS(ph)PEQSTAGKPSDGSSALDR -0.6200 0.4028 1.2021 SILAC 2 / Biological 3 H/M up
Q3UMF0 EQTAS(ph)APATPLVSK -0.0548 0.6331 0.8577 SILAC 2 / Biological 3 H/M up
Q6ZQH8 GAPSS(ph)PAAGVLPS(ph)PQGK -0.6163 -0.0027 0.9392 SILAC 2 / Biological 3 H/M up
Q6ZQH8 GAPSS(ph)PAAGVLPS(ph)PQGK -0.6152 -0.0027 0.9586 SILAC 2 / Biological 3 H/M up
P70698 GCRLS(ph)PR -0.8077 0.0106 0.9067 SILAC 2 / Biological 3 H/M up
Q99LL5 GKLQEEGGS(ph)EEEEAGNPSEDGMQSGPTQAPPR -0.4259 0.3095 0.8461 SILAC 2 / Biological 3 H/M up
O08539 GNKS(ph)PSPPPDGSPAATPEIR -0.3780 0.3278 1.0233 SILAC 2 / Biological 3 H/M up
O08539 GNKSPS(ph)PPPDGSPAATPEIR -0.4349 0.3495 0.9435 SILAC 2 / Biological 3 H/M up
Q9Z0U1 GSYGS(ph)DPEEEEYR -0.0937 0.1474 0.8475 SILAC 2 / Biological 3 H/M up
Q3THK3 GTS(ph)RPGTPS(ph)AEAASTSSTLR -0.9599 -0.2206 1.0272 SILAC 2 / Biological 3 H/M up
Q3THK3 GTS(ph)RPGTPS(ph)AEAASTSSTLR -0.8562 -0.0641 1.0272 SILAC 2 / Biological 3 H/M up
Q3THK3 GTSRPGT(ph)PS(ph)AEAASTSSTLR -0.6354 -0.2026 0.8630 SILAC 2 / Biological 3 H/M up
Q61990 GVT(ph)IPYRPKPSSSPVIFAGGQDR 0.3210 0.1793 0.7617 SILAC 2 / Biological 3 H/M up
Q61990 GVTIPYRPKPS(ph)SSPVIFAGGQDR 0.1184 -0.4535 1.1003 SILAC 2 / Biological 3 H/M up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR -0.5226 0.3885 1.3417 SILAC 2 / Biological 3 H/M up
A2A5R2 HLDVDLDRQS(ph)LS(ph)SIDR -0.5677 0.3529 1.4055 SILAC 2 / Biological 3 H/M up
A2A5R2 HLDVDLDRQS(ph)LSS(ph)IDR -0.7424 0.4241 1.4191 SILAC 2 / Biological 3 H/M up
Q8C2Q7 HTGPNS(ph)PDTANDGFVR -0.7056 0.0473 0.9379 SILAC 2 / Biological 3 H/M up
Q8C2Q7 HTGPNSPDT(ph)ANDGFVR -0.6136 -0.1472 0.8111 SILAC 2 / Biological 3 H/M up
Q6ZPV6 IKT(ph)EPS(ph)SPLSDPSDIIR -0.0798 0.6412 0.8600 SILAC 2 / Biological 3 H/M up
Q5U4B1 KDS(ph)EEGEESFSSVQDDLSK -0.1552 0.6564 0.8659 SILAC 2 / Biological 3 H/M up
Q8VDD5 KGT(ph)GDCSDEEVDGKADGADAK -0.4292 0.0141 0.9644 SILAC 2 / Biological 3 H/M up
Q76KJ5 KGTDASS(ph)DTQEAVNR -0.4991 0.0532 0.8700 SILAC 2 / Biological 3 H/M up
Q99L45 KKDAS(ph)DDLDDLNFFNQK -0.6072 -0.0432 0.9813 SILAC 2 / Biological 3 H/M up
Q8CI11 KLEVS(ph)PGDEQSNVETR -0.6434 0.5017 1.1863 SILAC 2 / Biological 3 H/M up
Q6ZQ58 KNTFTAWS(ph)EEDS(ph)DYEIDDR -0.6020 0.0540 1.0669 SILAC 2 / Biological 3 H/M up
Q8R1Q8 KPASVSPTT(ph)PT(ph)SPTEGEAS -0.9363 -0.0407 0.9985 SILAC 2 / Biological 3 H/M up
Q8R1Q8 KPASVSPTT(ph)PTS(ph)PTEGEAS -0.9363 -0.0407 1.1752 SILAC 2 / Biological 3 H/M up
Q8R1Q8 KPASVSPTTPTS(ph)PTEGEAS -0.3897 0.1942 0.9308 SILAC 2 / Biological 3 H/M up
Q6P9Q4 KPVS(ph)PPS(ph)PK 0.0818 0.7866 1.0781 SILAC 2 / Biological 3 H/M up
Q6P9Q4 KPVS(ph)PPS(ph)PK 0.0818 0.7866 1.0781 SILAC 2 / Biological 3 H/M up
Q9Z0U1 KVQVAPLQGS(ph)PPLSHDDR -0.3441 0.4272 1.1741 SILAC 2 / Biological 3 H/M up
Q80Y44 LASGDGDEEQDEET(ph)EDEETEDHLGK -0.3129 0.3266 0.8729 SILAC 2 / Biological 3 H/M up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.1922 0.0306 1.2759 SILAC 2 / Biological 3 H/M up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.1922 0.0306 1.2759 SILAC 2 / Biological 3 H/M up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.1922 0.0306 1.2759 SILAC 2 / Biological 3 H/M up
Q924Z4 LIEDERS(ph)DREET(ph)ES(ph)S(ph)EGEETAAGAGAK -0.1922 0.0306 1.2759 SILAC 2 / Biological 3 H/M up
Q8K019 LKELFDYS(ph)PPLHK 0.1862 0.5146 1.0847 SILAC 2 / Biological 3 H/M up
P53986 LKS(ph)KES(ph)LQEAGK -0.4138 -0.0032 0.8594 SILAC 2 / Biological 3 H/M up
A6PW47 LLS(ph)SSDDDANILSSPTDR -0.9535 -0.0453 1.0279 SILAC 2 / Biological 3 H/M up
B2RRE7 LQRPKEESS(ph)EDENEVS(ph)NILR -0.8392 0.5598 1.6293 SILAC 2 / Biological 3 H/M up
P14873 LSPAKS(ph)PSLSPSPPS(ph)PIEK 0.3699 0.3665 0.7742 SILAC 2 / Biological 3 H/M up
P58501 LVREDENDAS(ph)DDEDDDEKR 0.1358 0.7062 1.0356 SILAC 2 / Biological 3 H/M up
Q68EF0 NKS(ph)TSSAMGGSHQDLSVIQPIVK -0.9857 -0.8377 0.7899 SILAC 2 / Biological 3 H/M up
Q8R2M2 NMPNVS(ph)DSETY(ph)NSDFDDSS(ph)PR -0.2177 0.4392 0.8611 SILAC 2 / Biological 3 H/M up
Q8R2M2 NMPNVSDSETY(ph)NSDFDDS(ph)SPR -0.2507 0.5710 0.8924 SILAC 2 / Biological 3 H/M up
Q8R2M2 NMPNVSDSETY(ph)NSDFDDSS(ph)PR -0.2078 0.4392 0.8611 SILAC 2 / Biological 3 H/M up
Q3UZ39 NMPSLSAATLASLGGTS(ph)SR -0.5160 0.2822 1.4037 SILAC 2 / Biological 3 H/M up
Q3UZ39 NMPSLSAATLASLGGTSS(ph)R -0.4751 0.5427 1.3155 SILAC 2 / Biological 3 H/M up
Q60875 QILSQS(ph)T(ph)DSLNMR -0.4470 0.2958 0.8050 SILAC 2 / Biological 3 H/M up
Q60875 QILSQS(ph)TDS(ph)LNMR -0.6540 0.3026 1.1289 SILAC 2 / Biological 3 H/M up
Q3UZ39 QNKVEEDGPTEGPTDILDQNS(ph)PQCEDR -0.9832 0.4501 1.8697 SILAC 2 / Biological 3 H/M up
Q99JF8 QSNAS(ph)SDVEVEEKETNVSKEDTDQEEK -0.3457 0.6744 1.3272 SILAC 2 / Biological 3 H/M up
Q04692 RNDS(ph)S(ph)ELEDLSELEDLK -0.1237 0.5073 0.7873 SILAC 2 / Biological 3 H/M up
Q04692 RNDS(ph)S(ph)ELEDLSELEDLK -0.0801 0.4650 0.9074 SILAC 2 / Biological 3 H/M up
Q04692 RNDSS(ph)ELEDLS(ph)ELEDLKDAK -0.1721 0.4890 1.0091 SILAC 2 / Biological 3 H/M up
Q810V0 RPDGEEEDEEDIDLFEDIDS(ph)DES(ph)EGGLFGR -0.3933 0.2517 0.7881 SILAC 2 / Biological 3 H/M up
Q810V0 RPDGEEEDEEDIDLFEDIDS(ph)DES(ph)EGGLFGR -0.3933 0.2517 0.7881 SILAC 2 / Biological 3 H/M up
A5D6P2 RSS(ph)DPALTGLSTSVSDNNFSSEEPSR -0.2111 0.5040 0.9274 SILAC 2 / Biological 3 H/M up
Q8BTI8 RSS(ph)S(ph)ELSPEVVEK -0.8676 -0.1596 1.0707 SILAC 2 / Biological 3 H/M up
Q58A65 S(ph)ASQSSLDKLDQELK -0.9678 0.4889 1.3817 SILAC 2 / Biological 3 H/M up
P58871 S(ph)PPSGSQSLLEGIMTASSSK 0.0816 0.6839 0.7989 SILAC 2 / Biological 3 H/M up
Q9Z2B9 S(ph)S(ph)PPLRTPDVLESSGPAVR -0.6875 0.5540 0.8346 SILAC 2 / Biological 3 H/M up
Q9Z2B9 S(ph)S(ph)PPLRTPDVLESSGPAVR -0.6875 0.5540 0.8346 SILAC 2 / Biological 3 H/M up
Q9D1F4 S(ph)SDEENGPPSS(ph)PDLDR -0.0124 0.6844 0.7612 SILAC 2 / Biological 3 H/M up
Q5SNZ0 S(ph)SSQENLLDEVMK -0.4867 0.5102 0.9131 SILAC 2 / Biological 3 H/M up
Q58A65 SASQSS(ph)LDKLDQELK -0.1680 0.5510 0.7638 SILAC 2 / Biological 3 H/M up
Q8K019 SATSGDIWPGLSAYDNS(ph)PR 0.0206 0.4641 0.8536 SILAC 2 / Biological 3 H/M up
P31750 SGSPS(ph)DNS(ph)GAEEMEVSLAKPK -0.4849 0.2262 0.7534 SILAC 2 / Biological 3 H/M up
P27546 SKVGST(ph)ENIK -0.3606 -0.6415 1.5630 SILAC 2 / Biological 3 H/M up
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -0.7583 0.6667 1.6184 SILAC 2 / Biological 3 H/M up
Q9EPU0 SQIDVALS(ph)QDS(ph)TYQGER -0.7583 0.6667 1.6184 SILAC 2 / Biological 3 H/M up
Q5BL07 SQS(ph)GEDESLNQPGPIK 0.1164 0.7549 0.8686 SILAC 2 / Biological 3 H/M up
Q3UFM5 SRS(ph)S(ph)S(ph)EDDIEQQESHSVESGEK -0.5253 0.4332 1.0111 SILAC 2 / Biological 3 H/M up
Q3UFM5 SRS(ph)S(ph)S(ph)EDDIEQQESHSVESGEK -0.5253 0.4332 1.0111 SILAC 2 / Biological 3 H/M up
Q3UFM5 SRS(ph)S(ph)S(ph)EDDIEQQESHSVESGEK -0.5253 0.4332 1.0111 SILAC 2 / Biological 3 H/M up
Q5SXY1 SSKGSPT(ph)GSS(ph)PNNASELSLASLTEK -0.4593 0.1314 0.8858 SILAC 2 / Biological 3 H/M up
Q5SXY1 SSKGSPT(ph)GSS(ph)PNNASELSLASLTEK -0.4593 0.1314 0.8858 SILAC 2 / Biological 3 H/M up
Q3UHX0 SSMS(ph)DDDVDS(ph)EDELK -0.5169 -0.0296 0.7851 SILAC 2 / Biological 3 H/M up
Q9QZQ1 SSPNVANQPPS(ph)PGGK -0.2621 0.6235 1.0547 SILAC 2 / Biological 3 H/M up
Q9Z2B9 SSPPLRT(ph)PDVLESS(ph)GPAVR -0.6589 0.2733 1.4248 SILAC 2 / Biological 3 H/M up
Q6PDG5 TLTDEVNS(ph)PDSDRR -0.6287 -0.0146 0.8995 SILAC 2 / Biological 3 H/M up
O54774 VDIITEEMPENALPS(ph)DEDDKDPNDPYR -0.3050 0.6283 1.2629 SILAC 2 / Biological 3 H/M up
P35486 YGMGT(ph)SVER -0.8951 0.7035 1.4608 SILAC 2 / Biological 3 H/M up
P43277 (ac)S(ph)ETAPAAPAAPAPVEKT(ph)PVKK -0.3173 0.4440 1.0329 SILAC 3 / Biological 4 H/M up
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P43274 (ac)SETAPAAPAAPAPAEKT(ph)PVK -0.0748 0.7658 1.4272 SILAC 3 / Biological 4 H/M up
P43277 (ac)SETAPAAPAAPAPVEKT(ph)PVK -0.1962 0.6814 1.3997 SILAC 3 / Biological 4 H/M up
P43276 (ac)SETAPAETAAPAPVEKS(ph)PAK -0.2461 0.2733 0.7864 SILAC 3 / Biological 4 H/M up
Q80TM9 ACSDS(ph)LES(ph)IPAGQVASDDLR -0.6373 0.6997 1.1345 SILAC 3 / Biological 4 H/M up
Q80TM9 ACSDS(ph)LES(ph)IPAGQVASDDLR -0.6373 0.6997 1.1345 SILAC 3 / Biological 4 H/M up
Q6Y7W8 AGAEASEEVPQTSLSSARPGT(ph)PSDHQPQEATQFER -0.8047 0.3183 0.9266 SILAC 3 / Biological 4 H/M up
Q9CXF4 ANDQDS(ph)LISGILR -0.3302 0.5487 1.4582 SILAC 3 / Biological 4 H/M up
Q8BT07 ATS(ph)PKSPS(ph)AALNDSLVECPK -0.6335 -0.0930 2.5617 SILAC 3 / Biological 4 H/M up
Q3UGP0 DLYRPLS(ph)SDDLDSVGDSV -0.7072 0.4432 1.1550 SILAC 3 / Biological 4 H/M up
P27546 DMS(ph)PLPESEVTLGK -0.9327 0.0796 0.8716 SILAC 3 / Biological 4 H/M up
Q04692 DTVIIVS(ph)EPSEDEES(ph)HDLPSVTR -0.4813 0.3570 0.8043 SILAC 3 / Biological 4 H/M up
Q99P72 ESET(ph)FSDSS(ph)PIEIIDEFPTFVSAK -0.5128 0.1887 2.1928 SILAC 3 / Biological 4 H/M up
Q61609 EVKSS(ph)PS(ph)ESPLMEK -0.6201 0.6587 1.1216 SILAC 3 / Biological 4 H/M up
Q61609 EVKSS(ph)PS(ph)ESPLMEK -0.6072 0.6378 1.1610 SILAC 3 / Biological 4 H/M up
P58871 GEGVSQVGPGT(ph)PPAPESPR -0.4090 0.5228 0.8795 SILAC 3 / Biological 4 H/M up
P09405 GFGFVDFNS(ph)EEDAK -0.1828 0.6411 1.1446 SILAC 3 / Biological 4 H/M up
Q9Z1D1 GIPLPT(ph)GDTSPEPELLPGDPLPPPK -0.4099 0.1386 2.1894 SILAC 3 / Biological 4 H/M up
Q9Z1D1 GIPLPTGDT(ph)SPEPELLPGDPLPPPK -0.9604 0.6281 1.2614 SILAC 3 / Biological 4 H/M up
Q9Z1D1 GIPLPTGDTS(ph)PEPELLPGDPLPPPK -0.3795 0.5069 0.9998 SILAC 3 / Biological 4 H/M up
Q52KE7 GLNLDGTPALSTLGGFS(ph)PAS(ph)KPS(ph)SPR -0.8154 0.0242 0.8663 SILAC 3 / Biological 4 H/M up
Q52KE7 GLNLDGTPALSTLGGFS(ph)PAS(ph)KPSS(ph)PR -0.8154 0.0242 0.8663 SILAC 3 / Biological 4 H/M up
Q8CHU3 GS(ph)SQPNLSTSYSEQEYGK -0.6241 0.4300 1.4345 SILAC 3 / Biological 4 H/M up
Q542W3 HLEELEEKS(ph)AT(ph)PPPAEPASLPQEPPKPR -0.7103 0.2571 1.1186 SILAC 3 / Biological 4 H/M up
Q3V1V3 IDSEIS(ph)PK -0.8774 0.0131 0.7620 SILAC 3 / Biological 4 H/M up
Q8BTM8 IPEISIQDMTAQVTS(ph)PSGK -0.5171 0.2804 1.2862 SILAC 3 / Biological 4 H/M up
Q9ESV0 KAQAVS(ph)EEEEEEEGQSSSPK -0.6238 0.2006 0.8979 SILAC 3 / Biological 4 H/M up
P43277 KAS(ph)GPPVSELITK -0.3030 0.7548 1.3351 SILAC 3 / Biological 4 H/M up
Q52KI8 KPPAPPS(ph)PVQSQS(ph)PSTNWSPAVPAK -0.7346 -0.0478 1.0984 SILAC 3 / Biological 4 H/M up
Q52KI8 KPPAPPS(ph)PVQSQSPS(ph)TNWSPAVPAKK -0.8922 0.0963 0.9751 SILAC 3 / Biological 4 H/M up
O08784 KSAEPLANTVLAS(ph)ET(ph)EEEGNAQALGPTAK -0.6539 0.7342 1.6037 SILAC 3 / Biological 4 H/M up
Q9QZQ1 LFS(ph)QGQDVSDKVK -0.5049 0.0883 0.8684 SILAC 3 / Biological 4 H/M up
P53986 LKS(ph)KESLQEAGK -0.6777 0.3978 0.9243 SILAC 3 / Biological 4 H/M up
Q3UH27 LLHEDLDES(ph)DDDVDEK -0.8945 0.7771 1.4790 SILAC 3 / Biological 4 H/M up
Q3UQN2 LSGINEIPRPFS(ph)PPVTSNT(ph)SPPPTAPLAR -0.8196 0.5900 1.2307 SILAC 3 / Biological 4 H/M up
Q6A006 LSTT(ph)PS(ph)PTNS(ph)LHEDGVDDFRR -0.4745 0.3658 0.7544 SILAC 3 / Biological 4 H/M up
P58501 LVREDENDAS(ph)DDEDDDEKR -0.7261 0.0183 0.9562 SILAC 3 / Biological 4 H/M up
A2BH40 NPQMPQYTSPQPGSALS(ph)PR -0.6311 0.3157 2.5793 SILAC 3 / Biological 4 H/M up
Q6ZQ58 NTFTAWSEEDS(ph)DYEIDDRDVNK -0.8278 -0.2982 0.9018 SILAC 3 / Biological 4 H/M up
A2A5R2 QSLSS(ph)ADNLEPDVQGHQVAAR -0.5307 0.4784 0.9781 SILAC 3 / Biological 4 H/M up
P28028 RDS(ph)SDDWEIPDGQITVGQR -0.8119 -0.0660 0.8647 SILAC 3 / Biological 4 H/M up
Q5SSI6 RRTS(ph)S(ph)DDES(ph)EEDEDDLLQR -0.9140 0.0485 0.9363 SILAC 3 / Biological 4 H/M up
A2AJI0 RSS(ph)QPS(ph)PTTVPASDSPPAK -0.1391 0.5330 0.8785 SILAC 3 / Biological 4 H/M up
A2AJI0 RSS(ph)QPSPT(ph)TVPASDSPPAK -0.4384 0.5584 1.1686 SILAC 3 / Biological 4 H/M up
A2AJI0 RSS(ph)QPSPT(ph)TVPASDSPPAK -0.4384 0.5584 1.1686 SILAC 3 / Biological 4 H/M up
Q3UK83 S(ph)ESPKEPEQLR -0.6963 -0.0554 0.8420 SILAC 3 / Biological 4 H/M up
Q8CI95 S(ph)FSLASSGNSPISQR -0.5307 0.0996 0.8867 SILAC 3 / Biological 4 H/M up
Q9D1F4 S(ph)LPVSVPVWAFK -0.9896 -0.1486 0.8640 SILAC 3 / Biological 4 H/M up
P58871 S(ph)PPSGSQSLLEGIMTASSSK -0.9657 -0.2282 0.7775 SILAC 3 / Biological 4 H/M up
Q52KI8 S(ph)PS(ph)PAPPPPPPPPPPR -0.7923 0.6467 1.2660 SILAC 3 / Biological 4 H/M up
Q52KI8 S(ph)PS(ph)PAPPPPPPPPPPR -0.7923 0.6467 1.2660 SILAC 3 / Biological 4 H/M up
Q9CT10 S(ph)PSESAEETHTLEEK -0.3627 0.2361 0.8220 SILAC 3 / Biological 4 H/M up
Q3UFM5 S(ph)RSSS(ph)EDDIEQQES(ph)HSVESGEK -0.6554 0.1941 0.9074 SILAC 3 / Biological 4 H/M up
Q3UFM5 S(ph)RSSS(ph)EDDIEQQES(ph)HSVESGEK -0.6554 0.1941 0.9074 SILAC 3 / Biological 4 H/M up
Q61609 S(ph)SPSES(ph)PLMEK -0.5112 0.7478 1.2029 SILAC 3 / Biological 4 H/M up
Q9Z0U1 SFS(ph)PEER -0.3578 0.4126 1.2633 SILAC 3 / Biological 4 H/M up
Q9JIK5 SNSSDAPGEES(ph)SSET(ph)EKEIPVEQK -0.8286 0.0181 1.0028 SILAC 3 / Biological 4 H/M up
P58871 SPPS(ph)GSQSLLEGIMTASSSK -0.9215 -0.2744 0.8116 SILAC 3 / Biological 4 H/M up
Q80WJ7 SQEPISNDQKVS(ph)DDDKEK -0.4061 0.5971 0.9968 SILAC 3 / Biological 4 H/M up
Q61609 SS(ph)PSES(ph)PLMEK -0.5721 0.7137 1.1425 SILAC 3 / Biological 4 H/M up
Q9D1F4 SSDEENGPPS(ph)SPDLDR -0.8821 0.2186 1.0345 SILAC 3 / Biological 4 H/M up
Q5SXY1 SSKGS(ph)PT(ph)GSSPNNASELSLASLTEK -0.8309 0.1481 0.9731 SILAC 3 / Biological 4 H/M up
Q9QZQ1 SSPNVANQPPS(ph)PGGK -0.5612 0.4981 1.2954 SILAC 3 / Biological 4 H/M up
Q80X50 STSAPQMSPGSSDNQSS(ph)SPQPAQQK -0.8433 0.0896 0.9742 SILAC 3 / Biological 4 H/M up
Q6ZQ61 SY(ph)SPDGKESPS(ph)DKK -0.9191 0.2056 0.9700 SILAC 3 / Biological 4 H/M up
Q7TSC1 TAS(ph)ETRS(ph)EGSEY(ph)EEIPK -0.9400 0.0749 0.7942 SILAC 3 / Biological 4 H/M up
Q7M739 TDGFAEAIHS(ph)PQVAGVPR -0.6196 0.4656 1.1478 SILAC 3 / Biological 4 H/M up
Q9D1F4 TEARSS(ph)DEENGPPSS(ph)PDLDR -0.6470 0.3781 1.0038 SILAC 3 / Biological 4 H/M up
Q9QYB5 TEEVLSPDGS(ph)PSKS(ph)PSK -0.6511 0.6360 1.0395 SILAC 3 / Biological 4 H/M up
Q9QYB5 TEEVLSPDGS(ph)PSKS(ph)PSK -0.6511 0.6360 1.0395 SILAC 3 / Biological 4 H/M up
P14873 TPGDFNYAYQKPENAAGS(ph)PDEEDYDYESQEK -0.5344 0.4387 1.1693 SILAC 3 / Biological 4 H/M up
O08784 TVVHLLSGKS(ph)PK -0.4358 0.4262 0.9588 SILAC 3 / Biological 4 H/M up
Q921K9 VDSSTNSSPS(ph)PQQSESLS(ph)PAHTSDFR -0.4390 0.7085 0.9615 SILAC 3 / Biological 4 H/M up
P08775 Y(ph)SPTSPTYSPTS(ph)PVYTPTS(ph)PK -0.6225 0.8033 1.2863 SILAC 3 / Biological 4 H/M up
Q68G59 YGLQDS(ph)DEEEEEHPPK -0.5396 0.4942 0.9667 SILAC 3 / Biological 4 H/M up
P35822 YLCEGT(ph)ESPYQT(ph)GQLHPAIR -0.3183 0.6012 0.7785 SILAC 3 / Biological 4 H/M up
P35822 YLCEGTES(ph)PYQT(ph)GQLHPAIR -0.3183 0.5144 0.7785 SILAC 3 / Biological 4 H/M up
P08775 YS(ph)PTSPTYSPTSPVYTPTS(ph)PK -0.8969 0.7791 1.6337 SILAC 3 / Biological 4 H/M up
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